Sentence,class,file
"http://dx.doi.org/10.1016/j.cell.2008.10.01 8 Batchelder, E.M., and D. Yarar.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1091/mbc.E09-12-104 4 Belkin, A.M., N.I.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi   .org/10.1016/0014-5793(86)80505- 1 Bellve, K.D., D. Leonard, C. Standley, L.M.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1074/jbc.M51137020 0 Bitoun, M., S. Maugenre, P.Y.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1038/ng165 7 Blake, D.J., A. Weir, S.E.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1074/jbc.R20002120 0 Esk, C., C.Y.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1083/jcb.20090805 7 Ezratty, E.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1038/ncb126 2 Ezratty, E.J., C. Bertaux, E.E.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1083/   jcb.20090405 4 Fausser, J.L., E. Ungewickell, J.V.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
http://dx.doi.org/10.1034/ j.1600-0854.2000.010208.,Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1083/   jcb.84.3.56 0 Heuser, J.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1034/j.1600-0854.2000   .010704. x Kaisto, T., P. Rahkila, V. Marjomäki, R.G.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1016/0014-4827(90)90009- Y Kierdaszuk, B., M. Berdynski, J. Karolczak, M.J. Redowicz, C. Zekanowski,  and A.M. Kaminska.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi   .org/10.1016/j.nmd.2012.12.00 7 Kirchhausen, T. 1999.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.15.1.70 5 Legendre-Guillemin, V., M. Metzler, J.F.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1074/jbc.M40843020 0 Merisko, E.M. 1985.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1038/ncb83 7 Pardo, J.V., J.D.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1083/jcb.97.4.108 1 Pearse, B.M., and M.S.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1146/annurev.cb.06.110190   .00105 5 Pumplin, D.W. 1989.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1083/jcb.109.2.73 9 Pumplin, D.W., and R.J. Bloch.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1002/cm.97015020 8 Quach, N.L., and T.A.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1016/j.ydbio.2005.12.04 0 Randazzo, D., E. Giacomello, S. Lorenzini, D. Rossi, E. Pierantozzi, B. Blaauw,  C. Reggiani, S. Lange, A.K.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1083/jcb.20120511 8Bonazzi, M., L. Vasudevan, A. Mallet, M. Sachse, A. Sartori, M.C.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1111/tra.1200 9 Braun, V., C. Deschamps, G. Raposo, P. Benaroch, A. Benmerah, P. Chavrier,  and F. Niedergang.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1091/mbc.E07-04-039 2 Brodsky, F.M.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"101:2055– 2062. http://dx.doi.org/10.1083/jcb.101.6.205 5 Brodsky, F.M.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1146/   annurev-cellbio-101011-15571 6 Burridge, K., J. Feramisco, and S. Blose.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1242/jcs.07883 2 Chen, C.Y., and F.M.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1074/jbc.M40845420 0 Chiesi, M., M.M.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1016/j.cub.2011.05.04 8 Cowling, B.S., A. Toussaint, L. Amoasii, P. Koebel, A.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1016/j.ajpath.2011.01.05 4 De Deyne, P.G., A. O’Neill, W.G.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi .org/10.1083/   jcb.99.6.226 8 Dugast, M., H. Toussaint, C. Dousset, and P. Benaroch.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1074/jbc.M50135720 0 Durieux, A.C., A. Vignaud, B. Prudhon, M.T.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1093/hmg/ddq41 3 Engqvist-Goldstein, A.E., R.A. Warren, M.M.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1083/jcb.20010608 9 Engqvist-Goldstein, A.E., C.X.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1091/mbc.E03-09-063 9 Epstein, H.F., and D.A.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
http://dx.doi.org/   10.1126/science.199812 0,Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1038/sj.gt.330276 6 Saffarian, S., E. Cocucci, and T. Kirchhausen.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1371/journal.pbio.100019 1 Sanger, J.W., P. Chowrashi, N.C. Shaner, S. Spalthoff, J. Wang, N.L.",Non-OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/   10.1097/00003086-200210001-0001 8 Schafer, D.A., S.A. Weed, D. Binns, A.V.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/ 10.1016/S0960-9822   (02)01228- 9 Schook, W., S. Puszkin, W. Bloom, C. Ores, and S. Kochwa.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi   .org/10.1083/jcb.101.1.24 0 Sonnemann, K.J., D.P.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.07.00 1 Towler, M.C., P.A.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
"http://dx.doi.org/10.1091/ mbc.E04-03-024 9 Veiga, E., J.A.",OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
http://dx.doi.org/10.1016/j.ch om.2007.10.00 1,OADS,/arxiv_data1/oa_pdf/bd/9a/JCB_201309096.PMC4018784.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
http://dx.doi.org/10.1046/ j.1432-1327.1999.00563.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/   S0014-5793(01)02361- 4 Fujie, S., H. Maita, H. Ariga, and K. Matsumoto.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1248/bpb.32.179 5 Goodwin, A.E., and B.U.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/S0968-0004(03)00057- 4 Hynes, R.O.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1126/science.117600 9 Inman, G.J., F.J. Nicolás, J.F.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1124/mol.62.1.6 5 Kang, J.S., C. Liu, and R. Derynck.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/   10.1016/j.tcb.2009.05.00 8 Kim, S.-H., J. Turnbull, and S. Guimond.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1530/   JOE- 10-037 7 Koenig, A., C. Mueller, C. Hasel, G. Adler, and A. Menke.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"66:4662– 4671. http://dx.doi.org/10.1158/0008-5472.CAN-05-280 4 Lethias, C., F. Elefteriou, G. Parsiegla, J.Y .",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1074/jbc.M01021020 0 Lethias, C., A. Carisey, J. Comte, C. Cluzel, and J.-Y.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/j.febslet.2006.10.03 7 Mao, J.R., G. Taylor, W.B.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1038/ng85 0 Margaron, Y ., L. Bostan, J.-Y .",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"147:87– 91. http://dx.doi.org/10.1016/j.bpc.2009.12.01 1 Massagué, J.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1038/nrm343 4 Matsumoto, K., N. Takayama, J. Ohnishi, E. Ohnishi, Y .",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
http://dx.doi   .org/10.1046/j.1365-2443.2001.00482.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi   .org/10.1089/dna.2006.25.44 8 Miyazono, K., A. Olofsson, P. Colosetti, and C.H.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1242/dev   .03033 8 Mu, D., S. Cambier, L. Fjellbirkeland, J.L.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1083/   jcb.20010910 0 Munger, J.S., X. Huang, H. Kawakatsu, M.J.D.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80545- 0were determined by the comparative threshold cycle method with the  Gapdh  gene as a reference (Schmittgen and Livak, 2008).",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201308031/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/j.matbio.2009.08.00 7 Asano, Y., H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"52:2897– 2905. http://dx.doi.org/10.1002/art.2124 6 Asano, Y., H. Ihn, K. Yamane, M. Jinnin, and K. Tamaki.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi   .org/10.2353/ajpath.2006.04130 6 Brown, P.D., L.M.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10   .3109/0897719900903750 0 Crawford, S.E., V. Stellmach, J.E.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)81460- 9 DeMaio, L., S.T.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"226:633– 644. http://dx.doi.org/10.1002/path.301 6 Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1093/emboj/17.11.309 1 Egging, D., F. van den Berkmortel, G. Taylor, J. Bristow, and J. Schalkwijk.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi   .org/10.1007/s00403-006-0706- 9 Egging, D.F., A.C.T.M.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
http://dx.doi.org/10.1111/j.1742-4658.2007.05671.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1038/nrm226 2 Thiery, J.P., H. Acloque, R.Y.J.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/j.cell.2009.11.00 7 Thuault, S., U. Valcourt, M. Petersen, G. Manfioletti, C.-H. Heldin, and A.  Moustakas.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"283:33437– 33446. http://dx.doi.org/10.1074/jbc.M80201620 0 Tiger, C.F., F. Fougerousse, G. Grundström, T. Velling, and D. Gullberg.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1006/dbio.2001.036 3 Tucker, R.P., K. Drabikowski, J.F.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"6:60.  http://dx.doi.org/10.1186/1471-2148-6-6 0 Valcourt, U., M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1091/mbc.E04-08-065 8 Valcourt, U., S. Thuault, K. Pardali, C.-H. Heldin, and A. Moustakas.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/j.molonc.2007.02.00 2 Veit, G., U. Hansen, D.R.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi   .org/10.1074/jbc.M60314720 0 Velling, T., M. Kusche-Gullberg, T. Sejersen, and D. Gullberg.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
http://dx.doi.org/10   .1046/j.1523-1747.2002.01641.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1016/j.ejcb.2008.01.01 2 Wipff, P.-J., D.B.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1083/jcb.20070404 2 Wu, M.Y ., and C.S.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10   .1016/j.devcel.2009.02.01 2 Zhang, W.-M., J. Kapyla, J.S.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1074/jbc   .M21031320 0 Zweers, M.C., I.M.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
http://dx.doi.org/10.1111/j.0022-202X.2004.22401.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1091/mbc.3.2.18 1 Nakao, A., M. Afrakhte, A. Morén, T. Nakayama, J.L.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1038/3936 9 Nelson, C.M., and M.J. Bissell.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1146/ annurev.cellbio.22.010305.10431 5 Nunes, I., P.E.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1083/jcb.136.5.115 1 Piek, E., A. Moustakas, A. Kurisaki, C.H.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10   .1128/MCB.00041-0 7 Ribeiro, S.M., M. Poczatek, S. Schultz-Cherry, M. Villain, and J.E.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
http://dx.doi   .org/10.1111/j.1523-1755.2005.00607.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1056/NEJMoa00293 9 Schmittgen, T.D., and K.J.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/   10.1038/nprot.2008.7 3 Schultz-Cherry, S., and J.E.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"1993.122:1149) http://dx.doi.org/10   .1083/jcb.122.4.92 3 Schultz-Cherry, S., J. Lawler, and J.E.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1091/ mbc.E05-12-112 3 Shintani, Y ., Y .",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1083/jcb.20070813 7 Shintani, Y., M. Maeda, N. Chaika, K.R.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1165/rcmb.2007-0071O C Stegemann, C., A. Didangelos, J. Barallobre-Barreiro, S.R.",Non-OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/10.1161/CIRCGENETICS.112.96445 2 Taipale, J., K. Miyazono, C.H.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
"http://dx.doi.org/   10.1083/jcb.124.1.17 1 Taipale, J., J. Saharinen, K. Hedman, and J. Keski-Oja.",OADS,/arxiv_data1/oa_pdf/3c/32/JCB_201308031.PMC4018787.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/j.cell   .2008.09.04 6 Gardner, M.K., B.L.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1007/s12195-010-0101- 7 Gay, G., T. Courtheoux, C. Reyes, S. Tournier, and Y .",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/nature0413 2 Gupta, M.L., Jr., P. Carvalho, D.M.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/j.cub   .2012.02.00 6 Howard, J.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"6:1619– 1640. http://dx.doi.org/10.1091/mbc.6.12.161 9 Jaqaman, K., D. Loerke, M. Mettlen, H. Kuwata, S. Grinstein, S.L.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/nmeth   .1237 Kamiti, M., and T.G.M.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1021/ma950173 m Kawamura, R., L.H.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.20091008 5 Khodjakov, A., and J. Pines.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/ncb1010-91 9 Levi, V ., Q. Ruan, M. Plutz, A.S. Belmont, and E. Gratton.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1529/   biophysj.105.06667 0 Maddox, P.S., K.S.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/7135 7 Maddox, P., A.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.20030108 8 Maresca, T.J., and E.D.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.20080813 0 Marshall, W.F., A.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/S0960-9822(06)00412- X Marshall, W.F., J.F.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00180- 4 Michalet, X.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"82:041914. http://dx.doi.org/   10.1103/PhysRevE.82.04191 4 Mickey, B., and J. Howard.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb   .130.4.90 9 Moser, S.C., and J.R. Swedlow.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1007/s10577-011-9198- 3 Nicklas, R.B.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.43.1.4 0whose spindle lengths matched those observed in top2-4  cells or in WT  cells and by varying , creating simulated images, and finding the best  match to the experimental data.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/nature0959 4 Alexander, S.P., and C.L.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.113.4.80 5 Asbury, C.L., D.R.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/ncb180 9 Bouck, D.C., and K. Bloom.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10   .1016/j.cub.2007.03.03 3 Burnette, D.T., P. Sengupta, Y. Dai, J. Lippincott-Schwartz, and B. Kachar.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"1:130– 136. http://dx.doi.org/10.1038/3504007 2 Chacón, J.M., and M.K.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1007/s12195-013-0306- 7 Cimini, D., L.A. Cameron, and E.D.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/j.cub.2004.11.02 9 DiNardo, S., K. V oelkel, and R. Sternglanz.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1073/   pnas.81.9.261 6 Dumont, S., and T.J. Mitchison.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/j.cub.2009.07.02 8 Gardner, M.K., C.G.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1091/mbc.E05-04-027 5 Gardner, M.K., D.C. Bouck, L.V .",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"152:1255– 1266. http://dx.doi.org/10.1083/jcb.152.6.125 5 Pearson, C.G., P.S.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1091/mbc   .E03-03-018 0 Pearson, C.G., M.K.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1091/mbc.E06-04-031 2 Poirier, M.G., S. Eroglu, and J.F.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1091/mbc.E08-11-112 7 Rieder, C.L., and E.D.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.124.3.22 3 Rieder, C.L., and E.D.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10   .1016/S0962-8924(98)01299- 9 Skibbens, R.V ., and E.D.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1006/   excr.1997.369 1 Skibbens, R.V., V.P.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"122:859– 875. http://dx.doi.org/10.1083/jcb.122.4.85 9 Skibbens, R.V., C.L.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi   .org/10.1016/S0006-3495(03)75087- 5 Stephens, A.D., R.A. Haggerty, P.A.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1083/jcb.20120816 3 Svoboda, K., C.F.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1038/365721a 0 Thomann, D., D.R.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
http://dx.doi.org/   10.1046/j.1365-2818.2002.01066.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/   j.cub.2010.01.03 4 Verdaasdonk, J.S., P.A.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1016/j.molcel.2013   .10.02 1 Volkov, V.A., A.V.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10.1073/   pnas.130582111 0 Warsi, T.H., M.S.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"http://dx.doi.org/10   .1091/mbc.E08-05-054 7 Waters, J.C., R.V.",OADS,/arxiv_data1/oa_pdf/64/7d/JCB_201312024.PMC4018788.pdf
"These  causal connections provide the most rigorous evidence to  date that a niche signal can promote stem cell mainte - nance principally by stimulating stem cell proliferation.Coupling of Hedgehog and Hippo pathways promotes  stem cell maintenance by stimulating proliferation Jianhua Huang and Daniel Kalderon Department of Biological Sciences, Columbia University, New York, NY 10027 © 2014 Huang and Kalderon  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi - cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201309141/DC1.,Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/   j.cub.2012.12.02 1 Ling, C., Y. Zheng, F. Yin, J. Yu, J. Huang, Y. Hong, S. Wu, and D. Pan.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1006/meth.2001.126 2 Losick, V .P., L.X.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.06.01 8 Margolis, J., and A. Spradling.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi   .org/10.4161/spmg.2176 3 Méthot, N., and K. Basler.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)80592- 9 Neto-Silva, R.M., S. de Beco, and L.A. Johnston.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi   .org/10.1016/j.devcel.2010.09.00 9 Nystul, T., and A. Spradling.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.stem.2007.07.00 9 Nystul, T., and A. Spradling.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"184:503– 515. http://dx.doi.org/10.1534/genetics.109.10953 8 Orford, K.W., and D.T.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1038/nrg226 9 Pan, D. 2010.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.09.01 1 Pietras, E.M., M.R.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1083/   jcb.20110213 1 Polesello, C., S. Huelsmann, N.H. Brown, and N. Tapon.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"16:2459– 2465. http://dx.doi.org/10.1016/j.cub.2006.10.06 0 Ramos, A., and F.D.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/   j.tcb.2012.04.00 6 Rauskolb, C., G. Pan, B.V. Reddy, H. Oh, and K.D.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi   .org/10.1371/journal.pbio.100062 4 Ren, F., B. Wang, T. Yue, E.Y.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi   .org/10.1073/pnas.101275910 7 Rossi, L., K.K.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.stem.2012.08.00 6 Schlegelmilch, K., M. Mohseni, O. Kirak, J. Pruszak, J.R. Rodriguez, D. Zhou,  B.T.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.cell.2011   .02.03 1 Shaw, R.L., A. Kohlmaier, C. Polesello, C. Veelken, B.A.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1242/dev.05250 6 Simons, B.D., and H. Clevers.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/   j.cell.2011.05.03 3 Song, X., and T. Xie.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1242/dev.0052 4 Staley, B.K., and K.D.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1002/   dvdy.2272 3 Tapon, N., K.F.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1038/nature1169 3 Boggiano, J.C., and R.G.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.03.01 3 Cai, J., N. Zhang, Y .",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/   10.1101/gad.197881 0 Chakkalakal, J.V., K.M.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.gde.2011.07.00 8 Clevers, H. 2013.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.cell.2013.07.00 4 Escudero, L.M., S.Y .",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1242/   dev.0086 9 Fernandez-L, A., P.A.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.12.01 1 Hartman, T.R., D. Zinshteyn, H.K.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/   10.1083/jcb.20100714 2 Hsu, Y.C., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1038/nrm327 2 Huang, J., S. Wu, J. Barrera, K. Matthews, and D. Pan.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.cell.2005.06.00 7 Irvine, K.D.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/   j.semcdb.2012.04.00 6 Jansson, L., and J. Larsson.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1371/journal.pone.003201 3 Kagey, J.D., J.A.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.mod.2012.05.00 7 Karpowicz, P., J. Perez, and N. Perrimon.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1242/dev.06048 3 Kirilly, D., E.P.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.devcel   .2005.09.01 3 Kirilly, D., S. Wang, and T. Xie.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1242/dev.0249 2 Lee, T., and L. Luo.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00824- 3 Tyler, D.M., W. Li, N. Zhuo, B. Pellock, and N.E.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi   .org/10.1534/genetics.106.06192 9 Vied, C., and D. Kalderon.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1242/dev.03532 9 Vied, C., A. Reilein, N.S.",Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"23:836– 848. http://dx.doi.org/10.1016/j.devcel.2012.09.01 0 Wang, Z.A., and D. Kalderon.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/   10.1073/pnas.090927210 6 Wang, Z.A., J. Huang, and D. Kalderon.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"3:769. http://dx.doi.org/10.1038/ncomms176 5 Wu, S., Y. Liu, Y. Zheng, J. Dong, and D. Pan.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/   j.devcel.2008.01.00 7 Wu, X., P.S.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi.org/10.1016/j.cell.2011   .09.05 3 Yu, J., Y. Zheng, J. Dong, S. Klusza, W.M.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
"http://dx.doi   .org/10.1016/j.devcel.2009.12.01 2 Zhao, B., K. Tumaneng, and K.L.",OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
http://dx.doi.org/10.1038/ncb230 3,Non-OADS,/arxiv_data1/oa_pdf/2e/c9/JCB_201309141.PMC4018789.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/78/db/JHRS-7-2.PMC4018793.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3y sr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/78/db/JHRS-7-2.PMC4018793.pdf
Available from: http://www.eshre.eu/Press-Room/Press-releases/ Press-releases-ESHRE-2012/5-million-babies.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/JHRS-7-25.PMC4018794.pdf
Available from: http://www.business.outlookindia.com/printarticle.,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/JHRS-7-25.PMC4018794.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/26/cb/JHRS-7-30.PMC4018795.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/54/be/JHRS-7-34.PMC4018796.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.How to cite this article: Dejoie, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/57/49/srep04941.PMC4018809.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4941 | DOI: 10.1038/srep04941 9",Non-OADS,/arxiv_data1/oa_pdf/57/49/srep04941.PMC4018809.pdf
29. http://www.bbraun.com/cps/rde/xchg/bbraun-com/hs.xsl/products.,Non-OADS,/arxiv_data1/oa_pdf/ec/10/srep04945.PMC4018936.pdf
"48. http://www.google.co.in/patents/US4678660 [accessed May 13th, 2014] 49.",Non-OADS,/arxiv_data1/oa_pdf/ec/10/srep04945.PMC4018936.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ec/10/srep04945.PMC4018936.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4945 | DOI: 10.1038/srep04945 9",Non-OADS,/arxiv_data1/oa_pdf/ec/10/srep04945.PMC4018936.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/98/1c/srep04948.PMC4018964.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4948 | DOI: 10.1038/srep04948 7",Non-OADS,/arxiv_data1/oa_pdf/98/1c/srep04948.PMC4018964.pdf
"Received: November 6, 2013 Accepted: January 30, 2014*Corresponding author: e-mail: karai@cc.tuat.ac.jp ©2014Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.",Non-OADS,/arxiv_data1/oa_pdf/b6/ae/jes-25-007.PMC4019198.pdf
e-mail: drdzenda@yahoo.com ©2014Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.,Non-OADS,/arxiv_data1/oa_pdf/47/db/jes-25-001.PMC4019199.pdf
"Three out of the seven were treated  Received: September 27, 2013 Accepted: January 22, 2014*Corresponding author: e-mail: osawa@cc.miyazaki-u.ac.jp ©2014Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.",Non-OADS,/arxiv_data1/oa_pdf/0b/4a/jes-25-023.PMC4019200.pdf
"It requires the development of a model from the anatomical data obtained from other horses, the data from  a motion analysis system, and the ground reaction force  Received: December 17, 2013 Accepted: February 18, 2014*Corresponding author: e-mail: taka@center.equinst.go.jp ©2014Japanese Society of Equine Science This is an open-access article distributed under the terms of the  Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.J.",Non-OADS,/arxiv_data1/oa_pdf/03/ef/jes-25-015.PMC4019201.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4809 | DOI: 10.1038/srep04809 6",Non-OADS,/arxiv_data1/oa_pdf/8e/50/srep04809.PMC4019232.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/da/1545.PMC4019486.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/26/f8/1549.PMC4019487.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/42/df/1560.PMC4019488.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/89/4c/1574.PMC4019489.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b6/0d/1586.PMC4019490.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/77/df/1594.PMC4019491.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/57/8d/1608.PMC4019492.pdf
"To further examine the link between Mon1 phosphorylation and  membrane association, we generated Mon1 mutants that elimi - nated Yck3 phosphorylation sites (NetPhos, www.cbs.dtu.dk   /services/NetPhos/; Scansite, http://scansite.mit.edu/).",OADS,/arxiv_data1/oa_pdf/57/8d/1608.PMC4019492.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/82/1620.PMC4019493.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b8/b0/1629.PMC4019494.pdf
Colocalization was examined  using Colocalization Finder in ImageJ (http://rsbweb.nih.gov/ij   /plugins/colocalization-finder.html).,OADS,/arxiv_data1/oa_pdf/b8/b0/1629.PMC4019494.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cb/4f/1641.PMC4019495.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/72/1a/1653.PMC4019496.pdf
"C. albicans  sequence was obtained from the  Saccharomyces  Genome Database (http://yeastgenome.org), and alignment was done with ClustalW2 (Goujon et al.,   2007).",OADS,/arxiv_data1/oa_pdf/72/1a/1653.PMC4019496.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8d/f6/1666.PMC4019497.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c5/79/1676.PMC4019498.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/fb/1686.PMC4019499.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/37/mder-7-115.PMC4019608.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 115–124Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  115REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S4406 3MRi-conditional pacemakers: current perspectives António M Ferreira1,2 Francisco Costa2 António Tralhão2 Hugo Marques3 Nuno Cardim1 Pedro Adragão1,2 1Cardiology Department,    Hospital da Luz,  2Cardiology   Department, Hospital Santa Cruz-   CHLO,  3Radiology Department,    Hospital da Luz, Lisbon, Portugal Correspondence: António M Ferreira   Hospital da Luz, Avenida Lusíada  100,  1500-650 Lisbon, Portugal   Tel +351 21 710  4400  Fax +351 21 710  4409  Email antonio.ferreira@hospitaldaluz.p tAbstract:  Use of both magnetic resonance imaging (MRI) and pacing devices has undergone  remarkable growth in recent years, and it is estimated that the majority of patients with pace - makers will need an MRI during their lifetime.",Non-OADS,/arxiv_data1/oa_pdf/96/37/mder-7-115.PMC4019608.pdf
Available from: http://www.imvinfo.com/index.asp?sec=   mkt&sub=omkt&pag=def&pid=9063 1.,OADS,/arxiv_data1/oa_pdf/96/37/mder-7-115.PMC4019608.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/96/37/mder-7-115.PMC4019608.pdf
Available  from: http://clinicaltrials.gov/show/NCT0176116 2.,Non-OADS,/arxiv_data1/oa_pdf/96/37/mder-7-115.PMC4019608.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/e3/mder-7-125.PMC4019609.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2014:7 125–130Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  125Sho Rt REpo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/MDER.S6357 5Minimally invasive arthrodesis for chronic   sacroiliac joint dysfunction using the SImmetry   SI Joint Fusion system Larry E Miller1,2 Jon E Block2 1Miller Scientific Consulting, Inc.,    Asheville, NC, USA;  2the Jon Block   Group, San Francisco, CA, USA Correspondence: Jon E Block   the Jon Block Group,  2210 Jackson Street,   Suite 401, San Francisco, CA, USA   tel +1 415 775 7947  Fax +1 415 928 0765  Email jonblock@jonblockgroup.co mAbstract:  Chronic sacroiliac (SI) joint-related low back pain (LBP) is a common, yet under- diagnosed and undertreated condition due to difficulties in accurate diagnosis and highly variable  treatment practices.",Non-OADS,/arxiv_data1/oa_pdf/66/e3/mder-7-125.PMC4019609.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/66/e3/mder-7-125.PMC4019609.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/9a/ijn-9-2179.PMC4019610.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2179–2190International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2179OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6093 7Efficiently engineered cell sheet using a complex  of polyethylenimine–alginate nanocomposites plus  bone morphogenetic protein  2 gene to promote  new bone formation han Jin1 Kai Zhang2 Chunyan Qiao1 Anliang Yuan1 Daowei li1 Liang Zhao1 Ce Shi1 Xiaowei Xu1 Shilei Ni1 Changyu Zheng3 Xiaohua Liu4 Bai Yang2 Hongchen Sun1 1Department of Pathology, School  of Stomatology, Jilin University,  Changchun, People’s Republic of  China;  2State Key Laboratory of  supramolecular structure and  Materials, College of Chemistry,  Jilin University, Changchun, People’s  Republic of China;  3Molecular  Physiology and Therapeutics Branch,  National Institute of Dental and  Craniofacial Research, National  Institutes of Health, Bethesda, MD,  USA;  4Department of Biomedical  Sciences, Texas A&M University  Baylor College of Dentistry, Dallas,  TX, USA Correspondence: Hongchen Sun   Department of Pathology, School   of Stomatology, Jilin University,   1500 Qinghua Road, Changchun  130021,   People’s Republic of China   Tel +86 431 8879 6012  Fax +86 431 8897 5348  email hcsun@jlu.edu.c nAbstract:  Regeneration of large bone defects is a common clinical problem.",Non-OADS,/arxiv_data1/oa_pdf/1a/9a/ijn-9-2179.PMC4019610.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1a/9a/ijn-9-2179.PMC4019610.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/9a/ijn-9-2179.PMC4019610.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 671–682Patient Preference and Adherence Background:  Many female breast cancer (FBC) patients take Chinese herbal medicine (CHM)  and Western medication (WM) concurrently in Taiwan.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
"Keywords:  drug utilization patterns, complementary and alternative medicine, pharmacoep- idemiology Introduction Breast cancer is the most frequent cancer and the chief cause of cancer death among   women in Taiwan and worldwide.1,2 The mortality rate of breast cancer has declined, due  to the popularly used screening mammography and the greater use of adjuvant therapies in  recent decades.3 Modern systemic adjuvant treatments, including cytotoxic chem  otherapy,  endocrine therapy, and anti-human epidermal growth factor receptor 2 (anti-HER2)  therapy, should be selected based on the tumor size, grade, hormone-receptor content,   and HER2 status.4–7 However, treatment-related adverse effects, such as fatigue,  nausea,  Dove press submit your manuscript | www.dovepress.co m Dove press  671OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6128 0Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Wang et al Running head recto: Coprescription of CHM and WM among female breast cancer patients DOI: http://dx.doi.org/10.2147/PPA.S61280 coprescription of chinese herbal medicine   and Western medication among female patients  with breast cancer in Taiwan: analysis of national  insurance claims Bih-ru Wang1,2,* Yuh-lih chang1,2,* Tzeng-Ji chen3,4 Jen-hwey chiu5,6 Jing chong Wu7 Min-shan Wu1 chia-lin chou1 Yueh-ching chou1,2,8 1Department of Pharmacy, Taipei  Veterans general hospital, Taipei,   Taiwan; 2Department and institute  of Pharmacology, national Yang-Ming  University, Taipei, Taiwan; 3Department  of Family Medicine, Taipei Veterans  general hospital, Taipei, Taiwan;   4institute of hospital and health care  Administration, national Yang-Ming  University, Taipei, Taiwan; 5Division  of general surgery, Department  of surgery, Taipei Veterans general  hospital, Taipei, Taiwan; 6institute  of Traditional Medicine, school  of Medicine, national Yang-Ming  University, Taipei, Taiwan; 7Traditional  Medicine center, Kaohsiung Veterans  general hospital, Kaohsiung, Taiwan;   8college of Pharmacy, Taipei Medical  University, Taipei, Taiwan *These authors contributed equally to  this work correspondence: Yueh-ching chou   Department of Pharmacy, Taipei Veterans  general hospital, number 201,   section 2, shipai road, Beitou District,   Taipei, 112, Taiwan   T el +886 228 757 694   Fax +886 228 757 643   email ycchou@vghtpe.gov.t w",Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Materials and methods Data resources The NHI program in Taiwan was implemented in 1995 and  has covered approximately 98% of the total population of Tai - wan in recent years ( http://nhird.nhri.org.tw/en/index.ht m).,OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Available from: http://www.hpa.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Available  from: http://nhird.nhri.org.tw /.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Available from: http://www.nhi.gov.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Available from:  http://www.mohw.gov.tw/cht/DOCMAP/DM1.aspx?f_list_no=499.,OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
Available from:  http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c9/a2/ppa-8-671.PMC4019611.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 457–468International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  457OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6049 8risk of pneumonia with inhaled corticosteroid/ long-acting β2 agonist therapy in chronic  obstructive pulmonary disease: a cluster analysis rachael l Disantostefano1 hao li1 David hinds1 Dmitry V galkin2 David B rubin2 1Worldwide epidemiology,   2respiratory Clinical Development,   glaxosmithKline, research Triangle  Park, Durham, nC, Usa Correspondence: rachael l  Disantostefano   glaxosmithKline, 5 Moore Drive,  research Triangle Park, Durham,  nC 27709 Usa   Tel +1 919 483 2100  email rachael.l.disantostefano@gsk.co mBackground:  Pneumonia poses a significant risk in patients with moderate to severe chronic  obstructive pulmonary disease but data are limited on the disease phenotypes most susceptible  to pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
"Cluster analysis methodology Cluster analysis was employed using the R-package and  RPART procedure ( http://www.r-project.or g/).8,9 Using  the data-driven recursive partitioning algorithm to model  time to first or severe pneumonia, the decision tree created  clusters of patients based on the intent-to-treat population  such that differences in risk of pneumonia were maximized  among clusters.",OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
"Available from: http://www.fda.gov/downloads/ AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ Pulmonary- AllergyDrugs Advisory Committee/UCM347931.pd f. Accessed  January  6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
"Available from: http://cran.r-project.org/ web/packages/rpart/index.htm l. Accessed January  6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/ab/copd-9-457.PMC4019612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/bf/vhrm-10-279.PMC4019613.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 279–290Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  279ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5869 4effects of extended-release niacin/laropiprant,  simvastatin, and the combination on correlations  between apolipoprotein B, lDl cholesterol, and  non-HDl cholesterol in patients with dyslipidemia Michel Farnier1 erluo chen2 amy O Johnson-levonas2 christine Mccrary sisk2 Yale B Mitchel2 1Point Médical, Dijon, France;   2Merck and co, inc., Whitehouse  station, nJ, Usa correspondence: Michel Farnier   Point Médical, Rond Point de la nation,  21000 Dijon, France   Tel +33 3 8070 3813   Fax +33 3 8070 3814   email michelfarnier@nerim.ne tBackground:  Statins modify correlations between apolipoprotein B (apoB) and low-density  lipoprotein cholesterol (LDL-C) and apoB and non-high-density lipoprotein cholesterol (non- HDL-C); however, it is not known whether niacin-based therapies have similar effects.",Non-OADS,/arxiv_data1/oa_pdf/4b/bf/vhrm-10-279.PMC4019613.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/4b/bf/vhrm-10-279.PMC4019613.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/bf/vhrm-10-279.PMC4019613.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/e0/ijn-9-1957.PMC4019614.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1957–1965International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1957OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5704 8Preparation and properties of Bsa-loaded  microspheres based on multi-(amino acid)  copolymer for protein delivery Xingtao chen1 guoyu lv1 Jue Zhang2 songchao Tang2 Y onggang Yan1 Zhaoying Wu2 Jiacan su2 Jie Wei2 1college of Physical science and  T echnology, sichuan University,   chengdu, 2Key laboratory for  Ultrafine Materials of Ministry of  education, east china University of  science and T echnology, shanghai,   People’s republic of china correspondence: guoyu lv;   Yonggang Yan   college of Physical science and  Technology, sichuan University, chengdu  610041, People’s republic of china   email nic7505@263.ne t;  biomaterbone@163.co mAbstract:  A multi-(amino acid) copolymer (MAC) based on ω-aminocaproic acid,  γ-aminobutyric acid, L-alanine, L-lysine, L-glutamate, and hydroxyproline was synthetized, and  MAC microspheres encapsulating bovine serum albumin (BSA) were prepared by a double- emulsion solvent extraction method.",Non-OADS,/arxiv_data1/oa_pdf/36/e0/ijn-9-1957.PMC4019614.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/36/e0/ijn-9-1957.PMC4019614.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/e0/ijn-9-1957.PMC4019614.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/f8/ndt-10-727.PMC4019615.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 727–756Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  727OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5840 5More female patients and fewer stimuli per session  are associated with the short-term antidepressant  properties of repetitive transcranial magnetic  stimulation (rTMs): a meta-analysis of 54 sham- controlled studies published between 1997–2013 Karina Karolina Kedzior1 Valeriya azorina2 sarah Kim reitz1 1school of humanities and social  sciences, 2school of engineering and  science, Jacobs University Bremen,   Bremen, germany correspondence: Karina Kedzior De   santis   school of humanities and social sciences,   Jacobs University Bremen, campus ring 1,  Bremen, 28759, germany   Tel + 49 421 200 3011   Fax + 49 421 200 3303   email kkedzior@graduate.uwa.edu.a uBackground:  Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal  cortex (DLPFC) appears to have short-term antidepressant properties.",Non-OADS,/arxiv_data1/oa_pdf/e1/f8/ndt-10-727.PMC4019615.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e1/f8/ndt-10-727.PMC4019615.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/f8/ndt-10-727.PMC4019615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/cb/ott-7-667.PMC4019616.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 667–677OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  667Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6271 7Transcriptional targeting of sphingosine-1-   phosphate receptor s1P2 by epigallocatechin-   3-gallate prevents sphingosine-1-phosphate-   mediated signaling in macrophage-differentiated   hl-60 promyelomonocytic leukemia cells rima chokor sylvie lamy Borhane annabi laboratoire d’Oncologie   Moléculaire, centre de recherche   BiOM eD, Département de chimie,    Université du Québec à Montréal,    Montreal, Qc , canada correspondence: Borhane annabi   laboratoire d’Oncologie Moléculaire,   Université du Québec à Montréal,   cP 8888, succ centre-Ville,   Montréal, Qc, h3c  3P8, canada   Tel +1 514 987 3000 ext  7610  Fax +1 514 987 0246  email annabi.borhane@uqam.c aBackground:  Macrophage chemotaxis followed by blood–brain barrier transendothelial  migration is believed to be associated with inflammation in the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/ott-7-667.PMC4019616.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/db/cb/ott-7-667.PMC4019616.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/cb/ott-7-667.PMC4019616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/12/amep-5-133.PMC4019617.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 133–139Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  133OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5617 6impact of a medical student alcohol intervention   workshop using recovering alcoholics   as simulated patients J Aaron Johnson1 J Paul seale1 sylvia shellenberger1 Mary M Velasquez2 candice Alick1 Katherine T urk3 1Department of Family Medicine,   Medical center of central georgia  and Mercer University school of  Medicine, Macon, gA, 2school of  social Work, University of T exas- Austin, Austin, TX, 3Department  of surgery, University of Alabama- Birmingham, Birmingham, Al, UsA correspondence: J Aaron Johnson   Department of Family Medicine,   Medical center of central georgia   and Mercer University school of   Medicine, 3780 Eisenhower Parkway,   suite 3, Macon, gA 31206, UsA   Tel +1 478 633 5548   Fax +1 478 633 5575   Email j ohnson.aaron@mccg.or gBackground:  Alcohol screening and brief intervention (SBI) reduces drinking among at-risk  drinkers.",Non-OADS,/arxiv_data1/oa_pdf/80/12/amep-5-133.PMC4019617.pdf
Available from: http:// webcache .googleusercontent.com/search?q =cache:http://www.ncjrs.,OADS,/arxiv_data1/oa_pdf/80/12/amep-5-133.PMC4019617.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/80/12/amep-5-133.PMC4019617.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/12/amep-5-133.PMC4019617.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/57/oajsm-5-089.PMC4019618.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 89–98Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  89OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S5350 3Using the power balance model to simulate   cross-country skiing on varying terrain John F Moxnes1 Øyvind Sandbakk2 Kjell hausken3 1Department for Protection,   norwegian Defence research  establishment, Kjeller, norway;   2center for elite Sports research,   Department of neuroscience,   norwegian University of Science  and T echnology, Trondheim, norway;   3Faculty of Social Sciences, University  of Stavanger, Stavanger, norway correspondence: Kjell hausken   Faculty of Social Sciences, University   of Stavanger, 4036 Stavanger, norway   Tel +47 5183 1632   email kjell.hausken@uis.n oAbstract:  The current study adapts the power balance model to simulate cross-country skiing  on varying terrain.",Non-OADS,/arxiv_data1/oa_pdf/34/57/oajsm-5-089.PMC4019618.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/34/57/oajsm-5-089.PMC4019618.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/57/oajsm-5-089.PMC4019618.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 99–103Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  99OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S5800 5Self-reported concussion history: impact   of providing a definition of concussion clifford A robbins1 Daniel h Daneshvar1,2 John D Picano1,3 Brandon e gavett1,4 christine M Baugh1,2 David O riley1 christopher J nowinski1,2,5 Ann c McKee1,2,6–8 robert c cantu1,5,9,10 robert A Stern1,2,8,9 1center for the Study of Traumatic  encephalopathy, 2Department of  neurology, Boston University School  of Medicine, Boston, MA, USA; 3School  of Medicine and Biomedical Sciences,   University of Buffalo, Buffalo, nY, USA;   4Department of Psychology, University  of colorado, colorado Springs,   cO, USA; 5Sports legacy institute,   Waltham MA, USA; 6United States  Department of Veterans Affairs, VA  Boston healthcare System, Boston,   MA, USA; 7Department of Pathology,   8Alzheimer’s Disease center,   9Department of n eurosurgery,   Boston University School of Medicine,   Boston, MA, USA; 10Department of  neurosurgery, emerson hospital,   concord, MA, USA correspondence: robert Stern   Boston University center for the Study  of Traumatic encephalopathy,   72 east concord Street, Suite B-7800,   Boston, MA 02118, USA   Tel +1 617 638 5678   email bobstern@bu.ed uBackground:  In recent years, the understanding of concussion has evolved in the research and  medical communities to include more subtle and transient symptoms.",Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
Open Access Journal of Sports Medicine 2014:5submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 103Self-reported concussion history References  1. http://www.cdc.go v [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
Avail - able from: http://www.nflevolution.com/article/The-Zackery-Lystedt- Law?ref=270.,Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
"Available from: http://www.ncaa.org/ wps/wcm/connect/327bf600424d263692cdd6132e10b8df/Memo +C oncussion +Managment +04292010.pdf?MOD =AJPERES&CACHE ID=327bf600424d263692cdd6132e10b8d f. Accessed February 28,  2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
"Available from: http://www.nfl.com/news/story/09000d5d81990bdf/ article/new-nfl-rules-designed-to-limit-head-injurie s. Accessed   February 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ce/25/oajsm-5-099.PMC4019619.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/46/ppa-8-651.PMC4019620.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 651–659Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  651OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6190 3Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Liu et al Running head recto: Postoperative outcomes in geriatric patients DOI: http://dx.doi.org/10.2147/PPA.S61903 comparative outcomes of peripheral nerve blocks  versus general anesthesia for hip fractures   in geriatric chinese patients Jun le liu1,* Xiao lin Wang1,* Mao Wei gong1,* hai Xing Mai2 shu Jun Pei1 Wei Xiu Yuan1 hong Zhang1 1Anesthesia and Operation center,   chinese People’s liberation Army  general hospital and Medical school  of chinese People’s liberation Army,   Beijing, People’s republic of china;   2Department of Urology, Affiliated  hospital of Academy of Military  Medical sciences, Beijing, People’s  republic of china *These authors contributed equally   to this work correspondence:  hong Zhang   Anesthesia and Operation center,  chinese People’s liberation Army  general hospital, Fuxing road 28th,  Beijing, People’s republic of china   T el +86 10 6693 8051   Fax +86 10 8827 1427   email mazuimao301@sina.cnBackground:  Geriatric patients undergoing hemiarthroplasty for hip fractures have  unacceptably  high rates of postoperative complications and mortality.",Non-OADS,/arxiv_data1/oa_pdf/12/46/ppa-8-651.PMC4019620.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/12/46/ppa-8-651.PMC4019620.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/ppa-8-643.PMC4019621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 643–650Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  643OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6071 5characterizing weekly self-reported  antihypertensive medication nonadherence   across repeated occasions corrine i Voils1,2 heather A King1 Brian neelon1,2 rick h hoyle3 Bryce B reeve4 Matthew l Maciejewski1,2 William s Yancy Jr1,2 1health services research and  Development, Durham Veterans  Affairs Medical center; 2Department  of Medicine, Duke University;   3Department of Psychology and  neuroscience, Duke University;   4Department of health Policy and  Management, University of north  carolina at chapel hill, nc, UsA correspondence: corrine i Voils   Durham Veterans Affairs Medical   center, 508 Fulton st (152),   Durham, nc 27705, UsA   Tel +1 919 286 0411 ext 5196   Fax +1 919 416 5836   email corrine.voils@dm.duke.ed uBackground:  Little is known about weekly variability in medication nonadherence both  between and within persons.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/ppa-8-643.PMC4019621.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/82/b9/ppa-8-643.PMC4019621.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/b9/ppa-8-643.PMC4019621.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 767–776Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  767OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6006 1Nonergot dopamine-receptor agonists for  treating Parkinson’s disease – a network   meta-analysis Kristian Thorlund1,2,4 Ping Wu3,4 eric Druyts3,4 shawn eapen3,4 edward J Mills2–4 1Department of clinical epidemiology  and Biostatistics, McMaster University,   hamilton, ON, canada;  2stanford  Prevention research center, stanford  University, stanford, ca, Usa;   3Faculty of health sciences, University  of Ottawa, Ottawa, ON, canada;   4redwood Outcomes, Vancouver, Bc ,   canada correspondence: Kristian Thorlund   Department of clinical epidemiology   and Biostatistics, McMaster University,   1280 Main street West, hamilton,   ON l8s  4K1, canada   email thorluk@mcmaster.c aObjective:  To compare the efficacy of the three nonergot dopamine-receptor agonists (DAs)  pramipexole, ropinirole, and rotigotine for the treatment of early and advanced Parkinson’ s  disease (PD).",Non-OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
Available from: http://www.nice.org.uk/CG035 .,Non-OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
Statistics on Parkinson’ s. Available  from: http://www.pdf.org/en/parkinson_statistics .,OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
"Available from:  http://www.nicedsu.org.uk/TSD2%20General%20meta%20analy - sis%20corrected%2015April2014.pd f. Accessed March  19, 2011.",Non-OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/f9/ndt-10-767.PMC4019622.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/ndt-10-757.PMC4019623.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 757–765Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  757OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5996 8effects of quetiapine and olanzapine in patients  with psychosis and violent behavior: a pilot  randomized, open-label, comparative study gabriella gobbi1,2 stefano comai1 guy Debonnel1,2,† 1Neurobiological Psychiatric Unit,   Department of Psychiatry, Mc gill  University and Mc gill University  health center,  2institut Philippe Pinel,   Department of Psychiatry, Université  de Montréal, Montréal, Qc , canada †guy Debonnel passed away on  November 4,  2006 correspondence: gabriella gobbi   Neurobiological Psychiatry Unit,  Department of Psychiatry, Mcgill  University,  1033 av Des Pins Ouest,  Montréal, Qc, canada   Tel +1 514 398 1290  Fax +1 514 398 4866  email gabriella.gobbi@mcgill.c aObjective:  Patients suffering from psychosis are more likely than the general population to  commit aggressive acts, but the therapeutics of aggressive behavior are still a matter of debate.",Non-OADS,/arxiv_data1/oa_pdf/c5/22/ndt-10-757.PMC4019623.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c5/22/ndt-10-757.PMC4019623.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/22/ndt-10-757.PMC4019623.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 765–770Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  765OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5783 2Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Khatri et al Running head recto: Telehealth-based versus clinic-based group CBT for depression and anxiety DOI: http://dx.doi.org/10.2147/CIA.S57832 nasreen Khatri elsa Marziali Illia Tchernikov nancy shepherd rotman research Institute,    T oronto, On , Canada Correspondence: nasreen Khatri rotman research Institute, Baycrest,  room 714,  3560 Bathurst street, T oronto,  On, Canada M6A 2e1 T el +1 416 785 2500 extension 3515 Fax +1 416 785 2862 email nkhatri@research.baycrest.or gBackground:  The primary objective of this pilot study was to demonstrate reliable adherence  to a group cognitive behavioral (CBT) therapy protocol when delivered using on-line video  conferencing as compared with face-to-face delivery of group CBT.",Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
Available from:  http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
Available from: http://admin.nice.org.uk/nicemedia/ live/11478/32491/32491.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
Available  from: http://summaries.cochrane.org/CD009028/therapist-delivered- distance-  cognitive-behavioural-therapy-for-anxiety-disorders-in-adults.,Non-OADS,/arxiv_data1/oa_pdf/1c/10/cia-9-765.PMC4019624.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/40/ijn-9-2167.PMC4019625.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2167–2178International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2167OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6017 8Folate receptor-targeted liposomes enhanced   the antitumor potency of imatinib through   the combination of active targeting   and molecular targeting Peng Ye1,2 Wendian Zhang1 Tan Yang1 Yao lu1 Miao lu1 Y ongkang gai1 Xiang Ma1 guangya Xiang1 1school of Pharmacy, Tongji Medical  college, huazhong University of  science and T echnology, Wuhan,   People’s republic of china;   2Department of Pharmacy, Wuhan  University, renmin hospital, Wuhan,   People’s republic of china correspondence: Xiang Ma;   guangya Xiang   school of Pharmacy, Tongji Medical  college, huazhong University of science  and Technology, 13 hangkong road,  Wuhan, People’s republic of china   Tel +86 27 836 92793   Fax +86 27 836 92793   email xiangma@hust.edu.c n;  gyxiang1968@hotmail.co mPurpose:  Imatinib inhibits platelet-derived growth factor receptor (PDGFR), and evidence  shows that PDGFR participates in the development and progression of cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/d3/40/ijn-9-2167.PMC4019625.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d3/40/ijn-9-2167.PMC4019625.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/40/ijn-9-2167.PMC4019625.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/9e/idr-7-117.PMC4019626.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 117–127Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  117RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S3963 9Staphylococcus aureus  – antimicrobial resistance  and the immunocompromised child J Chase McNeil Department of Pediatrics, Section   of Infectious Diseases, Baylor College  of Medicine, Houston, TX, USA Correspondence: J Chase McNeil   Department of Pediatrics, Section of  Infectious Diseases, Baylor College of  Medicine,  1102 Bates St, Suite  1150,  Houston, TX  77030, USA   Tel +1 832 824 4330  email j m140109@bcm.tmc.ed uAbstract:  Children with immunocompromising conditions represent a unique group for the  acquisition of antimicrobial resistant infections due to their frequent encounters with the health  care system, need for empiric antimicrobials, and immune dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/bc/9e/idr-7-117.PMC4019626.pdf
Available from: http://aidsinfo.nih.gov/ guidelines .,Non-OADS,/arxiv_data1/oa_pdf/bc/9e/idr-7-117.PMC4019626.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/bc/9e/idr-7-117.PMC4019626.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/9e/idr-7-117.PMC4019626.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/ndt-10-723.PMC4019627.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 723–726Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  723EDiT orialopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5967 6Psychiatry 2050: from younger   psychiatrists’ perspective Tariq Mahmood Hassan Wasif Habib Mir Nadeem Mazhar Tariq Munshi Department of Psychiatry, Queen’s  University, Kingston, oN, Canada Correspondence: Tariq Mahmood Hassan   Providence Care Mental Health Services,  752 King Street West, Kingston, ontario,  K7l 4X3, Canada   Email hassant@queensu.c aThere have been various opinion pieces on predicting the future of psychiatry and  addressing its different domains.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/ndt-10-723.PMC4019627.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/ndt-10-723.PMC4019627.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/ndt-10-723.PMC4019627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/1f/opth-8-875.PMC4019628.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 875–882Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  875Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5993 2Prospective unmasked randomized evaluation   of the istent inject® versus two ocular   hypotensive agents in patients with primary   open-angle glaucoma antonio M Fea1 Jose i Belda2 Marek Rękas3 anselm Jünemann4 lydia Chang5 luis Pablo6 lilit Voskanyan7 l Jay Katz8 1Università degli studi di T orino,   Clinica Oculistica, T orino, italy;   2hospital T orrevieja salud,   UTe, servicio de Oftalmologia,   alicante, spain; 3Military institute  of Medicine, Department of  Ophthalmology, Warsaw, Poland;   4Universitätsaugenklinik, erlangen,   germany; 5hinchingbrooke hospital  nhs  Trust and Moorfields Bedford  hospital nhs Trust, United Kingdom;   6hospital Universitario Miguel servet,   servicio Oftalmologico, Zaragoza,   spain; 7sV Malayan Ophthalmological  Center, Yerevan, armenia; 8Wills eye  institute, Jefferson Medical College,   Philadelphia, P a, Usa Correspondence: antonia M Fea   Department of Clinical Physiopathology,   eye Clinic, University of T orino,   T orino, italy   email antoniofea@interfree.i tPurpose:  The purpose of this study was to compare outcomes of subjects with open-angle  glaucoma (OAG) not controlled on one medication who underwent either implantation of two  iStent inject® trabecular micro-bypass devices or received medical therapy consisting of a fixed  combination of latanoprost/timolol.",Non-OADS,/arxiv_data1/oa_pdf/1b/1f/opth-8-875.PMC4019628.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1b/1f/opth-8-875.PMC4019628.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/1f/opth-8-875.PMC4019628.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/dd/ijn-9-2137.PMC4019629.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2137–2148International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2137OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5765 6self-assembled or mixed peptide amphiphile  micelles from herpes simplex virus glycoproteins  as potential immunomodulatory treatment antonella accardo1 Mariateresa Vitiello2,3 Diego T esauro1 Marilena galdiero2 emiliana Finamore2 Francesca Martora2 rosalba Mansi1 Paola ringhieri1 giancarlo Morelli1 1Department of Pharmacy,   Interuniversitary centre for research  on Bioactive peptides, cIrPeB,   University of Naples “Federico  II”, Institute of Biostructures and  Bioimaging IBB-cN r, Naples, Italy;   2Department of experimental  Medicine, section of Microbiology  and clinical Microbiology, second  University of Naples, Naples, Italy;   3Department of clinical Pathology  and Transfusion Medicine, University  hospital “ ruggi d’aragona”,    salerno, Italy correspondence: giancarlo Morelli   Department of Pharmacy,  Interuniversitary centre for research on  Bioactive peptides, cIrPeB, University  of Naples “Federico II”, Institute of  Biostructures and Bioimaging IBB- cNr,  Via Mezzocannone 16, 80134 Naples, Italy   Tel +39 081 253 6650   Fax +39 081 253 6642   email gmorelli@unina.i tAbstract:  The use of micelle aggregates formed from peptide amphiphiles (PAs) as potential  synthetic self-adjuvant vaccines to treat Herpes simplex virus (HSV) infection are reported  here.",Non-OADS,/arxiv_data1/oa_pdf/5a/dd/ijn-9-2137.PMC4019629.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5a/dd/ijn-9-2137.PMC4019629.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/dd/ijn-9-2137.PMC4019629.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/06/ceg-7-105.PMC4019630.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 105–110Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  105OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S5936 0autism spectrum disorders in children of parents  with inflammatory bowel disease – a nationwide  cohort study in Denmark ane Birgitte T elén andersen Vera Ehrenstein rune Erichsen Trine Frøslev henrik T oft sørensen Department of Clinical Epidemiology,   aarhus University hospital, aarhus,   Denmark Correspondence: ane Birgitte Telén  andersen   Department of Clinical Epidemiology,  aarhus University hospital, Olof Palmes  allé, 43-45, 8200 aarhus n, Denmark   Tel +11 45 871 68237   Fax +11 45 871 67215   Email abta@dce.au.d kPurpose:  Inflammatory bowel disease (IBD) and autism spectrum disorders (ASD) may share  genetic and environmental risk factors.",Non-OADS,/arxiv_data1/oa_pdf/26/06/ceg-7-105.PMC4019630.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/26/06/ceg-7-105.PMC4019630.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/06/ceg-7-105.PMC4019630.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/ab/ehu096.PMC4019912.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/3a/ehu117.PMC4019913.pdf
"[page 6] [Clinics and Practice 2014; 4:608]http://emedicine.medscape.com/article/ 2085523-overview Accessed: Jan 18, 2014 .",Non-OADS,/arxiv_data1/oa_pdf/9e/b9/cp-2014-1-608.PMC4019919.pdf
"at ,http://arxiv.org/abs/cond-mat/0603132 .. 20.",Non-OADS,/arxiv_data1/oa_pdf/c1/26/srep04964.PMC4019945.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c1/26/srep04964.PMC4019945.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4964 | DOI: 10.1038/srep04964 6",Non-OADS,/arxiv_data1/oa_pdf/c1/26/srep04964.PMC4019945.pdf
"Photovoltaic Geographical Information System (EU-JRC PVGIS, Date of access: 06/02/2014) http://re.jrc.ec.europa.eu/pvgis/apps4/pvest.php 28.",Non-OADS,/arxiv_data1/oa_pdf/87/10/srep04959.PMC4019953.pdf
wrote themanuscript and all authors discussed the results and reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/87/10/srep04959.PMC4019953.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4959 | DOI: 10.1038/srep04959 6",Non-OADS,/arxiv_data1/oa_pdf/87/10/srep04959.PMC4019953.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/82/srep04957.PMC4019954.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4957 | DOI: 10.1038/srep04957 7",Non-OADS,/arxiv_data1/oa_pdf/db/82/srep04957.PMC4019954.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/d7/srep04952.PMC4019955.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Figure 6 |t-dependence of G(t) (left scale; blue line) and of R(F,t)/R(0) (right scale; black/red and full/dashed lines are /C22hv518.9/20 eV and F5 20/5 J/cm2, respectively).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4952 | DOI: 10.1038/srep04952 4",Non-OADS,/arxiv_data1/oa_pdf/b8/d7/srep04952.PMC4019955.pdf
"The encoded AVASTIN DNA information, including the batch number, expiration date, and URL of the Drug Integrity and Supply Chain Security of the U.S. FDA (http://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity), was stored in the DNA-image hybrid code matrix for Version 9 QR code (53 353 modules) using a conventional QR-code generator program (Formtec Design Pro 8), and for ColorZip code (5 35 cells) using a generator program for ColorZip name cards available at http://www.colorzip.co.kr.",OADS,/arxiv_data1/oa_pdf/96/83/srep04879.PMC4019957.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/83/srep04879.PMC4019957.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4879 | DOI: 10.1038/srep04879 6",Non-OADS,/arxiv_data1/oa_pdf/96/83/srep04879.PMC4019957.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/86/65/srep04961.PMC4019958.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4961 | DOI: 10.1038/srep04961 8",Non-OADS,/arxiv_data1/oa_pdf/86/65/srep04961.PMC4019958.pdf
"Worm 3, e28357 (2014) http://dx.doi.org/10.4161/ worm.28357.",Non-OADS,/arxiv_data1/oa_pdf/0e/c1/srep04926.PMC4019968.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/c1/srep04926.PMC4019968.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4926 | DOI: 10.1038/srep04926 6",Non-OADS,/arxiv_data1/oa_pdf/0e/c1/srep04926.PMC4019968.pdf
Available from: http://www.journals.,Non-OADS,/arxiv_data1/oa_pdf/5a/bb/IJNMR-19-113.PMC4020018.pdf
Available from: http://www.who.int/ countries/irn/en/ [Last accessed on 2012 Nov 18].,OADS,/arxiv_data1/oa_pdf/58/5e/IJNMR-19-119.PMC4020019.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK2665/.,Non-OADS,/arxiv_data1/oa_pdf/58/5e/IJNMR-19-119.PMC4020019.pdf
Available from: http://www.merriam‑webster.com/ dictionary/effectiveness [Last accessed on 2012 Oct 9].,OADS,/arxiv_data1/oa_pdf/de/48/IJNMR-19-132.PMC4020021.pdf
Available from: http://www.turner‑white.,Non-OADS,/arxiv_data1/oa_pdf/b9/79/IJNMR-19-145.PMC4020023.pdf
Available from: http://www.oise.utoronto.ca/ CASAE/cnf2003/2003_papers/kenmandefrotCA 03.pdf [Last  accessed on 2012 Nov 1].,Non-OADS,/arxiv_data1/oa_pdf/b9/79/IJNMR-19-145.PMC4020023.pdf
Available from: http://www.qualitative‑research.net/index.php/fqs/ article/viewArticle/1129/2511.,Non-OADS,/arxiv_data1/oa_pdf/b9/79/IJNMR-19-145.PMC4020023.pdf
Available from: http://www.who.int/chp/knowledge/ publications/adherence_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/5a/86/IJNMR-19-159.PMC4020025.pdf
"Available from: http://www.sabteahval.ir/Upload/Modules/ Contents/asset99/13‑89.pdf, [Last accessed on 2013].",OADS,/arxiv_data1/oa_pdf/60/6d/IJNMR-19-168.PMC4020026.pdf
"Washington, DC: Department of Health & Human Services; [updated 2010 June 30; cited 2011 Aug 1]; Available from: http://www.aoa.gov/ AoARoot/Aging_Statistics/index.aspx 2.",OADS,/arxiv_data1/oa_pdf/91/36/nihms447832.PMC4020238.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Role for RasGRP3 in the progression of PCa X Zeng et al 125 &2014 Macmillan Publishers Limited Prostate Cancer and Prostatic Disease (2014), 119 – 125",Non-OADS,/arxiv_data1/oa_pdf/89/32/pcan201351a.PMC4020276.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Prostate Cancer and Prostatic Diseases website (http://www.nature.com/pcan)Association of androgen reduction and PSA change CJ Ryan et al 198 Prostate Cancer and Prostatic Disease (2014), 192 – 198 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9d/f4/pcan20148a.PMC4020277.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdEDITORIAL Naruse http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/84/jdi-5-249.PMC4020325.pdf
http://onlinelibrary.wiley.com/journal/jdi 252 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
"Recently, the newer oral insulin secretagogues, such as, glimepi-REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cancer biology in diabetes ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
http://onlinelibrary.wiley.com/journal/jdi 254 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
Anti-CD26 monoclonal antibody treatment resulted in both in vitro and in vivo antitumor activityREVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cancer biology in diabetes ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
http://onlinelibrary.wiley.com/journal/jdi 256 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
"The role of heparanase in cancer, diabe- tes and in ﬂammation has elevated the importance of developing clinically effective antiheparanase therapies.REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cancer biology in diabetes ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
http://onlinelibrary.wiley.com/journal/jdi 258 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
Eur J Gastroenterol Hepatol 2011; 23: 1127 –1135.REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cancer biology in diabetes ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
http://onlinelibrary.wiley.com/journal/jdi 260 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
Available at http://www.fda.gov/Drugs/ DrugSafety/ucm239376.htm [Accessed 21 October 2011].,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
"Available at http://www.ema.europa.eu/ema/index.jsp?cu rl=pages/news_and_events/ news/2009/11/news_detail_000066.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1 [Accessed 21 October 2011 (30,31)].",Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
Exp Gerontol 2005; 40: 685 –693.REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cancer biology in diabetes ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
http://onlinelibrary.wiley.com/journal/jdi 262 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
Antiangiogenic therapy with anti-vascular endothelial growth factorREVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Cancer biology in diabetes ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
http://onlinelibrary.wiley.com/journal/jdi 264 JD i a b e t e sI n v e s tV o l .5N o .3M a y2 0 1 4 ª2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/a6/jdi-5-251.PMC4020326.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Fujita and Inagaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
3 May 2014 267REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Efﬁcacy of SGLT2 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Fujita and Inagaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
3 May 2014 269REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Efﬁcacy of SGLT2 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Fujita and Inagaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
3 May 2014 271REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Efﬁcacy of SGLT2 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Fujita and Inagaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
Avail able at: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm380829.,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
3 May 2014 273REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Efﬁcacy of SGLT2 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Fujita and Inagaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
from: http://www.fda.gov/down loads/AdvisoryCommittees/ CommitteesMeetingMaterials /Drugs/Endocrinologicand MetabolicDrugsAdvisoryCommittee/UCM262994.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
3 May 2014 275REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Efﬁcacy of SGLT2 inhibitors,Non-OADS,/arxiv_data1/oa_pdf/d8/b1/jdi-5-265.PMC4020327.pdf
3 May 2014 277COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Hepatic GLUT2 on b-cell function,Non-OADS,/arxiv_data1/oa_pdf/1e/70/jdi-5-276.PMC4020328.pdf
3 May 2014 279COMMENTARY http://onlinelibrary.wiley.com/journal/jdi LXR exacerbate insulin sensitivity,Non-OADS,/arxiv_data1/oa_pdf/a1/56/jdi-5-278.PMC4020329.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Ishikawa and Yokote http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a1/56/jdi-5-278.PMC4020329.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/75/77/jdi-5-281.PMC4020330.pdf
Available at http://www.nice.org.uk/nicemedia/live/12165/ 44318/44318.pdf [Accessed 1 January 2013].,Non-OADS,/arxiv_data1/oa_pdf/75/77/jdi-5-281.PMC4020330.pdf
3 May 2014 283COMMENTARY http://onlinelibrary.wiley.com/journal/jdi UKPDS outcomes model 2,Non-OADS,/arxiv_data1/oa_pdf/75/77/jdi-5-281.PMC4020330.pdf
3 May 2014 285COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Hypoglycemia and the brain,Non-OADS,/arxiv_data1/oa_pdf/21/cf/jdi-5-284.PMC4020331.pdf
3 May 2014 287SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Association between SRR and T2DM,Non-OADS,/arxiv_data1/oa_pdf/8d/f7/jdi-5-286.PMC4020332.pdf
All data analyses were carried out using PLINK 1.07 (http://pngu.mgh.,OADS,/arxiv_data1/oa_pdf/8d/f7/jdi-5-286.PMC4020332.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8d/f7/jdi-5-286.PMC4020332.pdf
3 May 2014 289SHORT REPORT http://onlinelibrary.wiley.com/journal/jdi Association between SRR and T2DM,Non-OADS,/arxiv_data1/oa_pdf/8d/f7/jdi-5-286.PMC4020332.pdf
3 May 2014 291ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome and OGTT,Non-OADS,/arxiv_data1/oa_pdf/c0/0e/jdi-5-290.PMC4020333.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/0e/jdi-5-290.PMC4020333.pdf
3 May 2014 293ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome and OGTT,Non-OADS,/arxiv_data1/oa_pdf/c0/0e/jdi-5-290.PMC4020333.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/0e/jdi-5-290.PMC4020333.pdf
3 May 2014 295ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Metabolic syndrome and OGTT,Non-OADS,/arxiv_data1/oa_pdf/c0/0e/jdi-5-290.PMC4020333.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/c0/0e/jdi-5-290.PMC4020333.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
3 May 2014 299ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Serum insulin and colorectal adenoma,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
3 May 2014 301ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Serum insulin and colorectal adenoma,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
3 May 2014 303ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Serum insulin and colorectal adenoma,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/d5/ba/jdi-5-297.PMC4020334.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
3 May 2014 307ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin tolerance test in insulin users,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
3 May 2014 309ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin tolerance test in insulin users,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
3 May 2014 311ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Insulin tolerance test in insulin users,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/82/96/jdi-5-305.PMC4020335.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8f/a2/jdi-5-313.PMC4020336.pdf
3 May 2014 315CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin improves albuminuria,Non-OADS,/arxiv_data1/oa_pdf/8f/a2/jdi-5-313.PMC4020336.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8f/a2/jdi-5-313.PMC4020336.pdf
3 May 2014 317CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin improves albuminuria,Non-OADS,/arxiv_data1/oa_pdf/8f/a2/jdi-5-313.PMC4020336.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/8f/a2/jdi-5-313.PMC4020336.pdf
3 May 2014 319CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Sitagliptin improves albuminuria,Non-OADS,/arxiv_data1/oa_pdf/8f/a2/jdi-5-313.PMC4020336.pdf
3 May 2014 321CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with DPP4i and SU,Non-OADS,/arxiv_data1/oa_pdf/b5/a1/jdi-5-320.PMC4020337.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b5/a1/jdi-5-320.PMC4020337.pdf
3 May 2014 323CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with DPP4i and SU,Non-OADS,/arxiv_data1/oa_pdf/b5/a1/jdi-5-320.PMC4020337.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b5/a1/jdi-5-320.PMC4020337.pdf
3 May 2014 325CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Combination therapy with DPP4i and SU,Non-OADS,/arxiv_data1/oa_pdf/b5/a1/jdi-5-320.PMC4020337.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b5/a1/jdi-5-320.PMC4020337.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/24/8b/jdi-5-327.PMC4020338.pdf
"3 May 2014 329CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Pioglitazone, metformin and chemerin",Non-OADS,/arxiv_data1/oa_pdf/24/8b/jdi-5-327.PMC4020338.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/24/8b/jdi-5-327.PMC4020338.pdf
"3 May 2014 331CLINICAL TRIAL http://onlinelibrary.wiley.com/journal/jdi Pioglitazone, metformin and chemerin",Non-OADS,/arxiv_data1/oa_pdf/24/8b/jdi-5-327.PMC4020338.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/24/8b/jdi-5-327.PMC4020338.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
3 May 2014 335ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Adipokines and microangiopathies in T2DM,Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
3 May 2014 337ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Adipokines and microangiopathies in T2DM,Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
"Available at: http://www.ngsp.org/docs/methods.pdf [accessed 2011, August 10].",Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
3 May 2014 339ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Adipokines and microangiopathies in T2DM,Non-OADS,/arxiv_data1/oa_pdf/f9/0d/jdi-5-333.PMC4020339.pdf
3 May 2014 341ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Evaluation of self-injection reliability,Non-OADS,/arxiv_data1/oa_pdf/aa/21/jdi-5-340.PMC4020340.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/aa/21/jdi-5-340.PMC4020340.pdf
3 May 2014 343ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Evaluation of self-injection reliability,Non-OADS,/arxiv_data1/oa_pdf/aa/21/jdi-5-340.PMC4020340.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/aa/21/jdi-5-340.PMC4020340.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdLETTER TO THE EDITOR Letter to the Editor http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/89/05/jdi-5-345.PMC4020341.pdf
"This is an Open Access article distributed under the terms ofthe Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permitsnon-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/be/aeu173.PMC4020385.pdf
"Systemic exposure for all patients receiving bendamustine 120 mg/m 2 was similar to that of the phase 1 group, with a mean Cmaxof 7490 ng/mL and mean AUC 0-twas 13,208 ng h/mL—again, the results were consistent with those reported for adults with indolent NHL8(see Supplementary Table, Supplemental Digital Content 1, http://links.lww.com/JPHO/A56, for asummary of the pharmacokinetic results for bendamustine and its metabolites in pediatric patients).",Non-OADS,/arxiv_data1/oa_pdf/6c/19/mph-36-e212.PMC4020582.pdf
"Developmental Cognitive Neuroscience 7 (2014) 65–75 Contents lists available at ScienceDirect Developmental Cognitive Neuroscience journal homepage: http://www.elsevier.com/locate/dcn White matter connectivity and aerobic ﬁtness in male adolescents Megan M. Hertinga,∗, John B. Colbyb, Elizabeth R. Sowella, Bonnie J. Nagelc,d aDepartment of Pediatrics, Keck School of Medicine at USC/Children’s Hospital of Los Angeles, Los Angeles, CA, USA bDavid Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA cDepartment of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail-Code: DC7P, Portland, OR 97239, USA dDepartment of Behavioral Neuroscience, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail-Code: DC7P, Portland, OR 97239, USA article info Article history: Received 11 June 2013 Received in revised form 14 November 2013 Accepted 16 November 2013 Keywords:AdolescenceAerobic exerciseWhite matterDiffusion tensor imaging Tractographyabstract Exercise has been shown to have positive effects on the brain and behavior throughout various stages of the lifespan.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
Published by Elsevier Ltd. http://dx.doi.org/10.1016/j.dcn.2013.11.003Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
Each raw diffusion weighted acquisition for each subject was preprocessed separately according to standard proto-cols available in FSL (http://www.fmrib.ox.ac.uk/fsl) andTrackVis (http://www.trackvis.org).,OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Non-linear registration, aka Spa- tial normalisation, FMRIB technical report TR07JA2 fromhttp://www.fmrib.ox.ac.uk/analysis/techrep Armstrong, N., et al., 2007.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Child and Teen BMI Calcula- tor, From http://apps.nccd.cdc.gov/dnpabmi/ Colby, J.B., et al., 2012.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Neuroimage 59 (4), 3227–3242, http://dx.doi.org/ 10.1016/j.neuroimage.2011.11.004.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Glia 55 (9), 966–975, http://dx.doi.org/10.1002/glia.20521.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Cortex 22 (9),1979–1992, http://dx.doi.org/10.1093/cercor/bhr246.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"233 (2), 517–525,http://dx.doi.org/10.1016/j.bbr.2012.05.012.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"25 (4), 595–612, http://dx.doi.org/ 10.1162/jocn a00344.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Neuroimage 59 (2), 1514–1523, http://dx.doi.org/ 10.1016/j.neuroimage.2011.08.032.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Neuroimage,http://dx.doi.org/10.1016/j.neuroimage.2012.06.081.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"120 (4), 280–290,http://dx.doi.org/10.3109/00207450903222741.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"1),165–175, http://dx.doi.org/10.1227/NEU.0b013e318270d9fb.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"45 (15), 1208–1215, http://dx.doi.org/10.1136/bjsm.2009.068114.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Neuroimage 39 (3), 1370–1382,http://dx.doi.org/10.1016/j.neuroimage.2007.09.071.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"R: A Language and Environment for Statistical Com- puting, From http://www.R-project.org Tseng, B.Y., et al., 2013.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Neuroimage 82C, 510–516, http://dx.doi.org/10.1016/ j.neuroimage.2013.06.011.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Brain Mapp.,http://dx.doi.org/10.1002/hbm.22119.",Non-OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
"Neuroimage 36 (3),630–644, http://dx.doi.org/10.1016/j.neuroimage.2007.02.049.",OADS,/arxiv_data1/oa_pdf/59/0a/main.PMC4020709.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/jpr-7-227.PMC4020878.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 227–236Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  227Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S5916 1Pain assessment in animal models:   do we need further studies?,Non-OADS,/arxiv_data1/oa_pdf/00/c8/jpr-7-227.PMC4020878.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/00/c8/jpr-7-227.PMC4020878.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/c8/jpr-7-227.PMC4020878.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/f7/cia-9-801.PMC4020879.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 801–811Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  801OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S5643 5Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Wu et al Running head recto: Acceptance of an assistive robot in older adults DOI: http://dx.doi.org/10.2147/CIA.S56435 Ya-huei Wu1,2 Jérémy Wrobel1,2 Mélanie Cornuet1,2 hélène Kerhervé1,2 souad Damnée1,2 Anne-sophie rigaud1,2 1hôpital Broca, Assistance   Publique – hôpitaux de Paris,   2research Team 4468, Faculté   de Médecine, Université Paris  Descartes, Paris, France Correspondence: Ya-huei Wu   hôpital Broca, 54–56 rue Pascal,   Paris 75013, France   T el +33 1 4408 3503   Fax +33 1 4408 3510   email yahuei.wu@brc.aphp.f rAcceptance of an assistive robot in older adults:   a mixed-method study of human–robot interaction  over a 1-month period in the living lab setting Background:  There is growing interest in investigating acceptance of robots, which are   increasingly being proposed as one form of assistive technology to support older adults, maintain  their independence, and enhance their well-being.",Non-OADS,/arxiv_data1/oa_pdf/b9/f7/cia-9-801.PMC4020879.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b9/f7/cia-9-801.PMC4020879.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b9/f7/cia-9-801.PMC4020879.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 777–789Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  777Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4340 4Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
"Or use: http://dvpr.es/RfQk4 oAddressing the unmet needs of patients with  persistent negative symptoms of schizophrenia:  emerging pharmacological treatment options Pierre Chue1 Justine K Lalonde2 1Department of Psychiatry, University  of Alberta, edmonton, AB, Canada;   2Roche SAS, Medical Affairs  Department, Boulogne-Billancourt,   France Correspondence: Pierre Chue   3rd Floor, 9942-108 St, edmonton,  Alberta, Canada T5K 2J5   Tel +1 780 342 7944   Fax +1 780 425 9317   email pchue@ualberta.c aAbstract:  The negative symptoms of schizophrenia represent an impairment of normal  emotional responses, thought processes and behaviors, and include blunting or flattening of affect,  alogia/aprosody, avolition/apathy, anhedonia, and asociality.",Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from: http://www.envivopharma.com/ news-item.php?id =35.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT0119290 6.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT01192880?term=   NCT01192880&rank= 1.,OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT01192867?term=   NCT01192867&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT01235559?term=   nCT01235559&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT01235585?term=   NCT01235585&rank= 1.,OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT01235520?term=   NCT01235520&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT017147 13?term=NCT01714713&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
Available from http://clinicaltrials.gov/ ct2/show/NCT01488929?term=NCT01488929&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
"Available from: http://www.targacept.com/newsroom/index.cf m.  Accessed March 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6b/be/ndt-10-777.PMC4020880.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 771–777Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  771OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5877 1Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Zhang et al Running head recto: Health insurance and long-term care disparities in Zhejiang province DOI: http://dx.doi.org/10.2147/CIA.S58771 Can medical insurance coverage reduce disparities  of income in elderly patients requiring long-term  care?,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
Available from: http://www.stats.gov.cn/english/NewsEvents/201104/ t20110428_26449.html.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
Available from: http://hdr.undp.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
Available from: http://www.nhfpc.gov.cn/cmsresources/ mohwsbwstjxxzx/cmsrsdocument/doc9912.pdf.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
Available  from: http://siteresources.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/37/8f/cia-9-771.PMC4020881.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 793–800Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  793OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6220 7Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Vennu and Bindawas Running head recto: Falls, knee osteoarthritis, and HRQoL DOI: http://dx.doi.org/10.2147/CIA.S62207 Vishal Vennu saad M Bindawas Department of rehabilitation science,   College of Applied Medical sciences,   King saud University, riyadh, saudi  Arabia Correspondence: Vishal Vennu Department of rehabilitation science,  College of Applied Medical sciences, King  saud University, PO Box 10219, riyadh  11433, saudi Arabia T el +96 61 1469 3550 email vvennu@ksu.edu.saBackground:  The purpose of this study was to examine the relationship between self-reported  falls, doctor-diagnosed knee osteoarthritis (OA), and health-related quality of life (HRQoL).",Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
"Notes: ‡OAI (Osteoarthritis Initiative) Online database provided by coordinating  center, University of California, san Francisco ( http://oai.epi-ucsf.org/datarelease /);  ±neither fall nor knee osteoarthritis defined as persons with neither a self-reported  history of falls nor doctor-diagnosed knee osteoarthritis; €either fall or knee  osteoarthritis defined as persons with a self-reported history of falls or doctor- diagnosed knee osteoarthritis; ¥fall and knee osteoarthritis defined as persons with a  self-reported history of falls and doctor-diagnosed knee osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
Available from: http://www.cdc.gov/homeandrec - reationalsafety/Falls/adultfalls.html.,Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
Available  from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a8.htm.,OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
Available from: http://www.cdc.gov/arthritis/resources/ policy.htm.,Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
Available from: https://oai.epi-ucsf.,Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
"San Francisco, CA,  USA: University of California, San Francisco; 2013 Available  from: https://oai.epi-ucsf.org/datarelease/About.asp.",Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
Available from: http://www.cdc.gov/HomeandRecreationalSafety/ images/CDC_Guide-a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
"Washington, DC, USA: US Department of Health and Human   Services; 2010 Available from: http://healthypeople.gov/2020/about/ QoLWBabout.aspx.",Non-OADS,/arxiv_data1/oa_pdf/20/40/cia-9-793.PMC4020882.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/ca/cia-9-779.PMC4020883.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 779–792Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  779OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5886 6Psychological well-being in individuals with mild  cognitive impairment nicola gates1–3 Michael Valenzuela3 Perminder s sachdev1,2,4 Maria A Fiatarone singh5,6 1school of Psychiatry, 2Centre for  healthy Brain Ageing (CheBA),   University of new south Wales,   sydney, nsW, Australia; 3regenerative  neuroscience group, Brain and  Mind research Institute , University  of sydney, sydney, nsW, Australi a;  4neuropsychiatric Institute, Prince  of Wales hospital, sydney, nsW,   Australia; 5exercise health and  Performance Faculty research group,   sydney Medical school, The University  of sydney, lidcombe, nsW, Australia;   6hebrew senior life, Boston, MA, and  Jean Mayer U sDA human nutrition  research Center on Aging at T ufts  University , Boston, MA, UsA Correspondence: nicola gates   school of Psychiatry, University   of new south Wales, randwick,   sydney, nsW 2031, Australia   Tel +61 2 9969 3301   Fax +61 2 9382 3774   email nicolagates@bigpond.co mObjectives:  Cognitive impairments associated with aging and dementia are major sources of  burden, deterioration in life quality, and reduced psychological well-being (PWB).",Non-OADS,/arxiv_data1/oa_pdf/6a/ca/cia-9-779.PMC4020883.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6a/ca/cia-9-779.PMC4020883.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/ca/cia-9-779.PMC4020883.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/8c/ppa-8-683.PMC4020884.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 683–692Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  683OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5881 3impact of hypoglycemia on patients with type 2   diabetes mellitus and their quality of life, work   productivity, and medication adherence Janice M s lopez1 Kathy Annunziata2 robert A Bailey1 Marcia FT rupnow1 Donald e Morisky3 1Janssen scientific Affairs, llc,   raritan, nJ, 2Kantar health, Princeton,   nJ, 3University of california at los  Angeles Fielding school of Public  health, los Angeles, cA, UsA correspondence: Janice Ms lopez   Janssen Scientific Affairs, LLC,   1000 route 202 south, raritan,   nJ 08869, UsA   Tel +1 410 465 5508   Fax +1 410 465 5538   email jmlopez@its.jnj.co mBackground:  The purpose of this study was to determine the characteristics of adults with  type 2 diabetes mellitus (T2DM) that correlate with greater risk of hypoglycemia and determine  the impact of hypoglycemia on health-related quality of life, work productivity, and medication  adherence from a patient perspective.",Non-OADS,/arxiv_data1/oa_pdf/bd/8c/ppa-8-683.PMC4020884.pdf
"Available from: http://www.cvd.idf.org/Diabetes/Risk_Factors_for_  Diabetes/index.htm l. Accessed March 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/bd/8c/ppa-8-683.PMC4020884.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/bd/8c/ppa-8-683.PMC4020884.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/8c/ppa-8-683.PMC4020884.pdf
"Available from: http://www.cdc.gov/ diabetes/statistics/prev/national/ figadults.ht m. Accessed November 6,  2013.",Non-OADS,/arxiv_data1/oa_pdf/bd/8c/ppa-8-683.PMC4020884.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/2b/dddt-8-459.PMC4020885.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 459–474Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  459Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5841 4Improving anticancer efficacy of  (-)-epigallocatechin-3-gallate gold   nanoparticles in murine B16F10 melanoma cells cheng-cheung chen1,2 Dar-shih hsieh1,3 Kao-Jean huang4 Yi-lin chan5 Po-Da hong6 Ming-Kung Yeh6–8,* chang-Jer Wu1,* 1Department of Food science,   national Taiwan Ocean University,   Keelung, 2institute of Preventive  Medicine, national Defense Medical  center, Taipei, 3Division of Urology,   Department of surgery, ren-ai  hospital, shulin, new Taipei city,   4Department of life science and  institute of Biotechnology, national  Dong hwa University, hualien,   5graduate institute of Medical  sciences, national Defense Medical  center, Taipei, 6Materials Technology  Program, graduate institute of  applied science and T echnology,   national Taiwan University of science  and T echnology, Taipei, 7school of  Pharmacy, national Defense Medical  center, Taipei, 8Food and Drug  administration, Ministry of health  and Welfare, Taipei, Taiwan, republic  of china *These authors contributed equally  to this work correspondence: chang-Jer Wu   Department of Food science, national  Taiwan Ocean University, 2, Pei-ning  road, Keelung, Taiwan, republic of china   Tel +886 224 622 192 x 5137   Fax +886 224 634 203   email cjwu@mail.ntou.edu.t wAbstract:  (-)-Epigallocatechin-3-gallate (EGCG), the major bioactive constituent in green tea,  has been reported to effectively inhibit the formation and development of tumors.",Non-OADS,/arxiv_data1/oa_pdf/2d/2b/dddt-8-459.PMC4020885.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2d/2b/dddt-8-459.PMC4020885.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/2b/dddt-8-459.PMC4020885.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/2d/hiv-6-069.PMC4020886.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2014:6 69–74HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  69ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S6015 7gut and mesenteric lymph node involvement  in pediatric patients infected with human  immunodeficiency virus Cecilia Mantegazza1 giovanni Maconi2 Vania giacomet1 Federica Furfaro2 Chiara Mameli1 Cristina Bezzio2 Michela Monteleone2 giulia Ramponi1 gian Vincenzo Zuccotti1 1Department of Paediatrics,   2gastroenterology Unit, l Sacco  University Hospital, Milan, Italy Correspondence: Cecilia Mantegazza   Department of Paediatrics, l Sacco  University Hospital, Via giovanni Battista  grassi, 74, 20157 Milan, Italy   Tel +39 02 3904 2268   Fax +39 02 3904 2254   email cecimante@hotmail.co mBackground:  The gastrointestinal tract is a primary target for human immunodeficiency virus  (HIV).",Non-OADS,/arxiv_data1/oa_pdf/96/2d/hiv-6-069.PMC4020886.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/96/2d/hiv-6-069.PMC4020886.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/2d/hiv-6-069.PMC4020886.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/ad/jpr-7-255.PMC4020887.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 255–263Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  255ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6336 1a preliminary report on stem cell therapy   for neuropathic pain in humans e Russell Vickers1 elisabeth Karsten2 John Flood3 Richard lilischkis2 1sydney Oral and Maxillofacial  surgery, nsW, australia; 2Regeneus  ltd, gordon, nsW, australia;    3st Vincents hospital, sydney, nsW,   australia correspondence: e Russell Vickers   sydney Oral and Maxillofacial   surgery, suite 1401, 520 Oxford   st, Bondi Junction, nsW, australia   Tel +61 2 9369 2153   Fax +61 2 9369 2154   email oralmaxima@bigpond.co mObjective:  Mesenchymal stem cells (MSCs) have been shown in animal models to attenuate  chronic neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/8f/ad/jpr-7-255.PMC4020887.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/8f/ad/jpr-7-255.PMC4020887.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/ad/jpr-7-255.PMC4020887.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/2c/tcrm-10-335.PMC4020888.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 335–340Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  335ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5151 8experimental study of tissue-engineered cartilage  allograft with Rnai chondrocytes in vivo Zhenghui Wang1 Xiaoli li2 Xi-Jing he3 Xianghong Zhang1 Zhuangqun Yang4 Min Xu1 Baojun Wu1 Junbo T u5 huanan luo1 Jing Yan1 1Department of Otolaryngology –  head and neck surgery, 2Department  of Dermatology, 3Department  of Orthopedics, The second  hospital, Xi’an Jiaotong University,   4Department of Plastic and Burns  surgery, The First hospital, Xi’an  Jiaotong University, 5Department of  Oral and Maxillofacial Plastic surgery,   The stomatological hospital, Xi’an  Jiaotong University, Xi’an, People’s  Republic of China Correspondence: Baojun Wu; Min Xu   Department of Otolaryngology –   head and neck surgery, The second  hospital, Xi’an Jiaotong University,  Xi Wu Road, Xi’an 710004, People’s  Republic of China   email wubaojun_bone@163.co m;  ent551205@163.co mPurpose:  To determine the effects of RNA interference (RNAi) on chondrocyte proliferation,  function, and immunological rejection after allogenic tissue-engineered cartilage transplantation  within bone matrix gelatin scaffolds.",Non-OADS,/arxiv_data1/oa_pdf/9c/2c/tcrm-10-335.PMC4020888.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/9c/2c/tcrm-10-335.PMC4020888.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/2c/tcrm-10-335.PMC4020888.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/91/ijn-9-2191.PMC4020889.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2191–2204International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2191OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5839 7aneuploidogenic effects and DNa oxidation   induced in vitro by differently sized gold   nanoparticles sebastiano Di Bucchianico1 Maria rita Fabbrizi1 silvia cirillo1 chiara Uboldi1 Douglas gilliland2 eugenia Valsami-Jones3,4 lucia Migliore1 1Department of Translational  research and New Technologies  in Medicine and surgery, Medical  genetics Unit, University of Pisa,   Pisa, Italy;  2european commission- Joint research centre, Institute for  health and consumer Protection,   NanoBio sciences Unit, Ispra, Italy;   3school of geography, earth and  environmental sciences, University of  Birmingham, edgbaston, Birmingham,   UK; 4earth sciences, Natural history  Museum, cromwell road, london, UK correspondence : sebastiano Di   Bucchianico   University of Pisa, Via san giuseppe,    22 – 56126 Pisa, Italy   Tel +39 050 221 1028  Fax +39 050 221 1034  email sebastiano.dibucchianico@for.",Non-OADS,/arxiv_data1/oa_pdf/d9/91/ijn-9-2191.PMC4020889.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d9/91/ijn-9-2191.PMC4020889.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/91/ijn-9-2191.PMC4020889.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/69/ijnrd-7-161.PMC4020890.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 161–168International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  161RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S4162 6Clinical and economic aspects of sevelamer  therapy in end-stage renal disease patients Shahrzad Ossareh Department of Medicine, Nephrology  Section, Hasheminejad Kidney Center,   Iran University of Medical Sciences,   T ehran, Iran Correspondence: Shahrzad Ossareh   Hemodialysis ward, Hasheminejad  Kidney Center, Iran University   of Medical Sciences, Tehran, Iran   Tel +98 21 8864 4420   Fax +98 21 8864 4441   email ossareh_s@hotmail.co mAbstract:  Phosphate control is still a great challenge in chronic kidney disease (CKD), and  in spite of the great improvements in dialysis techniques, achievement of the goals for mineral  metabolism control is still far from ideal.",Non-OADS,/arxiv_data1/oa_pdf/49/69/ijnrd-7-161.PMC4020890.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/49/69/ijnrd-7-161.PMC4020890.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/69/ijnrd-7-161.PMC4020890.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/53/ccide-6-045.PMC4020891.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2014:6 45–56Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  45RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCIDE.S6148 7A systematic review of nonsurgical single-visit  versus multiple-visit endodontic treatment Amy wY wong Chengfei Zhang Chun-hung Chu Faculty of Dentistry, The University  of Hong Kong, Hong Kong Special  Administrative Region, People’s  Republic of China Correspondence: Chengfei Zhang   Faculty of Dentistry, the University of  Hong Kong,  3B61, Prince Philip Dental  Hospital,  34 Hospital Road, Hong Kong  Special Administrative Region,   People’s Republic of China   Tel +852 2859 0371  Fax +852 2559 9013  email zhangcf@hku.h kAbstract:  Conventional endodontic treatment used to require multiple visits, but some  clinicians  have suggested that single-visit treatment is superior.",Non-OADS,/arxiv_data1/oa_pdf/8e/53/ccide-6-045.PMC4020891.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8e/53/ccide-6-045.PMC4020891.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8e/53/ccide-6-045.PMC4020891.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ndt-10-791.PMC4020892.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 791–795Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  791Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6307 3Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Short Report Y ear: 2014 Volume: 10 Running head verso: Lee et al Running head recto: Bipolar spectrum disorder in elderly depressed patients DOI: http://dx.doi.org/10.2147/NDT.S63073 The prevalence of bipolar spectrum disorder   in elderly patients with recurrent depression Chang-In Lee1 Y oung-eun Jung1 Moon-Doo Kim1 Seong-Chul hong2 Won-Myong Bahk3 Bo-hyun Y oon4 1Department of p sychiatry,   2Department of p reventive Medicine,   School of Medicine, Jeju National  University, Jeju, republic of Korea;   3Department of psychiatry, Yeouido   St Mary’s hospital, College   of Medicine, The Catholic University  of Korea, Seoul, republic of Korea;   4Department of psychiatry, Naju  National hospital, Naju, republic   of Korea Correspondence: Y oung-eun Jung Department of psychiatry, School of  Medicine, Jeju National University,   15 Aran 13-gil, Jeju 690-756,   republic of Korea T el +82 64 717 1234 Fax +82 64 717 1849 email jyejye77@daum.ne t Moon-Doo Kim Department of psychiatry, School   of Medicine, Jeju National University,   15 Aran 13-gil, Jeju 690-756,   republic of Korea T el +82 64 717 1234 Fax +82 64 717 1849 email mdkim66@jejunu.ac.k rPurpose:  Despite a growing body of knowledge on bipolar spectrum disorder (BSD), relatively  little is known about the clinical characteristics of BSD in elderly people.",Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ndt-10-791.PMC4020892.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ndt-10-791.PMC4020892.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 795Bipolar spectrum disorder in elderly depressed patients  17.,Non-OADS,/arxiv_data1/oa_pdf/e2/d8/ndt-10-791.PMC4020892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/13/jpr-7-243.PMC4020893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 243–253Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  243Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JPR.S5885 3Interstitial Cystitis – elucidation of  Psychophysiologic and Autonomic Characteristics  (the ICePAC Study): design and methods thomas Chelimsky1 gisela Chelimsky1 N Patrick McCabe2 Megan louttit3 Adonis hijaz3 Sangeeta Mahajan3 tatiana Sanses3 CA tony Buffington4 Bradford Fenton5 thomas Janicki3 Sarah Ialacci2 elias Veizi3 di Zhang2 Firouz daneshgari2,3 Robert elston2 Jeffrey Janata2,3 1the Medical College of Wisconsin,   departments of Neurology and  gastroenterology, Milwaukee, WI,   2Case Western Reserve University,   department of Neurology, Cleveland,   oh, 3University hospitals Case  Medical Center, School of Medicine,   Cleveland, oh, 4the ohio State  University, department of Veterinary  Clinical Sciences, Columbus, oh,   5Summa health System, department  of gynecology, Akron, oh, USA Correspondence: thomas Chelimsky   department of Neurology,   Medical College of Wisconsin,   9200 W Wisconsin Ave, Milwaukee,   WI 53226, USA   tel +1 414 805 5235   email tchelimsky@mcw.ed uBackground and purpose:  Interstitial cystitis/bladder pain syndrome (IC/BPS) is relatively  common and associated with severe pain, yet effective treatment remains elusive.",Non-OADS,/arxiv_data1/oa_pdf/26/13/jpr-7-243.PMC4020893.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/26/13/jpr-7-243.PMC4020893.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/13/jpr-7-243.PMC4020893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/b9/tcrm-10-331.PMC4020894.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 331–334Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  331Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S6291 7T ension-free repair during extensive radical  surgery for cecal cancer with abdominal wall  invasion and inguinal lymph node metastasis Kaiwu Xu Zhihui Chen Xinming song Gastrointestinal and pancreatic  surgery Department, The First  affiliated Hospital of sun Yat-sen  University, Guangzhou, Guangdong  province, people’s Republic of China Correspondence: Xinming song   Department of Gastrointestinal and  Pancreatic Surgery, The First Affiliated  Hospital of sun Yat-sen University,  Zhongshan second Road,  510080  Guangzhou, Guangdong province,   The people’s Republic of China   Tel +86 20 8775 5766   email songxm2010@163.co mAbstract:  We report a case of cecal cancer with invasion of the abdominal wall and right inguinal  lymph node metastasis.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/tcrm-10-331.PMC4020894.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/tcrm-10-331.PMC4020894.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/b9/tcrm-10-331.PMC4020894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2014:6 87–96Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  87Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S6251 2incidence and management of adverse events   in patients with relapsed and/or refractory   multiple myeloma receiving single-agent carfilzomib R Donald Harvey Phase 1 Clinical Trials Section,  winship Cancer institute of emory  University, Atlanta, GA, USA Correspondence: R Donald Harvey   Phase 1 Clinical Trials Section, winship  Cancer institute of emory University,  1365 Clifton Road Ne CPL017B,   Atlanta, GA 30322, USA   Tel +1 404 778 4381   Fax +1 404 778 5520   email donald.harvey@emory.ed uAbstract:  Carfilzomib, a selective proteasome inhibitor approved in the USA in 2012, is a  single agent for relapsed and refractory multiple myeloma.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
"Obtained from Haematologica/the Hematology Journal website http://www.haematologica.or g.12 Abbreviations:  AE, adverse event; ISA, integrated safety analysis.performance status was 29.7%, 58.4%, and 11.6% for  scores of 0, 1, and 2, respectively.",OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
"Adverse events graded according to the National Cancer institute Common Terminology Criteria.21 Obtained from Haematologica/the Hematology Journal  website http://www.haematologica.or g.12  Abbreviation:  SAe, serious Aes.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
Available from: http://clinicaltrials.gov/ show/NCT0051123 8.,Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
Available from: http://clinicaltrials.gov/show/NCT0053081 6.,Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
"Available from:  http://ctep.cancer.gov/protocoldevelopment/electronic_applications/ docs/ctcae_index.pd f. Accessed March 12, 2014.",OADS,/arxiv_data1/oa_pdf/4c/7c/cpaa-6-087.PMC4020895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ppa-8-661.PMC4020896.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 661–670Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  661OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6016 4Do parents of children with attention-deficit/ hyperactivity disorder (ADhD) receive   adequate information about the disorder   and its treatments?,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ppa-8-661.PMC4020896.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/03/e5/ppa-8-661.PMC4020896.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ppa-8-661.PMC4020896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/66/jbm-5-049.PMC4020897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Blood Medicine Journal of Blood Medicine 2014:5 49–53Dove press submit your manuscript | www.dovepress.co m Dove press  49Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JBM.S6257 0Back pain: the sole of presentation   of sickle cell disease samar osman shabina Khan Mohamed a Hendaus General pediatrics, Department  of pediatrics, Hamad Medical  Corporation, Doha, Qatar Correspondence: Mohamed a Hendaus   General p ediatrics, Department of  pediatrics, Hamad Medical Corporation,  po Box 3050, al-rayyan street,   Doha  3050, Qatar   tel +974 4439 2239  Fax +974 4443 9571  email mhendaus@yahoo.co mAbstract:  Diagnosing back pain in children and adolescents can be a challenge to health care  providers.",Non-OADS,/arxiv_data1/oa_pdf/cb/66/jbm-5-049.PMC4020897.pdf
"Available  from: http://emedicine.medscape.com/article/413542-overvie w.  Accessed March  18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cb/66/jbm-5-049.PMC4020897.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/cb/66/jbm-5-049.PMC4020897.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/66/jbm-5-049.PMC4020897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/90/imcrj-7-089.PMC4020898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 89–92International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  89Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6347 5a case of thyroid storm with cardiac arrest Yutaka Nakashima1 tsuneaki Kenzaka2 Masanobu okayama3 eiji Kajii3 1Department for support   of Rural Medicine, Yamaguchi Grand   Medical Center,  2Division of   General Medicine, Center for   Community Medicine, Jichi Medical   University school of Medicine,    shimotsuke, Japan;  3Division of  Community and Family Medicine,   Center for Community Medicine,   Jichi Medical University school of  Medicine, shimotsuke, Japan Correspondence: tsuneaki Kenzaka   Division of General Medicine,   Center for Community Medicine,   Jichi Medical University school of   Medicine,  3311-1 Yakushiji, shimotsuke,   tochigi  329-0498, Japan   tel +81 285 58 7394  Fax +81 285 44 0628  email smile.kenzaka@jichi.ac.j pAbstract:  A 23-year-old man became unconscious while jogging.",Non-OADS,/arxiv_data1/oa_pdf/9c/90/imcrj-7-089.PMC4020898.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/9c/90/imcrj-7-089.PMC4020898.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/90/imcrj-7-089.PMC4020898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/f0/ott-7-687.PMC4020899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 687–695OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  687Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5733 8Quality of life assessment in advanced cancer  patients treated at home, an inpatient unit,   and a day care center Wojciech leppert¹ Mikolaj Majkowicz² Maria Forycka1 eleonora Mess3 agata Zdun-ryzewska2 ¹Department of Palliative  Medicine, Poznan University of  Medical sciences, Poznan, Poland;  ²Department of Quality of life  research, gdansk Medical University,  gdansk, Poland; 3Palliative care  nursing Department, Wroclaw  Medical University, Wroclaw, Poland correspondence: Wojciech leppert   Department of Palliative Medicine,  Poznan University of Medical sciences,  Osiedle rusa 25a, 61–245 Poznan,  Poland   Tel/Fax +48 61 8738 303   email wojciechleppert@wp.p lAim of the study:  To assess quality of life (QoL) in cancer patients treated at home, at an  in-patient palliative care unit (PCU), and at a day care center (DCC).",Non-OADS,/arxiv_data1/oa_pdf/39/f0/ott-7-687.PMC4020899.pdf
Available at: http://www.who.int/ cancer/palliative/definition/en /.,Non-OADS,/arxiv_data1/oa_pdf/39/f0/ott-7-687.PMC4020899.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/39/f0/ott-7-687.PMC4020899.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/f0/ott-7-687.PMC4020899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/7d/ijn-9-2157.PMC4020900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2157–2165International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2157OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5933 1enhanced uptake and transport of ( +)-catechin  and ( −)-epigallocatechin gallate in niosomal  formulation by human intestinal caco-2 cells Qinxin song1–3 Danhui li3 Y ongzhi Zhou3 Jie Yang1 Wanqi Yang1 guohua Zhou2 Jingyuan Wen3 1Key laboratory of Drug Quality  control and Pharmacovigilance,   Ministry of education, school of  Pharmacy, china Pharmaceutical  University, 2Department of  Pharmacology, Jinling hospital,   Nanjing University school of  Medicine, Nanjing, People’s republic  of china; 3school of Pharmacy, Faculty  of Medical and health sciences,   University of auckland, auckland,    New Zealand correspondence: Jingyuan Wen   school of Pharmacy, Faculty of Medical  and health sciences, University of  auckland, auckland 1142, New Zealand   Tel +64 9 373 7599 ext 82762   email j.wen@auckland.ac.n zAbstract:  The aim of this study was to evaluate ( +)-catechin and ( −)-epigallocatechin gallate  (EGCG) cellular uptake and transport across human intestinal Caco-2 cell monolayer in both  the absence and presence of niosomal carrier in variable conditions.",Non-OADS,/arxiv_data1/oa_pdf/52/7d/ijn-9-2157.PMC4020900.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/52/7d/ijn-9-2157.PMC4020900.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/7d/ijn-9-2157.PMC4020900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/5e/ijn-9-2205.PMC4020901.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2205–2215International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2205OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6119 8Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Woltmann et al Running head recto: Biocompatibility of polyelectrolyte complex nanoparticles toward hMSCs DOI: http://dx.doi.org/10.2147/IJN.S61198 Interaction between immobilized polyelectrolyte  complex nanoparticles and human mesenchymal  stromal cells Beatrice Woltmann1 Bernhard T orger2,3 Martin Müller2,3,* Ute hempel1,* 1Dresden University of T echnology,    Faculty of Medicine carl gustav   carus, Institute of Physiological  chemistry, Dresden, germany;    2leibniz Institute of Polymer   research Dresden, Department   of Polyelectrolytes and Dispersions,   Dresden, germany; 3Dresden  University of Technology, Department  of chemistry and Food chemistry,   Dresden, germany *These authors contributed equally   to this workBackground:  Implant loosening or deficient osseointegration is a major problem in patients  with systemic bone diseases (eg, osteoporosis).",Non-OADS,/arxiv_data1/oa_pdf/25/5e/ijn-9-2205.PMC4020901.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/25/5e/ijn-9-2205.PMC4020901.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2215Biocompatibility of polyelectrolyte complex nanoparticles toward hMscs  10.,Non-OADS,/arxiv_data1/oa_pdf/25/5e/ijn-9-2205.PMC4020901.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/2e/ott-7-679.PMC4020903.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 679–685OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  679 Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5166 4Renal malignant solitary fibrous tumor with   single lymph node involvement: report of   unusual metastasis and review of the literature ettore Mearini1 Giovanni Cochetti1 Francesco Barillaro1 sonia Fatigoni2 Fausto roila2 1Department of Medical- surgical  Specialties and Public Health, Division  of Urological andrological surgery  and Minimally Invasive T echniques,   University of Perugia, T erni, Italy;   2Medical Oncology, S Maria Hospital,   T erni, Italy Correspondence: Giovanni Cochetti   Department of surgical and Biomedical  Surgery, Division of Urological and  andrological surgery and Minimally  Invasive Techniques, University of  Perugia, Via Tristano di Joannuccio, n.1,  Terni, Italy   Tel +39 07 44 20 58 22  Fax +39 07 44 20 58 22  email giovannicochetti@libero.i tAbstract:  Solitary fibrous tumors are rare mesenchymal spindle cell neoplasms that are usually  found in the pleura.",Non-OADS,/arxiv_data1/oa_pdf/fd/2e/ott-7-679.PMC4020903.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fd/2e/ott-7-679.PMC4020903.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/2e/ott-7-679.PMC4020903.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/09/dmso-7-145.PMC4020904.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 145–151Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  145Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S6029 4effects of body mass index-related disorders   on cognition: preliminary results Jerome a Yesavage1,2 lisa M Kinoshita1,2 art noda2 laura c lazzeroni2 Jennifer Kaci Fairchild1,2 Joy Taylor1,2 Doina Kulick3 leah Friedman1,2 Jauhtai cheng1,2 Jamie M Zeitzer1,2 ruth O’hara1,2 1Department of Veterans affairs  health care System, Palo alto, ca,   USa; 2Department of Psychiatry  and Behavioral Sciences, Stanford  University School of Medicine,   Stanford, ca, USa; 3Department of  Medicine, University of nevada School  of Medicine, reno, nV, USa correspondence: Jerome a Yesavage   Palo alto Va health care System (151Y),  3801 Miranda avenue, Palo alto,   ca 94304, USa   Tel +1 650 852 3287   Fax +1 650 852 3297   email yesavage@stanford.ed uBackground:  Well-known risk factors for cognitive impairment are also associated with   obesity.",Non-OADS,/arxiv_data1/oa_pdf/7b/09/dmso-7-145.PMC4020904.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/7b/09/dmso-7-145.PMC4020904.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/09/dmso-7-145.PMC4020904.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/64/ijn-9-2217.PMC4020905.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2217–2224International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2217O R I G I N A L  R E S E A R C H open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5658 8Gold-functionalized magnetic nanoparticles  restrict growth of Pseudomonas aeruginosa Katarzyna Niemirowicz1,2 Izabela Swiecicka3 Agnieszka Z Wilczewska4 Iwona Misztalewska4 Beata Kalska-Szostko4 Kamil Bienias2 Robert Bucki1,5,6 Halina Car2 1Department of Microbiological  and Nanobiomedical Engineering,   2Department of Experimental  Pharmacology, Medical University  of Bialystok, 3Department of  Microbiology, 4Institute of Chemistry,   University  of Bialystok, Bialystok,   5Faculty of Health Sciences, Jan  Kochanowski University, Kielce,   Poland; 6Institute for Medicine  and Engineering, University of  Pennsylvania, Philadelphia, PA, USA Correspondence: Halina Car   Department of Experimental  Pharmacology, Medical University of  Bialystok, 37 Szpitalna, 15-295 Bialystok,  Poland   Tel +48 8 5748 5554   Email zfarmdosw@umb.edu.p lAbstract : Superparamagnetic iron oxide nanoparticles (SPIONs) and their derivatives   (aminosilane and gold-coated) have been widely investigated in numerous medical applications,  including their potential to act as antibacterial drug carriers that may penetrate into bacteria  cells and biofilm mass.",Non-OADS,/arxiv_data1/oa_pdf/0f/64/ijn-9-2217.PMC4020905.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0f/64/ijn-9-2217.PMC4020905.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/64/ijn-9-2217.PMC4020905.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/9e/ott-7-697.PMC4020909.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 697–702OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  697Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5890 2antitumor activity of sorafenib and imatinib   in a patient with thymic carcinoma harboring   c-KIT exon 13 missense mutation K642e Chiara Catania1 Fabio Conforti1 Gianluca spitaleri1 Massimo Barberis2 Lorenzo preda3 Cristina Noberasco1 Chiara Lazzari1 Francesca T offalorio1 Filippo de Marinis1 Michela Manzotti2 T ommaso Martino De pas1 1Division of Thoracic Oncology,   2Division of pathology, 3Division  of radiology, european Institute of  Oncology, Milan, Italy Correspondence: Chiara Catania   Division of Thoracic Oncology, european  Institute of Oncology, Via ripamonti 435,  Milan 20141, Italy   Tel +39 02 5748 9502   email chiara.catania@ieo.i tAbstract:  We report the case of a man with an advanced nonkeratinizing squamous cell thymic  carcinoma harboring c-KIT exon 13 missense mutation K642E.",Non-OADS,/arxiv_data1/oa_pdf/0a/9e/ott-7-697.PMC4020909.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/9e/ott-7-697.PMC4020909.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/9e/ott-7-697.PMC4020909.pdf
"NMAC 7.4.3.12 was updated in 2009to include vulvar and vaginal pathology (http://nmhealth.org/ ERD/healthdata/documents/NotiﬁableDiseasesConditions0229 12ﬁnal.pdf).Study population and sample During the 17-month period of December 2007 throughApril 2009 /C24379,000 cervical cytology tests on 320,500 women were reported to the NMHPVPR by 9 in-state and 7 out-of-state clinical laboratories.",Non-OADS,/arxiv_data1/oa_pdf/27/ba/ijc0135-0624.PMC4020996.pdf
"1 1      http://www.medsci.org  646  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  646-651.  doi: 10.7150/ ijms.8577   Research Paper   Effects of Ang II Receptor Blocker Irbesartan on  Adipose Tissue Function  in Mice with Metabolic  Disorders  Akinobu Maeda1, Kouichi Tamura1, Hiromichi Wakui1, Masato Ohsawa1, Kengo Azushima1, Kazushi  Uneda1, Ryu Kobayashi1, Yuko Tsurumi -Ikeya1, Tomohiko Kanaoka1, Toru Dejima1, Koji Ohki1, Sona  Haku1, Akio Yamashita2 and Satoshi  Umemura1   1.",Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
This is an open- access article distributed under the terms of the Crea tive Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
11     http://www.medsci.org  647  cular  homeostasis.,Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
11     http://www.medsci.org  648  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
11     http://www.medsci.org  649    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
"11     http://www.medsci.org  650  process in adipose tissue in metabolic disorders [17,  19].",Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
11     http://www.medsci.org  651  References   1.,Non-OADS,/arxiv_data1/oa_pdf/85/05/ijmsv11p0646.PMC4021097.pdf
"1 1      http://www.medsci.org  652  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(6):  652-657.  doi: 10.7150/ ijms.6337   Research Paper   Risk-Factor Analysis of Poor Graft Function after  Allogeneic Hematopoietic Stem Cell Transplantation   Yang Xiao*,Jiayin  Song*, Zujun  Jiang, Yonghua Li, Yang Gao, Wenning Xu , Ziyuan Lu,  Yaochun Wang ,  Haowen Xiao  Department of Hematology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, China  * These author contributed equally to this study.",Non-OADS,/arxiv_data1/oa_pdf/50/a7/ijmsv11p0652.PMC4021098.pdf
11     http://www.medsci.org  653  congenital diseases.,Non-OADS,/arxiv_data1/oa_pdf/50/a7/ijmsv11p0652.PMC4021098.pdf
"11     http://www.medsci.org  654  TBI+CY in 10;  tomotherapy+CY in three, and  other  conditioning regimens in 11.",Non-OADS,/arxiv_data1/oa_pdf/50/a7/ijmsv11p0652.PMC4021098.pdf
11     http://www.medsci.org  655  months) by September 2012.,Non-OADS,/arxiv_data1/oa_pdf/50/a7/ijmsv11p0652.PMC4021098.pdf
"11     http://www.medsci.org  656  Variables  Group  Number of patients   χ2* P vale   No-PGF , N (%)  PGF , N (%)   Time to BMT (M)  <6 44(43.1)  7(58.3)  0.915  0.735   6~12  27(26.5)  2(16.7)     12~ 31(30.4)  3(25.0)     Infection before BMT  No 98(89.9)  13(86.7)  — 0.657   Yes 11(10.1)  2(13.3)     Bacterial infection post BMT (in 30  days)  No 65(59.6)  8(53.3)  0.216  0.642   Yes 44(40.4)  7(46.7)     History of Hepatitis B  No 87(79.8)  11(73.3)  — 0.516   Yes 22(20.2)  4(26.7)     MNC infusion number 5×108/kg  <5 13(13.1)  1(8.3)  0.807  0.712   5-10 70(70.7)  8(66.7)     10~ 16(16.2)  3(25.0)     CD34+ infusion number (2×106/kg)  <5 47(57.3)  11(78.6)  1.918  0.372   5-10 28(34.1)  3(21.4)     10~ 7(8.5)  0(0.0)     Note : *Count data was analyzed by Chi -square test and if theoretical frequency of any cell was less than 5, Fish exact test was conducted instead.",Non-OADS,/arxiv_data1/oa_pdf/50/a7/ijmsv11p0652.PMC4021098.pdf
"11     http://www.medsci.org  657  and molecular biological methods, and the emergence  of fluorescent multiplex short tandem repeat loci PCR amplification, has demonstrated that some patients may experience PGF even under conditions of 100% donor chimersim.",Non-OADS,/arxiv_data1/oa_pdf/50/a7/ijmsv11p0652.PMC4021098.pdf
"Available at: http://tolweb.org/Riodinidae/12174 Büttiker W, Krenn HW, Putterill J.",Non-OADS,/arxiv_data1/oa_pdf/a1/58/bij0110-0291.PMC4021108.pdf
"http://cpms.chiba-u.jp/ .A c c e s s e d2 5J u n e 2013 Mori C, Komiyama M, Adachi T, Sakurai K, Nishimura D, Takashima K, Todaka E (2002) Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals including endocrine disruptors in human fetuses.",OADS,/arxiv_data1/oa_pdf/c2/1d/11356_2013_Article_1965.PMC4021163.pdf
"Neurotoxicol Teratol 27:771 –780 WHO (2013) Health topics “Breast feeding ”.http://www.who.int/ topics/breastfeeding/en/ (accessed 3 February) Wilson ND, Shear NM, Paustenbach DJ, Price PS (1998) The effect of cooking practices on the concentration of DDT and PCB com-pounds in the edible tissue of fish.",Non-OADS,/arxiv_data1/oa_pdf/c2/1d/11356_2013_Article_1965.PMC4021163.pdf
This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.,Non-OADS,/arxiv_data1/oa_pdf/94/cd/TOMICROJ-8-25.PMC4021205.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lic- enses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/9c/TONEUJ-8-1.PMC4021206.pdf
"187 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgAsthma is characterized by chronic inflammation of the air - ways, and inhaled steroids (ICSs) currently represent the most  effective anti-asthma medication.",Non-OADS,/arxiv_data1/oa_pdf/24/95/aair-6-187.PMC4021234.pdf
"2014 May;6(3):187-188. http://dx.doi.org/10.4168/aair.2014.6.3.187 pISSN 2092-7355 • eISSN 2092-7363 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/95/aair-6-187.PMC4021234.pdf
"2014 May;6(3):187-188. http://dx.doi.org/10.4168/aair.2014.6.3.187Volume 6, Number 3, May 2014 188 http://e-aair.orgria is initiated by DCs.",Non-OADS,/arxiv_data1/oa_pdf/24/95/aair-6-187.PMC4021234.pdf
"189 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Obesity is an important risk factor in the development of asth - ma.1 The prevalence of asthma is higher in obese than in lean  adults1,2 and obesity increases the incidence of asthma by 2.0-  and 2.3-fold in children and adults, respectively.2,3 Moreover,  significant dose-dependent effects of elevated body mass index  on asthma are observed.1,2 Obese asthmatic patients are often described as severe and  poorly controlled4,5 perhaps because they are less responsive to  corticosteroids and exhibit a different ( e.g., less atopic) inflam - matory phenotype.6 Obesity is associated with chronic low-grade  systemic inflammation that is thought to enhance systemic  complications.7 It is known that adipose tissue can regulate sys - temic inflammation through the production of a variety of adi - pokines which may link the two disorders mechanistically.8  Such observations, made in a number of epidemiological stud - ies, imply that obesity increases the risk of developing asthma  and implicates immunological mechanisms relevant to both  disorders.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189 pISSN 2092-7355 • eISSN 2092-7363 Increasing epidemiological data identify a link between obesity and asthma incidence and severity.,Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"Key Words:  Obesity; asthma; adipokines; eosinophils; macrophages; adipose tissue This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189Volume 6, Number 3, May 2014 190 http://e-aair.orgrect role of leptin on airway inflammation in obese asthmatic  patients, several studies suggest that systemic leptin is associat - ed with severity of symptoms, impairment of lung function,20,21  and enhancement of airway hyperresponsiveness (AHR) includ - ing exercise-induced bronchoconstriction.21,22 A case-control  study demonstrated that body mass index was highly associat - ed with greater levels of urinary cysteinyl leukotrienes and lev - els of leptin were positively associated with urinary cysteinyl  leukotriene levels.23 In contrast, a controlled observational study  failed to show a significant obesity-by-asthma interaction al - though systemic inflammatory markers were higher in obese  subjects.24 Longitudinal analysis of a large population-based  cohort followed over 25 years demonstrated that body mass in - dex is a stronger predictor of incident asthma than the metabol - ic syndrome, especially in women.25 A similar trend in women  was shown in a second longitudinal study.19 Hersoug et al.26 hypothesized that changes in adipokines and  proinflammatory cytokines secreted by adipose tissue result in  increased risk of an allergic disease such as asthma, by decreas - ing development of immunologic tolerance.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189AAIR  191 http://e-aair.orgDelay in eosinophil crossing to the airway lumen  Most studies have failed to show differences in peripheral  blood, sputum, or bronchoalveolar lavage (BAL) fluid eosino - phil numbers comparing obese to non-obese asthmatics.42-47  Indeed, eosinophil numbers in BAL fluid or induced sputum  were often lower in obese compared to non-obese subjects.48-50  Interestingly, obesity may affect eosinophil trafficking from the  bone marrow to lung tissue and interfere with transit to the air - ways in mice with experimental asthma.50 In this study, mice  were fed a high-fat diet and eosinophil counts, Th1 and Th2 cy - tokines, and chemokines in bone marrow, lung tissue, and BAL  fluid after sensitization and challenge with ovalbumin were  monitored.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189Volume 6, Number 3, May 2014 192 http://e-aair.orgclassified by its distribution, visceral, subcutaneous on the trunk,  subcutaneous on the limbs, or ectopic.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189AAIR  193 http://e-aair.orgeosinophils, activated macrophages and innate lymphoid cells,  advancements in understanding associations of obesity with  asthma are becoming more fruitful (Figure).",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189Volume 6, Number 3, May 2014 194 http://e-aair.orgcentral adiposity, circulating levels of glucose, and insulin resistance:  the CARDIA study.",Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
2014 May;6(3):189-195. http://dx.doi.org/10.4168/aair.2014.6.3.189AAIR  195 http://e-aair.org64.,Non-OADS,/arxiv_data1/oa_pdf/12/e9/aair-6-189.PMC4021235.pdf
"196 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION It is essential to standardize allergen extracts for commercial  allergy diagnostic and immunotherapeutic reagents.1 A project  for the standardization of allergen extracts has been supported  by the Korea Center for Disease Control and Prevention since  2009.",Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
2014 May;6(3):196-200. http://dx.doi.org/10.4168/aair.2014.6.3.196 pISSN 2092-7355 • eISSN 2092-7363 Allergy diagnosis and immunotherapy in Korea rely mostly on imported allergen extracts.,Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
"Key Words:  Allergen; allergen extract; standardizationThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
"2014 May;6(3):196-200. http://dx.doi.org/10.4168/aair.2014.6.3.196AAIR  197 http://e-aair.orgEvaluation and Research (CBER, Food and Drug Administra - tion, USA) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
"2014 May;6(3):196-200. http://dx.doi.org/10.4168/aair.2014.6.3.196Volume 6, Number 3, May 2014 198 http://e-aair.orgStandardization of pollen allergens Pollens from various plants are important causes of seasonal  allergic rhinitis.",Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
"2014 May;6(3):196-200. http://dx.doi.org/10.4168/aair.2014.6.3.196AAIR  199 http://e-aair.orgparia , A. princeps , A. tridentate , A. annu , and A. campestris ) re- vealed essentially the same pattern of IgE reactivity both to A.  vulgaris  and A. princeps .35 Therefore, we are conducting in vivo   standardization of mugwort extract using A. vulgaris .",Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
"2014 May;6(3):196-200. http://dx.doi.org/10.4168/aair.2014.6.3.196Volume 6, Number 3, May 2014 200 http://e-aair.orgCS, Park JW.",Non-OADS,/arxiv_data1/oa_pdf/18/0b/aair-6-196.PMC4021236.pdf
"201 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Asthma is a chronic inflammatory disease that is characterized  by infiltration of inflammatory cells such as eosinophils, airway  hypersensitivity, and airflow obstruction.1,2 Th2 cells play a par - ticularly crucial role in the development of asthma by secreting  interleukin (IL)-4, IL-5, and IL-13: IL-4 causes naïve T cells to  differentiate into Th2 cells while IL-5 induces eosinophil infil - tration.3 The hygiene hypothesis proposes that westernized culture and  its associated improvements in sanitation cause the microbial  exposure of the population to be reduced.",Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Bacillus Calmette-Guérin (BCG) is known to suppress the asthmatic responses in a murine model of asthma and to induce dendritic cells  (DCs) maturation.,Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
"Key Words:  BCG; dendritic cells; T-lymphocytes, regulatory; asthma; allergic inflammation; mouseThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
"2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201Volume 6, Number 3, May 2014 202 http://e-aair.orging growth factor (TGF)- β14 and by cell-cell contact mechanism  that is mediated cytotoxic lymphocyte associated antigen-4  (CTLA-4) expressed by CD4+CD25+ Tregs, which interacts with  CD80 and/or CD86 on the surface of antigen-presenting cells  (APCs).15 Bacillus Calmette-Guérin (BCG) is a mycobacterial vaccine  organism that is used to prevent tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
"2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201AAIR  203 http://e-aair.orgBronchoalveolar lavage (BAL) and determination of the  cellular composition of the BAL fluid  After measurement of BHR, mice were anaesthetized.",Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
"2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201Volume 6, Number 3, May 2014 204 http://e-aair.orgBAL fluid analysis revealed that the anti-CD25 mAb treatment  also significantly increase the total cell numbers and eosino - phils relative to the mice that treated the BCG-stimulated DCs  (P<0.01, respectively, Fig.",Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201AAIR  205 http://e-aair.orgcounts in the BAL fluid and the infiltration of inflammatory  cells in the lung.,Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
"2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201Volume 6, Number 3, May 2014 206 http://e-aair.orgACKNOWLEDGMENTS All authors declare there are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
2014 May;6(3):201-207. http://dx.doi.org/10.4168/aair.2014.6.3.201AAIR  207 http://e-aair.orgClin Invest 2004;114:1389-97.,Non-OADS,/arxiv_data1/oa_pdf/bf/2b/aair-6-201.PMC4021237.pdf
"208 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Atopic dermatitis (AD) is the most common chronic inflam - matory skin disease in pediatric populations.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  To evaluate a therapeutic efficacy of probiotics mixture (probiotics) in the treatment of children with mild-to-moderate atopic dermatitis  (AD).,Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"Key Words:  Atopic dermatitis; cytokines; placebo-controlled trial; probiotics; Randomized Controlled TrialThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208AAIR  209 http://e-aair.orgAlthough a handful of species have been considered effective  for the prevention of AD, the efficacy of probiotics in the man - agement of AD is unknown.10 Humans regularly eat foods con - taining probiotic bacteria, such as yogurt or other fermented  foods.11 However, because most studies use only single strains  of probiotic bacteria, little is known about the efficacy of probi - otic mixtures, particularly whether mixing strains result in syn - ergistic or inhibitory effects on the treatment of atopic disease.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208Volume 6, Number 3, May 2014 210 http://e-aair.orgAs secondary outcomes we compared fecal CFUs for each pro - biotic strain ( L. casei , L. rhamnosus , L. plantarum , and B. lactis ),  and serum cytokine levels (interleukin-4, IL-4; interleukin 10,  IL-10; tumor necrosis factor alpha, TNF- α) in weeks 0 and 6.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208AAIR  211 http://e-aair.orgComparison of ∆ESAI, ∆VASP, and ∆fecal cell counts between  groups The degree of improvement (∆ESAI and ∆VASP) was similar  in both groups (∆ESAI, probiotics group, -2.00 vs placebo group,  -2.75, P=0.28; ∆VASP , probiotics group, -1.00 vs placebo group,  -1.00, P=0.32).",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208Volume 6, Number 3, May 2014 212 http://e-aair.orgwith protection from atopic and allergic disease, strongly sup - porting the so-called ‘hygiene hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208AAIR  213 http://e-aair.orgTo date, the clinical efficacy of probiotics on the treatment  and prevention of AD has been inconsistent, though probiotics  continue to be viewed as an effective strategy for the manage - ment of this disease.23 While the primary source of this incon - sistency may be differences in study populations and research  protocols, it may also be related to differences in dietary habits  associated with different ethnicities.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208Volume 6, Number 3, May 2014 214 http://e-aair.orgexpected to occur randomly in both the treatment and control  groups.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
2014 May;6(3):208-215. http://dx.doi.org/10.4168/aair.2014.6.3.208AAIR  215 http://e-aair.orgMed Microbiol 2010;300:57-62.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/aair-6-208.PMC4021238.pdf
"216 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION DRESS syndrome is characterized by fever, cutaneous erup - tion, internal organ involvement, and hematologic abnormali - ties 1-8 weeks after the administration of the culprit drug,1 with  an incidence ranging from 1 in 1,000 to 1 in 10,000 exposures in  patients taking the drug.2,3 In 1996, Bocquet et al .4 proposed the  term DRESS syndrome and its diagnostic criteria.",Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
2014 May;6(3):216-221. http://dx.doi.org/10.4168/aair.2014.6.3.216 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is characterized by prolonged clinical symptoms even after  the withdrawal of the culprit drug.,Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
"Key Words:  Diagnosis; drug hypersensitivity; lymphocytes; prognosisThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
2014 May;6(3):216-221. http://dx.doi.org/10.4168/aair.2014.6.3.216AAIR  217 http://e-aair.orgUniversity Hospital due to adverse drug reactions between Jan - uary 2005 and July 2012.,Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
"2014 May;6(3):216-221. http://dx.doi.org/10.4168/aair.2014.6.3.216Volume 6, Number 3, May 2014 218 http://e-aair.orgsatisfied RegiSCAR probable (or more) criteria and 28 (75.7%)  satisfied the RegiSCAR definite criteria.",Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
"2014 May;6(3):216-221. http://dx.doi.org/10.4168/aair.2014.6.3.216AAIR  219 http://e-aair.organd 5 patients (13.5%), respectively.",Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
"Forthcoming http://e-aair.org page 4 of 6and 5 patients (13.5%), respectively.",Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
"2014 May;6(3):216-221. http://dx.doi.org/10.4168/aair.2014.6.3.216Volume 6, Number 3, May 2014 220 http://e-aair.orgwere no differences in the values of WBC, lymphocyte, eosino - phil, hemoglobin, platelet, ESR, CRP , AST, ALT, total bilirubin,  LDH, or the duration of medication before symptoms between  fatal and non-fatal patients.",Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
2014 May;6(3):216-221. http://dx.doi.org/10.4168/aair.2014.6.3.216AAIR  221 http://e-aair.orgWe analyzed early prognostic factors that contribute to the  duration of clinical symptoms.,Non-OADS,/arxiv_data1/oa_pdf/fb/79/aair-6-216.PMC4021239.pdf
"222 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION The global prevalence and economic burden of allergic dis - eases has increased.1-5 The prevalence of allergic rhinitis, aller - gic conjunctivitis and asthma are 38.7%, 18.3%, and 10.3%, re - spectively, in Korean school-aged children.1 For Korean adults,  allergic rhinitis and asthma are 20.9% and 11.7%, respectively.6  Environmental factors are considered more crucial than genet - ic factors for the recent increase in the prevalence of allergic dis - eases.7 Environmental factors such as smoking, lifestyle, obesity,  pets, diet, and air pollution are considered causative or aug - menting factors of allergic diseases.8-10 House dust is an impor - tant indoor pollutant due to its inclusion of various indoor al - lergens such as house dust mites (HDM), animal dander, cock - roach allergen, and adjuvant materials from microbiologic or - ganisms such as chitin, endotoxins, and β-glucan.11 HDMs are  the primary inhalant allergen,12-14 and about 60% of the Korean A Nationwide Survey of Inhalant Allergens Sensitization and  Levels of Indoor Major Allergens in Korea  Hye Jung Park,1,2 Jae-Hyun Lee,1,2 Kyung Hee Park,1,2 Hea Won Ann,3 Moo-Nyun Jin,3 Soo-Young Choi,2 Yong-Won Lee,1,2  Chein-Soo Hong,1,2 Jung-Won Park1,2* 1Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea 2Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea 3Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea population is sensitized to HDM.6,15  The Korean National Health and Nutrition Examination Sur - vey (KNHANES) has been conducted by the Korean Centers for  Disease Control and Prevention since 1998 to compile basic re - sources for national health information; in addition, a Phase IV  survey was conducted from 2007 to 2009.",Non-OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
2014 May;6(3):222-227. http://dx.doi.org/10.4168/aair.2014.6.3.222 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  The higher prevalence of respiratory allergic disease may be due to increased exposure to inhalation allergens.,Non-OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
"Key Words:  Allergen; skin test; dust; indoor; KoreaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
"2014 May;6(3):222-227. http://dx.doi.org/10.4168/aair.2014.6.3.222AAIR  223 http://e-aair.orgMATERIALS AND METHODS Participants This study applied stratified, cluster, and systematic sampling  procedures to select enumeration districts based on population,  housing data and enumeration district information from the  2005 Population and Housing Census.",OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
"2014 May;6(3):222-227. http://dx.doi.org/10.4168/aair.2014.6.3.222Volume 6, Number 3, May 2014 224 http://e-aair.orgStatistical analysis Statistical analyses were performed using SPSS version 12.0  (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
2014 May;6(3):222-227. http://dx.doi.org/10.4168/aair.2014.6.3.222AAIR  225 http://e-aair.orgwide survey on allergic diseases in autumn and winter and the  levels of indoor allergens using various diagnostic tools.,Non-OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
"2014 May;6(3):222-227. http://dx.doi.org/10.4168/aair.2014.6.3.222Volume 6, Number 3, May 2014 226 http://e-aair.orgthat supplementary diagnostic tools or allergy specialist inter - view and physical examination are essential for accurate evalua - tion.",Non-OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
2014 May;6(3):222-227. http://dx.doi.org/10.4168/aair.2014.6.3.222AAIR  227 http://e-aair.orghealth perspective.,Non-OADS,/arxiv_data1/oa_pdf/22/cf/aair-6-222.PMC4021240.pdf
"228 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Anisakis  is a genus of parasitic nematodes belonging to the  family Anisakidae .",Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
2014 May;6(3):228-233. http://dx.doi.org/10.4168/aair.2014.6.3.228 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Recent studies have used the term “gastroallergic anisakiasis” to describe incidental gastrointestinal infection with Anisakis  spp.,Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
"Key Words:  Anisakis; food hypersensitivity; immediate hypersensitivity; skin tests; immunoglobulin E; nematode InfectionsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
"2014 May;6(3):228-233. http://dx.doi.org/10.4168/aair.2014.6.3.228AAIR  229 http://e-aair.orgIn a general hospital in Jeju, Korea, where the consumption of  raw seafood is common and habitual, we enrolled 17 cases of  gastroallergic anisakiasis along with a control group consisting  of patients who had never experienced a reaction to raw seafood,  despite frequent consumption.",Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
"2014 May;6(3):228-233. http://dx.doi.org/10.4168/aair.2014.6.3.228Volume 6, Number 3, May 2014 230 http://e-aair.orgRESULTS Demographic characteristics of the case and control subjects Seventeen cases (mean age, 53 ±16 years; male 58.8%) were  enrolled in the study.",Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
"2014 May;6(3):228-233. http://dx.doi.org/10.4168/aair.2014.6.3.228AAIR  231 http://e-aair.orgto other parasitic infestations, which are rarely encountered in  developed countries, the incidence of anisakiasis may be in - creasing due to the growing popularity of raw seafood dishes worldwide.1,18 The host sea creatures of Anisakis  spp.",Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
"2014 May;6(3):228-233. http://dx.doi.org/10.4168/aair.2014.6.3.228Volume 6, Number 3, May 2014 232 http://e-aair.orgcosa.",Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
2014 May;6(3):228-233. http://dx.doi.org/10.4168/aair.2014.6.3.228AAIR  233 http://e-aair.organd review of the literature.,Non-OADS,/arxiv_data1/oa_pdf/db/a8/aair-6-228.PMC4021241.pdf
"234 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTON Asthma is a polygenic disease of the lungs involving a complex  interplay of the genetic makeup of an individual and the envi - ronmental stimuli, characterized by wheeze, shortness of breath  (SOB), cough, dyspnea and bronchial hyperresponsiveness (BHR)  caused due to the bronchial inflammation.1,2  Over the last decade, the prevalence of atopic diseases such as  asthma, dermatitis and allergic rhinitis has been on a rise glob - ally, and understanding the mechanisms of onset and severity  of allergy, has offered a great challenge to researchers and sci - entists worldwide, due to the complex interplay of genetic as  well as environmental factors.3 According to the second Nation - al Family Health Survey (NFHS 2), conducted in the year 1998- 1999, asthma is the most common disease in India, both in ur - ban as well as rural areas, as compared to tuberculosis (TB), di - abetes, malaria, thyroid and other diseases.",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Asthma is the most prevalent disease in India according to the national survey conducted by NFHS 2 in 1998-1999.,Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"Key Words:  Asthma; collagenase; matrix metalloproteinase-2 (MMP-2); polymorphism This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234AAIR  235 http://e-aair.orgknown to modulate inflammation, inflammatory cells influx  and angiogenesis in asthma patients.12   Matrix metalloproteinases (MMPs) are zinc-dependent pro - teases that are involved in the breakdown of extracellular ma - trix (ECM) in the normal physiological processes13 of the body  such as cell proliferation, tissue remodeling, reproduction, em - bryonic development, differentiation, angiogenesis, apoptosis  and host defenses, while the dysregulation of these matrixins  has been associated with the disease processes such as arthri - tis, encephalomyelitis, chronic ulcers, tumor invasion, cancer  as well as inflammation.14 Matrix metalloproteinase-2 (MMP-2) is a 72 kDa gelatinase  and collagenase encoded by the MMP-2 gene in humans, which  degrades the type IV collagen of the basement membranes.",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234Volume 6, Number 3, May 2014 236 http://e-aair.orgforced expiratory and then a forced inspiratory manoeuvre.",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234AAIR  237 http://e-aair.org72°C for 1 minute, and final extension step at 72°C for 10 min - utes.",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234Volume 6, Number 3, May 2014 238 http://e-aair.orgmales (61.5%).",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234AAIR  239 http://e-aair.orgallergy.,Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234Volume 6, Number 3, May 2014 240 http://e-aair.orgmor invasion.36 A previous study conducted on MMP-2 structure and function  has reported that a C→T transition at nucleotide -1306 in the  promoter region of MMP-2 gene, abolishes the Sp-1 binding site  and ultimately leads to down-regulation of the MMP-2 gene ex - pression.37 Thus lesser MMP-2 in circulation, fails to induce in - flammation, thereby unable to exacerbate asthmatic conditions.",Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
2014 May;6(3):234-241. http://dx.doi.org/10.4168/aair.2014.6.3.234AAIR  241 http://e-aair.orgel of asthma.,Non-OADS,/arxiv_data1/oa_pdf/c9/de/aair-6-234.PMC4021242.pdf
"242 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Asthma is a chronic inflammatory airways disease character - ized by airway obstruction and bronchial airway hyperrespon - siveness.1 However, pulmonary function tests can be often nor - mal even in subjects with uncontrolled asthma symptoms.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242 pISSN 2092-7355 • eISSN 2092-7363 Purpose:  Our study tried to find a relationship between baseline FEF 25-75% and airway hyperresponsiveness (AHR) and whether a greater FEF 25-75% im - pairment may be a marker of a more severe hyperresponsiveness in subjects with normal FEV1 and FEV1/FVC and suggestive asthma symptoms.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"Key Words:  Airway hyperresponsiveness; small airways; methacholine test; asthma; FEF 25-75; diagnosisThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242AAIR  243 http://e-aair.orgevidence that FEF 25-75 may be also an asthma severity marker  especially in subjects with normal FEV1 and FEV1/FVC.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242Volume 6, Number 3, May 2014 244 http://e-aair.orgrange (IQR - 25° and 75° quartiles) according to whether they  were normally distributed.",OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242AAIR  245 http://e-aair.orgto FEF 25-75>70%) both in all subjects (OR, 1.39; 95%CI, 1.14-1.69;  P<0.01) and also only in those affected by moderate/severe  (OR, 1.35; 95%CI, 1.06-1.72; P<0.01) or borderline AHR (OR,  1.33; 95%CI, 1.05-1.69; P<0.01).",Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242Volume 6, Number 3, May 2014 246 http://e-aair.orgues of FEV1 and FEV1/FVC were observed with the increase of  FEF 25-75% (Fig.",OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242AAIR  247 http://e-aair.orgincrease in the number of hyperresponsive subjects and levels  of AHR in individuals with suggestive asthma symptoms and  normal pulmonary function.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242Volume 6, Number 3, May 2014 248 http://e-aair.orgasthma (as in our patients), make an asthma diagnosis less  probable.26 For this reason we arbitrarily used the 400 µg cut-off  to distinguish subjects with a higher from those with a lower  probability to be asthmatics, reducing to minimum the possi - bility that at least in the group with PD20 <400 µg there are not  any non-asthmatics.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242AAIR  249 http://e-aair.orgnormoreactive subjects.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"Available from: http://www.ginasth - ma.org/GINA-Report,-Global-Strategy-for-Asthma-Management- and-Prevention.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242Volume 6, Number 3, May 2014 250 http://e-aair.org11.",Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
Available from: http://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
2014 May;6(3):242-251. http://dx.doi.org/10.4168/aair.2014.6.3.242AAIR  251 http://e-aair.org53:91-5.,Non-OADS,/arxiv_data1/oa_pdf/d1/65/aair-6-242.PMC4021243.pdf
"252 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Asthma is a chronic inflammation of airways with complex  etiologies involving both genetic and environmental contribu - tions; the disease is associated with the release of myriad pro- inflammatory substances, including lipid mediators, inflam - matory peptides, chemokines, cytokines and growth factors.",Non-OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
2014 May;6(3):252-256. http://dx.doi.org/10.4168/aair.2014.6.3.252 pISSN 2092-7355 • eISSN 2092-7363 Several lines of evidence are implicating an increased persistence of apoptotic cells in patients with asthma.,Non-OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
"Key Words:  p53; ACP1 ; genetic polymorphism; asthma; allergy; apoptosisThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
"2014 May;6(3):252-256. http://dx.doi.org/10.4168/aair.2014.6.3.252AAIR  253 http://e-aair.orgenzyme controlled by an autosomal locus showing 3 codomi - nant alleles ACP1  A, B, and C. By a combination of the 3 alleles  can have 6 genotypes with a different enzymatic activity, in the  order of A/A <A/B<B/B≤A/C<B/C<C/C, the genotype C/C is  very rare.12  ACP1  specifically dephosphorylates the negative regulatory  Tyr-292 of ZAP-70 (zeta-chain-associated protein kinase 70),  thereby counteracting the inactivation of ZAP-70.",Non-OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
"2014 May;6(3):252-256. http://dx.doi.org/10.4168/aair.2014.6.3.252Volume 6, Number 3, May 2014 254 http://e-aair.orgchildren with allergic asthma and in controls in relation to ACP1   genotype.",Non-OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
2014 May;6(3):252-256. http://dx.doi.org/10.4168/aair.2014.6.3.252AAIR  255 http://e-aair.orgnisms and the role of genetic and environmental factors in sus - ceptibility and clinical course of disease.,Non-OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
"2014 May;6(3):252-256. http://dx.doi.org/10.4168/aair.2014.6.3.252Volume 6, Number 3, May 2014 256 http://e-aair.orgphage function.",OADS,/arxiv_data1/oa_pdf/88/d3/aair-6-252.PMC4021244.pdf
"257 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Dermatophagoides (D) siboney  was first reported in Cuba.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"2014 May;6(3):257-262. http://dx.doi.org/10.4168/aair.2014.6.3.257 pISSN 2092-7355 • eISSN 2092-7363 A significant-source of allergens come from house dust that contain particles derived from arthropods, molds, and pet dander.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"Key Words:  Dermatophagoides siboney; Dermatophagoides farinae; domestic mitesThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"2014 May;6(3):257-262. http://dx.doi.org/10.4168/aair.2014.6.3.257Volume 6, Number 3, May 2014 258 http://e-aair.orgUnion Medical College Hospital approved the study protocol.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
2014 May;6(3):257-262. http://dx.doi.org/10.4168/aair.2014.6.3.257AAIR  259 http://e-aair.orgdid not extend forward to the seta d2.,Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"2014 May;6(3):257-262. http://dx.doi.org/10.4168/aair.2014.6.3.257Volume 6, Number 3, May 2014 260 http://e-aair.orgBooklice in house dust  Booklouse specimens were found in 29 dust samples in 21  homes.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"2014 May;6(3):257-262. http://dx.doi.org/10.4168/aair.2014.6.3.257AAIR  261 http://e-aair.orgcalis  in 95.9%, Cheyletus malaccensis  in 69.9%, D. farinae  in 2%,  and D. siboney  in 6%.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"2014 May;6(3):257-262. http://dx.doi.org/10.4168/aair.2014.6.3.257Volume 6, Number 3, May 2014 262 http://e-aair.org6.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/aair-6-257.PMC4021245.pdf
"263 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Allergic asthma (BA) and allergic rhinitis (AR) are chronic air - way inflammatory diseases characterized by eosinophilic infil - tration in response to inhalant allergens in genetically suscepti - ble patients.",Non-OADS,/arxiv_data1/oa_pdf/45/02/aair-6-263.PMC4021246.pdf
"2014 May;6(3):263-266. http://dx.doi.org/10.4168/aair.2014.6.3.263 pISSN 2092-7355 • eISSN 2092-7363 Staphylococcus aureus  is the most common bacterium present in upper respiratory tract, and the toxins it produced are involved in allergic inflam - mation pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/45/02/aair-6-263.PMC4021246.pdf
"Key Words:  Superantigen; specific IgE; allergic rhinitis; bronchial asthmaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/02/aair-6-263.PMC4021246.pdf
"2014 May;6(3):263-266. http://dx.doi.org/10.4168/aair.2014.6.3.263Volume 6, Number 3, May 2014 264 http://e-aair.org(group II, n =100), and healthy controls (group III, n =88) from  Ajou University Hospital.",Non-OADS,/arxiv_data1/oa_pdf/45/02/aair-6-263.PMC4021246.pdf
"2014 May;6(3):263-266. http://dx.doi.org/10.4168/aair.2014.6.3.263AAIR  265 http://e-aair.orgDISCUSSION Since it was discovered that innate and adaptive immunity  were involved in the development of allergic inflammation and  that SA is common in the upper respiratory tract, the role of SA  and its toxins have been studied in many allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/45/02/aair-6-263.PMC4021246.pdf
"2014 May;6(3):263-266. http://dx.doi.org/10.4168/aair.2014.6.3.263Volume 6, Number 3, May 2014 266 http://e-aair.orgexposure has the ability to generate both a superantigen and a  chronic allergic response through IgE production.",Non-OADS,/arxiv_data1/oa_pdf/45/02/aair-6-263.PMC4021246.pdf
"267 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Asthma-like symptoms are anxiety producing for  patients, and  improper diagnosis leads to inappropriate use of asthma medi - cations, unnecessary office and emergency room visits and re - ferral to specialists to determine the cause.",Non-OADS,/arxiv_data1/oa_pdf/95/73/aair-6-267.PMC4021247.pdf
2014 May;6(3):267-269. http://dx.doi.org/10.4168/aair.2014.6.3.267 pISSN 2092-7355 • eISSN 2092-7363 We present a woman with heterozygous carnitine palmitoyl transferase 2 (CPT-2) deficiency who in the last 6 months suffered from episodic dyspnea  and choking.,Non-OADS,/arxiv_data1/oa_pdf/95/73/aair-6-267.PMC4021247.pdf
"Key Words:  Laryngeal spasm; asthma; vitamin D deficiency; calcium deficiencyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/73/aair-6-267.PMC4021247.pdf
"2014 May;6(3):267-269. http://dx.doi.org/10.4168/aair.2014.6.3.267Volume 6, Number 3, May 2014 268 http://e-aair.orgin FEV1 and in both expiratory and inspiratory airflow rates,  within the first minute (Figure A), which lasted more than 5  minutes.",Non-OADS,/arxiv_data1/oa_pdf/95/73/aair-6-267.PMC4021247.pdf
2014 May;6(3):267-269. http://dx.doi.org/10.4168/aair.2014.6.3.267AAIR  269 http://e-aair.orgcy.,Non-OADS,/arxiv_data1/oa_pdf/95/73/aair-6-267.PMC4021247.pdf
"270 © Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease http://e-aair.orgINTRODUCTION Drug rash with eosinophilia and systemic symptoms (DRESS)  syndrome, also known as drug induced hypersensitivity syn - drome (DIHS), is a type of adverse drug reaction, which is a se - vere life threatening systemic disease that should be differenti - ated from Stevens-Johnson syndrome and toxic epidermal  necrolysis.1,2 The primary clinical manifestations are fever,  lymphadenopathy, rash, hypereosinophilia, and involvement  of systemic organs.",Non-OADS,/arxiv_data1/oa_pdf/47/a2/aair-6-270.PMC4021248.pdf
"2014 May;6(3):270-272. http://dx.doi.org/10.4168/aair.2014.6.3.270 pISSN 2092-7355 • eISSN 2092-7363 Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, also known as drug-induced hypersensitivity syndrome (DIHS), is a rare, acute  and severe life-threatening systemic disease.",Non-OADS,/arxiv_data1/oa_pdf/47/a2/aair-6-270.PMC4021248.pdf
"Key Words:  Drug hypersensitivity; chloral hydrateThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/a2/aair-6-270.PMC4021248.pdf
2014 May;6(3):270-272. http://dx.doi.org/10.4168/aair.2014.6.3.270AAIR  271 http://e-aair.orgmg/dL]) were decreased.,Non-OADS,/arxiv_data1/oa_pdf/47/a2/aair-6-270.PMC4021248.pdf
"2014 May;6(3):270-272. http://dx.doi.org/10.4168/aair.2014.6.3.270Volume 6, Number 3, May 2014 272 http://e-aair.orgral hydrate in early childhood.",Non-OADS,/arxiv_data1/oa_pdf/47/a2/aair-6-270.PMC4021248.pdf
"Because the main mechanism is a delayed  hypersensitivity reaction, one might hypothesize that the im -REVIEW http://dx.doi.org/10.4046/trd.2014.76.4.153 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:153-159 153Address for correspondence: Doosoo Jeon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e3/9a/trd-76-153.PMC4021261.pdf
"Department of Internal Medicine, Pusan National University Yangsan  Hospital, 20 Geumo-ro, Yangsan 626-787, Korea  Phone:  82-55-360-1414, Fax: 82-55-360-1757 E-mail: sooli10kr@yahoo.co.kr Received:  Jan. 30, 2014 Revised:  Feb. 7, 2014 Accepted:  Feb. 14, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/e3/9a/trd-76-153.PMC4021261.pdf
Tuberculous pleurisy http://dx.doi.org/10.4046/trd.2014.76.4.153  155 www.e-trd.orgThe introduction of thoracoscopy has had a very important  impact on diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/e3/9a/trd-76-153.PMC4021261.pdf
"Tuberculous pleurisy http://dx.doi.org/10.4046/trd.2014.76.4.153  157 www.e-trd.orgTreatment  Tuberculous pleurisy usually resolve spontaneously with - out treatment, but active tuberculosis develops in 43−65% of  patients over the several next years54,55.",Non-OADS,/arxiv_data1/oa_pdf/e3/9a/trd-76-153.PMC4021261.pdf
Tuberculous pleurisy http://dx.doi.org/10.4046/trd.2014.76.4.153  159 www.e-trd.org40.,Non-OADS,/arxiv_data1/oa_pdf/e3/9a/trd-76-153.PMC4021261.pdf
"Causes for the increase in  incidence remain uncertain, but the use of a wide range of  pneumococcal vaccines in children and an increasingly aging  global society, with an increase of elderly with chronic dis - eases have been suggested1.REVIEW http://dx.doi.org/10.4046/trd.2014.76.4.160 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:160-162 160Address for correspondence: Yong Soo Kwon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1e/37/trd-76-160.PMC4021262.pdf
"Department of Internal Medicine, Chonnam National University Medical  School, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Phone:  82-62-220-6575, Fax: 82-62-225-8578 E-mail: yskwon@chonnam.ac.kr Received:  Jan. 27, 2014 Revised:  Feb. 5, 2014 Accepted:  Feb. 11, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/1e/37/trd-76-160.PMC4021262.pdf
Pleural infection and empyema http://dx.doi.org/10.4046/trd.2014.76.4.160  161 www.e-trd.orgPathogens and Selection of Antibiotics The proper use of antibiotics is the most important predic - tor for death in this disease.,Non-OADS,/arxiv_data1/oa_pdf/1e/37/trd-76-160.PMC4021262.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.76.4.163 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:163-168 163Address for correspondence: Jaechun Lee, M.D., Ph.D. Department of Internal Medicine, Jeju National University School of  Medicine, 102 Jejudaehak-ro, Jeju 690-756, Korea Phone:  82-64-754-8170, Fax: 82-64-717-1131 E-mail: doc4u@hanmail.net Received:  Dec. 9, 2013 Revised:  Jan. 7, 2014 Accepted:  Feb. 19, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/9d/90/trd-76-163.PMC4021263.pdf
"Induced sputum in the diagnosis of pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2014.76.4.163  165 www.e-trd.orgunder nebulization (P ARI Company, Starnberg, Germany) with  5 mL of 7% NaCl solution for at least 5 minutes, and thereafter  to produce 3 sputum samples into aseptic sputum jars for AFB  smear, mycobacterial culture, and real-time polymerase chain  reaction (PCR) for M. tuberculosis and nontuberculous myco - bacterium (MTB & NTM kit; BioSewoom Inc., Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/9d/90/trd-76-163.PMC4021263.pdf
Positive  mycobacterial culture was defined as identification of either  or both M. tuberculosis  and nontuberculous mycobacterium  in an automated liquid or solid culture system requested in  the Korea Institute of Tuberculosis (http://www.kit.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/9d/90/trd-76-163.PMC4021263.pdf
Induced sputum in the diagnosis of pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2014.76.4.163  167 www.e-trd.orgsamples (15 samples from each group).,Non-OADS,/arxiv_data1/oa_pdf/9d/90/trd-76-163.PMC4021263.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.76.4.169 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:169-174 169Address for correspondence: Sang-Do Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/bb/2b/trd-76-169.PMC4021264.pdf
"11, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/bb/2b/trd-76-169.PMC4021264.pdf
"Korean Obstructive Lung Disease Cohort Study http://dx.doi.org/10.4046/trd.2014.76.4.169  171 www.e-trd.orgoutcome measurements included clinical, pulmonary func - tional, radiological, genetic outcomes.",Non-OADS,/arxiv_data1/oa_pdf/bb/2b/trd-76-169.PMC4021264.pdf
Korean Obstructive Lung Disease Cohort Study http://dx.doi.org/10.4046/trd.2014.76.4.169  173 www.e-trd.orgThese risks are particularly relevant to non-smoking Asian  females.,Non-OADS,/arxiv_data1/oa_pdf/bb/2b/trd-76-169.PMC4021264.pdf
Available from: http://www.anold.org/.,Non-OADS,/arxiv_data1/oa_pdf/bb/2b/trd-76-169.PMC4021264.pdf
"This parasitic infection has diverse symptoms and can  mimic other conditions, such as mycobacterial infection or CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.4.175 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:175-178 175Address for correspondence: Won-Jung Koh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/27/2f/trd-76-175.PMC4021265.pdf
"Received:  Dec. 7, 2012 Revised:  Dec. 31, 2012 Accepted:  Oct. 28, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/27/2f/trd-76-175.PMC4021265.pdf
"Pleural paragonimiasis http://dx.doi.org/10.4046/trd.2014.76.4.175  177 www.e-trd.orgpresentation of pleuropulmonary paragonimiasis, the dif - ferentiation of this infection from other causes of pleural effu - sion is important12.",Non-OADS,/arxiv_data1/oa_pdf/27/2f/trd-76-175.PMC4021265.pdf
"Certain diseases which were thought to be CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.4.179 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:179-183 179Address for correspondence: Kyung Hoon Min, M.D., Ph.D. Division of Respiratory and Critical Care Medicine, Department of  Internal Medicine, Korea University Guro Hospital, Korea University  College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea Phone:  82-2-2626-3308, Fax: 82-2-2626-1166 E-mail: minkyunghoon@korea.ac.kr Received:  Oct. 24, 2013 Revised:  Oct. 31, 2013 Accepted:  Oct. 31, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/82/72/trd-76-179.PMC4021266.pdf
IgG4-related disease presenting as massive pleural effusion and thrombophlebitis http://dx.doi.org/10.4046/trd.2014.76.4.179  181 www.e-trd.organd upper chest.,Non-OADS,/arxiv_data1/oa_pdf/82/72/trd-76-179.PMC4021266.pdf
"IgG4-related disease presenting as massive pleural effusion and thrombophlebitis http://dx.doi.org/10.4046/trd.2014.76.4.179  183 www.e-trd.orgrelated lung disease can present in various forms according to  involved sites: parenchyma, nodules or masses, or interstitial  pneumonia; airway, tracheobroncheal stenosis; pleura, pleural  nodules or effusions; mediastinum, lymphadenopathy or fi - brosing mediastinitis2.",Non-OADS,/arxiv_data1/oa_pdf/82/72/trd-76-179.PMC4021266.pdf
"Most relapses of NK/CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.4.184 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:184-187 184Address for correspondence: Jin-Young An, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e6/fb/trd-76-184.PMC4021267.pdf
"Department of Internal Medicine, Chungbuk National University College  of Medicine, 776 ilsunhwan-ro, Heungdeok-gu, Cheongju 361-711,  Korea Phone:  82-43-269 -6308, Fax: 82-43-273-3252 E-mail: drahnjy@chungbuk.ac.kr Received:  Sep. 13, 2013 Revised:  Sep. 30, 2013 Accepted:  Oct. 1, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/e6/fb/trd-76-184.PMC4021267.pdf
Pleural relapse of a extranodal NK-T cell lymphoma http://dx.doi.org/10.4046/trd.2014.76.4.184  185 www.e-trd.orgcells were observed on cytological analysis.,Non-OADS,/arxiv_data1/oa_pdf/e6/fb/trd-76-184.PMC4021267.pdf
Pleural relapse of a extranodal NK-T cell lymphoma http://dx.doi.org/10.4046/trd.2014.76.4.184  187 www.e-trd.orgpleurisy accounts for 25% of all cases of pleural effusion9.,Non-OADS,/arxiv_data1/oa_pdf/e6/fb/trd-76-184.PMC4021267.pdf
"Although the pathogenesis of AEP remains unclear, CASE REPORThttp://dx.doi.org/10.4046/trd.2014.76.4.188 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;76:188-191 188Address for correspondence: Yon Ju Ryu, M.D., Ph.D. Division of Pulmonary and Critical Care Medicine, Department of  Internal Medicine, Ewha Medical Center and Ewha Medical Research  Institute, Ewha Womans University Mokdong Hospital, Ewha Womans  University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu,  Seoul 158-710, Korea Phone:  82-2-2650-2840, Fax: 82-2-2650-2559 E-mail: medyon@ewha.ac.kr Received:  Sep. 3, 2013 Revised:  Oct. 1, 2013 Accepted:  Nov. 18, 2013 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
"Acute eosinophilic pneumonia after passive smoking http://dx.doi.org/10.4046/trd.2014.76.4.188  189 www.e-trd.org49.8 mm Hg, HCO3 22.0 mEq/L, and oxygen saturation 83.6%.",Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
Acute eosinophilic pneumonia after passive smoking http://dx.doi.org/10.4046/trd.2014.76.4.188  191 www.e-trd.orgprehensive studies should be designed to evaluate the effect of  passive smoking on AEP .,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
Ethical guidelines for research and publication   All work must conform to the ethical guidelines specified  on Uniform Requirements for Manuscripts Submitted to  Biomedical Journals (http://www.icmje.org/).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
Research involving human subjects must conform to the  ethical guidelines specified by the Declaration of Helsinki  (http://www.bioscience.org/guides/declhels.htm).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
"It is  recommended that any research dealing with a clinical  trial be registered with a primary national clinical trial  registration site such as http://ncrc.cdc.go.kr/cris, or other  sites accredited by the WHO or the Internation Committee  of Medical Journal Editors.",Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
or.kr/publishing_ethics.html) and ‘Guidelines on Good  Publication’ (http://www.publicationethics.org.uk/ guidelines).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
"Submission of manuscripts     All cover letters, checklists, manuscripts, figures and tables  should be submitted through the on-line submission system  (http://esubmit.lungkorea.org) of The Korean Academy  of Tuberculosis and Respiratory Diseases (http://www.",Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
org) of The Korean Academy of Tuberculosis  and Respiratory Diseases (http://www.lungkorea.org).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
Authors should use MeSH  (http://www.ncbi.nlm.nih.gov/mesh) terms from Index  Medicus.,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/trd-76-188.PMC4021268.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:100-106 The Role of Heat Shock Response in Insulin Resistance  and Diabetes Tatsuya Kondo1, Hiroyuki Motoshima1, Motoyuki Igata1, Junji Kawashima1, Takeshi Matsumura1, Hirofumi Kai2, Eiichi Araki1 Departments of 1Metabolic Medicine, 2Molecular Medicine, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan The expansion of life-style related diseases, such as metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM), appears to  be unstoppable.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
"More importantly, we explore  the benefits of novel treatment modality with a combination  of HS and mild electrical stimulation (MES) that activate HSR  efficiently and may target other molecules, providing new in - sights into physical medicine.Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.2.100 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
"101HSR in insulin resistance and diabetes Diabetes Metab J 2014;38:100-106 http://e-dmj.orgTHE EFFECTS OF HSR ACTIV ATION ON  DIABETIC MODEL MICE Mild electrical stimulation with hyperthermia We found that activation of HSR using mild electric current  with specific pulse wave and frequency in heat stimulation of  42 degrees, maximally induced HSP72, which is a major HSR  product to exert HSR effects.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
"Diabetes Metab J 2014;38:100-106 http://e-dmj.orgHSP72 inducer geranylgeranyl acetone Besides MET, a HSP72 inducible medication, geranylgeranyl  acetone (GGA) can be used to activate HSR.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
103HSR in insulin resistance and diabetes Diabetes Metab J 2014;38:100-106 http://e-dmj.orgTHE EFFECTS OF HSR ACTIV ATION ON  HUMANS Normal subjects We performed the safe confirmation trial employing normal sub - jects before applying MET to life style related diseases in humans  with MS or T2DM (Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
Diabetes Metab J 2014;38:100-106 http://e-dmj.orgformed.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
105HSR in insulin resistance and diabetes Diabetes Metab J 2014;38:100-106 http://e-dmj.orginterorgan crosstalk may regulate whole body glucose homeo - stasis.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
"Diabetes Metab J 2014;38:100-106 http://e-dmj.orgno Koga S, Y amashita Y , Miyamura N, Kai H, Araki E. Heat  shock treatment with mild electrical stimulation safely reduced  inflammatory markers in healthy male subjects.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/dmj-38-100.PMC4021296.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/2d/dmj-38-107.PMC4021297.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:107-108 Internet-Based Mentoring Program for Patients with  Type 1 Diabetes Sun-Hye Ko, Seung-Hyun Ko Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine,  Seoul, Korea Corresponding author: Seung-Hyun Ko Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea E-mail: kosh@catholic.ac.krRegardless of the type of diabetes, lifestyle modifications is an  essential component of diabetes management in patients with  diabetes.",Non-OADS,/arxiv_data1/oa_pdf/6d/2d/dmj-38-107.PMC4021297.pdf
"Considering their study conditions, such as long diabe - tes duration (about 6 years), young-aged adult (about 32 year- old) subjects, small study number, and short observation peri -Editorial Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.2.107 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/6d/2d/dmj-38-107.PMC4021297.pdf
"Diabetes Metab J 2014;38:107-108 http://e-dmj.orgod, we believe that emotional or psychosocial support with  positive feedback were helpful in motivating patients to famil - iarize with SMBG.",Non-OADS,/arxiv_data1/oa_pdf/6d/2d/dmj-38-107.PMC4021297.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:109-119 Prevalence and Determinants of Diabetic Nephropathy  in Korea: Korea National Health and Nutrition  Examination Survey Jae Hee Ahn1, Ji Hee Yu1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Dae Jung Kim3, Jae Hyeon Kim4, Chul Sik Kim5,   Kee-Ho Song6, Jong Chul Won7, Soo Lim8, Sung Hee Choi8, Kyungdo Han9, Bong-Yun Cha2, Nan Hee Kim1,   on behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Ansan, 2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 3Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon,  4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of  Medicine, Anyang,  6Department of Internal Medicine, Konkuk University School of Medicine, Seoul,  7Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul,  8Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam,  9Department of Biostatistics, The Catholic University of Korea, Seoul, Korea Background:  Diabetic nephropathy is a leading cause of end stage renal disease and is associated with an increased risk of car - diovascular mortality.",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"Approximately 40% of persons with  diabetes develop diabetic nephropathy, which manifests as al -Original Article Complications http://dx.doi.org/10.4093/dmj.2014.38.2.109 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"111Diabetic nephropathy in Korea Diabetes Metab J 2014;38:109-119 http://e-dmj.orgincluded a history of congestive heart failure, coronary heart  disease, heart attack, angina, or stroke.",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"Diabetes Metab J 2014;38:109-119 http://e-dmj.orgPrevalence and determinants of albuminuria according to  the diabetes status Albuminuria was more prevalent in subjects with diabetes than  in those without (26.7% vs. 10.2%, P<0.0001).",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"113Diabetic nephropathy in Korea Diabetes Metab J 2014;38:109-119 http://e-dmj.orgAssociation between glucose tolerance categories and CKD In the logistic regression analysis to determine the impact of di - abetes on CKD, subjects with diabetes had an increased risk of  CKD compared to those without diabetes (OR, 1.83; 95% CI,  1.13 to 2.96; P<0.0001) after adjusting for age, sex, BMI, SBP ,  exercise status, smoking status, and alcohol consumption status.",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"Diabetes Metab J 2014;38:109-119 http://e-dmj.orgtional Health and Nutrition Examination Survey (NHANES  III), which was conducted between 1988 and 1994, reported  that the prevalence of microalbuminuria and macroalbumin - uria was 35% and 6%, respectively, in adults with type 2 diabe - tes aged ≥40 years [19].",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
115Diabetic nephropathy in Korea Diabetes Metab J 2014;38:109-119 http://e-dmj.orgbut not in those with diabetes.,Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"Diabetes Metab J 2014;38:109-119 http://e-dmj.orgel were associated with an increased risk of microalbuminuria  [11-16], blood pressure was the only significant variable in the  present study, and HbA1c was only a marginally significant  determinant.",Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
117Diabetic nephropathy in Korea Diabetes Metab J 2014;38:109-119 http://e-dmj.org Our study has some limitations.,Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
119Diabetic nephropathy in Korea Diabetes Metab J 2014;38:109-119 http://e-dmj.orgnal risk factor in diabetic nephropathy?,Non-OADS,/arxiv_data1/oa_pdf/ac/27/dmj-38-109.PMC4021298.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:120-133 The Appropriateness of the Length of Insulin Needles  Based on Determination of Skin and Subcutaneous Fat  Thickness in the Abdomen and Upper Arm in Patients  with Type 2 Diabetes Kang Hee Sim1, Moon Sook Hwang2, Sun Y oung Kim1, Hye Mi Lee1, Ji Y eun Chang3, Moon Kyu Lee4 1Department of Nursing, Samsung Medical Center, Seoul, 2Department of Nursing Science, Woo Suk University, Wanju, 3Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, 4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  Longer needle and complicated insulin injection technique such as injecting at a 45-degree angle and making skin - folds may decrease patient compliance to insulin injection therapy.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"However the subcutaneous tissue thickness  of patients varies depending on the age, gender, body mass in - dex (BMI), and parts of the body [2,3], and the injected sub -Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.2.120 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
121Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgcutaneous area depends on the length of a needle [4].,Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"Diabetes Metab J 2014;38:120-133 http://e-dmj.orgago were selected based on the following criteria: 1) Those who do not have any muscular or neural diseases at  the sites of insulin injection on the abdomen and upper arm 2) Those who do not have any skin damage, such as wart,  contusion, or brush-burns, at the sites of ultrasound mea - surements on the abdomen and upper arm 3) Those who are not using an insulin pump at the sites of ul - trasound measurements on the abdomen and upper arm 4) Those who do not have diseases that may affect the skin  thickness, such as malignant tumor or collagen diseases 5) Those who were not treated with steroids for a prolonged  period of time 6) Those who have fully understood the objectives of this re - search and can communicate, as well as being able to sign  the agreements to participate  Subjects were chosen from those who have read the brochure  attached outside the Department of Internal Medicine in Sam - sung Medical Center and met our criteria for selection.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"123Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgabdomen, whereas insulin was injected from top to bottom,  resulting in 2 columns in the upper arm.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"Diabetes Metab J 2014;38:120-133 http://e-dmj.orgThe skin and subcutaneous fat thicknesses  The skin and subcutaneous fat thicknesses and the total skin  and subcutaneous fat thickness of the abdomen depending on  injection sites are shown in Table 2, with the thickness of the  skin of 2.29±0.37 mm (range, 1.34 to 3.29 mm), thickness of  subcutaneous fat of 10.15±6.54 mm (range, 0.75 to 36.34 mm), and the total skin and subcutaneous fat thickness of 12.44±   6.56 mm (range, 2.24 to 38.24 mm)  The thickest point of the skin in the abdomen was 7 for males  and 8 for females, whereas the thinnest point was 13 for both.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
125Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgtistical significance.,Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"Diabetes Metab J 2014;38:120-133 http://e-dmj.orgFactors influencing skin and subcutaneous fat thicknesses  of the abdomen and upper arm depending on injection sites In order to determine the influential factors for the skin and  subcutaneous fat thicknesses and the total skin and subcuta - neous fat thickness of the abdomen and upper arm, multiple  regression analysis was performed with the identified factors  that are related to this such as gender, age, and BMI as inde - pendent variables, as shown in Table 5.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
127Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgTable 4.,Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
Diabetes Metab J 2014;38:120-133 http://e-dmj.orgarm.,Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"129Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgtocorrelation, with Dubin-Watson statistics of 1.791 to 2.058,  and the variation inflation factor was 1.005 to 1.010 which is  lower than 10 and therefore suggest no issues with the multi - collinearity of these variables.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"Diabetes Metab J 2014;38:120-133 http://e-dmj.orgfor males and 2.20 mm for females) and 2.00 mm (2.14 mm in  males and 1.84 mm in females) in the abdomen and upper  arm, respectively.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"131Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgmale and 7.19 mm for female) for the abdomen and upper arm,  respectively, denoting that female had thicker subcutaneous  fat layer and that abdomen was thicker than upper arm.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"Diabetes Metab J 2014;38:120-133 http://e-dmj.orgright angle to the skin, free of intradermal or intramuscular in - jection risks, without having to inject at a 45-degree angle or  making skinfolds.",Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
133Appropriateness of the length of insulin needles in the abdomen and upper arm Diabetes Metab J 2014;38:120-133 http://e-dmj.orgtramuscular needle length by skinfold thickness measure - ments in Korean adults.,Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
Available from: http://www.kipi.or.kr (cited 2013 Mar 4).,Non-OADS,/arxiv_data1/oa_pdf/64/87/dmj-38-120.PMC4021299.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:134-142 A Randomized Controlled Trial of an Internet-Based  Mentoring Program for Type 1 Diabetes Patients with  Inadequate Glycemic Control Sunghwan Suh1, Cheol Jean2, Mihyun Koo3, Sun Y oung Lee4, Min Ja Cho4, Kang-Hee Sim4, Sang-Man Jin4, Ji Cheol Bae4,   Jae Hyeon Kim4 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Dong-A University Medical Center, Busan,  2Manager of JahkEunSon (Small Hands) Type 1 Diabetes Cafe,  3Department of Medical Social Work, Samsung Medical Center, Seoul,  4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background:  To determine whether an internet-based mentoring program can improve glycemic control in subjects with type  1 diabetes mellitus (T1DM).",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
"However, the mentored group monitored their blood  glucose (1.41 vs. 0.30) and logged into our website (http://ubisens.co.kr/) more frequently (20.59 times vs. 5.07 times) than the  control group.",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
Close monitoring of blood glucose at home is a key compo -Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.2.134 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
"135Mentoring program for T1DM Diabetes Metab J 2014;38:134-142 http://e-dmj.orgnent of diabetes management, but without timely provider  feedback, it somewhat has lesser value.",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
Interventions We trained all the subjects enrolled in the study to connect to  the internet website (http://ubisens.co.kr/) and transmit glu - cometer data.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
Diabetes Metab J 2014;38:134-142 http://e-dmj.orgMentors Five mentors (three male and two female) were interviewed  and carefully selected based on their background of giving ad - vice to other Korean T1DM patients in an internet community  (JahkEunSon [Small Hands] Type 1 Diabetes Cafe; http://cafe.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
137Mentoring program for T1DM Diabetes Metab J 2014;38:134-142 http://e-dmj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
Diabetes Metab J 2014;38:134-142 http://e-dmj.orgRESULTS The descriptive characteristics of all of the groups are given in  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
139Mentoring program for T1DM Diabetes Metab J 2014;38:134-142 http://e-dmj.orggests that the program is effective in altering important out - come mediators.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
"Diabetes Metab J 2014;38:134-142 http://e-dmj.orgto other studies [8,18].",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
141Mentoring program for T1DM Diabetes Metab J 2014;38:134-142 http://e-dmj.orgCONFLICTS OF INTEREST No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
Diabetes Metab J 2014;38:134-142 http://e-dmj.orgal and meta-analysis.,Non-OADS,/arxiv_data1/oa_pdf/5e/b0/dmj-38-134.PMC4021300.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:143-149 Association of Vaspin with Metabolic Syndrome:   The Pivotal Role of Insulin Resistance Alireza Esteghamati, Sina Noshad, Mostafa Mousavizadeh, Ali Zandieh, Manouchehr Nakhjavani Endocrinology and Metabolism Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences School of Medicine, Tehran, Iran Background:  Previous studies evaluating the relationship between serum vaspin concentrations and metabolic syndrome  (MetS) have yielded contrasting results.",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"Therefore, the  purpose of this study was twofold: first, to assess the relation -Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2014.38.2.143 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"Diabetes Metab J 2014;38:143-149 http://e-dmj.orgship between vaspin and MetS in a group of Iranian adults;  and second, to investigate whether this association is mediated  through abdominal obesity, insulin resistance, or chronic in - flammation.",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
145Vaspin and metabolic syndrome Diabetes Metab J 2014;38:143-149 http://e-dmj.orgreported using median (interquartile range).,Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"Diabetes Metab J 2014;38:143-149 http://e-dmj.orgterquartile range, 0.30 to 1.37) in women and men, respective - ly.",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"147Vaspin and metabolic syndrome Diabetes Metab J 2014;38:143-149 http://e-dmj.orgDISCUSSION Vaspin (visceral adipose tissue-derived serine protease inhibi - tor) is a member of the serine protease inhibitor family, origi - nally identified as an adipokine secreted from visceral adipo - cytes in Otsuka Long-Evans Tokushima fatty (OLETF), a rat  model of obesity and type 2 diabetes [5].",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"Diabetes Metab J 2014;38:143-149 http://e-dmj.orgsome, but not all of the MetS components.",Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
149Vaspin and metabolic syndrome Diabetes Metab J 2014;38:143-149 http://e-dmj.org278-301.,Non-OADS,/arxiv_data1/oa_pdf/69/94/dmj-38-143.PMC4021301.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:150-157 Factors Associated for Mild Cognitive Impairment in  Older Korean Adults with Type 2 Diabetes Mellitus Yun Jeong Lee*, Hye Mi Kang*, Na Kyung Kim, Ju Y eon Y ang, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee,   Dong-Jun Kim Department of Internal Medicine, Inje University College of Medicine, Busan, Korea  Background:  The aim of this study was to identify factors associated with mild cognitive impairment (MCI) in older Korean  adults with type 2 diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
"Thus, the aim of this study was to  identify factors associated with developing MCI in older Ko - rean adults with type 2 diabetes.Original Article Others http://dx.doi.org/10.4093/dmj.2014.38.2.150 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
"151Mild cognitive impairment in type 2 diabetes Diabetes Metab J 2014;38:150-157 http://e-dmj.orgMETHODS Participants We recruited 226 older adults (≥65 years old) with type 2 dia - betes who attended the diabetes outpatient clinic at Inje Uni - versity Ilsan Paik Hospital between October 1 and December  31, 2011.",Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
"Diabetes Metab J 2014;38:150-157 http://e-dmj.orgglucose, BP , and serum lipids (HbA1c, 7.16%±0.91%, 54.7±9.9  mmol/mol; FPG, 7.12±2.26 mmol/L; SBP , 130.0±15.2 mmHg;  LDL-C, 2.31±0.57 mmol/L).",Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
"153Mild cognitive impairment in type 2 diabetes Diabetes Metab J 2014;38:150-157 http://e-dmj.org(≥74 years old vs. 65 –68 years old; odds ratio [OR], 3.69; 95%  confidence interval [CI], 1.55 to 8.82; P=0.003), educational  background (college graduation vs. no school or elementary  school graduation; OR, 0.16; 95% CI, 0.05 to 0.46; P=0.001), and  systolic blood pressure (≥135 mm Hg vs. ≤120 mm Hg; OR,  3.25; 95% CI, 1.29 to 8.17; P=0.012) were associated with MCI.",Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
Diabetes Metab J 2014;38:150-157 http://e-dmj.orgucts (AGEs) and receptors for advanced glycation end product  (RAGE).,Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
155Mild cognitive impairment in type 2 diabetes Diabetes Metab J 2014;38:150-157 http://e-dmj.orgfor cognitive impairment [39].,Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
Diabetes Metab J 2014;38:150-157 http://e-dmj.orging for mild cognitive impairment in elderly outpatient clinic:  validation of the Korean version of the Montreal Cognitive As - sessment.,Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
157Mild cognitive impairment in type 2 diabetes Diabetes Metab J 2014;38:150-157 http://e-dmj.orgspective population based study.,Non-OADS,/arxiv_data1/oa_pdf/6b/e1/dmj-38-150.PMC4021302.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/09/dmj-38-158.PMC4021303.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:158-159 Clinical Marker of Platelet Hyperreactivity in Diabetes  Mellitus ( Diabetes Metab J  2013;37:423-8) Cengiz Beyan1, Esin Beyan2 1Department of Hematology, Gulhane Military Medical Academy,  2Department of Internal Medicine, Kecioren Training and Research Hospital, Ankara, Turkey Corresponding author: Cengiz Beyan Department of Hematology, Gulhane Military Medical Academy, Etlik,   Ankara 06018, Turkey E-mail: cbeyan@gata.edu.tr Dear Editor, We read with great interest the review article by Kim et al.",Non-OADS,/arxiv_data1/oa_pdf/72/09/dmj-38-158.PMC4021303.pdf
CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was re - ported.Letter   http://dx.doi.org/10.4093/dmj.2014.38.2.158 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/72/09/dmj-38-158.PMC4021303.pdf
159MPV and platelet function abnormalities Diabetes Metab J 2014;38:158-159 http://e-dmj.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/72/09/dmj-38-158.PMC4021303.pdf
Available  from: http://www.uptodate.com/contents/automated-hema - tology-instrumentation (updated 2012 Jul 24).,Non-OADS,/arxiv_data1/oa_pdf/72/09/dmj-38-158.PMC4021303.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/ee/dmj-38-160.PMC4021304.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:160-161 Clinical Marker of Platelet Hyperreactivity in Diabetes  Mellitus ( Diabetes Metab J  2013;37:423-8) Jin Hwa Kim, Hak Y eon Bae, Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea Corresponding author: Sang Y ong Kim Department of Endocrinology and Metabolism, Chosun University Hospital,  Chosun University School of Medicine, 365 Pilmun-daero, Dong-gu,  Gwangju 501-717, Korea E-mail: diabetes@chosun.ac.krWe truly appreciate the interest and comments regarding our  article, “Clinical marker of platelet hyperreactivity in diabetes  mellitus, ” which was published in Diabetes  & Metabolism Jour - nal [1].",Non-OADS,/arxiv_data1/oa_pdf/de/ee/dmj-38-160.PMC4021304.pdf
"The rela - tionship of platelet count, mean platelet volume with metabol - ic syndrome according to the criteria of the American Associa - tion of Clinical Endocrinologists: a focus on gender differenc -Response http://dx.doi.org/10.4093/dmj.2014.38.2.160 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/de/ee/dmj-38-160.PMC4021304.pdf
161Diagnosis of aberrant platelet action in diabetes Diabetes Metab J 2014;38:160-161 http://e-dmj.orges.,Non-OADS,/arxiv_data1/oa_pdf/de/ee/dmj-38-160.PMC4021304.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:87-91 Dose Adjustment for Normal Eating: A Role for the  Expert Patient?,Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
Reported Review Clinical Care/Education http://dx.doi.org/10.4093/dmj.2014.38.2.87 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
"88McIntyre HD Diabetes Metab J 2014;38:87-91 http://e-dmj.orgbenefits of DAFNE training include improved overall glycae - mic control, reduced hypoglycaemia, and improved quality of  life [7].",Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
89DAFNE and the expert patient Diabetes Metab J 2014;38:87-91 http://e-dmj.orgagement in a well or poorly informed manner.,Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
90McIntyre HD Diabetes Metab J 2014;38:87-91 http://e-dmj.orgproving self-management of insulin therapy in people with  T1DM.,Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
91DAFNE and the expert patient Diabetes Metab J 2014;38:87-91 http://e-dmj.org22.,Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
Available from:  http://www.nice.org.uk/nicemedia/pdf/60Patienteducationm odelsfullguidance.pdf (updated 2003 Apr 29).,Non-OADS,/arxiv_data1/oa_pdf/5b/62/dmj-38-87.PMC4021305.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
"Copyright © 2014 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2014;38:92-99 Altered Transendothelial Transport of Hormones as a  Contributor to Diabetes Nanyoung Y oon, Thanh Q. Dang, Helen Chasiotis, Scott P .",Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
"After ligand binding to  receptors in caveolae, dynamin-mediated endocytosis occurs  followed by vectorial transport and fusion of the vesicle with  basolateral membrane, resulting in the release of contents by Review Pathophysiology http://dx.doi.org/10.4093/dmj.2014.38.2.92 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
93Paracellular hormone transport in diabetes Diabetes Metab J 2014;38:92-99 http://e-dmj.orgexocytosis [2].,Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
Diabetes Metab J 2014;38:92-99 http://e-dmj.orgof intercellular space or intermingled with adherens junctions  (AJs).,Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
95Paracellular hormone transport in diabetes Diabetes Metab J 2014;38:92-99 http://e-dmj.orgnectin in the pathophysiology of diabetic complications [32- 34].,Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
"Diabetes Metab J 2014;38:92-99 http://e-dmj.orgbeen generated for various TJ proteins, including occludin and  claudin-1, 2, 4, 5, 7, 9, 11, 14, 15, 16, 18, and 19 [50-63].",Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
97Paracellular hormone transport in diabetes Diabetes Metab J 2014;38:92-99 http://e-dmj.orgP .K.).,Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
"Diabetes Metab J 2014;38:92-99 http://e-dmj.orgKurtcuoglu V , Poulikakos D, Baluk P , McDonald D, Grazia  Lampugnani M, Dejana E. Phosphorylation of VE-cadherin is  modulated by haemodynamic forces and contributes to the  regulation of vascular permeability in vivo .",Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
Epub 2013 Sep 10. http://dx.doi.org/10.1007/s11154-013-9265-5.,Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
99Paracellular hormone transport in diabetes Diabetes Metab J 2014;38:92-99 http://e-dmj.orgRadic Biol Med 2012;53:1213-21.,Non-OADS,/arxiv_data1/oa_pdf/62/2f/dmj-38-92.PMC4021306.pdf
doi: http://dx.doi.org/10.1175/JCLI-D-12-00789.1 (2013).,OADS,/arxiv_data1/oa_pdf/1c/da/srep04943.PMC4021319.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4943 | DOI: 10.1038/srep04943 6",Non-OADS,/arxiv_data1/oa_pdf/1c/da/srep04943.PMC4021319.pdf
The preferred values of element concentrations for the USGS reference glasses are from the GeoReM database (http://georem.mpch-mainz.gwdg.de/).,OADS,/arxiv_data1/oa_pdf/d0/e7/srep04682.PMC4021322.pdf
The ZooBank LSIDs (Life Science Identifiers) can be resolved and the associated information viewed through any standard web browser by appending the LSID to the prefix ‘http://zoobank.org/’.The LSID for this publication is: urn:lsid:zoobank.org:pub:E1443FFB-9447-42DB- 91C3-131FAB223054.,Non-OADS,/arxiv_data1/oa_pdf/d0/e7/srep04682.PMC4021322.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/e7/srep04682.PMC4021322.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4682 | DOI: 10.1038/srep04682 7",Non-OADS,/arxiv_data1/oa_pdf/d0/e7/srep04682.PMC4021322.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4970 | DOI: 10.1038/srep04970 9",Non-OADS,/arxiv_data1/oa_pdf/a4/9a/srep04970.PMC4021323.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : S.R.T.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/srep04983.PMC4021325.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4983 | DOI: 10.1038/srep04983 9",Non-OADS,/arxiv_data1/oa_pdf/00/3c/srep04983.PMC4021325.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/34/ad/srep04976.PMC4021332.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4976 | DOI: 10.1038/srep04976 8",Non-OADS,/arxiv_data1/oa_pdf/34/ad/srep04976.PMC4021332.pdf
Multiple sequence alignment of S46 peptidases was performed using the program ClustalW52and a phylogenetic tree was produced using the program FigTree (http://tree.bio.ed.ac.uk/software/figtree/).,OADS,/arxiv_data1/oa_pdf/41/68/srep04977.PMC4021333.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/41/68/srep04977.PMC4021333.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4977 | DOI: 10.1038/srep04977 12",Non-OADS,/arxiv_data1/oa_pdf/41/68/srep04977.PMC4021333.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/94/srep04984.PMC4021334.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4984 | DOI: 10.1038/srep04984 7",Non-OADS,/arxiv_data1/oa_pdf/93/94/srep04984.PMC4021334.pdf
"The resulting positive hits of both AlkB and CYP153 were then aligned with the MUSCLE program and manually filteredwith the following criteria: for AlkB proteins, hit sequences without three histidineboxes and HYG motif were excluded 4,65; for CYP153 proteins, the hit sequences were compared against the bacterial cytochrome P450 database (http://drnelson.uthsc.",OADS,/arxiv_data1/oa_pdf/03/fa/srep04968.PMC4021335.pdf
"To identify thepossible conserved domains, the obtained proteins were analyzed using the Simple Modular Architecture Research Tool (SMART, http://smart.embl-heidelberg.de) 67.",OADS,/arxiv_data1/oa_pdf/03/fa/srep04968.PMC4021335.pdf
The inconsistent species inthe two trees were subjected to the analysis of genomic islands (GIs) using IslandViewer (http://www.pathogenomics.sfu.ca/islandviewer) 72.,OADS,/arxiv_data1/oa_pdf/03/fa/srep04968.PMC4021335.pdf
All authors discussed and reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/03/fa/srep04968.PMC4021335.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4968 | DOI: 10.1038/srep04968 11",Non-OADS,/arxiv_data1/oa_pdf/03/fa/srep04968.PMC4021335.pdf
"Genomic DNA extraction .Genomic DNA was extracted from ST 1275 using the CTAB/NaCl method according to the protocol from DOE Joint Genome Institute (JGI, http://my.jgi.doe.gov/general/protocols.html).",OADS,/arxiv_data1/oa_pdf/b9/d6/srep04974.PMC4021336.pdf
"Further annotation was obtained using the SEED-based automated annotation system provided by the RAST server58.Bioinformatic analysis .CRISPR finder, a web online tool (http://crispr.u-psud.fr/ Server/), was used for identifying CRISPR/Cas systems in bacteria.",OADS,/arxiv_data1/oa_pdf/b9/d6/srep04974.PMC4021336.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/d6/srep04974.PMC4021336.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4974 | DOI: 10.1038/srep04974 8",Non-OADS,/arxiv_data1/oa_pdf/b9/d6/srep04974.PMC4021336.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/83/srep04973.PMC4021338.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4973 | DOI: 10.1038/srep04973 10",Non-OADS,/arxiv_data1/oa_pdf/e3/83/srep04973.PMC4021338.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/bb/srep04971.PMC4021339.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4971 | DOI: 10.1038/srep04971 7",Non-OADS,/arxiv_data1/oa_pdf/b0/bb/srep04971.PMC4021339.pdf
"Finally, ‘‘Gapcloser’’ (http://soap.genomics.org.cn/ soapdenovo.html) was used to close the gaps inside the scaffolds.",Non-OADS,/arxiv_data1/oa_pdf/45/30/srep04958.PMC4021364.pdf
Repetitive sequence analysis .We screened DNA sequences for interspersed repeats and low complexity DNA sequences using RepeatMasker (http://www.repeatmasker.,OADS,/arxiv_data1/oa_pdf/45/30/srep04958.PMC4021364.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4958 | DOI: 10.1038/srep04958 7,Non-OADS,/arxiv_data1/oa_pdf/45/30/srep04958.PMC4021364.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4958 | DOI: 10.1038/srep04958 8",Non-OADS,/arxiv_data1/oa_pdf/45/30/srep04958.PMC4021364.pdf
http://www.cap.org/apps/docs /reference/myBiopsy/Breast InvasiveDuctalCarcinoma.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/3d/74/rju045.PMC4021385.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4975 | DOI: 10.1038/srep04975 5",Non-OADS,/arxiv_data1/oa_pdf/13/04/srep04975.PMC4021410.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4980 | DOI: 10.1038/srep04980 8",Non-OADS,/arxiv_data1/oa_pdf/6a/2e/srep04980.PMC4021411.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Tumour-initiating capacity and EMT status BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.153 2523,Non-OADS,/arxiv_data1/oa_pdf/f7/0d/bjc2014153a.PMC4021510.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Human testis and testis cancer ex vivo model 2614 www.bjcancer.com | DOI:10.1038/bjc.2014.160,Non-OADS,/arxiv_data1/oa_pdf/d0/4f/bjc2014160a.PMC4021512.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Subsite and relation of CD8 and FOXP3 in CRC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.161 2559,Non-OADS,/arxiv_data1/oa_pdf/94/54/bjc2014161a.PMC4021513.pdf
"Molecular classification infor- mation was available for 49 GBM samples from Chinese Glioma Genome Atlas (CGGA, http://www.cg cg.org.cn; proneural 4, neural 7, classical 15 and mesenchymal 23).",OADS,/arxiv_data1/oa_pdf/29/61/bjc2014162a.PMC4021514.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER TILs for prognosis of glioma patients 2568 www.bjcancer.com | DOI:10.1038/bjc.2014.162,Non-OADS,/arxiv_data1/oa_pdf/29/61/bjc2014162a.PMC4021514.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Platelet-to-lymphocyte ratio and breast cancer 2530 www.bjcancer.com | DOI:10.1038/bjc.2014.163,Non-OADS,/arxiv_data1/oa_pdf/01/c2/bjc2014163a.PMC4021515.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)HAGE is a prognostic and predictive marker in breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.168 2461,Non-OADS,/arxiv_data1/oa_pdf/70/d4/bjc2014168a.PMC4021517.pdf
Quantification of the protein expression was performed using Image J (http://rsbweb.nih.,OADS,/arxiv_data1/oa_pdf/6d/92/bjc2014169a.PMC4021518.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)S100A13 and chemoresistance in melanoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.169 2495,Non-OADS,/arxiv_data1/oa_pdf/6d/92/bjc2014169a.PMC4021518.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Erroneous identification of APOBEC3-edited DNA 2622 www.bjcancer.com | DOI:10.1038/bjc.2014.176,Non-OADS,/arxiv_data1/oa_pdf/eb/40/bjc2014176a.PMC4021520.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Amino-acid transporter expression in tongue cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.178 2513,Non-OADS,/arxiv_data1/oa_pdf/d5/71/bjc2014178a.PMC4021522.pdf
Available at http://www.uicc.org/tnm/.,Non-OADS,/arxiv_data1/oa_pdf/45/f7/bjc2014180a.PMC4021523.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Derived NLR in upper tract urothelial carcinoma 2536 www.bjcancer.com | DOI:10.1038/bjc.2014.180,Non-OADS,/arxiv_data1/oa_pdf/45/f7/bjc2014180a.PMC4021523.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Circulating microRNAs of prostate cancer chemoresponse BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.181 2471,Non-OADS,/arxiv_data1/oa_pdf/4f/8b/bjc2014181a.PMC4021524.pdf
Available from: http://globocan.iarc.fraccessed on day/month/year.Fowler JF (2005) The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.,Non-OADS,/arxiv_data1/oa_pdf/0a/b9/bjc2014191a.PMC4021525.pdf
http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Scientific_Discussion_-_Variation/ human/000687/WC500089487.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6a/c5/bjc2014194a.PMC4021528.pdf
"STATA 12.0 (Statacorp, College Station, TX, USA) was used for pair-wise meta-analysis, then R software (http://www.R-project.org, the R Foundation for Statistical Computing, Vienna, Austria) and WinBUGS 1.4.3 (MRC Biostatistics Unit, Cambridge, UK) for network meta-analysis.",OADS,/arxiv_data1/oa_pdf/ee/38/bjc2014197a.PMC4021530.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER EBRT for prostate cancer 2404 www.bjcancer.com | DOI:10.1038/bjc.2014.197,Non-OADS,/arxiv_data1/oa_pdf/ee/38/bjc2014197a.PMC4021530.pdf
National Cancer Intelligence Network (2012) Soft tissue sarcoma incidence and survival tumours diagnosed in England between 1985 and 2009.http://www.ncin.org.uk/cancer_type_and_topic_specific_work/cancer_type_specific_work/sarcomas/(accessed 11 January 2014).Localised limb soft tissue sarcomas BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.200 2425,Non-OADS,/arxiv_data1/oa_pdf/b1/76/bjc2014200a.PMC4021531.pdf
NCCN (2014) http://www.nccn.org/profession als/physician_gls/pdf/sarcoma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/76/bjc2014200a.PMC4021531.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)ALDH3A1 associates with prostate cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.201 2603,Non-OADS,/arxiv_data1/oa_pdf/7d/00/bjc2014201a.PMC4021532.pdf
"In fact, B50 000 new cases of lung cancer are diagnosed each year; 20 000 patients die of it in Japan alone (http://ganjoho.jp/professional /index.html, 2012).",Non-OADS,/arxiv_data1/oa_pdf/da/75/bjc2014202a.PMC4021533.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER ZNF143 and MIB-1 predicts prognosis in lung adenocarcinoma 2592 www.bjcancer.com | DOI:10.1038/bjc.2014.202,Non-OADS,/arxiv_data1/oa_pdf/da/75/bjc2014202a.PMC4021533.pdf
"In summary, parameters used for calculating transition probabilities between states within monthly cycles were extracted directly or estimated from various sources (Moss et al , 1993;Blamey et al, 2007; Gunsoy et al, 2012; Office for National Statistics, http://www.ons.gov.uk; NHS Breast Screening Programme, 2012) and included parameters for screening, breast cancer incidence and progression, breast cancer prognosis, and mortality (Supplementary Tables 1, 2, and 3).",OADS,/arxiv_data1/oa_pdf/e4/92/bjc2014206a.PMC4021535.pdf
http://www.clinicaltrials.gov/ct2/show/NCT01081288 (accessed 20 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/e4/92/bjc2014206a.PMC4021535.pdf
http://www.ons.gov.uk/ (accessed 20 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/e4/92/bjc2014206a.PMC4021535.pdf
http://www.associationofbreastsurgery.org.uk/media/2327/bccom_ar09.pdf(accessed 20 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/e4/92/bjc2014206a.PMC4021535.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Estimating breast cancer mortality reduction and overdiagnosis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.206 2419,Non-OADS,/arxiv_data1/oa_pdf/e4/92/bjc2014206a.PMC4021535.pdf
Available at http://plan.cancer.gov/plan_overview.shtml.,Non-OADS,/arxiv_data1/oa_pdf/02/54/bjc2014208a.PMC4021536.pdf
Available at http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.,Non-OADS,/arxiv_data1/oa_pdf/02/54/bjc2014208a.PMC4021536.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER PI3K/AKT/mTOR inhibition in mesothelioma 2488 www.bjcancer.com | DOI:10.1038/bjc.2014.220,Non-OADS,/arxiv_data1/oa_pdf/3b/3a/bjc2014220a.PMC4021537.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/af/3c/srep04985.PMC4021569.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4985 | DOI: 10.1038/srep04985 12",Non-OADS,/arxiv_data1/oa_pdf/af/3c/srep04985.PMC4021569.pdf
Available from: http://www.who.int/ infectious‑disease‑report/index.html.,OADS,/arxiv_data1/oa_pdf/9b/29/UA-6-107.PMC4021646.pdf
Available from: http://www.cdc.gov/ncidod/emergplan/plan98.,OADS,/arxiv_data1/oa_pdf/9b/29/UA-6-107.PMC4021646.pdf
Available  from: http://europa.eu.int/eurex/en/lif/dat/1999/en_399Y0713_01.html.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/UA-6-107.PMC4021646.pdf
Available from: http://www.harrisonspractice.com/practice/ub/view/ Harrisons%20Practice/141019/all/Sepsis_and_Septic_Shock.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/UA-6-107.PMC4021646.pdf
Available from: http://www.postersessiononline.com/160946071_it/ congresos/83siu/aula/‑P_128_83siu.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/29/UA-6-107.PMC4021646.pdf
Available from: http://www.harrisonspractice.com/practice/ub/view/ Harrisons%20Practice/141019/all/Sepsis_and_Septic_Shock.,Non-OADS,/arxiv_data1/oa_pdf/d2/2d/UA-6-112.PMC4021647.pdf
Available from: http://www.postersessiononline.com/160946071_it/ congresos/83siu/aula/‑P_128_83siu.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/2d/UA-6-112.PMC4021647.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT00326898?term=NCT00326898andrank=1.,Non-OADS,/arxiv_data1/oa_pdf/47/4b/UA-6-116.PMC4021649.pdf
Available from: http://www.asahq.org/For‑   Members/Clinical‑ Information/ASA ‑Physical‑ Status‑ Classification ‑System.,Non-OADS,/arxiv_data1/oa_pdf/97/f8/UA-6-147.PMC4021656.pdf
"Tropicamide Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> Received 14 November 2013 | Accepted 11 May 2014 | Published 13 May 2014© 2014 Molecular Vision 629Pharmacokinetics and retinal toxicity of various doses of  intravitreal triamcinolone acetonide in rabbits You-Fan Ye,1 Yong-Feng Gao,2 Hua-Tao Xie,1 Hai-Jun Wang3 1Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,  Wuhan, China; 2Henan Eye Institute, Henan Eye Hospital, Zhengzhou, China; 3Department of Neurosurgery, Union Hospital,  Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Purpose:  To compare the pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide  (TA) in rabbits.Methods:  The rabbits received intravitreal injections of 4 mg and 8 mg TA.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  630was applied to dilate the pupils.,Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
"Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  6314 mg/0.1 ml TA, and ten right eyes in group B were injected  with 8  mg/0.1  ml TA.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  632 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
"Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  633Retinal toxicity:  The vitreous was transparent with the intra - vitreal injection of PSS, and TA was visible as a white mass  in the vitreous after the injection (Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  634intravitreal injection has been applied in clinical treatment  [28].,Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
"Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  635and rabbits, caution should be exercised when analyzing  pharmacokinetic study using rabbit models.",Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
Molecular Vision 2014; 20:629-636 <http://www.molvis.org/molvis/v 20/629> © 2014 Molecular Vision  636chromatography-tandem mass spectrometry.,Non-OADS,/arxiv_data1/oa_pdf/9b/f0/mv-v20-629.PMC4021671.pdf
"Bevacizumab (Avastin®,  Genentech, Inc.) a full-length, humanized, monoclonal anti - body against all types of VEGF, is the most commonly used  drug in the United States for the treatment of neovascular Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> Received 20 July 2013 | Accepted 11 May 2014 | Published 13 May 2014© 2014 Molecular Vision 649The proliferation of malignant melanoma cells could be inhibited  by ranibizumab via antagonizing VEGF through VEGFR1 Jiao Li,1 Yan Cui,2 Qin Wang,3 Dadong Guo,2 Xuemei Pan,1 Xingrong Wang,1 Hongsheng Bi,1 Wei Chen,1  Zhengfeng Liu,4 Shengya Zhao1 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  650AMD.,Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  6510, 0.1, 0.25, 0.5, and 1 mg/ml, respectively.",Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  652Extraction of total RNA from formalin-fixed, paraffin- embedded tissue:  Total RNA from the tumor was extracted  from formalin-fixed, paraffin-embedded tissue using a  modification of the method described by Rupp and Locker  [23].",OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  653untreated cells (Figure 4B).,Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  654was 0.1 mg/ml, 0.25 mg/ml, and 0.5 mg/ml, the survival rates  of malignant melanoma cells decreased to 12%, 57.5%, and  72% compared with the untreated cells (Figure 5B).",Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  655(PI3K)/protein kinase B (PKB/AKT), and the stress kinase  p38MAPK [ 27], in which VEGFR1-mediated signaling  pathways are essential for VEGFR1 biology in vivo.",Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  656Uveal melanoma (UM) is an intraocular malignant tumor  occurring mainly in Caucasian adults that usually originates  from melanocytes of the choroid, iris, and ciliary body  [34,35].",Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  657increase in melanin synthesis with increased cell density was  accompanied by a parallel increase in tyrosinase synthesis.,Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  658the levels of VEGF secreted by malignant melanoma cells  were much greater than those of ARPE-19, and the levels of  VEGF of malignant melanoma cells declined markedly via  the action of ranibizumab.",Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  659cancer xenografts.,Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
Molecular Vision  2014; 20:649-660 <http://www.molvis.org/molvis/v 20/649> © 2014 Molecular Vision  660p r o p e rt i e s .,Non-OADS,/arxiv_data1/oa_pdf/6b/b7/mv-v20-649.PMC4021672.pdf
"The basic way in which collagen  type VI tetramers can assemble explains the organization  of morphologically distinct aggregates [ 22-24], which also  depends on the structure and physiology of the tissue [ 25-28]  in which they are found.Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> Received 17 October 2013 | Accepted 11 May 2014 | Published 13 May 2014© 2014 Molecular Vision 638Three-dimensional architecture of collagen type VI in the human  trabecular meshwork Elena Koudouna,1 Robert D. Young,1 Morio Ueno,2 Shigeru Kinoshita,2 Andrew J. Quantock,1 Carlo Knupp1 1Structural Biophysics Group, School of Optometry and Vision Sciences, Cardiff University, Wales, UK; 2Department of  Ophthalmology, Kyoto Prefectural University of Medicine, Hirokoji Kawaramachi, Kyoto, Japan Purpose:  Type VI collagen is a primary component of the extracellular matrix of many connective tissues.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
"Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  639Type VI collagen interacts with extracellular matrix  constituents [ 29,30] in several connective tissues [ 31-33].",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
"Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  640ORIUS SC1000 charge coupled device camera (Gatan,  Pleasanton, CA) at 20,000X magnification.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  641arranged in essentially the same way.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
"Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  642by other investigators [ 46,47], who confirmed they were  proteoglycans by specific enzyme digestion protocols.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  643in the human trabecular meshwork by three-dimensional  electron tomography.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  644VI tetramers through their globular domains.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  645these proteins may interact with the collagen VI assemblies.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  646arrowheads).,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  647characterization of the native protein.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
Molecular Vision  2014; 20:638-648 <http://www.molvis.org/molvis/v 20/638> © 2014 Molecular Vision  64846.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/mv-v20-638.PMC4021673.pdf
"Presentation of the stimulation was controlled by Psychophysics Toolbox (http://psychtoolbox.org/) 37,38.",Non-OADS,/arxiv_data1/oa_pdf/5f/ff/srep04953.PMC4021798.pdf
"In our study, STRF was estimated by the response-triggered average method from the STRFlab Toolbox (http://www.strflab.berkeley.edu/), and the PIF model was implemented with the TED Toolbox 44.",OADS,/arxiv_data1/oa_pdf/5f/ff/srep04953.PMC4021798.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Xie, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/ff/srep04953.PMC4021798.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4953 | DOI: 10.1038/srep04953 9",Non-OADS,/arxiv_data1/oa_pdf/5f/ff/srep04953.PMC4021798.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4960 | DOI: 10.1038/srep04960 8",Non-OADS,/arxiv_data1/oa_pdf/7e/2a/srep04960.PMC4021812.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/41/srep04955.PMC4021813.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4955 | DOI: 10.1038/srep04955 9",Non-OADS,/arxiv_data1/oa_pdf/96/41/srep04955.PMC4021813.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/RI n o u e et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/ee/jid201422a.PMC4021815.pdf
"To view a copy of this license, visit http://creativecommons.org/li-censes/by-nc-sa/3.0/ Modern Pathology (2014) 27, 644–650BRAFV600E and MMR IHC in colon cancer 650 CW Toon et al",Non-OADS,/arxiv_data1/oa_pdf/57/3a/modpathol2013200a.PMC4021849.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/2b/glt142.PMC4022094.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs  licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution  of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is  properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/74/glt143.PMC4022096.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/73/glt136.PMC4022099.pdf
"OncoImmunology 2014; 3:e28246; http://dx.doi.org/10.4161/onci.28246slanDCs in carcinoma-draining lymph nodes wi lliam Vermi1,2,*, sil via Lonardi1, Mattia Bugatti1, Federica Calzetti3, Alessandra Micheletti3, and Marco A Cassatella3,* 1Department of Molecular and tr anslational Medicine; se ction of Pathology; un iversity of Brescia; Brescia, it aly; 2Department of Pathology and im munology; wa shington  un iversity  sc hool of Medicine;  sa int Louis, M o   usA ; 3Department of Pathology and Diagnostics; se ction of General Pathology; un iversity of Verona; Verona, it aly Keywords:  carcinoma, slanDCs, tumor-draining lymph nodes Dendritic cells (DCs) are known to initiate adaptive immune responses against malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Science 2011; 331:1565-70; PMID:21436444 ; http://dx.doi.org/10.1126/ science.1203486 2.,Non-OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Blood 2010; 116:e74-80; PMID:20628149 ; http://dx.doi.org/10.1182/ blood-2010-02-2585584.,Non-OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Immunity 2002; 17:289-301; PMID:12354382 ; http://dx.doi.org/10.1016/ S1074-7613(02)00393-X 5.,OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Immunity 2006; 24:767-77; PMID:16782032 ;  http://dx.doi.org/10.1016/j.immuni.2006.03.0206.,OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
"J Allergy Clin Immunol 2011; 127:787, e1-9; PMID:21377044 ;  http://dx.doi.org/10.1016/j.jaci.2010.12.009 7.",OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Eur J Immunol 1998; 28:4084-93; PMID:9862344 ; http://dx.doi.org/10.1002/ (SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4Figure 1.  ro ute of nodal entry by carcinoma-associated slanDCs.,Non-OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Nat Commun 2014; 5:3029; PMID:24398631 ; http://dx.doi.org/10.1038/ ncomms40299.,OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Blood 2007; 109:5276-85; PMID:17327411 ;  http://dx.doi.org/10.1182/blood-2006-10-05350410.,Non-OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
Blood 2011; 117:1677-86; PMID:21098395 ; http://dx.doi.org/10.1182/ blood-2010-06-287243 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/c1/00/onci-3-e28246.PMC4022602.pdf
"Cellular Logistics 2014; 4:e28023; http://dx.doi.org/10.4161/cl.28023The proteolytic landscape of the yeast vacuole Karen A Hecht1,†, Allyson F O’Donnell2 and Jeffrey L Brodsky1,* 1Department of Biological Sciences; University of Pittsburgh; Pittsburgh, PA USA; 2Department of Cell Biology; University of Pittsburgh School of Medicine; Pittsburgh, PA USA †Current affiliation: Marine Biotechnology; Pacific Northwest National Laboratory; Sequim, wA U SA Keywords:  protease, S. cerevisiae , hydrolysis, autophagy, endocytosis, metalloprotease, Vps10, CPY, secretory pathway, Pff1 The vacuole in the yeast Saccharomyces cerevisiae  plays  a number of essential roles, and to provide some of these  required functions the vacuole harbors at least seven distinct  proteases.",Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
The MEROPS peptidase database (http://merops.sanger.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Biochim Biophys Acta  2009; 1793:650-63;  PMID:18786576 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Curr Opin Microbiol 2008; 11:503- 10; PMID:18935977 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Arch Mikrobiol 1970; 70:89-103;  PMID:4914043 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
PLoS One 2011; 6:e17619;   PMID:21423800 ; http://dx.doi.org/10.1371/jour - nal.pone.0017619 8.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Proc Natl Acad Sci U S A  1989; 86:7027-31;  PMID:2674942 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
FEBS J 2007;  274:4287-305;  PMID:17651441 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Cell Proteomics 2009; 8:380- 92; PMID:19001347 ; http://dx.doi.org/10.1074/ mcp.M800372-MCP200 11.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 2005;  280:3121-4;  PMID :15590627 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2002; 156:271- 85; PMID:11807092 ; http://dx.doi.org/10.1083/ jcb.200109077 14 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Dev Cell 2002; 2:283- 94; PMID:11879634 ; http://dx.doi.org/10.1016/ S1534-5807(02)00127-2 15.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 1997; 91:109- 18; PMID:9335339 ; http://dx.doi.org/10.1016/ S0092-8674(01)80013-1 16 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1997; 139:1761- 74; PMID:9412470 ; http://dx.doi.org/10.1083/ jcb.139.7.176117.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Biochim Biophys Acta 2005; 1744:438- 54; PMID :15913810 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1990; 111:2871- 84; PMID:2269659 ; http://dx.doi.org/10.1083/ jcb.111.6.2871 19 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1993; 121:1245-56; PMID:8509446 ; http://dx.doi.org/10.1083/ jcb.121.6.1245 20 .,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Proc Natl Acad Sci U S A 1986; 83:9075- 9; PMID:3538017 ; http://dx.doi.org/10.1073/ pnas.83.23.9075 21.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1988; 107:1369- 83; PMID:3049619 ; http://dx.doi.org/10.1083/ jcb.107.4.1369 22.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell  1986; 47:1041-51;  PMID:3536126 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell 2008; 19:4826-36;   PMID:18784256 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Nat Rev Mol Cell Biol 2004; 5:23- 32; PMID:14708007 ; http://dx.doi.org/10.1038/ nrm1279 26.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell  2006; 17:3907-20;  PMID:16790491 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2000; 149:81-94;  PMID:10747089 ;  http://dx.doi.org/10.1083/jcb.149.1.81 28.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1998; 143:65- 79; PMID:9763421 ; http://dx.doi.org/10.1083/ jcb.143.1.65 29.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 1998; 95:847- 58; PMID:9865702 ; http://dx.doi.org/10.1016/ S0092-8674(00)81707-9 30 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2001; 153:649- 62; PMID:11352928 ; http://dx.doi.org/10.1083/ jcb.153.4.64931 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
EMBO J 2001; 20:5176- 86; PMID :11566881 ; http://dx.doi.org/10.1093/ emboj/20.18.5176 32 .,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1999; 146:1227-38; PMID:10491387 ; http://dx.doi.org/10.1083/ jcb.146.6.1227 33 .,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2009;  185:493-502;  PMID:19398763 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Trends Cell Biol 2010; 20:196-204;   PMID:20138522 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Traffic  2005; 6:2-9;  PMID:15569240 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Sci 2013; 126:1307- 16; PMID:23645161 ; http://dx.doi.org/10.1242/ jcs.107805 37 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Proc Natl Acad Sci U S A  2012; 109:1991-6;  PMID:22308417 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Small GTPases 2011; 2:182-6;   PMID:21776422 ; http://dx.doi.org/10.4161/ sgtp.2.3.16701 39.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell 2009; 20:4563-74;  PMID:19741093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Yeast 1996; 12:1-16;  PMID:8789256 ;  http://dx.doi.org/10.1002/(SICI)1097- 0061(199601)12:1<1::AID-YEA902>3.0.CO;2-N 41.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Microsc Res Tech 2000; 51:563-72;  PMID:11169858 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Genes Dev 2007; 21:2861-73; PMID:18006683 ;  http://dx.doi.org/10.1101/gad.1599207 44.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
F1000 Biol Rep 2011; 3:25;  PMID:22162728 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Eukaryot Cell 2002; 1:11-21;  PMID:12455967 ;  http://dx.doi.org/10.1128/EC.01.1.11-21.2002,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Nat Cell Biol  2007; 9:1102-9;  PMID:17909521 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 2011; 286:13704-13;   PMID:21343297 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol  1997; 138:37-44;  PMID:9214379 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol  1997; 139:1687-95;  PMID:9412464 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 2001; 276:20491-8;  PMID:11264288 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Biochim Biophys Acta 2009; 1793:1404-12;  PMID:19264099 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 1985; 40:1001-9;  PMID :3886157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell 1995; 6:1721-42;  PMID:8590801 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1996;  135:1485-500;  PMID:8978817 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1993; 120:55-65;  PMID:8380177 ;  http://dx.doi.org/10.1083/jcb.120.1.55 59 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 2005; 123:305-20;  PMID:16239147 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell  2012; 150:508-20;  PMID:22863005 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Dev Cell 2005; 9:87-98;  PMID:15992543 ;  http://dx.doi.org/10.1016/j.devcel.2005.04.01462.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Nat Cell Biol 2012; 14:2-10;  PMID :22193158 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2013; 203:717-25;  PMID:24322426 ; http://dx.doi.org/10.1083/ jcb.201307100 65.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Nat Rev Mol Cell Biol 2006; 7:404-14;  PMID:16723976 ;  http://dx.doi.org/10.1038/nrm1940 66 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Trends Cell Biol 2012; 22:1- 13; PMID:22018597 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
PLoS Biol 2011; 9:e1000604;  PMID:21445324 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2011; 195:657- 71; PMID:22065638 ; http://dx.doi.org/10.1083/ jcb.201104045 70.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 1996; 84:277-87;  PMID:8565073 ;  http://dx.doi.org/10.1016/S0092-8674(00)80982-4 71 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell 1998; 9:1253-63;  PMID:9614172 ;  http://dx.doi.org/10.1091/mbc.9.6.1253 73.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 2001; 276:25974-81;  PMID:11356856 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell 2001; 12:421- 35; PMID:11179425 ; http://dx.doi.org/10.1091/ mbc.12.2.421 75.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Microbiol 1995; 18:77-87;  PMID:8596462 ;  http://dx.doi.org/10.1111/j.1365-2958.1995.mmi_18010077.x 76 .,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
EMBO Rep  2008; 9:1216-21;  PMID:18953286 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 2012; 196:247- 59; PMID:22249293 ; http://dx.doi.org/10.1083/ jcb.201109113 79.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Cell Biol 2012; 32:4510-22;  PMID:22966204 ;  http://dx.doi.org/10.1128/MCB.00463-12 80.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 2013;  288:24063-80;  PMID:23824189 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Nucleic Acids Res 2012; 40:D343-50;   PMID:22086950 ; http://dx.doi.org/10.1093/nar/ gkr987 89.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Chem Rev 2002; 102:4501-24;  PMID:12475199 ;  http://dx.doi.org/10.1021/cr000033x 90.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Methods Enzymol 1995; 248:183-228;  PMID:7674922 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biochem 1987; 33:53-63;  PMID:3546346 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Chem Rev 2002; 102:4431-58;  PMID:12475196 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell  1982; 30:439-48;  PMID:6754086 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Mol Biol Cell 2002;  13:2486-501;  PMID:12134085 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 1994; 77:579-86;  PMID:8187177 ;  http://dx.doi.org/10.1016/0092-8674(94)90219-4 100.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Curr Biol  2001; 11:1074-8;  PMID:11470415 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 2001; 106:145-55;  PMID:11511343 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Multivesicular body sorting: ubiquitin ligase Rsp5 is required for the modification and sorting of car - boxypeptidase S. Mol Biol Cell 2004; 15:468-80;   PMID:14657247 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
EMBO J  2004; 23:1279-88;  PMID:14988731 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Nat Cell Biol 2002; 4:117-23;  PMID:11788821 ; http://dx.doi.org/10.1038/ncb743 106 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol  1992; 119:287-99;  PMID:1400574 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Eur J Biochem  1978; 85:599-608;  PMID:348476 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 1996; 271:17621-4; PMID:8663607 ; http://dx.doi.org/10.1074/ jbc.271.30.17621 110 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Multiple pathways for vacuolar sorting of yeast proteinase A. J Biol Chem 1996;  271:11865-70;  PMID:8662642 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Eur J Biochem 1992; 207:277-83;  PMID:1628653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
The structure and function of Saccharomyces  cerevisiae proteinase A. Yeast 2007; 24:467-80;   PMID:17447722 ; http://dx.doi.org/10.1002/ yea.1485 115.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Eur J Biochem 1999; 260:461-9;  PMID:10095782 ;  http://dx.doi.org/10.1046/j.1432-1327.1999.00176.x 116.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
FEBS Lett  1991; 293:62-6;  PMID:1959673 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Biochim Biophys Acta 1981; 661:136-41;  PMID:7028121 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Biochem Biophys Res Commun  2002; 296:78-84;  PMID:12147230 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Eur J Biochem 1991; 197:399-405;  PMID:2026161 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1997; 137:609- 18; PMID:9151668 ; http://dx.doi.org/10.1083/ jcb.137.3.609 131.,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Acta Crystallogr Sect F Struct Biol  Cryst Commun 2007; 63:200-3;  PMID:17329814 ;  http://dx.doi.org/10.1107/S1744309107005441 132 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Biol Chem 2012;  287:10121-33;  PMID:22123825 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Biometals 2009; 22:243- 9; PMID:18716881 ; http://dx.doi.org/10.1007/ s10534-008-9160-9 135 .,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Genetics 2007; 175:1137- 51; PMID:17179087 ; http://dx.doi.org/10.1534/ genetics.106.066944 136 .,Non-OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
J Cell Biol 1989; 108:1363-73; PMID:2647766 ; http://dx.doi.org/10.1083/ jcb.108.4.1363 140 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Cell 1983; 32:839-52;  PMID:6339075 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Development 2007; 134:945- 57; PMID:17267443 ; http://dx.doi.org/10.1242/ dev.02795 142 .,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
Bioinformatics 2007; 23:2947-8;   PMID:17846036 ; http://dx.doi.org/10.1093/ bioinformatics/btm404,OADS,/arxiv_data1/oa_pdf/55/d4/cl-4-e28023.PMC4022603.pdf
"OncoImmunology 2014; 3:e28325; http://dx.doi.org/10.4161/onci.28325Immune checkpoints A therapeutic target in triple negative breast cancer Akhil Chawla1, Anne V Philips1, Gheath Alatrash2, and el izabeth Mittendorf1,* 1Department of su rgical on cology; th e un iversity of te xas MD Anderson Cancer Center; ho uston, tX usA ; 2Department of st em Cell tr ansplant and Cellular th erapy;   th e  un iversity of  te xas MD Anderson Cancer Center;  ho uston,  tX  usA Keywords:  PD-L1, PI3K, triple negative breast cancer, biomarker, immunotherapy ea rly clinical trials investigating monoclonal antibodies targeting the t- cell inhibitory receptor programmed cell  death 1 (PD-1) and its ligand PD-L1 have shown efficacy in melanoma, non-small cell lung cancer and renal cell carci - noma.",Non-OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
Science 2013; 342:1432- 3; PMID:24357284 ; http://dx.doi.org/10.1126/ science.342.6165.1432 2.,Non-OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
J Exp Med 1995; 182:459-65; PMID:7543139 ;  http://dx.doi.org/10.1084/jem.182.2.459 3.,Non-OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 4.,OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa12006907.,OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
Cancer Immunol Res 2014; (Forthcoming); http://dx.doi.org/10.1158/2326-6066.CIR-13-01279.,Non-OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
Nat Med 2004 ; 10 :909-15;  PMID:15340416 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/cd/onci-3-e28325.PMC4022604.pdf
"Tissue Barriers 2014; 2:e28320; http://dx.doi.org/10.4161/tisb.28320Posttranscriptional Regulation of Intestinal  Epithelial Tight Junction Barrier by RNA-binding  Proteins and microRNAs Hong Yang1,3,†, Jaladanki N Rao1,3 and Jian-Ying w ang1,2,3,* 1Cell Biology Group; Department of Surgery; University of Maryland School of Medicine; Baltimore, MD USA; 2Department of Pathology; University of Maryland School of  Medicine; Baltimore, MD USA; 3Baltimore v eterans Affairs Medical Center; Baltimore, MD USA †Current Address: Department of Gastroenterology; Peking Union Hospital; Shuai Fu Yuan Dong Dan; Beijing, China Keywords:  permeability, intercellular junctions, intestinal epithelium, mRNA stability and translation,   RNA-binding proteins, microRNAs intestinal epithelial tight junctions (TJs) are a specialized  structure that determines the cell polarity and prevents the dif - fusion of toxins, allergens, and pathogens from the lumen into  the tissue.",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Nat Rev Immunol 2009; 9:799- 809; PMID:19855405 ; http://dx.doi.org/10.1038/ nri2653 2.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Annu Rev Pathol   2010 ; 5:119-44; PMID:20078218 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
"J Allergy Clin Immunol  2009 ; 124:3- 20, quiz 21-2 ; PMID:19560575 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Kidney Int  2013 ; 83:1010 -6;  PMID:23325079 ; http://dx.doi.org/10.1038/ ki.2012.440 6.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
J Gastroenterol Hepatol  2011 ;  26:423-5; PMID:21332539 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
FEBS Lett  2008 ; 582:1977 -86;  PMID:18342629 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Curr Protein Pept Sci  2012 ;  13:372-9; PMID:22708488 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
RNA Biol   2013 ; 10:579-89; PMID:23603827 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Genome Res  2009 ; 19:92-105;  PMID:18955434 ; http://dx.doi.org/10.1101/ gr.082701.108 13.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Nucleic Acids Res   2009 ; 37:7623 -37; PMID:19825980 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol Biol Cell  2009 ; 20:4885 -98;  PMID:19812253 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
J  Biol Chem  2006 ; 281:19387 -94; PMID:16690610 ;  http://dx.doi.org/10.1074/jbc.M602344200 17.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Nat Rev Genet  2007 ; 8:533- 43; PMID:17572691 ; http://dx.doi.org/10.1038/ nrg2111 19.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Biochem J  2010 ; 426:293- 306; PMID:20001965 ; http://dx.doi.org/10.1042/ BJ2009145921.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Cell 2004 ; 116:281- 97; PMID:14744438 ; http://dx.doi.org/10.1016/ S0092-8674(04)00045-5 22.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Nucleic Acids Res  2011 ; 39:D152 - 7; PMID:21037258 ; http://dx.doi.org/10.1093/nar/ gkq1027 23.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Nat Rev  Mol Cell Biol  2007 ; 8:23-36; PMID:17183358 ;  http://dx.doi.org/10.1038/nrm2085 24.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Genome Res  2009 ; 19:92-105;  PMID:18955434 ; http://dx.doi.org/10.1101/ gr.082701.108 25.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Cell 2007 ;  129:1401 -14; PMID:17604727 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Genes Dev   2009 ; 23:1743 -8; PMID:19574298 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Gastroenterology  2011 ; 141:1323 - 33; PMID:21763238 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
"Gastroenterology  2010 ; 139:1654 -64, e1 ;  PMID:20659473 ; http://dx.doi.org/10.1053/j.",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol  Cell Biol  2010 ; 30:5021 -32; PMID:20805360 ;  http://dx.doi.org/10.1128/MCB.00807-10 33.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol Biol Cell  2011 ; 22:3055 -69; PMID:21737690 ;  http://dx.doi.org/10.1091/mbc.E11-01-0069 35.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol Biol Cell   2012 ; 23:151-62; PMID:22072795 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Biochem J  2008 ; 409:389-98; PMID:17919121 ;  http://dx.doi.org/10.1042/BJ20070860 38.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Am J Physiol Gastrointest Liver  Physiol  2005 ; 288:G1159 -69; PMID :15691870 ;  http://dx.doi.org/10.1152/ajpgi.00407.2004 40.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Nucleic  Acids Res  2011 ; 39:8472 -87; PMID:21745814 ;  http://dx.doi.org/10.1093/nar/gkr56741.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Carcinogenesis   2013 ; 34:2610 -21; PMID:23880304 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
J Biol Chem  2008 ; 283:22457 - 63; PMID:18559347 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol Biol Cell  2013 ; 24:85-99; PMID:23155001 ;  http://dx.doi.org/10.1091/mbc.E12-07-0531 46.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol Biol Cell  2008 ; 19:3701 -12;  PMID:18562690 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
EMBO J  2012 ;  31:1999 -2012 ; PMID:22373575 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
"Fertil  Steril  2013 ; 99:1346 -55, e5 ; PMID:23312222 ;  http://dx.doi.org/10.1016/j.fertnstert.2012.11.055 50.",OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Am J Pathol  2013 ; 182:431-48;  PMID:23201090 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Mol Cell  2009 ; 36:932- 41; PMID:20064460 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Biochem Soc Trans  2010 ; 38:242-51;  PMID:20074068 ; http://dx.doi.org/10.1042/ BST0380242 53.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Am J Physiol Cell Physiol  2012 ; 303:C308 - 17; PMID:22592407 ; http://dx.doi.org/10.1152/ ajpcell.00120.2012 55.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Am J Physiol Cell Physiol  2010 ;  299:C579 -88; PMID:20631248 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Gut  2010 ; 59:710-2; PMID:20551452 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
Gut 2010 ; 59:775-84; PMID:19951903 ;  http://dx.doi.org/10.1136/gut.2009.181834 58.,Non-OADS,/arxiv_data1/oa_pdf/d6/2d/tisb-2-e28320.PMC4022605.pdf
"Cellular Logistics 2014; 4:e27732; http://dx.doi.org/10.4161/cl.27732Novel effects of Brefeldin A (BFA) in signaling  through the insulin receptor (IR) pathway and  regulating FoxO1-mediated transcription Paulina Wyrozumska1, Jason W as hley1, sa sanka Ramanadham1, Qinglan Liu2, W Timothy Garvey2 and eli zabeth s ztul1,* 1Department of ce ll, Developmental and Integrative Biology; University of al abama at Birmingham; Birmingham, aL Us a; 2Department of Nutrition sc iences University of  al abama at Birmingham; Birmingham, aL  Us a Keywords : insulin pathway, Brefeldin A (BFA), FoxO1, SIRT-1, GLUT4, intracellular trafficking Brefeldin a (BFa) i s a fungal metabolite best known for its ability to inhibit activation of aD P-ribosylation factor ( ar f)  and thereby inhibit secretory traffic.",Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Nature  1992; 360:350-2;  PMID :1448151 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Traffic  2010 ;  11:1537-51; PMID:20854417 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Cell  1989 ; 56:801-13; PMID:2647301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Cell  1991 ; 67:601-16; PMID:1682055 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem 1995 ;  270:30199 -204; PMID:8530430 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Traffic  2011 ;  12:672-81; PMID:21401839 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochemistry  2011 ; 50:3048 -61;  PMID:21405107 ; http://dx.doi.org/10.1021/ bi2000356 12.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Traffic  2011 ;  12:665-71; PMID:21306486 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Biol Cell  2005 ; 16:2882 -90;  PMID:15800058 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Nat Rev  Mol Cell Biol  2013 ; 14:83-97; PMID:23325358 ;  http://dx.doi.org/10.1038/nrm3507 17.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochim Biophys Acta  2011 ; 1813 :1938 - 45; PMID:21708191 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Curr Diab Rep   2009 ; 9:208-14; PMID:19490822 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Endocrinol  2007 ; 193:195-207; PMID:17470511 ;  http://dx.doi.org/10.1677/JOE-06-0191 20.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Nat Neurosci   2006 ; 9:901-6; PMID:16783365 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Lipid Res 2011 ; 52:1693 -701;  PMID:21743036 ; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem 2011 ; 286:5289 -99;  PMID:21149440 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Am J  Physiol Endocrinol Metab  2007 ; 293:E159 -64;  PMID:17374693 ; http://dx.doi.org/10.1152/ ajpendo.00629.2006 24.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Apoptosis   2013 ; 18:689-701; PMID:23479127 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Proc Natl Acad Sci U S A   2008 ; 105:3374 -9; PMID:18296641 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem  2008 ; 283:31087 -96; PMID:18799457 ;  http://dx.doi.org/10.1074/jbc.M806592200 29.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Sci 2007 ;  120:3929 -40; PMID:17956946 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Proc Natl Acad Sci U S A  2003 ; 100:6469 - 74; PMID:12738886 ; http://dx.doi.org/10.1073/ pnas.0631766100 32.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Oncology   2003 ; 64:459-67; PMID:12759546 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem  2000 ; 275:14025 - 30; PMID:10799475 ; http://dx.doi.org/10.1074/ jbc.275.19.14025 34 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Biol   1997 ; 139:1137 -55; PMID:9382862 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem 2009 ; 284:30016 -23;  PMID:19740738 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochem J   2012 ; 447:137-47; PMID:22793019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochem J  2011 ;  435:539-44; PMID:21348862 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Curr Oncol Rep 2009 ; 11:102- 10; PMID:19216841 ; http://dx.doi.org/10.1007/ s11912-009-0016-4 40.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Cell Endocrinol   2012 ; 355:96-105; PMID:22333157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Biol 1999 ; 147:1205 -22;  PMID:10601335 ; http://dx.doi.org/10.1083/ jcb.147.6.1205 45.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Biol   1997 ; 137:319-33; PMID:9128245 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Biol  1995 ; 131:1715 - 26; PMID:8557739 ; http://dx.doi.org/10.1083/ jcb.131.6.1715 47.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Am J Physiol Endocrinol Metab  2007 ; 292:E715 - 22; PMID:17077344 ; http://dx.doi.org/10.1152/ ajpendo.00380.2006 48 .,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
"Kono-Sugita  E, Satoh  S, Suzuki  Y, Egawa  M,  Udaka  N, Ito T, Sekihara  H. Insulin-induced  GLUT4 recycling in rat adipose cells by a pathway  insensitive to brefeldin A.  Eur J Biochem 1996 ;  236:1033 -7; PMID:8665891 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Endocr Relat Cancer   2008 ; 15:917-29; PMID:18775975 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Can J Physiol  Pharmacol  2006 ; 84:713-24; PMID:16998535 ;  http://dx.doi.org/10.1139/y05-152 51.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Arch Biochem Biophys  2002 ; 403:292-8;  PMID:12139979 ; http://dx.doi.org/10.1016/ S0003-9861(02)00207-2 53.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Diabetes  2008 ; 57:1355 -62;  PMID:18316359 ; http://dx.doi.org/10.2337/ db07-0714 54 .,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Cell  2003 ; 12:1403 - 11; PMID:14690595 ; http://dx.doi.org/10.1016/ S1097-2765(03)00475-1 55 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Science  1999 ; 284:974- 7; PMID:10320380 ; http://dx.doi.org/10.1126/ science.284.5416.974 56 .,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochemistry  2011 ; 50:3048 -61;  PMID:21405107 ; http://dx.doi.org/10.1021/ bi200035657.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Am J  Physiol Endocrinol Metab  2012 ; 302:E950 -60;  PMID:22297303 ; http://dx.doi.org/10.1152/ ajpendo.00466.2011 59 .,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Cell Metab   2010 ; 12:250-9; PMID:20816091 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Biol 2005 ; 169:481- 9; PMID:15866888 ; http://dx.doi.org/10.1083/ jcb.200412069 61 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Curr Drug Targets  2011 ; 12:1322 - 50; PMID:21443460 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Bone  2012 ; 50:437- 43; PMID:21816244 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Trends Mol Med   2008 ; 14:219-27; PMID:18403263 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Diabetes  2006 ; 55:2042 - 50; PMID:16804074 ; http://dx.doi.org/10.2337/ db05-0705 66 .,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Proc Natl Acad Sci U S A 2008 ; 105:2877 - 82; PMID:18287014 ; http://dx.doi.org/10.1073/ pnas.0712224105 67.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Cell Biol   2012 ; 32:2268 -78; PMID:22493067 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Methods Enzymol  1991 ; 201:347-61; PMID:1658552 ;  http://dx.doi.org/10.1016/0076-6879(91)01031-V 72.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Plant Physiol   2007 ; 145:527-38; PMID:17704232 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochem Biophys Res Commun  2004 ; 319:83- 94; PMID :15158446 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochem J   2002 ; 362:359-66; PMID:11853543 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Anat Rec  2001 ; 263:127-38;  PMID:11360230 ; http://dx.doi.org/10.1002/ar.1085 77.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Eur J Cell Biol 1999 ; 78:1- 14; PMID:10082419 ; http://dx.doi.org/10.1016/ S0171-9335(99)80002-8 78.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Nat Chem  Biol 2009 ; 5:157-65; PMID:19182783 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem  2012 ;  287:3885 -97; PMID:22158626 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Virol 2010 ; 84:7535 - 42; PMID:20504936 ; http://dx.doi.org/10.1128/ JVI.02684-09 81.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Biosyst  2010 ; 6:2030 -8; PMID:20697620 ;  http://dx.doi.org/10.1039/c0mb00035c 82 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Cell Sci 2006 ; 119:3743 -53;  PMID:16926190 ; http://dx.doi.org/10.1242/ jcs.03173,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Cell Struct Funct  2012 ; 37:141- 54; PMID:22971977 ; http://dx.doi.org/10.1247/ csf.12015 85 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
PLoS One   2010 ; 5:e9898 ; PMID:20360857 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Biol Cell   2008 ; 19:2650 -60; PMID:18417613 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Methods Enzymol  2005 ; 404:206-15;  PMID:16413271 ; http://dx.doi.org/10.1016/ S0076-6879(05)04020-688 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Mol Biol Cell  2004 ; 15:5283 -94; PMID :15385626 ;  http://dx.doi.org/10.1091/mbc.E04-05-0388 89 .,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Biochem Biophys  Res Commun  2002 ; 294:254-60; PMID:12051703 ;  http://dx.doi.org/10.1016/S0006-291X(02)00456-4 90 .,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Nat Cell Biol 2012 ;  14:764-74; PMID:22660414 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Commun Integr Biol   2009 ; 2:35-6; PMID:19704864 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
J Biol Chem 1998 ;  273:33825 -34; PMID:9837973 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
Cancer Res  2007 ;  67:3145 -52; PMID:17409421 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/a6/cl-4-e27732.PMC4022606.pdf
"Tissue Barriers 2014; 2:e28127;  http://dx.doi.org/10.4161/tisb.28127 Extra View to: Hirate Y, Hirahara S, Inoue K, Suzuki  A, Alarcon VB, Akimoto K, Hirai T, Hara T, Adachi  M, Chida K, et al.",OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Curr Biol 2013; 23:1181- 94; PMID:23791731;   http://dx.doi.org/10.1016/j.cub.2013.05.014,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Genes Dev 2013; 27:355- 71; PMID:23431053 ; http://dx.doi.org/10.1101/ gad.210773.112 2.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Dev  Growth Differ 2010; 52:263-73;  PMID:20100249 ;  http://dx.doi.org/10.1111/j.1440-169X.2009.01158.x 3.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Nat Rev Cancer  2013; 13:246-57;  PMID:23467301 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2006; 124:267-73;   PMID:16439203 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Mol Cell 2003; 11:11- 23; PMID:12535517 ; http://dx.doi.org/10.1016/ S1097-2765(02)00776-1 6.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2007;  130:1120-33;  PMID:17889654 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Curr Biol 2013; 23:1181-94;   PMID:23791731 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Dev Cell 2009; 16:398-410;  PMID:19289085 ;  http://dx.doi.org/10.1016/j.devcel.2009.02.003 11.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Mech Dev 2008;  125:270-83;  PMID:18083014 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Development  2007; 134:3827-36;  PMID:17913785 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Development 2010; 137:395-403;  PMID:20081188 ;  http://dx.doi.org/10.1242/dev.038828 14.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Proc Natl Acad Sci U S A 2012; 109:7362- 7; PMID:22529382 ; http://dx.doi.org/10.1073/ pnas.1201595109 15.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2005; 123:917-29;  PMID:16325584 ;  http://dx.doi.org/10.1016/j.cell.2005.08.040 17.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Nat Commun 2013; 4:2251;   PMID:23903990 ; http://dx.doi.org/10.1038/ ncomms3251 18.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Gene 2002; 298:69- 77; PMID:12406577 ; http://dx.doi.org/10.1016/ S0378-1119(02)00928-9 19.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2006; 125:535-48;  PMID:16678097 ;  http://dx.doi.org/10.1016/j.cell.2006.02.045 20.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Genes Cells  2007; 12:473-86;  PMID:17397395 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cancer Cell 2011; 19:527- 40; PMID:21481793 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Mol Biol Cell 2011; 22:3725-33;   PMID:21832154 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Genes Dev  2011; 25:51-63;  PMID:21205866 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
J Biol Chem  2011; 286:7018-26;  PMID:21224387 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
FEBS J 2006;  273:2000-11;  PMID:16640563 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Curr Biol 2003; 13:613-7;  PMID:12676095 ;  http://dx.doi.org/10.1016/S0960-9822(03)00204-5 28.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Sci Signal 2013; 6:ra77;   PMID:24003254 ; http://dx.doi.org/10.1126/ scisignal.2004060 29.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Development 2010; 137:3383-91;  PMID:20826529 ;  http://dx.doi.org/10.1242/dev.050195 31.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Dev Cell  2010; 19:727-39;  PMID:21074722 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Curr Biol 2013; 23:1195- 201; PMID:23791728 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Biol Reprod 2010; 83:347- 58; PMID:20505164 ; http://dx.doi.org/10.1095/ biolreprod.110.084400 37.,Non-OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
J Cell Sci  2005; 118:505-15;  PMID :15657073 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2013; 154:1342-55;  PMID:24012335 ;  http://dx.doi.org/10.1016/j.cell.2013.08.025 41.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
EMBO J 2011; 30:2325- 35; PMID:21556047 ; http://dx.doi.org/10.1038/ emboj.2011.157 42.,Non-OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Development 2011; 138:3907- 14; PMID:21831922 ; http://dx.doi.org/10.1242/ dev.070987 43.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2012; 150:780- 91; PMID:22863277 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Curr Biol 2010; 20:573- 81; PMID:20362447 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Proc Natl Acad Sci U S A  2009; 106:8579-84;  PMID:19439659 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Dev Cell 2010; 19:831- 44; PMID:21145499 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
Cell 2011; 147:759-72;  PMID:22078877 ;  http://dx.doi.org/10.1016/j.cell.2011.09.048 50.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
J Biol Chem 2013; 288:15181-93;   PMID:23564455 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/64/ce/tisb-2-e28127.PMC4022607.pdf
"Tissue Barriers 2014; 2:e28755; http://dx.doi.org/10.4161/tisb.28755PLEKHA7 modulates epithelial tight junction  barrier function serge Paschoud1,2, Lionel Jond1,2, Diego Guerrera1,2, and s andra c iti1,2 1Departments of c ell Biology and Molecular Biology; University of Geneva; Geneva; 2Institute of Genetics and Genomics in Geneva; University of Geneva; Geneva, s witzerland Keywords:  PLEKHA7 , microtubules, paracingulin, cingulin, barrier, epithelium PLeKha7 is a recently identified protein of the epithelial zonula adhaerens  (Za), and is part of a protein complex  that stabilizes the Z a, by linking it to microtubules.",Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol  1963 ; 17:375-412;  PMID:13944428 ; http://dx.doi.org/10.1083/ jcb.17.2.375 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Annu Rev Cell Dev Biol  2006 ; 22:207- 35; PMID:16771626 ; http://dx.doi.org/10.1146/ annurev.cellbio.22.010305.104219 4.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Cold Spring Harb  Perspect Biol  2009 ; 1:a002899 ; PMID:20457565 ;  http://dx.doi.org/10.1101/cshperspect.a002899 6.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Annu Rev Cell Biol  1985 ; 1:209-41;  PMID:3916317 ; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Biol Cell  2009 ; 20:3930 -40; PMID:19605556 ;  http://dx.doi.org/10.1091/mbc.E09-04-0320 9.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol  1986 ; 102:457-68;  PMID:3511070 ; http://dx.doi.org/10.1083/ jcb.102.2.457 10.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
EMBO  J 2005 ; 24:1146 -56; PMID:15775979 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Biol Cell  2007 ; 18:189-200;  PMID:17093058 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol   1980 ; 87:736-45; PMID:6780571 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Membr Biol  1985 ; 86:113- 25; PMID:4032460 ; http://dx.doi.org/10.1007/ BF01870778 14.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol  1992 ; 117:169- 78; PMID :1556151 ; http://dx.doi.org/10.1083/ jcb.117.1.169 15.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Clin Invest   2005 ; 115:2702 -15; PMID:16184195 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Cell 2008 ;  135:948-59; PMID:19041755 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
PLoS One  2010 ; 5:e12207 ;  PMID:20808826 ; http://dx.doi.org/10.1371/ journal.pone.0012207 23.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Exp Cell Res  1995 ; 218:540- 50; PMID:7796888 ; http://dx.doi.org/10.1006/ excr.1995.1189 25.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Physiol  2004 ; 201:55-70; PMID :15281089 ;  http://dx.doi.org/10.1002/jcp.20055 26.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
BMC Cell  Biol 2006 ; 7:12; PMID:16509970 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol  Microbiol  2005 ; 56:447-64; PMID :15813736 ;  http://dx.doi.org/10.1111/j.1365-2958.2005.04571.x 28.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Nat Genet  2012 ; 44:1142 - 6; PMID:22922875 ; http://dx.doi.org/10.1038/ ng.2390 29.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Biol Cell  2006 ; 17:3569 -77;  PMID:16723500 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Biol Cell  2008 ; 19:4442 -53;  PMID:18653465 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Sci  2006 ;  119:4155 -63; PMID:17038542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol  2007 ; 176:147-54;  PMID:17227889 ; http://dx.doi.org/10.1083/ jcb.200609109 34.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Curr  Opin Cell Biol  2008 ; 20:186-93; PMID:18359618 ;  http://dx.doi.org/10.1016/j.ceb.2008.02.001 35.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol  2013 ; 203:605-14; PMID:24385485 ;  http://dx.doi.org/10.1083/jcb.201304194 36.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Sci   2004 ; 117:5245 -56; PMID:15454572 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Sci  2012 ; 125:5005 - 14; PMID:22946046 ; http://dx.doi.org/10.1242/ jcs.101261 38.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Membr Biol  2008 ; 25:1-13; PMID:18097951 ;  http://dx.doi.org/10.1080/09687680701474009 39.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Cell Motil Cytoskeleton  2001 ;  48:201-12; PMID:11223951 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Nat Cell Biol  2003 ; 5:599- 609; PMID:12833063 ; http://dx.doi.org/10.1038/ ncb0703-599 41.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol   1999 ; 146:1117-32; PMID:10477764 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Biol Cell  2011 ; 22:2491 - 508; PMID:21613546 ; http://dx.doi.org/10.1091/ mbc.E11-05-0411 45.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Biol Chem  2010 ; 285:5003 -12;  PMID:20008323 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Sci   2011 ; 124:2231 -40; PMID:21652626 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Cell Biol  1991 ; 113:881- 92; PMID:2026652 ; http://dx.doi.org/10.1083/ jcb.113.4.881 50.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mech Dev  2000 ; 96:51- 65; PMID:10940624 ; http://dx.doi.org/10.1016/ S0925-4773(00)00368-3 51.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Traffic  2007 ;  8:808-19; PMID:17550375 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Cell Motil Cytoskeleton   2009 ; 66:893-908; PMID:19479825 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Br J Ophthalmol   2013 ; 97:704-7; PMID:23505305 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Nat Genet   2009 ; 41:677-87; PMID:19430479 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Hum Genet  2010 ; 55:336- 41; PMID:20414254 ; http://dx.doi.org/10.1038/ jhg.2010.31 56.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Atherosclerosis  2011 ; 219:709- 14; PMID:21963141 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Dev Dyn  1996 ; 207:104- 13; PMID:8875080 ; http://dx.doi.org/10.1002/ (SICI)1097-0177(199609)207:1<104::AID- AJA10>3.0.CO;2-0 58.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
Mol Membr Biol  2008 ; 25:1-13; PMID:18097951 ;  http://dx.doi.org/10.1080/09687680701474009 59.,Non-OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
J Biol Chem  2012 ; 287:13159 -69;  PMID:22315225 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3a/91/tisb-2-e28755.PMC4022608.pdf
"Cellular Logistics 2014; 4:e28114;  http://dx.doi.org/10.4161/cl.28114.From all to (nearly) none Tracing adaptin evolution in Fungi Lael D Barlow, Joel B Dacks* and Jeremy G Wideman* Department of c ell Biology; Faculty of Medicine and Dentistry; University of a lberta; e dmonton, a lberta, c anada Keywords:  Adaptins, AP complex, membrane trafficking, evolutionary cell biology, Microsporidia, clathrin mediated endocytosis,  fungal evolution Abbreviations: AP, adaptor protein or adaptin; BLAST, basic local alignment search tool; CCVs, clathrin coated vesicles; CME,  clathrin mediated endocytosis; COP, coat protein; HMM, hidden Markov model; TGN trans-Golgi network The five adaptor protein ( aP) complexes function in cargo-selection and coat-recruitment stages of vesicular trans - port in eukaryotic cells.",Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
"Methods Genome databases Publicly available genomes analyzed in this study include: from  the Joint Genome Institute42: Aspergillus nidulans, Tuber mela - nosporum, Yarrowia lipolytica, Rhodotorula graminis, Atractiellales   sp., Cryptococcus neoformans, Ustilago maydis, Rhizophagus irregu - laris, Rhizopus oryzae, Conidiobolus coronatus, Coemansia reversa,  Catenaria anguillulae, Batrachochytrium dendrobatidis, Piromyces  sp., Rozella allomyces, Antonospora locustae ; from the Broad insti - tute Microsporidia Comparative Sequencing Project, Broad  Institute of Harvard and MIT (http://www.broadinstitute.org/):  Fonticula alba, Spizellomyces punctatus, Allomyces macrogynus,  Nematocida parisii, Vavraia culicis floridensis, Vittaforma cor - neae, Edhazardia aedis, Nosema ceranae, Encephalitozoon cunic - uli, Encephalitozoon intestinalis ; from NCBI: Neurospora crassa,  Saccharomyces cerevisiae, Schizosaccharomyces pombe, Spraguea  lophii, Enterocytozoon bieneusi, Nosema bombycis, Nosema apis .",Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
AP-5 subunit  HMMs were constructed separately using a set of previously vali - dated sequences found by Hirst et al.12 These HMMs were then  used to search for homologs in various holomycotan genomes  using HMMer (http://hmmer.janelia.org/).,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol Biol Cell 2001; 12:2907-20;  PMID :11598180 ;  http://dx.doi.org/10.1091/mbc.12.10.2907 2.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Traffic  2013 ; 14:153-64 ;  PMID:23167973 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Dev Cell 2010; 18:324- 31; PMID :20159602 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Dev Cell 2010; 18:425- 36; PMID:20230749 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol Biol Cell 1999; 10:2787-802;   PMID:10436028 ; http://dx.doi.org/10.1091/ mbc.10.8.2787 6.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Biol Chem 1999; 274:7278-85;  PMID:10066790 ;  http://dx.doi.org/10.1074/jbc.274.11.7278 7.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Med Genet 2011; 48:141- 4; PMID:20972249 ; http://dx.doi.org/10.1136/ jmg.2010.082263 8.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Am J  Hum Genet 2011; 88:788-95;  PMID:21620353 ;  http://dx.doi.org/10.1016/j.ajhg.2011.04.019 9.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
PLoS Biol 2010; 8:e1000408;  PMID:20613862 ;  http://dx.doi.org/10.1371/journal.pbio.1000408 10.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Arch Neurol 2008; 65:393-402;  PMID:18332254 ;  http://dx.doi.org/10.1001/archneur.65.3.393 11.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol Biol Cell 2013;  24:2558-69;  PMID:23825025 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
PLoS Biol 2011;  9:e1001170;  PMID:22022230 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Science 1998; 280:431- 4; PMID:9545220 ; http://dx.doi.org/10.1126/ science.280.5362.43114.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Cell Biol 1996; 133:749-60;   PMID:8666661 ; http://dx.doi.org/10.1083/ jcb.133.4.749 15.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Cell Biol 2002;  156 :327-36 ;  PMID:11807095 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol Biol Cell 2013; 24:2378-88;  PMID:23761069 ;  http://dx.doi.org/10.1091/mbc.E12-12-0860 17.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Nat Cell Biol 1999; 1:346-53;   PMID:10559961 ; http://dx.doi.org/10.1038/14037 18.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Mol Evol  1999; 48:770-8;  PMID:10229581 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Adv  Exp Med Biol 2007; 607:84-96;  PMID:17977461 ;  http://dx.doi.org/10.1007/978-0-387-74021-8_7 21.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol  Phylogenet Evol 2013; 67:123-8;  PMID:23337175 ;  http://dx.doi.org/10.1016/j.ympev.2013.01.002 22.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Parasitol  Int 2009; 58:86-94;  PMID:19146987 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Mol Evol 2004; 59:695-702;   PMID :15693625 ; http://dx.doi.org/10.1007/ s00239-003-0085-1 24.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Adv Parasitol 2013; 82:253-319;   PMID:23548087 ; http://dx.doi.org/10.1016/ B978-0-12-407706-5.00004-6 25.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Curr Opin Genet Dev 1997;  7:792-9;  PMID:9468789 ; http://dx.doi.org/10.1016/ S0959-437X(97)80042-1 26.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Nature 2002; 418:865- 9; PMID:12192407 ; http://dx.doi.org/10.1038/ nature00949 27.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Eukaryot  Microbiol 2013; 60:166-78;  PMID:23316714 ;  http://dx.doi.org/10.1111/jeu.12019 28.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Nat Commun 2010;  1:77;  PMID:20865802 ; http://dx.doi.org/10.1038/ ncomms1082 30.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Annu  Rev Microbiol 2002; 56:93-116;  PMID:12142484 ;  http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Nature 2001;  414:450-3;  PMID:11719806 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
PLoS Pathog 2012; 8:e1002979;   PMID:23133373 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol Biol Evol 2009; 26:2699-709;   PMID:19692665 ; http://dx.doi.org/10.1093/ molbev/msp185 34.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Nature  2006; 443:818-22;  PMID:17051209 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Curr Biol 2013; 23:1548-53;   PMID:23932404 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
PLoS One 2013; 8:e77620;   PMID:24147036 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
J Cell Sci  2007; 120:1288-98;  PMID:17356068 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Nucleic Acids Res  2012; 40:D26-32;  PMID:22110030 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
BMC Bioinformatics  2013; 14:141;  PMID:23621955 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Bioinformatics  2005; 21:2104-5;  PMID:15647292 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Bioinformatics 2003; 19:1572-4;  PMID:12912839 ;  http://dx.doi.org/10.1093/bioinformatics/btg18047.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Syst Biol 2003;  52:696-704;  PMID:14530136 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Syst Biol  2010; 59:307-21;  PMID:20525638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Bioinformatics 2006;  22:2688-90;  PMID:16928733 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
Mol Biol Evol 2008; 25:1307- 20; PMID:18367465 ; http://dx.doi.org/10.1093/ molbev/msn06751.,Non-OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
"Folia Parasitol (Praha) 2005; 52:131-42, discussion  130; PMID:16004372 ; http://dx.doi.org/10.14411/ fp.2005.017 53.",OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
BMC  Biol 2012; 10:47;  PMID:22651672 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/07/75/cl-4-e28114.PMC4022609.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org57Invasion and Metastasis in the Viewpoint of Cell Adhesive  Molecules Jong-Woo Kim Department of Surgery, CHA University College of Medicine, Seongnam, KoreaEditorial Ann Coloproctol 2014;30(2):57-58 http://dx.doi.org/10.3393/ac.2014.30.2.57 cell signaling pathways of transmembrane protein kinases such as  receptor tyrosine kinase.",OADS,/arxiv_data1/oa_pdf/7a/e9/ac-30-57.PMC4022751.pdf
"Department of Surgery, CHA Bundang Medical Center, CHA University,   59 Yatap-ro, Bundang-gu, Seongnam 463-712, Korea  Tel: +82-31-780-5250, Fax: +82-31-780-5259  E-mail: kjw@cha.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/e9/ac-30-57.PMC4022751.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org59The New Stapler Device Is Good, But Needs More  Evaluation Y oung Wan Kim, Ik Y ong Kim Department of Surgery, Y onsei University Wonju College of Medicine, Wonju, KoreaEditorial Ann Coloproctol 2014;30(2):59 http://dx.doi.org/10.3393/ac.2014.30.2.59 enced one anastomosis leakage in patients with rectosigmoid co - lon cancer.",Non-OADS,/arxiv_data1/oa_pdf/09/34/ac-30-59.PMC4022752.pdf
"Department of Surgery, Yonsei University Wonju College of Medicine,   20 Ilsan-ro, Wonju 220-701, Korea  Tel: +82-33-741-0573, Fax: +82-33-744-6604   E-mail address: iykim@yonsei.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/34/ac-30-59.PMC4022752.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org60Preoperative Body Mass Index and Postoperative  Complications After Pelvic Exenteration in Recurrent or  Locally Advanced Rectal Cancer Patients Moo-Jun Baek Department of Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, KoreaEditorial Ann Coloproctol 2014;30(2):60 http://dx.doi.org/10.3393/ac.2014.30.2.60 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/b7/9a/ac-30-60.PMC4022753.pdf
"Department of Surgery, Soonchunhyang University Cheonan Hospital,  Soonchunhyang University College of Medicine, 31 Suncheonhyang 6-gil,  Dongnam-gu, Cheonan 330-930, Korea Tel: +82-41-570-3633, Fax: +82-41-571-0129  E-mail: ssurge@sch.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/9a/ac-30-60.PMC4022753.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 61Role of β1-Integrin in Colorectal Cancer:   Case-Control Study Bo-Y oung Oh, Kwang Ho Kim, Soon Sup Chung, Kyoung Sook Hong, Ryung-Ah Lee Department of Surgery, Ewha Womans University School of Medicine, Seoul, KoreaOriginal Article Ann Coloproctol 2014;30(2):61-70 http://dx.doi.org/10.3393/ac.2014.30.2.61 Purpose:  In the metastatic process, interactions between circulating tumor cells (CTCs) and the extracellular matrix or sur - rounding cells are required.",Non-OADS,/arxiv_data1/oa_pdf/d1/e6/ac-30-61.PMC4022754.pdf
"Department of Surgery, Ewha Womans University School of Medicine,   1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea Tel: +82-2-2650-2659, Fax: +82-2-2644-7984 E-mail: ralee@ewha.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/e6/ac-30-61.PMC4022754.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 71Comparison of Surgical Skills in Laparoscopic and Robotic  Tasks Between Experienced Surgeons and Novices in  Laparoscopic Surgery: An Experimental Study Hye Jin Kim, Gyu-Seog Choi, Jun Seok Park, Soo Y eun Park Colorectal Cancer Center, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Daegu, KoreaOriginal Article Ann Coloproctol 2014;30(2):71-76 http://dx.doi.org/10.3393/ac.2014.30.2.71 Purpose:  Robotic surgery is known to provide an improved technical ability as compared to laparoscopic surgery.",Non-OADS,/arxiv_data1/oa_pdf/12/ae/ac-30-71.PMC4022755.pdf
"Colorectal Cancer Center, Kyungpook National University Medical Center,  130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea  Tel: +82-53-200-2166, Fax: +82-53-200-2027 E-mail: kyuschoi@mail.knu.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/ae/ac-30-71.PMC4022755.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 77Niti CAR 27 Versus a Conventional End-to-End Anastomosis  Stapler in a Laparoscopic Anterior Resection for Sigmoid  Colon Cancer Seung-Jin Kwag, Jun-Gi Kim1, Won-Kyung Kang1, Jin-Kwon Lee1, Seong-Taek Oh1 Department of Surgery, Gyeongsang National University, Postgraduate School of Medicine, Jinju; 1Department of Surgery, The Catholic  University of Korea, Seoul St. Mary’s Hospital, Seoul, KoreaOriginal Article Ann Coloproctol 2014;30(2):77-82 http://dx.doi.org/10.3393/ac.2014.30.2.77 Purpose:  The Niti CAR 27 (ColonRing) uses compression to create an anastomosis.",Non-OADS,/arxiv_data1/oa_pdf/41/45/ac-30-77.PMC4022756.pdf
"Department of Surgery, The Catholic University of Korea, Seoul St. Mary’s  Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-6100, Fax: +82-2-595-2822 E-mail: stoh@catholic.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/45/ac-30-77.PMC4022756.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 83Preoperative Body Mass Index, 30-Day Postoperative  Morbidity, Length of Stay and Quality of Life in Patients  Undergoing Pelvic Exenteration Surgery for Recurrent and  Locally-Advanced Rectal Cancer Jessica Beaton, Sharon Carey, Michael J Solomon1,2, Ker-Kan Tan1, Jane Y oung2 Departments of Nutrition & Dietetics and 1Colorectal Surgery, 2Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital,  Sydney, AustraliaOriginal Article Ann Coloproctol 2014;30(2):83-87 http://dx.doi.org/10.3393/ac.2014.30.2.83 Purpose:  Malnutrition is associated with an increased risk of developing complications following gastrointestinal surgery,  especially following radical surgeries such as pelvic exenteration.",Non-OADS,/arxiv_data1/oa_pdf/09/8c/ac-30-83.PMC4022757.pdf
"While nutritional status and malnutrition are ideally measured us - ing multifaceted tools, including the subjective global assessment  (SGA) [14], the body mass index (BMI) is the standard anthropo - metric measure of health and nutrition [15], and it has previously  been associated with morbidity and mortality in post-surgical pa - tients [6, 16].Received: March 7, 2013   •   Accepted: July 7, 2013 Correspondence to: Michael J Solomon, MSc Department of Colorectal Surgery, Surgical Outcomes Research Centre  (SOuRCe), Royal Prince Alfred Hospital, Missenden Road, Camperdown,  NSW 2050, Australia Tel: +61-2-95153210, Fax: +61-2-95153222 E-mail: professor.solomon@sydney.edu.au © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/8c/ac-30-83.PMC4022757.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 88A Survey of Colonoscopic Surveillance After Polypectomy Dae Kyung Sohn; Colonoscopy Study Group of the Korean Society of Coloproctology1 Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang; 1Colonoscopy Study Group of Korean Society  of Coloproctology, Seoul, KoreaOriginal Article Ann Coloproctol 2014;30(2):88-92 http://dx.doi.org/10.3393/ac.2014.30.2.88 Purpose:  Several guidelines have been proposed for surveillance colonoscopy after polypectomy.",Non-OADS,/arxiv_data1/oa_pdf/f5/b3/ac-30-88.PMC4022758.pdf
"© 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/b3/ac-30-88.PMC4022758.pdf
Available from: http://www.doctorsnews.co.kr/news/ articleView.html?idxno=81769.,Non-OADS,/arxiv_data1/oa_pdf/f5/b3/ac-30-88.PMC4022758.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 93An Extragastrointestinal Stromal Tumor in the Omentum  With Peritoneal Seeding Mimicking an Appendiceal  Mucinous Cancer With Carcinomatosis Jeonghyun Kang, Tae Joo Jeon1, Sun Och Y oon2, Kang Y oung Lee, Seung-Kook Sohn Departments of Surgery, 1Nuclear Medicine, and 2Pathology, Y onsei University College of Medicine, Seoul, KoreaCase Report Ann Coloproctol 2014;30(2):93-96 http://dx.doi.org/10.3393/ac.2014.30.2.93 Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/72/85/ac-30-93.PMC4022759.pdf
"Department of Nuclear Medicine, Gangnam Severance Hospital, Yonsei  University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720,  Korea Tel: +82-2-2019-3740, Fax: +82-2-3462-5472 E-mail: tjeonnm@yuhs.ac © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/85/ac-30-93.PMC4022759.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 97Surgical Management of Unicentric Castleman’s Disease in  the Abdomen Min-Sang Kim, Jae-Kyun Ju, Y oung Kim1 Departments of Surgery and 1Pathology, Chonnam National University Medical School, Gwangju, KoreaCase Report Ann Coloproctol 2014;30(2):97-100 http://dx.doi.org/10.3393/ac.2014.30.2.97 Castleman’s disease (CD) is a rare lymphoproliferative disorder that can involve single or multiple lymph nodes in the body.",Non-OADS,/arxiv_data1/oa_pdf/26/59/ac-30-97.PMC4022760.pdf
"Department of Surgery, Chonnam National University Hospital, Chonnam  National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju   501-757, Korea Tel: +82-62-220-6456, Fax: +82-62-227-1635 E-mail: jkju@jnu.ac.kr © 2014 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/59/ac-30-97.PMC4022760.pdf
"1Review http://dx.doi.org/10.9758/cpn.2014.12.1.1 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):1-7 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  December 27, 2013/ Revised:  February 4, 2014 Accepted:  February 6, 2014 Address for correspondence: Kotaro Hatta, MD, PhD Department of Psychiatry, Juntendo University Nerima Hospital,  Takanodai 3-1-10, Nerima-ku, Tokyo 177-8521, JapanTel: +81-3-5923-3111, Fax: +81-3-5923-3217E-mail: khatta@juntendo.ac.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of  Acute-phase Schizophrenia Kotaro Hatta1, Hiroto Ito2 1Department of Psychiatry, Juntendo University Nerima Hospital, Tokyo, 2Department of Social Psychiatry, National Center of Neurology  and Psychiatry, Tokyo, Japan As a strategy for antipsychotic treatment of schizophrenia, mon otherapy is clearly optimal when both effective and tolerated.",Non-OADS,/arxiv_data1/oa_pdf/39/60/cpn-12-1.PMC4022761.pdf
"19Review http://dx.doi.org/10.9758/cpn.2014.12.1.19 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):19-30 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  February 4, 2014/ Revised:  March 17, 2014 Accepted:  March 20, 2014 Address for correspondence: Geon Ho Bahn, MD, PhD Department of Psychiatry, Kyung Hee University School of Medici ne,  23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-702, KoreaTel: +82-2-958-8556 Fax: +82-2-957-1997E-mail: mompeian@khu.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum  Disorder Yeon Jung Lee1, Soo Hyun Oh2, Chanmin Park1, Minha Hong7, Ah Rah Lee3, Hee Jeong Yoo4, Chan Young Shin5,  Keun-Ah Cheon6, Geon Ho Bahn1 1Department of Psychiatry, Kyung Hee University School of Medici ne, Seoul, 2Department of Life Sciences, Ewha Womans University,  Seoul, 3Kyung Hee University School of Medicine, Seoul, 4Department of Neuropsychiatry, Seoul National University Bundan g Hospital,  Seongnam, 5Department of Pharmacology, Konkuk University School of Medicin e, Seoul, 6Department of Psychiatry, Yonsei University  College of Medicine, Seoul, 7Department of Psychiatry, Dankook University Medical College, C hungnam, Korea In clinical practice, pharmacological treatment is mostly focus ed on behavioral symptoms in everyday life.",Non-OADS,/arxiv_data1/oa_pdf/73/1f/cpn-12-19.PMC4022762.pdf
"31Original Article http://dx.doi.org/10.9758/cpn.2014.12.1.31 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):31-36 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  April 11, 2013/ Revised:  June 3, 2013 Accepted:  June 12, 2013 Address for correspondence: Kenji Hashimoto, PhD Division of Clinical Neuroscience, Chiba University Center for  Forensic Mental Health, 1-8-1 Inohara, Chiba 260-8670, Japan Tel: +81-43-226-2517, Fax: +81-43-226-2561E-mail: hashimoto@faculty.chiba-u.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Effects of Brilliant Blue G on Serum Tumor Necrosis Factor- α Levels and  Depression-like Behavior in Mice af ter Lipopolysaccharide Administration Min Ma, Qian Ren, Ji-chun Zhang, Kenji Hashimoto Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan Objective: Accumulating evidence suggests that inflammation plays a role i n the pathophysiology of major depression.",Non-OADS,/arxiv_data1/oa_pdf/44/f4/cpn-12-31.PMC4022763.pdf
"37Original Article http://dx.doi.org/10.9758/cpn.2014.12.1.37 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):37-40 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  April 9, 2013/ Revised:  June 13, 2013 Accepted:  August 6, 2013 Address for correspondence: Reiji Yoshimura, MD, PhD Department of Psychiatry, University of Occupational and  Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu   8078555, JapanTel: +81-936917253, Fax: +81-6924894E-mail: yoshi621@med.uoeh-u.ac.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma  Levels of 3-Methoxy-4-hydroxyphenylg lycol but Not Homovanillic Acid in  Patients with Major Depressive Disorder Kiyokazu Atake, Reiji Yoshimura, Hikaru Hori, Asuka Katsuki, At suko Ikenouchi-Sugita,  Wakako Umene-Nakano, Jun Nakamura Department of Psychiatry, University of Occupational and Enviro nmental Health, Kitakyushu, Japan Objective:  We investigated the effects of duloxetine on the plasma levels  of catecholamine metabolites and serum brain-derived  neurotrophic factor (BDNF) in 64 patients with major depressive  disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/c9/07/cpn-12-37.PMC4022764.pdf
"41Original Article http://dx.doi.org/10.9758/cpn.2014.12.1.41 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):41-47 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  October 15, 2013/ Revised:  November 11, 2013 Accepted:  November 13, 2013 Address for correspondence: Seung-Hwan Lee, MD, PhD,  Department of Psychiatry, Inje University Ilsan Paik Hospital, 170  Juhwa-ro, Ilsanseo-gu, Goyang 411-706, KoreaTel: +82-31-910-7260, Fax: +82-31-910-7268E-mail: Ishpss@paik.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Comparison of Memory Function and MMPI-2 Profile between Post-traumatic  Stress Disorder and Adjustment Disorder after a Traffic Accident Sung-Man Bae1, Myoung-Ho Hyun3, Seung-Hwan Lee1,2 1Department of Psychiatry, Inje University Ilsan Paik Hospital, 2Clinical Emotion and Cognition Research Laboratory, Goyang, 3Department  of Psychology, Chung-Ang University, Seoul, Korea Objective: Differential diagnosis between post-traumatic stress disorder ( PTSD) and adjustment disorder (AD) is rather difficult,  but very important to the assignment of appropriate treatment a nd prognosis.",Non-OADS,/arxiv_data1/oa_pdf/08/ea/cpn-12-41.PMC4022765.pdf
"48Original Article http://dx.doi.org/10.9758/cpn.2014.12.1.48 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):48-53 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  July 8, 2013/ Revised:  September 25, 2013 Accepted:  November 25, 2013 Address for correspondence: Antonio Eblen-Zajjur, MD, PhD P,O.",Non-OADS,/arxiv_data1/oa_pdf/fb/cb/cpn-12-48.PMC4022766.pdf
Available from http://www.galiander.ca/quikgrid/index.,Non-OADS,/arxiv_data1/oa_pdf/fb/cb/cpn-12-48.PMC4022766.pdf
"54Original Article http://dx.doi.org/10.9758/cpn.2014.12.1.54 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):54-64 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  October 15, 2013/ Revised:  December 14, 2013 Accepted:  March 1, 2014 Address for correspondence: Hyo Deog Rim, MD, PhD Department of Psychiatry, Kyungpook National University Hospita l,  130 Dongdeok-ro, Jung-gu, Daegu 700-721, KoreaTel: +82-53-420-5755, Fax: +82-53-426-5361E-mail: psyleebd@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in  Methamphetamine Abusers: Case-control Association Study Byung Dae Lee1,2, Je Min Park1,2, Young Min Lee1,2, Eun Soo Moon1,2, Hee Jeong Jeong1,2, Young In Chung1,2,  Hyo Deog Rim3 1Department of Psychiatry, Medical Research Institute, Pusan Nat ional University Hospital, Busan, 2Department of Psychiatry, Pusan  National University College of Medicine, Yangsan, 3Department of Psychiatry, Kyungpook National University Hospita l, Daegu, Korea Objective:  It was previously suggested that the malic enzyme 2 ( ME2) as the candidate gene for psychosis in fine mapping  of chromosome 18q21.",Non-OADS,/arxiv_data1/oa_pdf/50/28/cpn-12-54.PMC4022767.pdf
"22,27)  Finally genotyped SNPs in selected neuronal genes were  chosen from previous literatures and availability in Illumina Customized Sentrix Array Matrix genotyp- ing_v6A with Standard Illumina procedures using  Illumina BeadStation 500G array scanner in the NCBI ENTREZ SNP (http://www.ncbi.nlm.nih.gov/sites/entrez).",OADS,/arxiv_data1/oa_pdf/50/28/cpn-12-54.PMC4022767.pdf
"65Case Report http://dx.doi.org/10.9758/cpn.2014.12.1.65 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):65-66 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  April 10, 2013 / Accepted:  April 25, 2013 Address for correspondence: Hidehiro Umehara, MD Department of Psychiatry, Course of Integrated Brain Sciences,  University of Tokushima School of Medicine, Kuramoto-cho 2-50-1 , Tokushima 770-8503, JapanTel: +81-86-633-7130, Fax: +81-86-633-7131E-mail: umeharatokushima@yahoo.co.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with  Risperidone Long-acting Injection Hidehiro Umehara, Junichi Iga, Tetsuro Ohmori Department of Psychiatry, Course of Integrated Brain Sciences, University of Tokushima School of Medicine, Tokushima, Japan Although the effectiveness of medication in the treatment of an orexia nervosa is uncertain, atypical antipsychotics such as ol an- zapine and risperidone have been used empirically for decades.",Non-OADS,/arxiv_data1/oa_pdf/88/92/cpn-12-65.PMC4022768.pdf
"67Case Report http://dx.doi.org/10.9758/cpn.2014.12.1.67 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):67-68 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  July 31, 2013/ Revised:  September 3, 2013 Accepted:  September 11, 2013 Address for correspondence: Kentaro Kawabe, MD Department of Neuropsychiatry, Graduate School of Medicine,  Ehime University, Shitsukawa, Toon city, Ehime 791-0295, JapanTel: +81-89-960-5315, Fax: +81-89-960-5317E-mail: k_kentaro_k@yahoo.co.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.A Case of Acute Pancreatitis Associated with Risperidone Treatment Kentaro Kawabe, Shu-ichi Ueno Department of Neuropsychiatry, Graduate School of Medicine, Ehi me University, Ehime, Japan Acute pancreatitis with antipsychotic treatment is rare but som etimes causes a fatal adverse effect.",Non-OADS,/arxiv_data1/oa_pdf/88/7c/cpn-12-67.PMC4022769.pdf
"69Case Report http://dx.doi.org/10.9758/cpn.2014.12.1.69 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):69-71 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  September 16, 2013/ Revised:  November 29, 2013 Accepted:  December 2, 2013 Address for correspondence: Rakesh Goyal, MD Braceland Bldg #234, Institute of Living/Hartford Hospital, 200   Retreat Avenue, Hartford, CT 06106, USATel: +1-860-545-7239, Fax: +1-862-220-1828E-mail: rkg8910@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.A Case of Aripiprazole Induced Tard ive Dyskinesia in a Neuroleptic-Naïve  Patient with Two Years of Follow Up Rakesh Goyal1, Salam Hemabati Devi2 1Institute of Living/Hartford Hospital, Hartford, CT, USA, 2Department of Psychiatry, Lady Hardinge Medical College and Hos pitals, New  Delhi, India  Tardive dyskinesia (TD) is arguably the most serious and potent ial irreversible side effect of antipsychotic medication.",Non-OADS,/arxiv_data1/oa_pdf/01/0e/cpn-12-69.PMC4022770.pdf
"72Letter to the Editor http://dx.doi.org/10.9758/cpn.2014.12.1.72 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):72-73 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  November 26, 2013/ Accepted:  November 27, 2013 Address for correspondence: Kenji Hashimoto, PhD  Division of Clinical Neuroscience, Chiba University Center for  Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, JapanTel: +81-423-226-2517, Fax: +81-423-226-2561E-mail: hashimoto@faculty.chiba-u.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The R-Stereoisomer of Ketamine as an Alternative for Ketamine for  Treatment-resistant Major Depression Kenji Hashimoto Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan TO THE EDITOR The N-methyl-D-aspartate (NMDA) receptor antago- nist ketamine is one of the most attractive antidepressants  for treatment-resistant major depression.1,2) I read the re- cent article by  Murrough et al.3) about the rapid and robust  antidepressant effects of a sing le intravenous infusion of  ketamine in treatment-resistant patients with major de-pression with great interest.",Non-OADS,/arxiv_data1/oa_pdf/8d/f5/cpn-12-72.PMC4022771.pdf
"8Review http://dx.doi.org/10.9758/cpn.2014.12.1.8 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2014;12(1):8-18 Copyrightⓒ 2014, Korean College of Neuropsychopharmacology                       Received:  December 9, 2013/ Accepted:  February 3, 2014 Address for correspondence: Ganesan Venkatasubramanian,  MD, PhD Department of Psychiatry, National Institute of Mental Health a nd  Neurosciences (NIMHANS), Bangalore 560029, IndiaTel: +91-80-26995256, Fax: +91-80-26564830E-mail: venkat.nimhans@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Neuroimmunological Aberrations and Cere bral Asymmetry Abnormalities in  Schizophrenia: Select Perspectives on Pathogenesis Ganesan Venkatasubramanian1,2, Monojit Debnath3 1The Schizophrenia Clinic, Department of Psychiatry, National In stitute of Mental Health and Neurosciences, 2Translational Psychiatry  Laboratory, Neurobiology Research Centre, National Institute of  Mental Health and Neurosciences, 3Department of Human Genetics,  National Institute of Mental Health and Neurosciences, Bangalor e, India Within the wide-ranging gamut of factors that comprise gene-env ironment interactions postulated to underlie schizophrenia,  the crosstalk between environmental factors and feto-maternal i mmune components has been put forth as one of the important  mechanisms that increase the risk towards schizophrenia in the offspring.",Non-OADS,/arxiv_data1/oa_pdf/92/96/cpn-12-8.PMC4022772.pdf
"2: 100-106, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.100 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 100Received on December 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fb/bf/in-14-100.PMC4022777.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/bf/in-14-100.PMC4022777.pdf
"2: 107-115, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.107 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 107Received on January 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7a/eb/in-14-107.PMC4022778.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/eb/in-14-107.PMC4022778.pdf
in press:  http://informahealthcare.com/doi/abs/10.3109/09637486.201 3.869796  9.,Non-OADS,/arxiv_data1/oa_pdf/7a/eb/in-14-107.PMC4022778.pdf
in press:  http://dx.doi.org/10.1016/j.jep.2013.12.059 11.,OADS,/arxiv_data1/oa_pdf/7a/eb/in-14-107.PMC4022778.pdf
"2: 116-122, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.116 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 116Received on January 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a6/20/in-14-116.PMC4022779.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/20/in-14-116.PMC4022779.pdf
"2: 67-72, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.67 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 67Received on January 13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/68/95/in-14-67.PMC4022780.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/95/in-14-67.PMC4022780.pdf
"2: 73-80, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.73 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 73Received on December 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/70/58/in-14-73.PMC4022781.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/58/in-14-73.PMC4022781.pdf
"2: 81-88, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.81 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 81Received on January 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c2/bb/in-14-81.PMC4022782.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/bb/in-14-81.PMC4022782.pdf
"2: 89-99, April, 2014http://dx.doi.org/10.4110/in.2014.14.2.89 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 89Received on December 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/39/3e/in-14-89.PMC4022783.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/3e/in-14-89.PMC4022783.pdf
"The following prime r sets were used and validated  by PrimerBank (http://pga.mgh.harvard.edu/primerbank/):  β-actin (PrimerBank ID: 6671509a1), IFN- γ (PrimerBank ID:  145966741c1), and IL-17A (PrimerBank ID: 6754324a1).",Non-OADS,/arxiv_data1/oa_pdf/39/3e/in-14-89.PMC4022783.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.1 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:1-5  1Review Article www.cmj.ac.k r FIG.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/cmj-50-1.PMC4022791.pdf
"Key Words:  Epithelium; Permeability; Tight junctions This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 January, 2014 revised 17 February, 2014 accepted 18 February, 2014 Corresponding Author: An-Soo JangDivision of Allergy and Respiratory Medicine, Department of Internal  Medicine, Soonchunhyang University  Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea  TEL: +82-32-621-5143 FAX: +82-32-621-6950 E-mail: jas877@schmc.ac.kr INTRODUCTION 　The epithelium, including th e respiratory system and  other organs, acts as a selective gate between the outside environment and underlying tissue.",Non-OADS,/arxiv_data1/oa_pdf/47/b2/cmj-50-1.PMC4022791.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.15 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:15-20  15Original Article-Surgery www.cmj.ac.k r Comparison of the Outcome in Bilateral Staged Total Hip  Arthroplasty: Modified Two-Incision Minimally Invasive Technique versus the Conventional Posterolateral Approach Masjudin Tumin, Kyung Soon Park, Azlina Amir Abbas and Taek Rim Yoon * Department of Orthopedic Surgery, Center for Joint Disease, Chonnam National University Hwasun Hospital, Hwasun, Korea  This retrospective study was undertaken to compare the outcomes of staged bilateral  total hip arthroplasty (THA) by the conventi onal approach with those of two-incision  minimally invasive (MIS-2) THA in terms of c linical and radiological results, complica- tions, and patient preference s. Twenty-two patients aged 30 to 80 years underwent  staged bilateral THA.",Non-OADS,/arxiv_data1/oa_pdf/b8/9d/cmj-50-15.PMC4022792.pdf
"Key Words:  Arthroplasty; Hip; Risk This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 20 November, 2013 revised 11 December, 2013 accepted 12 December, 2013 Corresponding Author: Taek Rim Yoon Department of Orthopedic Surgery, Center for Joint Disease, Chonnam  National University Hwasun Hospital,  322 Seoyang-ro, Hwasun-eup, Hwasun 519-809, Korea TEL: +82-61-379-7677, 7676 FAX: +82-61-379-7681E-mail: tryoon@chonnam.ac.kr INTRODUCTION 　Total hip arthroplasty (THA ) using a smaller incision  has generated substantial interest among orthopedic sur-geons and patients during the past decade.",Non-OADS,/arxiv_data1/oa_pdf/b8/9d/cmj-50-15.PMC4022792.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.21 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:21-22  21Images in Clinical Medicine www.cmj.ac.k r FIG.",Non-OADS,/arxiv_data1/oa_pdf/29/bd/cmj-50-21.PMC4022793.pdf
"Key Words:  Medullary sponge kidney; Urogra phy; Urinary tract infections This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 September, 2013 accepted 17 September, 2013 Corresponding Author: Shu-Pin HuangDepartment of Urology, Kaohsiung  Medical University Hospital,  Kaohsiung, Taiwan, 100 Tz-You 1 st Road, Kaohsiung, Taiwan TEL: +886-7-312-1101 FAX: +886-7-3211033E-mail: shpihu@yahoo.com.tw WHAT CAUSES FREQUENT URINARY TRACT  INFECTION AND GROSS HEMATURIA?",Non-OADS,/arxiv_data1/oa_pdf/29/bd/cmj-50-21.PMC4022793.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.23 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:23-26  23Case Report www.cmj.ac.k r Terrible Stent Thrombosis Induced by a Treadmill Test Performed  Three Days after Percutaneous Coronary Intervention  Hyun Soo Kim, Se Yun Kim, Un Joo Lee and Weon Kim * Division of Cardiology, Department of In ternal Medicine, Kyung Hee University Hosp ital, Kyung Hee University, Seoul, Korea Generally, early exercise after coronary stenting is considered safe, but isolated cases  of acute stent thrombosis have been associat ed with the performance of a treadmill ex- ercise test after percutaneous coronary interv ention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/c4/f9/cmj-50-23.PMC4022794.pdf
"Key Words:  Exercise; Stents; Thrombosis; Percu taneous coronary intervention This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 1 December, 2013 revised 9 January, 2014 accepted 15 January, 2014 Corresponding Author: Weon Kim Division of Cardiology, Department of  Internal Medicine, Kyung Hee Uni- versity Hospital, Kyung Hee University, 1, Hoegi-dong, Dongdaemoon-gu,  Seoul 130-702, Korea TEL: +82-2-958-8170FAX: +82-2-958-8160 E-mail: mylovekw@hanmail.net INTRODUCTION 　Generally, early exercise afte r coronary stenting is con- sidered safe, as shown by some reports in the literature.1  However, several reports have described acute thrombotic occlusion associated with exer cise testing shortly after suc- cessful percutaneous corona ry intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/c4/f9/cmj-50-23.PMC4022794.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.27 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:27-30  27Case Report www.cmj.ac.k r Diffuse Infiltrative Primary Cardiac Lymphoma with Delayed  Extracardiac Involvement Yong Jeoung, Se Ryeon Lee *, Ho Kim, Ji Won Kim, Jae Joong Lee and Sang Yoon Chung Department of Internal Medicine, Korea University Medical Center, Seoul, Korea Primary cardiac lymphoma (PCL) is an extremely rare and fatal neoplasm of the heart.",Non-OADS,/arxiv_data1/oa_pdf/8f/fc/cmj-50-27.PMC4022795.pdf
"Key Words:  Heart; Lymphoma; Diagnosis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 1 October, 2013 revised 15 October, 2013 accepted 16 October, 2013 Corresponding Author: Se Ryeon LeeDepartment of Internal Medicine,  Korea University Medical Center, 512 Gojan-dong, Danwon-gu, Ansan  425-707, Korea TEL: +82-31-412-5114FAX: +82-31-412-5984 E-mail: logost@hanmail.net INTRODUCTION 　Primary cardiac lymphoma (PCL) is a very rare neo- plasm originating in the hear t. Traditionally, PCL is de- fined as an extranodal lymphoma limited to the heart or pericardium.",Non-OADS,/arxiv_data1/oa_pdf/8f/fc/cmj-50-27.PMC4022795.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.31 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:31-36  31Case Report www.cmj.ac.k r Successful Endovascular Aneurysm Repair for Abdominal Aortic  Aneurysm in a Patient with Severe Coronary Artery Disease Undergoing Off-Pump Coronary Artery Bypass Grafting Sun Min Kim, Jae Yeong Cho, Ju Han Kim, Keun-Ho Park, Doo Sun Sim, Young Joon Hong,  Youngkeun Ahn and Myung Ho Jeong * Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea It is well known that patients with abdo minal aortic aneurysm (AAA) often have con- comitant coronary artery disease (CAD).",Non-OADS,/arxiv_data1/oa_pdf/a2/0d/cmj-50-31.PMC4022796.pdf
"Key Words:  Aortic aneurysm, Abdominal; An eurysm; Coronary artery disease This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 1 October, 2013 revised 11 February, 2014 accepted 12 February, 2014 Corresponding Author: Myung Ho JeongPrincipal Investigator of Korea Acute Myocardial Infarction Registry  (KAMIR), Director of Heart Research  Center Nominated by Korea Ministry of Health & Welfare, Chonnam National  University Hospital, 671 Jaebong-ro,  Dong-gu, Gwangju 501-757, KoreaTEL: +82-62-220-6243 FAX: +82-62-228-7174 E-mail: myungho@chollian.net INTRODUCTION 　Endovascular aneurysm repa ir (EVAR) is an important  advance in the treatment of abdominal aortic aneurysm  (AAA).",Non-OADS,/arxiv_data1/oa_pdf/a2/0d/cmj-50-31.PMC4022796.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.1.6 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:6-14  6Original Article-Gastroenterology www.cmj.ac.k r Gastroprotective Effects of Glutinous Rice Extract against Ethanol-,  Indomethacin-, and Stress-induced Ulcers in Rats Dong Up Song, Mi Sun Jang, Hyun Woo Kim, Hyun Joong Yoon1, Kee Oh Chay1, Young Eun Joo2,  Young Do Jung1, Sung Yeul Yang1 and Bong Whan Ahn1,* Chonnam University Research Institute of Medical Sciences and Departments of 1Biochemistry and 2Internal Medicine, Chonnam National  University Medical School, Gwangju, Korea  This study was designed to evaluate the efficacy of an orally administered aqueous ex- tract of glutinous rice (GRE) to protect ag ainst acute gastric mucosal lesions induced  by ethanol, indomethacin, an d water immersion restraint stress in rats and to charac- terize the active substances responsible for the protection.",Non-OADS,/arxiv_data1/oa_pdf/8a/95/cmj-50-6.PMC4022797.pdf
"Key Words:  Glutinous rice; Gastroprotectio n; Ulcer; Proteins; Prolamins This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 17 December, 2013 revised 27 January, 2014 accepted 28 January, 2014 Corresponding Author: Bong Whan AhnDepartment of Biochemistry, Chonnam National University Medical School,  160, Baekseok-ro, Dong-gu, Gwangju  501-757, KoreaTEL: +82-62-220-4102 FAX: +82-62-223-8321 E-mail: bwahn@jnu.ac.kr INTRODUCTION 　Rice is a staple food in many countries.",Non-OADS,/arxiv_data1/oa_pdf/8a/95/cmj-50-6.PMC4022797.pdf
"2014;46(2):109-123 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.109  Special Article Open Access  Cancer Statistics in Korea: Incidence, Mortality, Survival,  and Prevalence in 2011  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │109 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/37/crt-46-109.PMC4022819.pdf
"2014;46(2):124-130 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.124     ---- Special Article Open Access  Prediction of Cancer Incidence and Mortality in Korea, 2014  1The Korea Central Cancer Registry,  2National Cancer Control Institute,  National Cancer Center, Goyang,    Korea Purpose We studied and reported on cancer incidence and mortality rates as projected for the  year 2014 in order to estimate Korea’s current cancer burden.",Non-OADS,/arxiv_data1/oa_pdf/89/9f/crt-46-124.PMC4022820.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │124 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/9f/crt-46-124.PMC4022820.pdf
"2014;46(2):131-140 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.131  Original Article Open Access  A Nationwide Survey of Knowledge of and Compliance with Cancer  Pain Management Guidelines by Korean Physicians  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Department of Internal Medicine,  Dongguk University Ilsan Hospital,  Dongguk University  College of Medicine, Goyang,  2Department of Medicine,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, Seoul,  3Department of Internal Medicine,  Yeungnam University  College of Medicine, Daegu,  4Department of Internal Medicine,  Chonnam National University  Hwasun Hospital,  Chonnam National University  Medical School, Hwasun,  5Department of Biostatistics,  Korea University College of Medicine, Seoul,  6Department of Internal Medicine,  Kyung Hee University Hospital,  Kyung Hee University School of Medicine,  Seoul, Korea  Correspondence: Si-Young Kim, MD  Division of Hematology and Medical Oncology,  Department of Internal Medicine,  Kyung Hee University Hospital,  26 Kyungheedae-ro, Dongdaemun-gu,  Seoul 130-701, Korea  Tel: 82-2-958-8721  Fax: 82-2-959-7192  E-mail: sykim@khu.ac.kr  Received  March 15, 2013  Accepted  June 25, 2013 Purpose Although cancer pain is prevalent, under-treatment still remains a problem.",Non-OADS,/arxiv_data1/oa_pdf/9b/c0/crt-46-131.PMC4022821.pdf
"Key words Pain, Neoplasms, Knowledge, Analgesics,  Guideline, Compliance  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │131 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/c0/crt-46-131.PMC4022821.pdf
"2014;46(2):141-147 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.141  Open Access  Clinical Features and Treatment of Collecting Duct Carcinoma of the  Kidney from the Korean Cancer Study Group Genitourinary and  Gynecology Cancer Committee  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │141 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/47/crt-46-141.PMC4022822.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │148 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/fe/crt-46-148.PMC4022823.pdf
"2014;46(2):148-157 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.148  Open Access  Impact on Loco-regional Control of Radiochemotherapeutic Sequence and  Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer  Patients Treated with Postoperative Concurrent Radiochemotherapy  1Department of Radiation Oncology,  Hallym University Dongtan  Sacred Heart Hospital, Hwasung,  2Department of Radiation Oncology,  Seoul National University  College of Medicine, Seoul,  3Department of Radiation Oncology,  Samsung Comprehensive Cancer Center,  Sungkyunkwan University  School of Medicine, Seoul,  4Department of Radiation Oncology,  Korea University Ansan Hospital,  Ansan, Korea Purpose This study was designed to evaluate the impact of radiochemotherapeutic sequence  and time to initiation of adjuvant treatment on loco-regional control for resected stage  II and III rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/6b/fe/crt-46-148.PMC4022823.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │158 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/a9/crt-46-158.PMC4022824.pdf
"2014;46(2):158-164 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.158  Nam Kwon Lee , MD 1,2  Dae Yong Kim, MD 1,3  Sun Young Kim, MD 3 Jae Hwan Oh, MD 3 Won Park, MD 4 Doo Ho Choi, MD 4 Taek-Keun Nam, MD 5 Kyung-Ja Lee, MD 6 1Proton Therapy Center,  Research Institute and Hospital,  National Cancer Center, Goyang,  2Department Radiation Oncology,  Korea University Medical Center,  Korea University College of Medicine, Seoul,  3Center for Colorectal Cancer,  Research Institute and Hospital,  National Cancer Center, Goyang,  4Department of Radiation Oncology,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, Seoul,  5Department of Radiation Oncology,  Chonnam National University  Ewha Womans University  Mokdong Hospital, Gwangju,  6Department of Radiation Oncology,  Ewha Womans University Mokdong  Hospital, Ewha Womans University  School of Medicine, Seoul, Korea  Correspondence: Dae Yong Kim, MD  Center for Colorectal Cancer,  Research Institute and Hospital,  National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 410-769, Korea  Tel: 82-31-920-1721  Fax: 82-31-920-0149  E-mail: radiopiakim@hanmail.net  Received  March 19, 2013  Accepted  May 17, 2013 Purpose To evaluate the treatment outcomes of local excision following preoperative chemora - diotherapy in patients with locally advanced rectal cancer who have not undergone  radical surgery for any reason.",Non-OADS,/arxiv_data1/oa_pdf/d9/a9/crt-46-158.PMC4022824.pdf
"2014;46(2):165-171 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.165  Original Article Open Access  Metabolic Burden Measured by 18 F-Fluorodeoxyglucose Positron  Emission Tomography/Computed Tomography Is a Prognostic Factor  in Patients with Small Cell Lung Cancer  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Department of Internal Medicine,  Pusan National University  School of Medicine, Busan,  2Biomedical Research Institute,  Pusan National University Hospital, Busan,  3Department of Nuclear Medicine,  Pusan National University  School of Medicine, Busan, Korea  Correspondence: Min Ki Lee, MD, PhD  Department of Internal Medicine,  Pusan National University  School of Medicine, 179 Gudeok-ro,  Seo-gu, Busan 602-739, Korea  Tel: 82-51-240-7206    Fax: 82-51-245-3127  E-mail: leemk@pusan.ac.kr  Received  April 25, 2013  Accepted  June 21, 2013  * Mi-Hyun Kim and Ji Seok Lee contributed  equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/bb/43/crt-46-165.PMC4022825.pdf
"Currently, tumor stage is the most impor - tant prognostic factor in SCLC: other prognostic factors  include performance status, weight loss, sex, serum albumin,  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │165 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/43/crt-46-165.PMC4022825.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │172 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/06/crt-46-172.PMC4022826.pdf
"2014;46(2):172-177 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.172  Original Article Open Access  Modified MVAC as a Second-Line Treatment for Patients with  Metastatic Urothelial Carcinoma after Failure of Gemcitabine and  Cisplatin Treatment  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Korea University College of Medicine,  2Department of Urology,  3Division of Oncology/Hematology,  Department of Internal Medicine,  Departments of 4Radiation Oncology and  5Radiology, Korea University  College of Medicine, Seoul, Korea  Correspondence: Kyong Hwa Park, MD, PhD  Division of Oncology/Hematology,  Department of Internal Medicine,  Korea University College of Medicine,  73 Inchon-ro, Seongbuk-gu,  Seoul 136-705, Korea  Tel: 82-2-920-6841  Fax: 82-2-920-6520  E-mail: khpark@korea.ac.kr  Received  June 10, 2013  Accepted  July 19, 2013 Purpose There is no established standard second-line chemotherapy for patients with  advanced or metastatic urothelial carcinoma (UC) who failed gemcitabine and  cisplatin (GC) chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/6c/06/crt-46-172.PMC4022826.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │178 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/85/crt-46-178.PMC4022827.pdf
"2014;46(2):178-185 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.178  Original Article Open Access  Diagnostic Value of Circulating Extracellular miR-134, miR-185,  and miR-22 Levels in Lung Adenocarcinoma-Associated  Malignant Pleural Effusion  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Department of Internal Medicine,  Cheongju St. Mary Hospital, Cheongju,  2Bioevaluation Center,  Korea Research Institute of Bioscience  and Biotechnology, Cheongwon,  Departments of 3Pathology and  4Internal Medicine, Chungbuk National  University College of Medicine,  Cheongju, Korea  Correspondence: Hye-Suk Han, MD, PhD  Department of Internal Medicine,  Chungbuk National University  College of Medicine, 776 1sunhwan-ro,  Heungdeok-gu, Cheongju 361-711, Korea  Tel: 82-43-269-6306  Fax: 82-43-273-3252  E-mail: sook3529@hanmail.net  Received  June 5, 2013  Accepted  July 9, 2013 Purpose The accurate and timely diagnosis of malignant pleural effusion (MPE) in lung cancer  patients is important because MPE has a poor prognosis and is classified as stage IV  disease.",Non-OADS,/arxiv_data1/oa_pdf/bf/85/crt-46-178.PMC4022827.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │186 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/e2/crt-46-186.PMC4022828.pdf
"2014;46(2):186-193 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.186  Original Article Open Access  Preclinical Efficacy Testing for Stomach and Liver Cancers  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Biomolecular Function Research Branch,  National Cancer Center, Goyang,  2Department of Veterinary Pathology,  College of Veterinary Medicine,  Seoul National University, Seoul,  3National OncoVenture,  4Molecular Imaging and Therapy Branch,  National Cancer Center, Goyang, Korea  Correspondence: Hark Kyun Kim, MD, PhD  Biomolecular Function Research Branch,  National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 410-769, Korea  Tel: 82-31-920-2255  Fax: 82-31-920-2006  E-mail: hkim@ncc.re.kr  Co-Correspondence: Dae Yong Kim, DVM, PhD  Department of Veterinary Pathology,  College of Veterinary Medicine,  Seoul National University, 599 Gwanak-ro,  Gwanak-gu, Seoul 151-742, Korea  Tel: 82-2-880-1249  Fax: 82-2-879-2736  E-mail: daeyong@snu.ac.kr  Received  December 10, 2012  Accepted  June 26, 2013  * Jun Won Park and Nam Suk Baek contributed  equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/18/e2/crt-46-186.PMC4022828.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │194 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/f5/crt-46-194.PMC4022829.pdf
"2014;46(2):194-199 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.194  Case Report Open Access  Case Series of Different Onset of Skin Metastasis According to the  Breast Cancer Subtypes  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Division of Medical Oncology,  Department of Internal Medicine,  Incheon Sarang Hospital, Incheon,  2Department of Internal Medicine,  Yonsei University College of Medicine,  Seoul, Korea  Correspondence: Soohyeon Lee, MD, PhD  Department of Internal Medicine,  Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, Korea  Tel: 82-2-2228-8130  Fax: 82-2-393-3652  E-mail: socmed0127@gmail.com  Received  December 4, 2012  Accepted  April 19, 2013 We report on five cases of skin metastasis according to the breast cancer (BC)  subtype.",Non-OADS,/arxiv_data1/oa_pdf/ab/f5/crt-46-194.PMC4022829.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │200 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/c6/crt-46-200.PMC4022830.pdf
"2014;46(2):200-203 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.200  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 1Division of Hematology-Oncology,  Department of Medicine,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, Seoul,  2Division of Hematology-Oncology,  Department of Medicine, Kosin University  College of Medicine, Busan,  3Department of Pathology,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, Seoul, Korea  Correspondence: Yeon Hee Park, MD, PhD  Division of Hematology-Oncology,  Department of Medicine,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: 82-2-3410-1780  Fax: 82-2-3410-1757  E-mail:yhparkhmo@skku.edu  Received  December 23, 2012  Accepted  April 4, 2013 Cases of phenotypic heterogeneity of cells within tumors have recently been reported.",Non-OADS,/arxiv_data1/oa_pdf/b7/c6/crt-46-200.PMC4022830.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │204 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/66/crt-46-204.PMC4022831.pdf
"2014;46(2):204-207 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.2.204  Case Report Open Access  Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer  after Treatment with 5-Fluorouracil/Leucovorin and Oxaliplatin:  Case Report and Literature Review  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Departments of 1Internal Medicine and  2Hospital Pathology,  Yeouido St. Mary’s Hospital,  The Catholic University of Korea  College of Medicine, Seoul, Korea  Correspondence: In Sook Woo, MD  Division of Medical Oncology,  Department of Internal Medicine,  Yeouido St. Mary’s Hospital,  The Catholic University of Korea  College of Medicine, 10 63(yuksam)-ro,  Yeongdeungpo-gu, Seoul 150-713, Korea  Tel: 82-2-3779-1574  Fax: 82-2-780-3132  E-mail: insookwoo@catholic.ac.kr  Received  March 21, 2013  Accepted  April 10, 2013 Development of tumor lysis syndrome (TLS) may occur after chemotherapy or spon - taneously in bulky or rapidly growing tumors.",Non-OADS,/arxiv_data1/oa_pdf/47/66/crt-46-204.PMC4022831.pdf
"Cell Reports Report Phosphorylation of the Proapoptotic BH3-Only Protein Bid Primes Mitochondria for Apoptosisduring Mitotic Arrest Pengbo Wang,1,2Jennefer Lindsay,1,2Thomas W. Owens,1Ewa J. Mularczyk,1Stacey Warwood,1Fiona Foster,1 Charles H. Streuli,1Keith Brennan,1and Andrew P. Gilmore1,* 1Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK 2These authors contributed equally to this work *Correspondence: agilmore@manchester.ac.uk http://dx.doi.org/10.1016/j.celrep.2014.03.050 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/ea/18/main.PMC4022835.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article online at http://dx.doi.org/ 10.1016/j.celrep.2014.03.050 .,Non-OADS,/arxiv_data1/oa_pdf/ea/18/main.PMC4022835.pdf
"Neuron Article Miniature Neurotransmission Regulates Drosophila Synaptic Structural Maturation Ben Jiwon Choi,1,2,3Wendy L. Imlach,1,2,4Wei Jiao,1,2,4Verena Wolfram,5Ying Wu,6Mark Grbic,1,2Carolina Cela,1,2 Richard A. Baines,5Michael N. Nitabach,6and Brian D. McCabe1,2,4,* 1Department of Pathology and Cell Biology 2Center for Motor Neuron Biology and Disease 3Department of Physiology and Cellular Biophysics 4Department of Neuroscience College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA 5Faculty of Life Sciences, University of Manchester, Manchester M13 9PL, UK 6Department of Cellular and Molecular Physiology, Department of Genetics, Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, New Haven, CT 06520, USA*Correspondence: brian@mccabelab.org http://dx.doi.org/10.1016/j.neuron.2014.03.012 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5a/05/main.PMC4022839.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, eight ﬁgures, and one table and can be found with this article online athttp://dx.doi.org/10.1016/j.neuron.2014.03.012 .",OADS,/arxiv_data1/oa_pdf/5a/05/main.PMC4022839.pdf
http://irs.ub.rug.nl/ppn/2549 39104 .,Non-OADS,/arxiv_data1/oa_pdf/23/36/40263_2014_Article_157.PMC4022988.pdf
119. http://www.pituitary.org/disorders/prolactinomas.aspx .,Non-OADS,/arxiv_data1/oa_pdf/23/36/40263_2014_Article_157.PMC4022988.pdf
348. http://injurylawyer-news.com/risperdal/gynecomastia/ .,Non-OADS,/arxiv_data1/oa_pdf/23/36/40263_2014_Article_157.PMC4022988.pdf
349. http://westrikeback.com/practice-areas/dangerous-defective-drugs/ risperdal/ .,Non-OADS,/arxiv_data1/oa_pdf/23/36/40263_2014_Article_157.PMC4022988.pdf
Rockville: Vanda Pharma- ceuticals; 2013. http://www.pharma.us.novartis.com/product/pi/ pdf/fanapt.pdf .,Non-OADS,/arxiv_data1/oa_pdf/23/36/40263_2014_Article_157.PMC4022988.pdf
Sunovion Pharmaceuticals Inc. http://www.latuda.com/LatudaPrescribingInformation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/23/36/40263_2014_Article_157.PMC4022988.pdf
In spite of promising in vitro andin vivo data of several experimental immunotherapeutic trials and numerous immu- notherapeutic approaches in the pipeline (http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/5e/db/all0069-0137.PMC4022995.pdf
"This perception that malignancies in companion dogs and humans occur according to very similar biologic principles has attracted attention because it offers a chance to speedup drug development for both, humans and animals, for now peaking in the establishment of the comparative oncol- ogy trial consortium (COTC) by the National Cancer Insti-tute (NCI; http://ccr.cancer.gov/resources/cop/COTC.asp; an overview of the most recent clinical comparative trials initi- ated by the COTC is depicted in Table 3).",Non-OADS,/arxiv_data1/oa_pdf/5e/db/all0069-0137.PMC4022995.pdf
Name Status COTC001 Evaluation of RGD Targeted Delivery of Phage Expressing TNF-alpha to Tumor Bearing DogsClosed trial COTC003 Evaluation of the MTOR inhibitor Rapamycin in dogs with osteosarcomaClosed trial COTC005 Evaluation of immunocytokine fusion protein in tumor-bearing dogsClosed trial COTC006 Evaluation Cryobiopsy Instrumentation And Cellsave Blood Collections In Dogs With LymphomaClosed trial COTC007a A Pilot Study of Topotecan in Dogs with LymphomaClosed trial COTC007b Preclinical Comparison of Three Indenoisoquinolines Candidates in Tumor Bearing DogsOpen COTC008 Evaluation of the mTOR inhibitor Rapamycin in Dogs with Metastatic OsteosarcomaClosed trial COTC010 Evaluation of two immunocytokine fusion proteins in tumor bearing dogsClosed trial COTC013 Evaluation of Orally Administered mTOR inhibitor Rapamycin in Tumor Bearing DogsClosed trial COTC016 A Pilot Study to Assess Feasibility of Tissue Collections and Molecular Proﬁling for future Comparative Oncology Personalized Medicine StudiesClosed trial COTC018 Evaluation of a novel anticancer agent in tumor bearing dogs to deﬁne its pharmacokinetic proﬁle and biological activityOpen Source:http://ccrod.cancer.gov/conﬂuence/display/CCRCOPWeb/ Clinical+Trials.,Non-OADS,/arxiv_data1/oa_pdf/5e/db/all0069-0137.PMC4022995.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S62Thoracic and lumbar spinal surgery under local anesthesia for  patients with multiple comorbidities: A  consecutive case series Muhammad Babar Khan, Rajesh Kumar, Syed Ather Enam Section of Neurosurgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan E‑mail:  Muhammad Babar Khan ‑ babarkhan08@gmail.com; Rajesh Kumar ‑ rajesh.kumar@aku.edu; *Syed Ather Enam ‑ ather.enam@aku.edu   *Corresponding author Received: 22 August 13  Accepted: 03 January 14  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130669 Quick Response Code: Abstract Background:  Although some patients with symptomatic spinal disease may benefit  greatly from surgery, their multiple attendant comorbidities may make general  anesthesia risky or contraindicated.",Non-OADS,/arxiv_data1/oa_pdf/97/c8/SNI-5-62.PMC4022997.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/62/130669 Copyright: © 2014 Khan MB.,Non-OADS,/arxiv_data1/oa_pdf/97/c8/SNI-5-62.PMC4022997.pdf
Surg Neurol Int 2014;5:S79-80.Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/79/130682 Copyright: © 2014 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/89/55/SNI-5-79.PMC4022998.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S74Adjacent segment disease after anterior cervical discectomy and  fusion: Incidence and clinical outcomes of patients requiring  anterior versus posterior repeat cervical fusion Mohamad Bydon1,2, Risheng Xu1,2,3, Rafael De la Garza‑Ramos1,2, Mohamed Macki1,2,  Daniel M. Sciubba1,2, Jean‑Paul Wolinsky1,2, Timothy F .",Non-OADS,/arxiv_data1/oa_pdf/d7/98/SNI-5-74.PMC4022999.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/74/130676 Copyright: © 2014 Bydon M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d7/98/SNI-5-74.PMC4022999.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S59Computed tomographic evaluation of C5 root exit foramen in  patients with cervical spondylotic myelopathy Rania M. Hegazy, Ahmed Y. Abdelrahman1, Waleed A. Azab1 Departments of Diagnostic Radiology, Jahra Hospital, 1Neurosurgery, Ibn Sina Hospital, Kuwait City, Kuwait E‑mail: Rania M. Hegazy ‑ raniahegazy@hotmail.com; Ahmed Y .",Non-OADS,/arxiv_data1/oa_pdf/3c/d4/SNI-5-59.PMC4023000.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/59/130668 Copyright: © 2014 Hegazy RM.,Non-OADS,/arxiv_data1/oa_pdf/3c/d4/SNI-5-59.PMC4023000.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S131Commentary on four recently published papers on chronic pain  and spinal surgery Ronald Pawl Department of Neurosurgery, University of Illinois, Chicago (Ret), Center for Pain Treatment and Rehabilitation, Lake Forest Hospital, Lake Forest, Illinois (Ret) E‑mail:  *Ronald Pawl‑ron@pawl.com   *Corresponding author Received: 13 February 14   Accepted: 13 February 14  Published: 16 April 14 Abstract This commentary evaluates four articles dealing with chronic pain from very different  perspectives.",Non-OADS,/arxiv_data1/oa_pdf/54/0a/SNI-5-131.PMC4023001.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/131/130671 Copyright: © 2014 Pawl R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/54/0a/SNI-5-131.PMC4023001.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S55Medicolegal Corner: When minimally invasive thoracic surgery  leads to paraplegia Nancy E. Epstein Chief of Neurosurgical Spine and Education, Winthrop University Hospital, Mineola, N.Y .",Non-OADS,/arxiv_data1/oa_pdf/d1/21/SNI-5-55.PMC4023002.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/55/130667 Copyright: © 2014 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/d1/21/SNI-5-55.PMC4023002.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S119Nontropical pyomyositis complicated with spinal epidural  abscess in a previously healthy child Mohamed Boulyana, Mohammad Saeed Kilani1 Department of Pediatrics, Hospital of Saint Omer, 62500, 1Department of Radiology, Lille University Hospital, 59037, France E‑mail: *Mohamed Mohamed Boulyana ‑ boulya77@hotmail.fr; Mohammad Saeed Kilani ‑ mohammadalikilani@yahoo.com   *Corresponding author Received: 30 November 13  Accepted: 20 January 14  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130718 Quick Response Code: Abstract Background: Pyomyositis (PM), a rare pyogenic infection that involves skeletal  muscles, if not immediately diagnosed, can be fatal.",Non-OADS,/arxiv_data1/oa_pdf/6c/79/SNI-5-119.PMC4023003.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/119/130718 Copyright: © 2014 Boulyana M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6c/79/SNI-5-119.PMC4023003.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S88Cervical surgery for ossification of the posterior longitudinal  ligament: One spine surgeon’s perspective Nancy E. Epstein Chief of Neurosurgical Spine and Education, Winthrop University Hospital, Mineola, NY 11051, USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com   *Corresponding author Received: 15 December 13  Accepted: 18 December 13  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130693 Quick Response Code: Abstract Background:  The selection, neurodiagnostic evaluation, and surgical management  of patients with cervical ossification of the posterior longitudinal ligament (OPLL)  remain controversial.",Non-OADS,/arxiv_data1/oa_pdf/c7/61/SNI-5-88.PMC4023004.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/88/130693 Copyright: © 2014 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/c7/61/SNI-5-88.PMC4023004.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S133Clinical results of cervical laminectomy and fusion for the  treatment of cervical spondylotic myelopathy in 58 consecutive  patients Victor Chang1, Daniel C. Lu1,2, Haydn Hoffman1, Colin Buchanan1, Langston T .",Non-OADS,/arxiv_data1/oa_pdf/38/6e/SNI-5-133.PMC4023005.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/133/130670 Copyright: © 2014 Chang V.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/38/6e/SNI-5-133.PMC4023005.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Spine, a supplement to  Surgical Neurology International  S126Esophageal, pharyngeal and hemorrhagic complications  occurring in anterior cervical surgery: Three illustrative cases Víctor Rodrigo Paradells, Juan Bosco Calatayud Pérez, Francisco Javier Díaz Vicente,   Luciano Bances Florez, Marta Claramonte de la Viuda, Francisco Javier Villagrasa Neurosurgery Division Hospital Clínico Universitario “Lozano Blesa” de Zaragoza, Avenida San Juan Bosco 1550009 Zaragoza, Zaragoza, ESPAÑA, Spain E‑mail: *Víctor Rodrigo Paradells ‑ vrodrigo84@gmail.com; Juan Bosco Calatayud Pérez ‑ jbcalata@comz.org; Francisco Javier Díaz Vicente ‑  jdiazvicente@telefonica.net; Luciano Bances Florez ‑ bancesluciano@hotmail.com; Marta Claramonte de la Viuda ‑ martaclaramonte@hotmail.com;   Francisco Javier Villagrasa ‑ villacomp@yahoo.es   *Corresponding author Received: 06 November 13  Accepted: 20 February 14  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130673 Quick Response Code: Abstract Background:  The number of esophageal and pharyngeal perforations occurring  in anterior cervical surgeries ranges from 0.25% to 1% and 0.2% to 1.2%,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/52/63/SNI-5-126.PMC4023006.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/126/130673 Copyright: © 2014 Víctor R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/52/63/SNI-5-126.PMC4023006.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S122Diffuse idiopathic skeletal hyperostosis: A  review Fábio A. Nascimento, Luana Antunes Maranha Gatto1, Roberto Oliver Lages2, Heraldo Mello Neto3,  Zeferino Demartini Junior4, Gelson Luis Koppe5 Faculty of Medicine, Universidade Federal do Paraná,1,2,4,5Department of Neurosurgery of Hospital Universitário Cajuru,  Curitiba, Paraná, Brazil,  1Neurosurgeon,  Fello w of Interventional Neuroradiology, Neurosurgery Resident, 4Neurosurgeon and Interventional Neuroradiologist, 5Interventional Neuroradiologist in Hospital  Universitário Cajuru, 3Radiologist in Clínica X‑Leme, Curitiba, Paraná, Brazil E‑mail: *Fábio Augusto Nascimento e Silva ‑ nascimento.fabio.a@gmail.com; Luana Gatto ‑ luanamaranha@yahoo.com.br; Roberto Lages ‑ oliverdrum@hotmail.com;  Heraldo Mello ‑ heraldomello@gmail.com; Zeferino Demartini ‑ demartiniz@gmail.com; Gelson Koppe ‑ koppe@bighost.com.br   *Corresponding author Received: 30  November 13   Accepted: 09  December 13   Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130675 Quick Response Code: Abstract Background:  Diffuse idiopathic skeletal hyperostosis  (DISH) is a systemic  noninflammatory disease characterized by ossification of the entheses.",Non-OADS,/arxiv_data1/oa_pdf/d8/ee/SNI-5-122.PMC4023007.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/122/130675 Copyright: © 2014 Nascimento FA.,Non-OADS,/arxiv_data1/oa_pdf/d8/ee/SNI-5-122.PMC4023007.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S81Few patients with neurodegenerative disorders require spinal  surgery Nancy E. Epstein, Malcolm Gottesman1 Chief of Neurosurgical Spine and Education, Winthrop University Hospital, Mineola, 1Director of Winthrop Comprehensive Multiple Sclerosis Care Center,  Mineola, Winthrop University Hospital, Mineola, NY , 11501 and Clinical Professor of Neurology, Stony Brook, NY , USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com; Malcolm Gottesman ‑ mgottesman@winthrop.org   *Corresponding author Received: 13 October 13  Accepted: 14 October 13  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130685 Quick Response Code: Abstract Background: Few patients with neurodegenerative disorders (ND) (e.g., Multiple  Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), and Postpolio Syndrome  (PPS)) require spinal surgery.",Non-OADS,/arxiv_data1/oa_pdf/87/66/SNI-5-81.PMC4023008.pdf
Available FREE in open access from:  http://www.surgicalneurologyint.com/text.asp?2014/5/4/81/130685 Copyright: © 2014 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/87/66/SNI-5-81.PMC4023008.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S66A review article on the benefits of early mobilization following  spinal surgery and other medical/surgical procedures Nancy E. Epstein Chief of Neurosurgical Research and Education, Winthrop University Hospital, Mineola, NY 11501, USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com   *Corresponding author Received: 29 December13   Accepted: 02 January 14  Published: 16 April 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130674  Quick Response Code: Abstract Background:  The impact of early mobilization on perioperative comorbidities and  length of stay (LOS) has shown benefits in other medical/surgical subspecialties.",Non-OADS,/arxiv_data1/oa_pdf/47/46/SNI-5-66.PMC4023009.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/66/130674 Copyright: © 2014 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/47/46/SNI-5-66.PMC4023009.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S93Abstract What are the risks, benefits, alternatives, and pitfalls for operating on cervical  ossification of the posterior longitudinal ligament (OPLL)?",Non-OADS,/arxiv_data1/oa_pdf/0c/48/SNI-5-93.PMC4023010.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/93/130696 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.130696 Quick Response Code: What you need to know about ossification of the posterior  longitudinal ligament to optimize cervical spine surgery: A  review Nancy E. Epstein Chief of Neurosurgical Spine and Education, Winthrop University Hospital, Mineola, N.Y .",Non-OADS,/arxiv_data1/oa_pdf/0c/48/SNI-5-93.PMC4023010.pdf
Availableathttp://phi.uhce.ox.ac.uk/pdf/ChronicConditions/DH_REVIEWS_ NOVEMBER_2007.pdf Accessed 17 December 22.,Non-OADS,/arxiv_data1/oa_pdf/b8/cb/198_2014_Article_2695.PMC4023015.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/15/129455 Copyright: © 2014 Bernard C. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and  reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15INTRODUCTION The following guidelines have been developed upon  request from the president of the Canadian Association  of Pathologists.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
One such site is  iPath at the University of Basel (http://telemed.ipath.ch/ ipath/).,Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15block (hematoxylin and eosin section, special stains,  immunohistochemistry,  in situ hybridization) in anatomic  pathology.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15entire specimen located on a microscope glass slide.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15Implementation Key considerations when implementing telepathology  solutions are changes to the roles, responsibilities,  processes, and workflow.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15Validation Validation	refers	to	the	demonstration	 of	equivalent	 diagnostic performance between digital pathology systems  and light microscopy (i.e.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15implementation and for successful change management.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15in which the pathologist is located, as well as the  province/territory in which the patient is located.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"J Pathol Inform 2014, 1:15  http://www.jpathinformatics.org/content/5/1/15June 2010.bernard.tetu@fmed.ulaval.ca.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"T elepathology:  A Review of the Clinical Effectiveness, Cost‑Effectiveness, and Guidelines  July, 2010.http://www.cadth.ca/media/pdf/l0200_ telepathology_ htis‑2.pdf.",Non-OADS,/arxiv_data1/oa_pdf/d8/e4/JPI-5-15.PMC4023030.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/11/129444 Copyright: © 2014 Mandelker D. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and  reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11integrate, and communicate this important clinical  information.",OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11interested in becoming directors) and a “1 + 1” track in  which a trainee does two coordinated fellowships: 1 year  of clinical informatics and a 1‑ or 2‑year fellowship in  another pathology domain.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11the accuracy of the variant calls and the limitations of  the clinical test (i.e.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11T able 5: Suggested curriculum areas and fellow rotations for fellowship training in pathology informatics  and molecular pathology Curriculum topic Subtopic Examples of fellow rotations/projects Information Fundamentals Information  ArchitectureData Architecture and Modeling Validation of predictive algorithms for sequence variants Metadata in healthcare information Classification of sequence variants and associated supporting  evidence Database design and architecture Developing or improving a lab’s gene and variant curation  database Information Quality Information quality principles Participation in working groups that develop standards for gene  and variant annotations Information  ManipulationInformation retrieval Automating information gathering for novel variant assessment Data analysis principles Understanding metrics used to evaluate analytical performance  of sequencing runs and the statistics and limitations of variant  calling Decision support principles Automating methods for identifying inappropriate molecular  test ordering Information Systems Laboratory Information  SystemsLIS general concepts Designing an automated method for identifying inappropriate  molecular test ordering Specimen identification systems Create barcode system for sample accessioning and tracking  through molecular workflow Outreach systems Work with information technology department to develop  LIS‑HIS interface at remote sites ordering molecular testing Interfaces Instrument interfaces Develop/validate interface of molecular data from instruments  to LIS LIS to hospital information system  interfacesWork with IT department to develop bidirectional LIS‑HIS  interface to order tests and report results Middleware Identify, implement, and/or validate appropriate middleware that  may facilitate interfaces between instruments, LIS, and HIS Health Information  SystemsElectronic health record Ensure proper display of molecular reports in structured  format in EHR Computerized provider order entry Work with clinicians to optimize online ordering for molecular  testing  Results reporting principles Development of enhanced reporting templates (i.e., pathology  reports with graphical elements) Workflow and Process Process management  and quality  improvementProcess improvement  methodologiesRedesign of sample accessioning and tracking, material  generation, and testing to improve molecular workflow Software Implement software to improve molecular workflow Data storage principles Participate in the development of institutional polices for data  storage, use, and sharing Workflow analysis  methodsProcess redesign/reengineering Process improvements such as introducing electronic sign‑out Workflow redesign/reengineering Workflow analysis for specific test workflows (e.g., bottlenecks) Modeling data flow in health  systemsInvestigation of metrics and digital dashboards useful to a  molecular pathologist (i.e., displaying turnaround time for  different tests) Pathology decision  supportBusiness intelligence and decision  supportIntroduce commercial intelligence solutions into molecular  laboratory Decision support systems and  analysisUse analytic approaches to design optimal genetic test ordering  and reflex protocols Governance and  Management Leadership Leadership principles, models, and  practiceParticipate in the molecular laboratory’s administrative  meetings Effective communication practices Examination of clinician needs and satisfaction with the  molecular lab’s services Contd...",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11clinical standard, though large consortium efforts such  as	the	ClinVar	database	are	being	developed	to	address	 this issue.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11requires a confidence in today’s reference sequences and  aligners, while storing the raw data allows for realignment  as	knowledge	and	informatics	evolve.",OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11may be placed by either the original ordering clinician  or internally by the pathologist (add‑on testing), and  multiple tests may be ordered on the same sample both  within molecular and in other pathology subspecialties.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11individual tests ordered at an extremely low frequency.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11informatics fellowship.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"J Pathol Inform 2014, 1:11  http://www.jpathinformatics.org/content/5/1/11areas of molecular pathology that could benefit from  informatics approaches, and by extension, areas in which  pathology informatics fellows could develop relevant  and useful molecular pathology operational and research  projects.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
"Available from: http://www.aruplab.com/files/resources/genetics/ White‑paper‑1‑value‑of‑GCs‑in‑lab.pdf [Last accessed on October 14,  2013.",Non-OADS,/arxiv_data1/oa_pdf/96/de/JPI-5-11.PMC4023031.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/9/129442,Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9smears is of a great importance.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/998.9% maximum cell accuracy using feature scale‑space  filtering and watershed clustering.",OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/998.43% maximum accuracy for nucleus segmentation  and 98.69% for cell segmentation.",OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9the filter type as averaging of two redundant features can  lead to a better CCR than a single noisy one.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9unit is a sigmoidal unit and is a smoothly differentiable  function: −=+1()1xfxe (2) The commonly used learning algorithm for a multilayer  network using sigmoidal units is the conjugate gradient  decent back‑propagation algorithm.",OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9This yields: αα= == = ∑∑110, 0nn ii i ii iiy yx  (7) The optimization problem can be expressed by: α α αα= = == −∑ ∑∑ , 1 111max ( )2n nn i ji j i j i ij iw yy xx  (8) xi with the non‑zero value of αi are called support  vectors.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9paper by Freund and Schapire.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9•	Boosting: In this case, a new sample of the training  set is obtained using a distribution based on previous  results.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
Available from: http://www.spectralcameras.com/files/./ American_Laboratory_2000.pdf.,OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
"J Pathol Inform 2014, 1:9  http://www.jpathinformatics.org/content/5/1/9Learning Theory; ACM; 1992.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
Available from: https://www.gnu.org/ software/octave/.,OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
Available from:  http://rsbweb.nih.gov/ij/.,OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
Available from:  http://www.hemacam.com/.,Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
Available from: http://www.cellavision.,Non-OADS,/arxiv_data1/oa_pdf/5a/d6/JPI-5-9.PMC4023032.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/13/129450 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.129450 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13INTRODUCTION Autoverification is a process whereby clinical  laboratory results are released without manual human  intervention.",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13regularly with the medical director to review and discuss  laboratory issues.",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 ContdTable  1: Parameters for all the chemistry assays including manual review limits, critical values, delta checks, interference indices (hemolysis,  icterus, lipemia), AMR, and auto-extended range (for automated dilution protocols) T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Acetaminophen μg/mL Modular P/Cobas  8000 c502Sekisui Acetaminophen‑   SL, 8/16/201140 200 1,200 40 1.2‑378 NA Full  value Adrenocorticotropic  hormonepg/mL Modular E/Cobas  8000 e602Roche ACTH, 2011‑12,  V7400 1,500 25 1‑2,000 NA >2,000 Alanine  aminotransferaseU/L Modular P/Cobas  8000 c702Roche ALT, 2011‑03, V3 200 150 60 5‑700 5‑7,000 Full  value Albumin g/dL Modular P/Cobas  8000 c702Roche Albumin, 2010‑ 12, V31,000 550 60 0.2‑6.0 0.2‑30.0 Full  value Alkaline phosphatase U/L Modular P/Cobas  8000 c702Roche ALP , 2012‑08, V3 200 2,000 60 5‑1,200 5‑6,000 Full  value Alpha‑1 antitrypsin mg/dL Modular P/Cobas  8000 c502Roche A1AT, 2012‑03,  V81,000 350 60 20‑600 20‑1,200 Full  value Alpha‑fetoprotein ng/mL Modular E/Cobas  8000 e602Roche AFP , 2010‑04, V4 2,200 1,500 65 0.6‑1,210 0.6‑60,500 Full  value Amikacin μg/mL Modular P/Cobas  8000 c502Roche AMIK2, 2012‑ 02, V835 1,000 2,000 50 0.8‑40.0 NA Full  value Ammonia μmol/L Modular P/Cobas  8000 c502Roche NH3L, 2012‑03,  V7200 50 30 10 ‑700 10‑1,400 Full  result Amylase U/L Modular P/Cobas  8000 c702Roche AMYL, 2010‑12,  V3500 1,500 60 3‑1,500 3‑7,500 Full  value Amylase, urine U/L Modular P/Cobas  8000 c502Roche AMYL, 2010‑12,  V3NA NA NA 3‑1,500 3‑7,500 Full  value Angiotensin converting  enzymeU/L Modular P/Cobas  8000 c502Trinity  BiotechACE, 3/2011 NA NA NA 1‑120 1‑240 Full  value Anticyclic citrullinated  peptideU/mL Modular E/Cobas  8000 e602Roche Anti‑CCP , 2010‑ 08, V2500 1,500 25 8‑1,500 NA >500 Antinuclear antigen‑   anticentromere B  antibodiesAntibody  indexBioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑antichromatin  antibodiesAI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑double‑   stranded  deosyribonucleic  acid antibodiesIU/mL BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 1‑300 NA Full  value ANA‑Jo1 antibodies AI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑ribosomal  P antibodiesAI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR ANA‑RNP antibodies AI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑RNP/ Smith (common motif)  antibodiesAI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑Smith antibodies AI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑SS‑A antibodies AI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 ANA‑SS‑B antibodies AI BioPlex 2200 Bio‑Rad ANA Screen,  3/2012NA NA NA 0.2‑8.0 NA >8.0 Aspartate  aminotransferaseU/L Modular P/Cobas  8000 c702Roche AST, 2011‑03,  V340 150 60 5‑700 5‑7,000 Full  result Beta‑2 microglobulin mg/L Modular P/Cobas  8000 c502Roche 2012‑01, V4 1,000 1,000 60 0.1‑8.0 0.1‑88.0 >88.0 Beta‑  hydroxybutyratemEq/L Modular P/Cobas  8000 c502Stanbio LiquiColor  06/20042,000 417 36 0.1‑5.0 0.1‑10.0 Full  result Bilirubin, direct mg/dL Modular P/Cobas  8000 c502Roche D‑BILI, 2011‑12,  V930 60 None 0.2‑40.0 NA Full  result Bilirubin, total mg/dL Modular P/Cobas  8000 c702Roche TBILI, 2012‑12,  V4>10 (younger  than 1‑day‑old)   >13  (1–31‑days‑old)500 90 None 0.1‑35.1 0.1‑175.5 Full  result C3 complement mg/dL Modular P/Cobas  8000 c502Roche C3c, 2012‑01,  V61,000 2,000 60 4‑500 4‑1,000 Full  result C4 complement mg/dL Modular P/Cobas  8000 c502Roche C4, 2012‑01, V7 500 1,000 60 2‑100 2‑200 Full  result Calcium, total mg/dL Modular P/Cobas  8000 c702Roche 2012‑08, V2 6.0 13.0 ±20%  to  previous  if <7.5  mg/dL;  ±10%  to  previous  if >15.0  mg/dL1,000 1,000 60 0.8‑20.1 NA Full  result Calcium, urine mg/dL Modular P/Cobas  8000 c502Roche 2012‑08, V2 NA NA NA 0.8‑30.1 0.8‑150.5 Full  result Cancer antigen ‑125 U/mL Modular E/ Cobas 8000  e602Roche CA 125 II,  2011‑05, V23,200 2,000 66 1‑5,000 1‑25,000 >25,000 Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Carbamazepine μg/mL Modular P/Cobas  8000 c502Roche CEDIA  Carbamazepine  II, 2012‑10, V1112 1,000 1,000 60 0.5‑20.0 NA Full  result Carbohydrate  antigen‑19‑9U/mL Modular E/Cobas  8000 e602Roche CA 19‑9, 2010‑ 09, V42,200 1,500 66 0.6‑1,000 0.6‑10,000 >10,000 Carbon dioxide mEq/L Modular P/Cobas  8000 c502Roche CO2‑L, 2012‑ 02, V610 50 ±66% to  previous  if <10  mEq/L600 1,800 60 2‑50 NA Full  result Carcinoembryonic  antigenng/mL Modular E/Cobas  8000 e602Roche CEA, 2012‑05,  V42,200 1,500 66 0.2‑1,000 0.2‑50,000 >50,000 Ceruloplasmin mg/dL Modular P/Cobas  8000 c502Roche 2012‑04, V7 1,000 200 60 3‑140 3‑420 Full  result Chloride mmol/L Modular P/Cobas  8000 c702Roche ISE N, K, Cl;  2010‑09, V1±20% to  previous  if <80  mmol/L;  ±10% to  previous  if >120  mmol/LNone 2,000 60 60‑140 NA Full  result Chloride, urine mmol/L Modular P/Cobas  8000 c502Roche ISE N, K, Cl;  2010‑09, V1NA NA NA 10‑250 NA Full  result Cholesterol, total mg/dL Modular P/Cobas  8000 c702Roche CHOL, 2010‑ 12, V32.0 (clinically  significant)700 2,000 16 4‑800 4‑8,000 Full  result Cortisol μg/dL Modular E/Cobas  8000 e602Roche 2010‑08, V4 1,900 2,700 60 0.3‑63.4 0.3‑634 Full  result C‑peptide ng/mL Modular E/Cobas  8000 e602Roche 2011‑12, V7 300 2,000 50 0.01‑40.0 NA >40.0 C‑reactive protein mg/dL Modular P/Cobas  8000 c702Roche CRPL3, 2011‑ 12, V61,000 1,000 60 0.5‑35.0 0.5‑70.0 Full  result CRP , high sensitivity mg/L Modular P/Cobas  8000 c502Roche CRPHS, 2012‑ 03, V81,000 600 60 0.2‑20.0 NA >20.0 Creatine kinase U/L Modular P/Cobas  8000 c702Roche CKm 2012‑03,  V3100 1,000 60 7‑2,000 7‑22,000 Full  result Creatinine mg/dL Modular P/ Cobas 8000  c702Roche CREP2, 2011‑ 03, V4±50% to  previous  if <0.15  mg/dL800 2,000 15 0.1‑30.5 0.1‑120 Full  result Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Creatinine, urine mg/dL Modular P/Cobas  8000 c502Roche CREP2,  2011‑ 03, V4NA NA NA 0.1‑610 0.1‑1,525 Full  result Cyclosporine ng/mL Abbott Architect Abbott Cyclosporine,  October 201024 1,501 NA NA NA 25‑1,500 NA >1,500 Cystatin C mg/L Modular P/Cobas  8000 c502Roche CYSC, 2012‑04,  V6700 1,000 60 0.3‑8.0 0.3‑12.0 Full  result Cytomegalovirus  antibodies, IgGIU/mL BioPlex 2200 Bio‑Rad T oRC IgG,  3/2012Avoid  hemolysisNA NA 0.2‑8.0 NA >8.0 CMV antibodies, IgM IU/mL BioPlex 2200 Bio‑Rad RC‑M, 8/2011 Avoid  hemolysisNA NA 0.2‑4.0 NA >4.0 D‑Dimer μg/mL Modular P/Cobas  8000 c502Roche 2012‑04, V7 500 750 20 0.10‑9.0 0.1‑21.6 Full  result Dehydroepiandrosterone  sulfateμg/dL Modular E/Cobas  8000 e602Roche 2011‑01, V15 560 2,000 13 0.1‑1,000 NA >1,000 Digoxin ng/mL Modular E/Cobas  8000 e602Roche 2012‑10, V4 2.1 1,000 1,500 65 0.15‑5.0 0.15‑10.0 Full  result Drug of abuse‑   amphetaminesQualitative Modular P/Cobas  8000 c502Roche Amphetamines  II, 2012‑02, V6NA NA NA NA NA NA Drug of abuse‑ benzodiazepinesQualitative Modular P/Cobas  8000 c502Roche Benzodiazepines  Plus, 2012‑03,  V6NA NA NA NA NA NA Drug of abuse‑cocaine  metaboliteQualitative Modular P/Cobas  8000 c502Roche Cocaine II,  2012‑04, V6NA NA NA NA NA NA Drug of abuse‑opiates Qualitative Modular P/Cobas  8000 c502Roche Opiates II,  2012‑05, V9NA NA NA NA NA NA Drug of abuse‑ oxycodone/ oxymorphoneQualitative Modular P/Cobas  8000 c502Roche Oxycodone,  2012‑04, V5NA NA NA NA NA NA Drug of abuse‑ tetrahydrocannabinolQualitative Modular P/Cobas  8000 c502Roche Cannabinoids II,  2012‑03, V8NA NA NA NA NA NA Epstein‑barr virus early  nuclear antibodyAI BioPlex 2200 Bio‑Rad EBV IgG, 3/2012 NA NA NA 0.2‑8.0 NA >8.0 EBV heterophile  antibodiesQualitative BioPlex 2200 Bio‑Rad EBV IgM, 3/2012 NA NA NA NA NA NA EBV viral capsid  antibodies,  immunoglobulin (Ig) GAI BioPlex 2200 Bio‑Rad EBV IgG, 3/2012 NA NA NA 0.2‑8.0 NA >8.0 EBV viral capsid  antibodies, IgMAI BioPlex 2200 Bio‑Rad EBV IgM, 3/2012 NA NA NA 0.2‑8.0 NA >8.0 Estradiol pg/mL Modular E/Cobas  8000 e602Roche Estradiol II,  2012‑03, V21,000 1,000 66 5‑4,300 5‑21,500 Full  result Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Ethanol mg/dL Modular P/Cobas  8000 c502Roche 2012‑04, V9 300 200 500 60 10‑498 NA Full  result Ethanol, urine mg/dL Modular P/Cobas  8000 c502Roche 2012‑04, V9 NA NA NA 10‑498 NA Full  result Ethylene glycol mg/dL Modular P/Cobas  8000 c502Catachem Catachem  AB1620079 200 1,000 15 0.1‑300 NA Full  result Everolimus ng/mL Modular P/Cobas  8000 c502Thermo‑   scientificQMS  Everolimus,  2/2011NA NA NA 2.0‑20.0 NA >20.0 Ferritin ng/mL Modular E/Cobas  8000 e602Roche 2012‑06, V2 500 3,300 65 0.5‑2,000 0.5‑ 100,000Full  result Folate ng/mL Modular E/Cobas  8000 e602Roche Folate III, 2012‑ 02, V640 1,500 33 1.5‑20.0 NA >20.0 Follicle stimulating  hormonemIU/mL Modular E/Cobas  8000 e602Roche FSH, 2010‑08,  V171,000 1,900 64 0.1‑200 NA >200 Gamma‑glutamyl  transpeptidaseU/L Modular P/Cobas  8000 c702Roche GGT ‑2, 2012‑07,  V4200 1,000 35 3‑1,200 3‑3,000 Full  result Gentamicin μg/mL Modular P/Cobas  8000 c502Thermo‑   fisherGentamicin,  9/201015 1,000 2,000 60 0.3‑10.0 NA Full  result Glucose mg/dL Modular P/Cobas  8000 c702Roche GLUC3, 2010‑ 12, V340 (less than  1‑month‑old);  50 (1 month or  older)300 (less than  1‑month‑old);  450 (1 month  or older)±25%  to  previous  if <20  mg/dL1,000 1,000 60 2‑750 2‑1,500 Full  result Glucose, body fluid or  cerebrospinal fluidmg/dL Modular P/Cobas  8000 c502Roche 2010‑12, V3 5 NA NA NA 2‑750 2‑1,500 Full  result Glucose, urine mg/dL Modular P/Cobas  8000 c502Roche 2010‑12, V3 NA NA NA 2‑750 2‑1,500 Full  result Haptoglobin mg/dL Modular P/Cobas  8000 c502Roche 2012‑03, V8 10 200 60 10‑750 10‑1,140 Full  result Hemoglobin A1C‑ absolute value %A1Cg/dL % Modular P/Cobas  8000 c502Roche HBA1C II,  2012‑08, V110.29, 4 3, 17 NA NA NA 0.9‑3.1 NA Full  result Hemoglobin, plasma mg/dL Modular P/Cobas  8000 c502Roche SI2, 2011‑02, V2 NA NA NA 1‑1,200 NA >1,200 Hepatitis A IgM  antibodiesCutoff  indexModular E/Cobas  8000 e602Roche Anti‑HAV IgM,  2010‑09, V21,000 2,000 50 NA NA NA Hepatitis A  total (IgG+IgM)  antibodiesIU/mL Modular E/Cobas  8000 e602Roche Anti‑HAV, 2011‑ 08, V3100 1,500 50 NA NA NA Hepatitis B core IgM  antibodiesCOI Modular E/Cobas  8000 e602Roche Anti‑Hbc IgM,  2011‑11, V12,000 1,000 25 NA NA NA Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Hepatitis B core  total (IgG+IgM)  antibodiesCOI Modular E/Cobas  8000 e602Roche Anti‑HBc, 2011‑ 05, V1800 1,000 25 NA NA NA Hepatitis B surface  antibodymIU/mL Modular E/Cobas  8000 e602Roche Anti‑HBs, 2012‑ 05, V141,600 1,500 60 3.5‑1,000 NA >1,000 Hepatitis B surface  antigenIU/mL Modular E/Cobas  8000 e602Roche HBsAg, 2012‑ 04, V91,400 1,500 60 0.041  (lower  limit)NA NA Hepatitis C antibody COI Modular E/Cobas  8000 e602Roche HEPC, 2011‑03,  V3100 2,100 50 NA NA NA Herpes simplex  virus (HSV) type 1  antibodiesCOI Modular E/Cobas  8000 e602Roche HSV‑1 IgG,  2012‑09, V11,000 2,000 66 NA NA NA Herpes simplex  virus (HSV) type 2  antibodiesCOI Modular E/Cobas  8000 e602Roche HSV‑2 IgG,  2012‑09, V11,000 2,000 66 NA NA NA High density lipoprotein mg/dL Modular P/Cobas  8000 c702Roche HDL‑3 PLUS  3rd generation,  2010‑12, V31,200 1,800 60 3‑120 3‑240 Full  result Human  immunodeficiency  virus antigeNAntibody  comboSample/ cutoff,  relative  light unitsAbbott Architect Abbott 2010‑07 Avoid  hemolysisNA NA NA NA NA Homocysteine μmol/L Modular P/Cobas  8000 c502Axis‑Shield Homocysteine,  6/2011500 500 20 3‑50 NA Full  result Human chorionic  gonadotropin‑pregnancy,  serummIU/mL Modular E/Cobas  8000 e602Roche HCG STAT,  2012‑04, V151,500 2,400 29 2‑1,0000 2‑1,000,000 Full  result hCG‑tumor marker,  serummIU/mL Modular E/Cobas  8000 e602Roche HCG+‑, 2010‑ 08, V141,000 1,400 24 2‑1,0000 2‑1,000,000 Full  result hCG‑urine pregnancy Qualitative Modular E/Cobas  8000 e602Roche HCG STAT,  2012‑04, V15NA NA NA 2‑1,0000 2‑1,000,000 NA Human growth  hormoneng/mL Modular E/Cobas  8000 e602Roche hGH, 2011‑02,  V2500 1,500 25 0.03‑50 NA >50 IgA mg/dL Modular P/Cobas  8000 c502Roche IgA, 2012‑03, V8 1,000 2,000 60 50‑800 5‑6,400 Full  result IgE mg/dL Modular E/Cobas  8000 e602Roche IgE, 2010‑08, V5 100 2,200 37 1‑2,500 1‑50,000 Full  result Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR IgG mg/dL Modular P/Cobas  8000 c502Roche IgG‑2, 2012‑02,  V71,000 2,000 60 300‑5,000 30‑27,500 Full  result IgM IU/mL Modular P/Cobas  8000 c502Roche IgM‑2, 2012‑03,  V71,000 2,000 60 25‑650 5‑5,850 Full  result N‑terminal pro B‑type  natriuretic peptidepg/mL Modular E/Cobas  8000 e602Roche proBNP II STAT,  2012‑09, V41,000 1,500 25 5.0‑ 35,0005.0‑70,000 Full  result Osmolality, plasma/ serummOsm/kg A2 Advanced  Automated  OsmometerAdvanced  Instruments3LA028,  version 3lP027,  rev 9NA NA NA 0‑2,000 NA Full  result Osmolality, urine mOsm/kg A2 Advanced  Automated  OsmometerAdvanced  Instruments3LA028,  version 3lP027,  rev 9NA NA NA 0‑2,000 NA Full  result Parathyroid hormone pg/mL Modular E/Cobas  8000 e602Roche 2010‑07, V6 200 1,500 65 1.2‑5,000 NA >5,000 Phenobarbital μg/mL Modular P/Cobas  8000 c502Roche PHNO2, 2012‑ 01, V760 1,000 600 60 2.4‑60.0 NA Full  result Phenytoin, free μg/mL Modular P/Cobas  8000 c502Siemens Emit 2000  Phenytoin,  8/2009800 750 30 0.5‑40 NA >40 Phenytoin, total μg/mL Modular P/Cobas  8000 c502Roche 2012‑02, V9 40 1,000 800 50 0.8‑40.0 NA Full  result Phosphorus, inorganic mg/dL Modular P/Cobas  8000 c702Roche 2011‑01, V5 1.0 (clinically  significant)±0.6 to  previous  if <1.0  mg/dL300 800 60 0.3‑20.0 0.3‑40.0 Full  result Phosphorus, inorganic,  urinemg/dL Modular P/Cobas  8000 c502Roche 2011‑01, V5 NA NA NA 3.4‑285.0 3.4‑570.0 Full  result Potassium mmol/L Modular P/Cobas  8000 c702Roche ISE N, K, Cl;  2010‑09, V13.0 (birth to  15 years);  2.8 (16 years  and older)6.5 (birth to  15 years);  6.2 (16 years  and older)±15%  to  previous  if <2.9  mmol/L;  ±10%  to  previous  if >6.2  mmol/L60 2,000 60 1.5‑10 NA Full  result Potassium, urine mEq/L Modular P/Cobas  8000 c502Roche ISE N, K, Cl;  2010‑09, V1NA NA NA 1.5‑100 NA Full  result Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Prealbumin mg/dL Modular P/Cobas  8000 c502Roche PREA, 2012‑04,  V71,000 100 60 3‑80 3‑240 Full  result Progesterone ng/mL Modular E/Cobas  8000 e602Roche Progesterone II,  2012‑09, V21,000 720 54 0.2‑60 NA Full  result Prolactin ng/mL Modular E/Cobas  8000 e602Roche Prolactin II,  2012‑03, V51,500 1,500 30 0.1‑470 0.1‑4,700 Full  result N‑terminal pro B‑type  natriuretic peptidepg/mL Modular E/Cobas  8000 e602Roche proBNP II STAT,  2012‑09, V41,000 1,500 25 5.0‑ 35,0005.0‑70,000 Full  result Osmolality, plasma/ serummOsm/kg A2 Advanced  Automated  OsmometerAdvanced  Instruments3LA028,  version 3lP027,  rev 9NA NA NA 0‑2,000 NA Full  result Osmolality, urine mOsm/kg A2 Advanced  Automated  OsmometerAdvanced  Instruments3LA028,  version 3lP027,  rev 9NA NA NA 0‑2,000 NA Full  result Parathyroid hormone pg/mL Modular E/Cobas  8000 e602Roche 2010‑07, V6 200 1,500 65 1.2‑5,000 NA >5,000 Phenobarbital μg/mL Modular P/Cobas  8000 c502Roche PHNO2, 2012‑ 01, V760 1,000 600 60 2.4‑60.0 NA Full  result Phenytoin, free μg/mL Modular P/Cobas  8000 c502Siemens Emit 2000  Phenytoin,  8/2009800 750 30 0.5‑40 NA >40 Phenytoin, total μg/mL Modular P/Cobas  8000 c502Roche 2012‑02, V9 40 1,000 800 50 0.8‑40.0 NA Full  result Phosphorus, inorganic mg/dL Modular P/Cobas  8000 c702Roche 2011‑01, V5 1.0 (clinically  significant)±0.6 to  previous  if <1.0  mg/dL300 800 60 0.3‑20.0 0.3‑40.0 Full  result Phosphorus, inorganic,  urinemg/dL Modular P/Cobas  8000 c502Roche 2011‑01, V5 NA NA NA 3.4‑285.0 3.4‑570.0 Full  result Potassium mmol/L Modular P/Cobas  8000 c702Roche ISE N, K, Cl;  2010‑09, V13.0 (birth to  15 years);  2.8 (16 years  and older)6.5 (birth to  15 years);  6.2 (16 years  and older)±15%  to  previous  if <2.9  mmol/L;  ±10%  to  previous  if >6.2  mmol/L60 2,000 60 1.5‑10 NA Full  result Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Potassium, urine mEq/L Modular P/ Cobas 8000  c502Roche ISE N, K, Cl;  2010‑09, V1NA NA NA 1.5‑100 NA Full  result Prealbumin mg/dL Modular P/ Cobas 8000  c502Roche PREA, 2012‑ 04, V71,000 100 60 3‑80 3‑240 Full  result Progesterone ng/mL Modular E/ Cobas 8000  e602Roche Progesterone  II, 2012‑09, V21,000 720 54 0.2‑60 NA Full  result Prolactin ng/mL Modular E/ Cobas 8000  e602Roche Prolactin II,  2012‑03, V51,500 1,500 30 0.1‑470 0.1‑4,700 Full  result Syphilis IgG AI BioPlex 2200 Bio‑Rad Syphilis IgG,  3/2012Avoid  hemolysisNA NA 0.1‑8.0 NA >8.0 Tacrolimus ng/mL Abbott  ArchitectAbbott Tacrolimus,  4/20091.9 NA NA NA 2‑30 NA >30 T estosterone, total ng/dL Modular E/Cobas  8000 e602Roche TST II, 2010‑07,  V2600 1,000 30 5‑1,500 NA >1,500 Theophylline μg/dL Modular P/Cobas  8000 c502Roche Theophylline  Online, 2012‑01,  V720 1,000 300 50 0.8‑40.0 NA Full  result Thyroglobulin  autoantibodiesIU/mL Modular E/Cobas  8000 e602Roche Anti‑Tg, 2010‑ 10, V31,690 2,000 66 10‑4,000 NA >4,000 Thyroid peroxidase  autoantibodiesIU/mL Modular E/Cobas  8000 e602Roche Anti‑TPO,  2011‑08, V21,500 2,100 66 5.0‑600 NA >600 Thyroid stimulating  hormone (TSH)mIU/mL Modular E/Cobas  8000 e602Roche 2012‑02, V1 1,000 1,500 41 0.01‑100 NA Full  result Thyroxine (T4), free ng/dL Modular E/Cobas  8000 e602Roche FT4, 2012‑11,  V22,000 2,000 41 0.02‑7.77 NA >7.77 T4, total μg/dL Modular E/Cobas  8000 e602Roche T4, 2011‑10, V4 2,300 2,500 37 0.4‑24.9 0.4‑124.5 Full  result T obramycin μg/mL Modular P/Cobas  8000 c502Roche 2012‑02, V6 10.1 800 750 30 0.3‑10.0 NA Full  result T oxoplasma antibodies,  IgGIU/mL BioPlex 2200 Bio‑Rad T oRC IgG,  3/2012Avoid  hemolysisNA NA 3‑ NA NA Transferrin mg/dL Modular P/Cobas  8000 c502Roche TRFS2, 2011‑01,  V31,000 500 60 10‑520 10‑780 Full  result Triglycerides mg/dL Modular P/Cobas  8000 c702Roche 2011‑01, V3 700 2,000 35 9‑885 9‑4,425 Full  result Contd",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 T able 1: Contd... T est name Units Instrumentation  (previous/ current)Assay  vendorCurrent assay  versionManual  review,  low  valueManual  review,  high  valueCritical low  value belowCritical high  value aboveDelta Hemolysis  indexLipemic  indexIcteric  indexAMR Auto  extended  rangeFinal  result,  if  above  AMR Triiodothyronine (T3),  freepg/mL Modular E/Cobas  8000 e602Roche FT3, 2011‑09,  V144,300 2,000 33 0.26‑ 32.55NA >32.55 T3, total ng/mL Modular E/Cobas  8000 e602Roche T3, 2011‑08,  V202,000 1,800 35 0.19‑6.51 NA >6.51 Troponin T ng/mL Modular E/Cobas  8000 e602Roche Troponin T Stat,  2012‑07, V7300 1,500 27 0.03‑25 0.03‑250 Full  result Unsaturated iron  binding capacityμmol/L Modular P/Cobas  8000 c502Roche UIBC, 2011‑04,  V340 300 60 3‑125 NA Full  result Urea nitrogen,  blood (BUN)mg/dL Modular P/Cobas  8000 c702Roche BUN, 2011‑03,  V3±50%  to  previous  if <2  mg/dL1,000 1,000 60 2‑112 2‑336 Full  result Urea nitrogen, urine mg/dL Modular P/Cobas  8000 c502Roche BUN, 2011‑03,  V3NA NA NA 3‑5,600 3‑10,080 Full  result Uric acid mg/dL Modular P/Cobas  8000 c502Roche Uric Acid Plus,  2010‑09, V71,000 1,500 40 0.2‑25 0.2‑62.5 Full  result Valproic acid μg/mL Modular P/Cobas  8000 c502Roche 2012‑03, V9 150 500 500 30 2.8‑150 NA Full  result Vancomycin μg/mL Modular P/Cobas  8000 c502Roche 2012‑04, V10 50 650 500 30 1.7‑80 NA Full  result Varicella zoster virus  antibodies, IgGAI BioPlex 2200 Bio‑Rad MMRV IgG,  3/2012Avoid  hemolysisNA NA 0.2‑8.0 NA >8.0 Vasculitis‑glomerular  basement membrane  antibodies, IgGAI BioPlex 2200 Bio‑Rad Vasculitis IgG,  4/2012Avoid  hemolysisNA NA 0.2‑8.0 NA >8.0 Vasculitis‑ myeloperoxidase  antibodies, IgGAI BioPlex 2200 Bio‑Rad Vasculitis IgG,  4/2012Avoid  hemolysisNA NA 0.2‑8.0 NA >8.0 Vasculitis‑proteinase 3  antibodies, IgGAI BioPlex 2200 Bio‑Rad Vasculitis IgG,  4/2012Avoid  hemolysisNA NA 0.2‑8.0 NA >8.0 Vitamin B12 pg/dL Modular E/Cobas  8000 e602Roche 2012‑01, V2 1,000 1,500 65 30‑2,000 NA >2,000 Vitamin D, 25‑hydroxy ng/mL Modular E/Cobas  8000 e602Roche Vitamin D,  2012‑07, V12,000 400 66 5‑60 NA Full  result ACTH: Adrenocorticotropic hormone, ALT: Alanine aminotransferase, AFP: Alpha‑fetoprotein, ACE: Angiotensin converting enzyme, CCP: Anticyclic citrullinated peptide, ANA: Antinuclear antigen, AST: Aspartate aminotransferase,  CA‑125: Cancer antigen‑125, CA‑19‑9: Carbohydrate antigen‑19‑9, CEA: Carcinoembryonic antigen, CRP: C‑reactive protein, hsCRP: CRP , high sensitivity, CK: Creatine kinase, CMV: Cytomegalovirus, DHEA: Dehydroepiandrosterone,  THC: Drug of abuse – tetrahydrocannabinol, EBV: Epstein‑Barr virus, EBNA: Early nuclear antibody, FSH: Follicle stimulating hormone, GGT: Gamma‑glutamyl transpeptidase, CSF: Glucose, body fluid or cerebrospinal fluid, HSV: Herpes  simplex virus, HDL: High density lipoprotein, HIV: Human immunodeficiency virus, hCG: Human chorionic gonadotropin, LDH: Lactate dehydrogenase, LDL: Low density lipoprotein, LH: Luteinizing hormone, PTH: Parathyroid hormone,  PSA: Prostate specific antigen, SHBG: Sex‑hormone binding globulin, T3: Triiodothyronine, UIBC: Unsaturated iron binding capacity, BUN: Urea nitrogen, blood, VZV: Varicella zoster virus, MPO: myeloperoxidase, PR3: proteinase 3",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13over a 4‑month period in 2013.",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13 Figure 2:  Increases in autoverification rate (black circles) and staff  productivity (red squares)T able 2: Autoverification rules and actions Rules Action(s) Quality control Stop and investigate if QC not passed; no autofile Error flags on instrument Stop and investigate if present; no autofile Interference indices (hemolysis, icterus, and lipemia) Autofile hemolyzed, icteric, or lipemic as appropriate Credit charges Notification to clinical areas, if applicable (inpatient units and  select outpatient clinics) Questionable specimen (e.g., possible contamination) Suppress all results on that specimen; contact clinical area Result above analytical measurement range If manual protocol, perform dilution and manually review/verify Certain analytes have automated dilution protocol; once  completed, proceed to other rules Result below AMR Rules dictate how result to be filed (e.g., “<6” or “0”); proceed  with other rules For certain therapeutic drugs, contact clinical area Repeat testing Specified with certain results for some analytes Delta checks (if applicable) If violated, do not autofile Critical value Printout to notify clinical area (result may proceed to other  rules if manual review limit not exceeded) Analytic inconsistency rules (e.g., albumin>total protein) Stop and investigate; no autofile Reflex testing May be automatically performed (e.g., abnormal thyroid  stimulating hormone reflex to free (thyroxine) T4 for TSH  reflex panel); reflex tests evaluated by autoverification rules With some infectious disease tests, positive results initiate  reflex confirmatory testing Positive infectious disease tests results requiring medical director  review (e.g., syphilis; hepatitis B or hepatitis C gray zones)Medical director notified QC: Quality control, AMR: Analytical measurement range, TSH: Thyroid stimulating hormone times per year over the course of 3 years.",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13In this report, we present our experience with autoverification  in a busy automated core chemistry laboratory in an academic  medical center.",Non-OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"J Pathol Inform 2014, 1:13  http://www.jpathinformatics.org/content/5/1/13Informatics support is critical to successful  implementation and maintenance of autoverification.",OADS,/arxiv_data1/oa_pdf/c4/2c/JPI-5-13.PMC4023033.pdf
"Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/14/129452 Abstract   Recent technological advances have improved the whole slide imaging (WSI) scanner  quality and reduced the cost of storage, thereby enabling the deployment of digital  pathology for routine diagnostics.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14experiences from two Swedish pathology laboratories  having deployed whole slide imaging (WSI) for virtually  all histopathology, where more than 550,000 scanned  slides have been available for primary review to date.",OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14aspects of the clinical situation is still lacking.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14 Figure 1: Combined work flow when adding scanning and digital diagnostics.",OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14loop between pathologists and lab technicians, similar  to Pantanowitz et al .",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14electronic work lists.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14have a digital workstation.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14DISCUSSION From the beginning a major driver behind the transition  to digital pathology in Kalmar was the ergonomics.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/14explains part of the gap between the validated level of  80% and the voluntary adoption rate reported here.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
"J Pathol Inform 2014, 1:14  http://www.jpathinformatics.org/content/5/1/142009;55:294‑300.",Non-OADS,/arxiv_data1/oa_pdf/12/b6/JPI-5-14.PMC4023034.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/8/129441 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.129441 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8INTRODUCTION Background Radical prostatectomy is a common therapy for prostate  cancer (CaP), with 158,000 performed in 2009,[1] which  involves excising the gland from the body.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8The rest of the paper is organized as follows.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8result is rendered.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8possible by the fast rendering capabilities.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8Rendering Requirements The limitations of the prior system[6] can be attributed  to the lack of rendering and interactivity considerations  in the fundamental software architecture.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8hierarchy allows smooth panning, rotating and zooming,  whereas preloading coarser visualization levels allows to  substitute missing tiles with coarser resolution tiles, until  the needed tiles have been loaded into graphics memory.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/8ability to remove or move fiducials and the ability to  quickly move and align the quadrants prior to fiducial  selection.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
Available  from: http://www.cdc.gov/nchs/data/nhds/4procedures/2009pro4_number  procedureage.pdf.,OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"J Pathol Inform 2014, 1:8  http://www.jpathinformatics.org/content/5/1/82.",Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
Available from: http://proceedings.spiedigitallibrary.org/ proceeding.aspx?articleid=828471.,Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
Available from: http://proceedings.spiedigitallibrary.org/ proceeding.aspx?articleid=1345988; 2012. p.  8315.,Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
Available from: http://www.vtk.org.,Non-OADS,/arxiv_data1/oa_pdf/10/08/JPI-5-8.PMC4023035.pdf
"Materials and Methods: A secure,  web‑based portal (http://pathconsult.upmc.com/) was created to facilitate remote  transmission of digital images for teleconsultation.",OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2014/5/1/10/129443,Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
"J Pathol Inform 2014, 1:10  http://www.jpathinformatics.org/content/5/1/10slides via telecommunication links for remote interpretation  (telediagnosis) and/or consultation (teleconsultation).",Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
"[6,7] This digital pathology consultation  portal (http://pathconsult.upmc.com/) was designed  primarily to facilitate second opinion consults using whole  slide images.",Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
"J Pathol Inform 2014, 1:10  http://www.jpathinformatics.org/content/5/1/10https and at rest to eliminate the risk of electronic  protected health information (ePHI) exposure.",Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
"J Pathol Inform 2014, 1:10  http://www.jpathinformatics.org/content/5/1/10images to pathology experts at our institution for  consultation.",Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
Available from: http://www.infoq.,Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
Available from: http://www.infoq.com/news/2013/11/mobile‑html5.,Non-OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
"J Pathol Inform 2014, 1:10  http://www.jpathinformatics.org/content/5/1/10smartphone applications for melanoma detection: Representative  lesion sets and the role for adjunctive technologies.",OADS,/arxiv_data1/oa_pdf/89/c9/JPI-5-10.PMC4023036.pdf
"• Tel: (8231) 787-7617 • Fax: (8231) 787-4011 • E-mail: kimsmlms@daum.net This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/f5/kjr-15-305.PMC4023048.pdf
"However, digital mammography is  plagued by low sensitivity and high false-positive rates http://dx.doi.org/10.3348/kjr.2014.15.3.305 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/b3/f5/kjr-15-305.PMC4023048.pdf
http://www.cancer.org/.,Non-OADS,/arxiv_data1/oa_pdf/b3/f5/kjr-15-305.PMC4023048.pdf
"• Tel: (822) 2228-7400  • Fax: (822) 393-3035 • E-mail: artemis4u@yuhs.ac This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/97/kjr-15-313.PMC4023049.pdf
"Recently, five states of  the United States of America including Connecticut, Texas,  New York, California, and Virginia have passed a law that http://dx.doi.org/10.3348/kjr.2014.15.3.313 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/3b/97/kjr-15-313.PMC4023049.pdf
"It is important that radiologists in ECMO centers apply well-designed imaging protocols and familiarize themselves with post-contrast CT imaging findings in patients on ECMO.Index terms: Extracorporeal membrane oxygenation; CT; Cardiopulmonary bypass Received November 16, 2013; accepted after revision January 24, 2014.Corresponding author: Chin-Chen Chang, MD, Department of Medical Imaging, National Taiwan University Hospital, No.7, Chung-Shan South Road, Taipei 100, Taiwan, R.O.C.• Tel: (886) 2-23562570 • Fax: (886) 2-23224552• E-mail: macotocc@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/07/kjr-15-322.PMC4023050.pdf
"Korean J Radiol 2014;15(3):322-329 http://dx.doi.org/10.3348/kjr.2014.15.3.322 pISSN 1229-6929 · eISSN 2005-8330Pictorial Essay | Cardiovascular Imaging INTRODUCTION Extracorporeal membrane oxygenation (ECMO) is a  modified cardiopulmonary bypass to support life, permitting  further treatment and recovery during severe cardiac or pulmonary failure.",Non-OADS,/arxiv_data1/oa_pdf/1e/07/kjr-15-322.PMC4023050.pdf
"• Tel: (822) 950-1189  • Fax: (822) 950-1220 • E-mail: s2621@paik.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/1a/kjr-15-330.PMC4023051.pdf
Final  CT obtained two months later demonstrated spontaneous http://dx.doi.org/10.3348/kjr.2014.15.3.330 pISSN 1229-6929  · eISSN 2005-8330,OADS,/arxiv_data1/oa_pdf/e3/1a/kjr-15-330.PMC4023051.pdf
"• Tel: (822) 2072-2057 • Fax: (822) 743-6385• E-mail: shkim7071@gmail.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/90/kjr-15-334.PMC4023052.pdf
"Also, there was a tendency to achieve http://dx.doi.org/10.3348/kjr.2014.15.3.334 pISSN 1229-6929 ·  eISSN 2005-8330Original Article  | Gastrointestinal Imaging",Non-OADS,/arxiv_data1/oa_pdf/6e/90/kjr-15-334.PMC4023052.pdf
"Conclusion: Shear wave elastographic parameters are significantly different between prostate cancer and benign prostate tissue and correlate with Gleason score.Index terms: Prostate cancer; Shear wave elastography; Young modulus; Ultrasonography; Gleason score Received October 20, 2013; accepted after revision January 24, 2014.Corresponding author: Sang Youn Kim, MD, Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea.• Tel: (822) 2072-4897 • Fax: (822) 743-6385• E-mail: iwishluv@empas.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/3b/kjr-15-346.PMC4023053.pdf
Korean J Radiol 2014;15(3):346-355 http://dx.doi.org/10.3348/kjr.2014.15.3.346 pISSN 1229-6929 · eISSN 2005-8330Original Article  | Genitourinary Imaging INTRODUCTION Prostate cancer is the most common malignancy in men in the western world (1).,Non-OADS,/arxiv_data1/oa_pdf/04/3b/kjr-15-346.PMC4023053.pdf
"• Tel: (822) 3010-4380  • Fax: (822) 476-0090 • E-mail: jhshin@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/46/kjr-15-356.PMC4023054.pdf
Postoperative  hemorrhage after myomectomy is a potential complication http://dx.doi.org/10.3348/kjr.2014.15.3.356 pISSN 1229-6929  · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/db/46/kjr-15-356.PMC4023054.pdf
"• Tel: (39) 0382502836 • Fax: (39) 0382502014• E-mail: p.quaretti@smatteo.pv.itThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/82/kjr-15-364.PMC4023055.pdf
"CASE REPORT A 79-year-old female patient presented in 2004 with  edema of the arms, neck and face and initial difficulty in http://dx.doi.org/10.3348/kjr.2014.15.3.364 pISSN 1229-6929 ·  eISSN 2005-8330Case Report  | Intervention",Non-OADS,/arxiv_data1/oa_pdf/93/82/kjr-15-364.PMC4023055.pdf
"• Tel: (8253) 620-3045  • Fax: (8253) 653-5484 • E-mail: khcho@med.yu.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/b8/kjr-15-370.PMC4023056.pdf
"Also, there were http://dx.doi.org/10.3348/kjr.2014.15.3.370 pISSN 1229-6929  · eISSN 2005-8330",Non-OADS,/arxiv_data1/oa_pdf/01/b8/kjr-15-370.PMC4023056.pdf
"• Tel: (65) 66022689 • Fax: (65) 66023796• E-mail: syed.zama@gmail.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/59/kjr-15-376.PMC4023057.pdf
The http://dx.doi.org/10.3348/kjr.2014.15.3.376 pISSN 1229-6929 ·  eISSN 2005-8330Case Report | Nuclear Medicine,Non-OADS,/arxiv_data1/oa_pdf/fb/59/kjr-15-376.PMC4023057.pdf
"• Tel: (822) 2258-1455 • Fax: (822) 599-6771• E-mail: saim@catholic.ac.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/43/kjr-15-381.PMC4023058.pdf
"In addition to this mass in the left kidney, multiple http://dx.doi.org/10.3348/kjr.2014.15.3.381 pISSN 1229-6929 · eISSN 2005-8330Case Report | Pediatric Imaging",Non-OADS,/arxiv_data1/oa_pdf/c9/43/kjr-15-381.PMC4023058.pdf
"Conclusion: Our proposed CAC system demonstrated the potential for regional ventilation pattern analysis and enhanced interobserver agreement on visual classification of regional ventilation.Index terms: Computer-aided classification; Computed tomography; Chronic obstructive pulmonary disease; Regional  ventilation; Xenon CT Received November 13, 2013; accepted after revision January 24, 2014.Corresponding author: Jin Mo Goo, MD, PhD, Department of Radiology and Cancer Research Institute, Seoul National University College of Medicine, and Institute of Radiation Medicine, Seoul National University Medical Research Center, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea.• Tel: (822) 2072-2624 • Fax: (822) 743-7418 • E-mail: jmgoo@plaza.snu.ac.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/32/kjr-15-386.PMC4023059.pdf
"Korean J Radiol 2014;15(3):386-396 http://dx.doi.org/10.3348/kjr.2014.15.3.386 pISSN 1229-6929 · eISSN 2005-8330Original Article  | Thoracic Imaging INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a slowly progressing, irreversible airway disease caused by a mixture  of airway inflammation and parenchymal destruction (1).",Non-OADS,/arxiv_data1/oa_pdf/84/32/kjr-15-386.PMC4023059.pdf
"• Tel: (90) 232 4125901 • Fax: (90) 232 2599723• E-mail: cananaltay@yahoo.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/9d/kjr-15-397.PMC4023060.pdf
"There is an overlap of radiologic appearances of spindle cell lipomas with liposarcomas and other sarcomatous tumors, especially in cases with “fat-free” spindle cell lipomas.Korean J Radiol 2014;15(3):397-398http://dx.doi.org/10.3348/kjr.2014.15.3.397 pISSN 1229-6929 ·  eISSN 2005-8330 Fig.",Non-OADS,/arxiv_data1/oa_pdf/da/9d/kjr-15-397.PMC4023060.pdf
"• Tel: (39) 633775989 • Fax: (39) 633775322• E-mail: aresedo1992@yahoo.itThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/46/kjr-15-399.PMC4023061.pdf
J Comput Assist Tomogr 1996;20:300-304Korean J Radiol 2014;15(3):399-400http://dx.doi.org/10.3348/kjr.2014.15.3.399 pISSN 1229-6929 · eISSN 2005-8330,OADS,/arxiv_data1/oa_pdf/55/46/kjr-15-399.PMC4023061.pdf
"• Tel: (90) 3124844928 • Fax: (90) 3124844929• E-mail: dr.m.sait@hotmail.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/bd/kjr-15-401.PMC4023062.pdf
Am J Surg Pathol 1988;12:708-715Korean J Radiol 2014;15(3):401-401http://dx.doi.org/10.3348/kjr.2014.15.3.401 pISSN 1229-6929 · eISSN 2005-8330,Non-OADS,/arxiv_data1/oa_pdf/50/bd/kjr-15-401.PMC4023062.pdf
"Received:  March 26, 2013    Revised:  August 23, 2013 Accepted:  September 5, 2013    Available online:  October 16, 2013  Correspondence:  Jin Y oung Park, MD, PhD Department of Psychiatry and Section of Affect and Neuroscience, Institute  of Behavioral Science in Medicine, Y onsei University College of Medicine,  Gangnam Severance Hospital, 211 Eonju-ro, Gangnam-gu, Seoul 135-720,  Republic of Korea Tel: +82-2-2019-3342, Fax: +82-2-3462-4304, E-mail:  empathy@yuhs.ac  Correspondence:  Suk Kyoon An, MD, PhD Department of Psychiatry and Head of Section of Affect and Neuroscience,  Institute of Behavioral Science in Medicine, Y onsei University College of  Medicine, Severance Mental Health Hospital, 119 Gyeongchung-daero  1926beon-gil, Gwangju 464-100, Republic of Korea Tel: +82-31-760-9404, Fax: +82-31-761-7582, E-mail:  ansk@yonsei.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.105ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/87/38/pi-11-105.PMC4023082.pdf
"Received:  March 4, 2013    Revised:  July 26, 2013 Accepted:  September 7, 2013    Available online:  April 11, 2014  Correspondence:  Han-Y ong Jung, MD, PhD Department of Psychiatry, Soonchunhyang University Bucheon Hospital, 170  Jomaru-ro, Wonmi-gu, Bucheon 420-767, Republic of Korea Tel: +82-32-621-5232, Fax: +82-32-621-6950, E-mail:  hanyjung@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.112ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/be/72/pi-11-112.PMC4023083.pdf
"Received: March 8, 2013    Revised: April 24, 2013 Accepted:  May 7, 2013    Available online: April 11, 2014  Correspondence: Kyeong Mi Kim, PhD, OT  Department of Occupational Therapy, College of Biomedical Science and En- gineering, Inje University, 197 Inje-ro, Gimhae 621-749, Republic of Korea Tel: +82-55-320-3821, Fax: +82-55-326-4885 E-mail: kmik321@inje.ac.kr *Current Affilation: Department of Occupational Therapy, Kaya University, Gim - hae, Republic of Korea cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.119ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/e3/ed/pi-11-119.PMC4023084.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.124ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/ee/ab/pi-11-124.PMC4023085.pdf
"Received: March 31, 2013    Revised: May 22, 2013 Accepted:  May 28, 2013    Available online: April 11, 2014  Correspondence: Cheol-Soon Lee, MD, PhD Department of Psychiatry, School of Medicine, Gyeongsang National Univer - sity, 79 Gangnam-ro, Jinju 660-702, Republic of KoreaTel: +82-55-750-8872, Fax: +82-55-759-0003, E-mail: psy@gnu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2014.11.2.131",Non-OADS,/arxiv_data1/oa_pdf/83/24/pi-11-131.PMC4023086.pdf
"Received: March 28, 2013    Revised: July 23, 2013 Accepted:  September 12, 2013    Available online: April 11, 2014  Correspondence: Michela Di Trani, PhD  Department of Dynamic and Clinical Psychology, University of Rome “Sapi- enza” , Via dei Marsi 78, Rome 00185, Italy Tel: +39 06 49917989, Fax: +39 06 49917903 E-mail: micheladitrani@hotmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2014.11.2.137",Non-OADS,/arxiv_data1/oa_pdf/6f/c9/pi-11-137.PMC4023087.pdf
"Received: May 6, 2013    Revised: August 30, 2013 Accepted:  September 2, 2013    Available online: April 11, 2014  Correspondence: Doug Hyun Han, MD, PhD Department of Psychiatry, Chung-Ang University Hospital, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755, Republic of Korea Tel: +82-2-6299-3132, Fax: +82-2-6299-1114, E-mail: hduk@yahoo.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2014.11.2.143",Non-OADS,/arxiv_data1/oa_pdf/55/fe/pi-11-143.PMC4023088.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.152 152  Copyright © 2014 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Factors Associated with Caregiver Burden in Patients   with Alzheimer’s Disease  Hyo Shin Kang1*, Woojae Myung2*, Duk L. Na3, Seong Yoon Kim4, Jae-Hong Lee5,   Seol-Heui Han6, Seong Hye Choi7, SangYun Kim8, Seonwoo Kim9, and Doh Kwan Kim1,2 1Center for Clinical Research, Samsung Biomedical Research Institute, Seoul, Republic of Korea  2Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea  3Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea  4Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea  5Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea  6Department of Neurology, Konkuk University School of Medicine, Seoul, Republic of Korea  7Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea  8Department of Neurology, Seoul National University College of Medicine, Seoul, Republic of Korea  9Biostatistics Unit, Samsung Biomedical Research Institute, Seoul, Republic of Korea Objective aaCaregivers for patients with Alzheimer’s disease (AD) suffer from psychological and financial burdens.",Non-OADS,/arxiv_data1/oa_pdf/3e/97/pi-11-152.PMC4023089.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Alzheimer’s disease (AD) is a progressive and degenerative  disease of the brain that causes multiple cognitive areas to be -come seriously impaired and results in a decline in functional  abilities and behavioral changes.",Non-OADS,/arxiv_data1/oa_pdf/3e/97/pi-11-152.PMC4023089.pdf
"Received:  July 9, 2013    Revised:  September 13, 2013 Accepted:  September 14, 2013    Available online:  April 11, 2014  Correspondence:  Y oul-Ri Kim, MD, PhD Department of Neuropsychiatry, Seoul-Paik Hospital, Inje University, 9 Ma - reunnae-ro, Jung-gu, Seoul 100-032, Republic of Korea Tel: +82-2-2270-0063, Fax: +82-2-2270-0344, E-mail:  youlri.kim@paik.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.160ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/4f/99/pi-11-160.PMC4023090.pdf
The study was registered the Clinical Re - search Information Service (http://cris.nih.go.kr) (the registra - tion number: KCT0000716).,Non-OADS,/arxiv_data1/oa_pdf/4f/99/pi-11-160.PMC4023090.pdf
"In a previous study, we found high leptin levels in Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.167   Copyright © 2014 Korean Neuropsychiatric Association   167depressive women but not in men, and focused attention on sexual dimorphism.",Non-OADS,/arxiv_data1/oa_pdf/ea/f6/pi-11-167.PMC4023091.pdf
"Received: April 20, 2013    Revised: September 5, 2013 Accepted:  September 11, 2013    Available online: April 11, 2014  Correspondence: Saliha Ozsoy, MD Department of Psychiatry, Erciyes University School of Medicine, 38039 Kay- seri, Turkey Tel: +90-352-4372583, Fax: +90-352-4372583, E-mail: sozsoy@erciyes.edu.tr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/f6/pi-11-167.PMC4023091.pdf
"Received:  March 8, 2013    Revised:  August 26, 2013 Accepted:  September 2, 2013    Available online:  April 11, 2014  Correspondence:  Dai-Jin Kim, MD, PhD Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University  of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701,  Republic of Korea Tel: +82-2-2258-6086, Fax: +82-2-594-3870, E-mail:  kdj922@chollian.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.173ORIGINAL ARTICLE",Non-OADS,/arxiv_data1/oa_pdf/f6/3b/pi-11-173.PMC4023092.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.179   Copyright © 2014 Korean Neuropsychiatric Association   179ORIGINAL ARTICLE Association of the PP AR- γ Gene with Altered Glucose Levels   and Psychosis Profile in Schizophrenia Patients Exposed   to Antipsychotics Yun-Ru Liu1*, Tsung-Ming Hu2*, Tsuo-Hung Lan3,4,5, Hsien-Jane Chiu3,6,7, Yung-Han Chang8,   Shuo-Fei Chen9,10, Yen-Hsin Yu11, Cheng-Chung Chen12, and El-Wui Loh12  1Office of Research and Development, Taipei Medical University, Taipei, Taiwan   2Yuli Veterans Hospital, Yuli Township, Hualian County, Taiwan  3Faculty of Medicine, National Yang Ming University, Taipei, Taiwan  4Department of Psychiatry, Taichung Veterans General Hospital, Taichung, Taiwan  5Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli County, Taiwan  6Chung Hwa University of Medical Technology, Tainan, Taiwan  7Department of Psychiatry, Min-Sheng General Hospital, Taoyuan City, Taiwan  8Institute of Public Health and Department of Public Health, National Yang Ming University, Taipei, Taiwan  9Department of Health Care and Social Work, Yu Da University of Science and Technology, Chao-chiao Township, Miaoli County, Taiwan  10Institute of Food Science and Technology, National Taiwan University, Taipei, Taiwan  11Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan  12Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan Objective aaMetabolic abnormalities, e.g., diabetes, are common among schizophrenia patients.",Non-OADS,/arxiv_data1/oa_pdf/a4/68/pi-11-179.PMC4023093.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Metabolic abnormalities, e.g., DM, are common among schizophrenia patients.",Non-OADS,/arxiv_data1/oa_pdf/a4/68/pi-11-179.PMC4023093.pdf
"21 Information of single nucleotide polymorphisms (SNPs) of  the PPAR- γ gene in Han Chinese population (Beijing, China)  and Japanese population (Tokyo, Japan) were retrieved from the HapMap database (phase II, 7 Jan 2007, http://hapmap.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/a4/68/pi-11-179.PMC4023093.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.186 186  Copyright © 2014 Korean Neuropsychiatric Association   ORIGINAL ARTICLE A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with  Clinical Symptomatology in Patients with First-Episode Psychosis Javier Vázquez-Bourgon1,2 , Ignacio Mata2, Roberto Roiz-Santiáñez1,2, Rosa Ayesa-Arriola1,2,   Paula Suárez Pinilla1, Diana Tordesillas-Gutiérrez1,2, José Luis Vázquez-Barquero1,2, and   Benedicto Crespo-Facorro1,2 1Department of Psychiatry, University Hospital Marqués de Valdecilla-IFIMAV, School of Medicine, University of Cantabria, Santander, Spain  2Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain Objective aaDISC1 gene is one of the main candidate genes for schizophrenia since it has been associated to the illness in several popu- lations.",Non-OADS,/arxiv_data1/oa_pdf/8e/88/pi-11-186.PMC4023094.pdf
"Valdecilla s/n, 39008  Santander, SpainTel: +34-942-202537, Fax: +34-942-203447, E-mail: javazquez@humv.es cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Disrupted-in-Schizophrenia 1 (DISC1) and DISC2 genes  are located at the breakpoint of a chromosomal translocation  at 1q42.1 (1;11) (q42.1;q14.3), which was firstly described to be linked to major psychiatric disorders, including schizo-phrenia, in a Scottish family.",Non-OADS,/arxiv_data1/oa_pdf/8e/88/pi-11-186.PMC4023094.pdf
Available at: http://www.schizophrenia - forum.org/for/curr/AbiDargham/default.asp.,Non-OADS,/arxiv_data1/oa_pdf/8e/88/pi-11-186.PMC4023094.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.192 192  Copyright © 2014 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Genetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms  on Depressive Disorder Kyu Young Lee1,2, Seong Hoon Jeong1,3, Se Hyun Kim4, Yong Min Ahn4,5,6,7, Yong Sik Kim8,   Hee Yeon Jung5,9, Yang Weon Bang10, and Eun-Jeong Joo1,2  1Department of Neuropsychiatry, Eulji University School of Medicine, Daejeon, Republic of Korea  2Department of Psychiatry, Eulji General Hospital, Seoul, Republic of Korea  3Department of Psychiatry, Eulji University Hospital, Daejeon, Republic of Korea  4Institute of Human Behavioral Medicine, Medical Research Institute, Seoul National University, Seoul, Republic of Korea  5Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, Seoul, Republic of Korea  6Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea  7Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea  8Department of Neuropsychiatry, Dongguk University International Hospital, Dongguk University Medical School, Goyang, Republic of Korea  9Department of Psychiatry, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea  10Department of Psychiatry, Keyo Hospital, Uiwang, Republic of Korea Objective aaWe investigated possible association between depressive disorders and BDNF Val66Met and 5-HTTLPR.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/pi-11-192.PMC4023095.pdf
"Received: May 10, 2013    Revised: June 28, 2013 Accepted:  August 2, 2013    Available online: April 11, 2014  Correspondence: Eun-Jeong Joo, MD, PhD Department of Psychiatry, Eulji General Hospital, 68 Hangeulbiseok-ro, No- won-gu, Seoul 139-711, Republic of Korea Tel: +82-2-970-8611, Fax: +82-2-949-2356, E-mail: jej1303@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Depressive disorder is a complex disease phenotype.",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/pi-11-192.PMC4023095.pdf
The entire analysis was conducted using  UNPHASED 3.0.13 software (http://www.mrc-bsu.cam.ac.uk/personal/frank/software/unphased/).,OADS,/arxiv_data1/oa_pdf/bd/a5/pi-11-192.PMC4023095.pdf
"Considering the minor allele l as a risk allele for 5-HT - TLPR and Met allele for BDNF Val66Met and a significance level of p=0.05, our analysis had a power of 79.42% for 5-HTTLPR and 65.23% for BDNF Val66Met under a domi-nant model (genotypic relative risk of AA and Aa=1.5; disease prevalence=0.10) calculated using the Genetic power calcula - tor (http://pngu.mgh.harvard.edu/~purcell/gpc/cc2.html).",Non-OADS,/arxiv_data1/oa_pdf/bd/a5/pi-11-192.PMC4023095.pdf
"Received: April 4, 2013    Revised: May 20, 2013 Accepted:  May 20, 2013    Available online: April 11, 2014  Correspondence: Chi-Un Pae, MD, PhD Department of Psychiatry, Bucheon St. Mary’s Hospital, The Catholic Univer - sity of Korea College of Medicine, 327 Sosa-ro, Wonmi-gu, Bucheon 420-717, Republic of KoreaTel: +82-32-340-7067, Fax: +82-32-340-2255, E-mail: pae@catholic.ac.kr  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2014.11.2.200",Non-OADS,/arxiv_data1/oa_pdf/74/e9/pi-11-200.PMC4023096.pdf
"The two SNPs mentioned above were selected in accordance with the following criteria: 1) among SNPs available in our dataset, 12 2)  we chose 1 SNP for each gene, 3) that tagged the largest num - ber of SNPs within the same gene, so as to cover a portion of the gene as high as possible (data from http://hapmap.ncbi.nlm.nih.gov/).",Non-OADS,/arxiv_data1/oa_pdf/74/e9/pi-11-200.PMC4023096.pdf
He complained of severe left pleuritic pain and dys-Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.204 204  Copyright © 2014 Korean Neuropsychiatric Association   pnea with large amount of parapneumonic effusion.,Non-OADS,/arxiv_data1/oa_pdf/62/5d/pi-11-204.PMC4023097.pdf
"Received: April 5, 2013    Revised: June 28, 2013 Accepted:  July 7, 2013    Available online: April 11, 2014  Correspondence: Y oung-Min Park, MD, PhD  Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medi - cine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, Republic of KoreaTel: +82-31-910-7260, Fax: +82-31-910-7268 E-mail: medipark@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/5d/pi-11-204.PMC4023097.pdf
"Received:  April 13, 2013    Revised:  May 23, 2013 Accepted:  May 28, 2013    Available online:  April 11, 2014  Correspondence:  Daeho Kim, MD, PhD Department of Psychiatry, Hanyang University Guri Hospital, 153 Gyeongchun- ro, Guri 471-701, Republic of Korea Tel: +82-31-560-2274, Fax: +82-31-554-2599  E-mail:  dkim9289@hanyang.ac.kr *Current Affilation: Department of Psychiatry, CHA Bundang Medical Center, CHA  University School of Medicine, Seongnam, Republic of Korea cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2014.11.2.207CASE REPORT",Non-OADS,/arxiv_data1/oa_pdf/8f/5d/pi-11-207.PMC4023098.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2014.11.2.210",Non-OADS,/arxiv_data1/oa_pdf/2b/2a/pi-11-210.PMC4023099.pdf
"For example, recent -LETTER TO THE EDITOR Filicide: Needing Psychiatrists’ Attention Chi-Un Pae1,2  1Department of Psychiatry, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, Republic of Korea  2Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA Received: August 18, 2013    Revised: August 18, 2013 Accepted:  September 30, 2013    Available online: April 11, 2014  Correspondence: Chi-Un Pae, MD, PhD  Department of Psychiatry, Bucheon St. Mary’s Hospital, The Catholic Univer - sity of Korea College of Medicine, 327 Sosa-ro, Wonmi-gu, Bucheon 420-717, Republic of KoreaTel: +82-32-340-2140, Fax: +82-32-340-2255, E-mail: pae@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2014.11.2.214",Non-OADS,/arxiv_data1/oa_pdf/f4/b4/pi-11-214.PMC4023100.pdf
http://www.smh.com.au/articles/2008/11/11/1226318655533.html.,Non-OADS,/arxiv_data1/oa_pdf/f4/b4/pi-11-214.PMC4023100.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.How to cite this article: Pan, D., Wei, H., Jia, Z.L.",Non-OADS,/arxiv_data1/oa_pdf/68/65/srep04993.PMC4023128.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4993 | DOI: 10.1038/srep04993 7",Non-OADS,/arxiv_data1/oa_pdf/68/65/srep04993.PMC4023128.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/8e/srep05003.PMC4023129.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5003 | DOI: 10.1038/srep05003 10",Non-OADS,/arxiv_data1/oa_pdf/74/8e/srep05003.PMC4023129.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/20/srep04988.PMC4023130.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4988 | DOI: 10.1038/srep04988 7",Non-OADS,/arxiv_data1/oa_pdf/ce/20/srep04988.PMC4023130.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/83/srep04995.PMC4023131.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4995 | DOI: 10.1038/srep04995 7",Non-OADS,/arxiv_data1/oa_pdf/67/83/srep04995.PMC4023131.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4986 | DOI: 10.1038/srep04986 6",Non-OADS,/arxiv_data1/oa_pdf/0c/eb/srep04986.PMC4023132.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9e/c8/srep05004.PMC4023134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5004 | DOI: 10.1038/srep05004 11",Non-OADS,/arxiv_data1/oa_pdf/9e/c8/srep05004.PMC4023134.pdf
8437).Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/10/e1/srep05001.PMC4023135.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5001 | DOI: 10.1038/srep05001 11",Non-OADS,/arxiv_data1/oa_pdf/10/e1/srep05001.PMC4023135.pdf
"http://www.statcan.gc.ca, 2012 25 BALSAC: Rapport annuel 2011–2012.",Non-OADS,/arxiv_data1/oa_pdf/0e/cf/ejhg2013227a.PMC4023206.pdf
"http://balsac.uqac.ca, 2012Genome-wide patterns of IBD sharing H Gauvin et al 820 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/0e/cf/ejhg2013227a.PMC4023206.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Genome-wide patterns of IBD sharing H Gauvin et al 821 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/0e/cf/ejhg2013227a.PMC4023206.pdf
"For Permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.For commercial re-use, please contact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/e0/48/trs009.PMC4023275.pdf
2011. http://www.sphereproject.org [accessed 15 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/8d/cd/trt085.PMC4023276.pdf
London: Me ´decins Sans Frontie `res; 2012. http://www.msf.org.uk/sites/uk/ﬁles/older_people_in_ crisis_ﬁnal_oct_2012.pdf [accessed 22 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/8d/cd/trt085.PMC4023276.pdf
http://data.unhcr.org/SouthSudan/ settlement.php?id=149&country=251&region=25 [accessed 15 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/8d/cd/trt085.PMC4023276.pdf
10 May 2013. http://www.msf.org.,Non-OADS,/arxiv_data1/oa_pdf/8d/cd/trt085.PMC4023276.pdf
http://www.indepth-ishare.org/index.php/ home [accessed 20 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/8d/cd/trt085.PMC4023276.pdf
Available from: http://www.acponline.org/advocacy/ current_policy_papers/assets/racial_disparities.pdf [Last accessed on  2013 May 27].,Non-OADS,/arxiv_data1/oa_pdf/82/68/IJPhS-76-107.PMC4023279.pdf
Available from: http://aids.about.com/cs/doctors/a/ culture.htm [Last accessed on 2013 May 27].,Non-OADS,/arxiv_data1/oa_pdf/82/68/IJPhS-76-107.PMC4023279.pdf
Available from:  http://www.minoritynurse.com/article/nurses- vs-hivaids-dispariti es-creating-culturally-competent-interventions [Last accessed on  2013 May 27].,Non-OADS,/arxiv_data1/oa_pdf/82/68/IJPhS-76-107.PMC4023279.pdf
Clinical  Pharmacology 2006. available at http://www.fda.gov/OHRMS/ DOCKETS/98fr/06d-0344-gdl0001.pdf [Last accessed on 2014 Feb 27].,Non-OADS,/arxiv_data1/oa_pdf/a4/ab/IJPhS-76-138.PMC4023283.pdf
Av ailable from: http://www.drug.com/nebivolol:  Med line plus  druginformation.html.,Non-OADS,/arxiv_data1/oa_pdf/75/22/IJPhS-76-166.PMC4023287.pdf
Available at http://en.cnki.com.cn/Article_en/CJFDTOTAL- GDYY8Z1.017.htm [Last accessed on 2014 Jan 17].,OADS,/arxiv_data1/oa_pdf/2c/e3/IJPhS-76-97.PMC4023290.pdf
Available at http://en.cnki.com.cn/Article_en/CJFDTOTAL- ZGTL199906011.htm [Last accessed on 2014 Jan 17].,OADS,/arxiv_data1/oa_pdf/2c/e3/IJPhS-76-97.PMC4023290.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/dkt490.PMC4023300.pdf
"http://www.fda.gov/downloads/ Drugs/.../Guidances/ucm071185.pdf (8 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/dkt490.PMC4023300.pdf
"2012. http://www.vibativ.com/docs/VIBATIV_PI_Final.pdf (8 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/dkt490.PMC4023300.pdf
"http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM234907.pdf (8 July 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/2d/dkt490.PMC4023300.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/5e/trt005.PMC4023319.pdf
"However,  there are ongoing trials studying optimal  use of docetaxel, cabazitaxel and novel  combinations.30 In addition, we eagerly await  the upcoming presentation of data from  ECOG 3805 which has described in the  press release format that adding 6 cycles of  docetaxel chemotherapy to standard androgen  deprivation therapy (ADT) at the time of new  metastatic prostate cancer offers a significant  survival advantage (http://www.nih.gov/news/ health/dec2013/nci-05.htm).",Non-OADS,/arxiv_data1/oa_pdf/7c/81/AJA-16-331.PMC4023355.pdf
The World Health Organization  fracture risk assessment model FRAX  (http://www.shef.ac.uk/FRAX/)  is one such model.,Non-OADS,/arxiv_data1/oa_pdf/16/a7/AJA-16-341.PMC4023357.pdf
Available from: http://www.cancer.gov/cancertopics/ druginfo/fda‑docetaxel.,Non-OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
Available from: http://www.cancer.gov/cancertopics/ druginfo/fda‑sipuleucel‑T.,Non-OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
Available from: http://www.cancer.gov/ cancertopics/druginfo/fda‑abirateroneacetate.,Non-OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
Available from:  http://www.investors.medivation.com/releasedetail.cfm?ReleaseID=798880.,Non-OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
Available from: http://www.cancer.gov/cancertopics/ druginfo/fda‑enzalutamide.,Non-OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/appletter/2013/203971Orig1s000ltr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/67/AJA-16-348.PMC4023358.pdf
"It will be important to determine the frequency of GR upregulation,  as well as activating AR mutations in the ongoing analyses of CRPC  using exome sequencing and RNAseq through the efforts of the  AACR -PCR -SU2C dream teams (http://www.standup2cancer.org/ dream_teams/view/precision_therapy_for_advanced_prostate_cancer).",Non-OADS,/arxiv_data1/oa_pdf/9f/ac/AJA-16-354.PMC4023359.pdf
8 Available from: http://www.uspreventiveservicestaskforce.,Non-OADS,/arxiv_data1/oa_pdf/78/72/AJA-16-413.PMC4023367.pdf
9 Available from: http://www.fda.gov/drugs/drugsafety/ ucm258314.htm [Last accessed on 2013 Sep 21].,Non-OADS,/arxiv_data1/oa_pdf/78/72/AJA-16-413.PMC4023367.pdf
8 Available from: http://www.uspreventiveservicestaskforce.,Non-OADS,/arxiv_data1/oa_pdf/9f/de/AJA-16-414.PMC4023368.pdf
9 Available from: http://www.fda.gov/drugs/drugsafety/ ucm258314.htm [Last accessed on 2013 Sep 21].,Non-OADS,/arxiv_data1/oa_pdf/9f/de/AJA-16-414.PMC4023368.pdf
"New Engl J Med  2013;  368: 138–48.9 http://investors.medivation.com/releasedetail.cfm?ReleaseID=798880 (accessed  November 19, 2013) 10 Mezynski J, Pezaro C, Bianchini D, Zivi A, Sandhu S, et al.",OADS,/arxiv_data1/oa_pdf/01/d0/AJA-16-426.PMC4023372.pdf
Available from: http://www.cochrane‑handbook.org.,OADS,/arxiv_data1/oa_pdf/a0/c9/AJA-16-472.PMC4023381.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/89/TOORTHJ-8-74.PMC4023390.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/76/srep04987.PMC4023398.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4987 | DOI: 10.1038/srep04987 6",Non-OADS,/arxiv_data1/oa_pdf/84/76/srep04987.PMC4023398.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non- Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ )  which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/a4/TOORTHJ-8-78.PMC4023405.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non- Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ )  which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/93/TOORTHJ-8-69.PMC4023406.pdf
"For commercial re-use, please contact journals.permissions@oup.comThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),3",Non-OADS,/arxiv_data1/oa_pdf/e6/bf/mdt247.PMC4023407.pdf
Data The 30 data sets (14 maize trials and 16 wheat trials) and the R and Java scripts used in this work are deposited at http://repository.cim-myt.org/xmlui/handle/10883/2976.,OADS,/arxiv_data1/oa_pdf/54/43/hdy2013144a.PMC4023444.pdf
http://www.eclipsetutorial.sourceforge.net (accessed10 April 2013).,OADS,/arxiv_data1/oa_pdf/54/43/hdy2013144a.PMC4023444.pdf
http://cran.r-projec-t.org/web/packages/randomForest/index.html.,Non-OADS,/arxiv_data1/oa_pdf/54/43/hdy2013144a.PMC4023444.pdf
"R: a Language and Environment for Statistical Computing .R Foundation for Statistical Computing: Vienna, Austria, http://www.R-project.org/ Sarkar D (2008).",Non-OADS,/arxiv_data1/oa_pdf/54/43/hdy2013144a.PMC4023444.pdf
org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Prediction with classiﬁcation algorithms LO r n e l l a et al 626 Heredity,Non-OADS,/arxiv_data1/oa_pdf/54/43/hdy2013144a.PMC4023444.pdf
"DOI:  http://dx.doi.org/10.1006/bbrc.1994.1313 [2] Palmer, R.H., Ridden, J., Parker, P.J.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI:  http://dx.doi.org/10.1111/j.1432-1033.1995.tb20395.x [3] Taylor, S.S., Radzio-Andzelm, E. Three protein k i n a s e  s t r u c t u r e s  define a common motif.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1093/jb/ mvg019 [6] Kitagawa, M., Mukai, H., Shibata, H., Ono, Y. Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1006/ bbrc.1999.1116 [8] Lachmann, S., Jevons, A., De Rycker, M., Casamassima, A., Radtke, S., Collazos, A., Parker P.J.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI:  http://dx.doi.org/10.1006/bbrc.1994.2466 [10] Hashimoto, T., Mukai H., Kawamata, T., Taniguchi, T., Ono, Y., Tanaka, C. Localization of PKN mRNA in the rat brain.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/ 10.1016/S0169-328X(98)00155-7 [11] Quilliam, L.A., Lambert, Q.T., Mickelson-Young, L.A., Westwick, J.K., Sparks, A.B., Kay, B.K., Jenkins, N.A., Gilbert, D.J., Copeland, N.G., Der, C.J.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1074/jbc.271.46.28772 [12] Palmer, R.H., Dekker, L.V., Woscholski, R., Le Good, J.A., Gigg, R., Parker, P.J.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1074/jbc.270.38.22412 [13] Gudi, T., Chen, J.C., Casteel, D.E., Seasholtz, T.M., Boss, G.R., Pilz, R.B.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/j.yexcr.2007.04.010 [16] Thauerer, B., zur Nedden, S., Baier-Bitterlich, G. Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1111/j.1471-4159.2010.06624.x [17] Volonte, C., Greene, L.A. Nerve growth factor-activated protein kinase N. Characterization and rapid near homogeneity purification by nucleotide affinity-exchange chromatography.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/j.febslet.2008.05.034 [19] Xiao, S., McLean, J., Robertson, J. Neuronal intermediate filaments and ALS: a new look at an old question.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/ j.bbadis.2006.09.003 [20] Kawamata, T., Taniguchi, T., Mukai, H., Kitagawa M., Hashimoto, T., Maeda, K., Ono, Y., Tanaka, C. A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1074/ jbc.M007427200 [22] Tomaselli, B., Podhraski, V., Böck, G., Baier-Bitterlich, G. Early cellular responses of purine nucleoside-mediated protection of hypoxia-induced injuries of neuronal PC12 cells.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.3844/ ajbbsp.2005.160.166 [23] Thauerer, B., zur Nedden, S., Baier-Bitterlich, G. Vital role of protein kinase C-related kinase in the formation and s t a b i l i t y  o f  neurites during hypoxia.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1111/j.1471-4159.2010.06624.x [24] Yoshinaga, C., Mukai, H., Toshimori, M., Miyamoto, M., Ono, Y. Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI:  http://dx.doi.org/10.1042/BJ20110521 [27] Maesaki, R., Ihara, K., Shimizu, T., Kuroda, S., Kaibuchi, K., Hakoshima, T. The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI:  http://dx.doi.org/10.1016/S1097-2765(00)80389-5 [28] Amano, M., Chihara, K., Nakamura, N., Kaneko, T., Matsuura, Y., Kaibuchi, K. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science, 1996, 271(5249), 648-50.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI:  http://dx.doi.org/10.1126/science.271.5249.648 [29] Watanabe, G., Saito, Y., Madaule, P., Ishizaki, T., Fujisawa, K., Morii, N., Mukai, H., Ono, Y., Kakizuka, A., Narumiya, S. Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1074/jbc.273.5.2698 [31] Vincent, S., Settleman, J.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1101/ gad.13.9.1168 [33] Modha, R., Campbell L.J., Nietlispach, D., Buhecha, H.R., Owen, D., Mott, H.R.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI:  http://dx.doi.org/10.1074/jbc.M706760200 [34] Unsal-Kacmaz, K., Ragunathan, S., Rosfjord, E., Dann, S., Upeslacis, E., Grillo, M., Hernandez, R., Mack, F., Klippel, A.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/ j.molonc.2011.12.001 [35] Blumenstein, L., Ahmadian, M.R.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1074/jbc.M409551200 [36] Owen, D., Lowe, P.N., Nietlispach, D., Brosnan, C.E., Chirgadze, D.Y., Parker, P.J., Blundell, T.L., Mott, H.R.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1074/ jbc.275.15.11064 [38] Wallace, S.W., Magalhaes A., Hall A.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/ 10.1128/MCB.01001-10 [39] Gabrielli, B., Wettenhall, R.E., Kemp, B.E., Quinn, M., Bizonova, L. Phosphorylation of ribosomal protein S6 and a peptide analogue of S6 by a protease-activated kinase isolated from rat liver.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/0014-5793(84)80740-1 [40] Shiga, K., Takayama K., Futaki S., Hutti J.E., Cantley L.C., Ueki, K., Ono, Y., Mukai, H. Development of an intracellularly acting inhibitory peptide selective f o r  P K N .",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1042/BJ20090380 [41] Shibata, H., Oishi K., Yamagiwa, A., Matsumoto, M., Mukai, H., Ono, Y.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.org/10.1016/0014-5793(96)00385-7,OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1006/bbrc.1996.0515 [43] Morrice, N.A., Fecondo, J., Wettenhall, R.E.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/j.cellsig.2004.12.003 [48] Yu, W., Liu, J., Morrice, N.A., Wettenhall, R.E.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1093/emboj/cdg023 [50] Metzger, E., Yin, N., Wissmann, M., Kunowska, N., Fischer, K., Friedrichs, N., Patnaik, D., Higgins, J.M., Potier, N., Scheidtmann, K.H., Buettner, R., Schule R. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.org/10.1111/j.1471-4159.2007.,Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1038/sj.emboj.7600345 [53] Gotoh, Y., Oishi, K., Shibata, H., Yamagiwa, A., Isagawa, T., Nishimura, T., Goyama E., Takahashi, M., Mukai, H., Ono, Y.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1096/fj.04-1876fje [56] Amano, M., Mukai, H., Ono Y., Chihara, K., Matsui, T., Hamajima, Y., Okawa, K., Iwamatsu, A., Kaibuchi, K. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science, 1996, 271, 648-50.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1126/science.271.5249.648 [57] Davies, S.P., Reddy, H., Caivano, M., Cohen, P. Specificity  and mechanism of action of some commonly used protein  kinase inhibitors.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1042/0264-6021:3510095 [58] Schmidt, A., Durgan, J., Magalhaes, A., Hall, A. Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1161/CIRCRESAHA.110.217554 [62] Kajimoto, K., Shao, D., Takagi, H., Maceri, G., Zablocki, D., Mukai, H., Ono, Y., Sadoshima, J. Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1152/ajpheart.00232.2010 [63] Marinissen, M.J., Chiariello, M., Gutkind, J.S.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1083/ jcb.200105140 [65] Aleku, M., Schulz P., Keil O., Santel A., Schaeper U., Dieckhoff B., Janke O., Endruschat J., Durieux B., Roder N., Loffler K., Lange C., Fechtner M., Mopert K., Fisch G., Dames S., Arnold W., Jochims K., Giese K., Wiedenmann B., Scholz A., Kaufmann J. Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1038/375061a0 [69] Zhang, B., Tu, P., Abtahian, F., Trojanowski, J.Q., Lee, V.M.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1111/ j.1471-4159.2012.07692.x [71] zur Nedden, S., Tomaselli B., Baier-Bitterlich G. HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons.",Non-OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/j.mcn.2008.05.004 [76] Tomaselli, B., Podhraski, V., Heftberger, V., Böck, G., Baier-Bitterlich, G. Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 MAPK activation.",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
"DOI: http://dx.doi.org/10.1016/j.mcn.2008.05.004 [80] Mukai, H., Toshimori, M., Shibata, H., T a k a n a g a ,  H .",OADS,/arxiv_data1/oa_pdf/62/f9/CN-12-213.PMC4023452.pdf
Available in: http://biblioteca.ibge.gov.br/visualizacao/periodicos/93/cd_2010_ caracteristicas_populacao_domicilios.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/56/CN-12-239.PMC4023454.pdf
Available in: http://www.alzheimermed.,Non-OADS,/arxiv_data1/oa_pdf/13/56/CN-12-239.PMC4023454.pdf
Available in: http://www.alz.org/ downloads/Facts_Figures_2012.pdf.,OADS,/arxiv_data1/oa_pdf/13/56/CN-12-239.PMC4023454.pdf
Available in: https://apps.who.int/inf-fs/en/fact135.,OADS,/arxiv_data1/oa_pdf/13/56/CN-12-239.PMC4023454.pdf
Available in: http://www.ibge.gov.br/home/estatistica/populacao/ censo2000/populacao/censo2000_populacao.pdf.,Non-OADS,/arxiv_data1/oa_pdf/13/56/CN-12-239.PMC4023454.pdf
"Neuropharmacol., 2011, 9(3), 409-416. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neurology, 2008, 71, 129-135. http://dx.doi.org/10.1212/01.wnl.0000316802.35974.34 [3] Limmroth, V. Multiple sclerosis: oral BG12 for treatment of relapsing-remitting MS. Nat.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neurol., 2012, 25, Suppl, 1 1-19. http://dx.doi.org/10.1097/01.wco.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Ther., 2011, 5, 255-274. http://dx.doi.org/10.2147/DDDT.S10498 [8] Oh, J.; O'Connor, P.W.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"CNS Drugs, 2013, 27(8), 591-609. http://dx.doi.org/10.1007/s40263-013-0080-z [9] Stangel, M.; Linker, R.A. Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Pharmacol., 2013, 6(4), 355-362. http://dx.doi.org/10.1586/17512433.2013.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neuropharmacol., 2009, 7(1), 60-64. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neurol., 2005, 58(6), 840-846. http://dx.doi.org/10.1002/ana.20703 [12] Jadad, A.R.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Trials, 1996, 17(1), 1-12. http://dx.doi.org/10.1016/0197-2456(95) 00134-4 [13] Higgins, J.P.T.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://dx.doi.org/10.1002/jrsm.38 [14] Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"PLoS Med., 2009, 151, 264-649. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Med., 2012, 367, 1098-1107. http://dx.doi.org/10.1056/NEJMoa1114287 [16] Bar-Or, A.; Gold, R.; Kappos, L.; Arnold D.L.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"J Neurol., 2013, 260(9), 2297-2305. http://dx.doi.org/10.1007/ s00415-013-6954-7 [17] Kappos, L.; Gold, R.; Arnold, D.L.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://dx.doi.org/10.1177/1352458513507817 [18] Kappos L.; Gold, R.; Arnold D.L.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://dx.doi.org/10.1016/ j.jval.2012.08.1987 [19] Bar-Or, A.; Gold, R.; Kappos, L., Arnold, D.; Giovannoni, G.; Selmaj, K.; O'Gorman, J; Stephan, M.; Dawson, K. Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: Findings from the DEFINE study.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Med., 2012, 367, 1087-1097. http://dx.doi.org/10.1056/NEJMoa1206328 [21] Hutchinson, M.; Fox, R.J.; Miller, D.H.; Phillips J.T.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neurol., 2013, 260(9), 2286-2296. http://dx.doi.org/10.1007/s00415-013-6968-1 [22] Kita, M.; Fox, R.J.; Phillips, J.T.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://dx.doi.org/10.1177/1352458513507818 [23] Kita, M.; Fox, R.J.; Phillips, J.T.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://dx.doi.org/10.1016/j.jval.2012.08.1982 [24] Havrdova, E.; Miller, D.; Fox, R.J.; Phillips, J.T.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
http://dx.doi.org/10.1016/j.jval.,OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://dx.doi.org/10.1016/j.jval.2012.08.1927	  [31] Havrdova, E.; Phillips, J.T.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"1, 368-369. http://dx.doi.org/10.1016/j.jns.2013.07.1347 [32] Havrdova, E.; Hutchinson, M.; Kurukulasuriya, N.C.; Raghupathi, K.; Sweetser, M.T.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Pharmacother., 2013, 14(15), 2145-56. http://dx.doi.org/10.1517/14656566.2013.826190 [33] Hutchinson, M.; Fox, R.J.; Havrdova, E.; Kurukulasuriya, N.C.; Sarda, S.P.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"http://www.neurology.org/cgi/content/meeting_ abstract/80/1_MeetingAbstracts/P07.127 [34] Gold, R. Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"CNS Drugs, 2011, 25, 37-52. http://dx.doi.org/10.2165/11539820-000000000-00000 [35] Castro-Borrero, W.; Graves, D.; Frohman, T.C.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Disord., 2012, 5(4), 205-220. http://dx.doi.org/10.1177/1756285612450936 [36] Polman, C.H.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neurology, 2008, 70, 1134-1140. http://dx.doi.org/ 10.1212/01.wnl.0000306410.84794.4d [37] Schimrigk, S.; Brune, N,; Hellwig, K.; Lukas, C.; Bellenberg, B.; Rieks, M.; Hoffmann, V.; Pöhlau, D.; Przuntek, H. O r a l  f u m a r i c  acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Neurol., 2006, 13(6), 604-610. http://dx.doi.org/10.1111/j.1468-1331.2006.01292.x [38] Kappos, L.; Gold, R.; Miller, D.H.; Havrdova, E.; Limmroth, V.; Polman, C.H.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Lancet, 2008, 372, 1463-1472. http://dx.doi.org/10.1016/S0140-6736(08)61619-0 [39] Kappos, L.; Gold, R.; Miller, D.H.; MacManus, D.G.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"Scler., 2012, 18 (3), 314-321. http://dx.doi.org/10.1177/1352458511421054 [40] MacManus, D.G.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"J Neurol., 2011, 258(3), 449-456. http://dx.doi.org/10.1007/s00415-010-5777-z [41] Selmaj, K.; Phillips, J.T.",Non-OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
"1, 367-368. http://dx.doi.org/10.1016/j.jns.2013.07.1344 [42] Song, F.; Altman, D.G.",OADS,/arxiv_data1/oa_pdf/09/cb/CN-12-256.PMC4023455.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.neubiorev.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.sleep.2009.09.011 [4] Sehgal, A.; Mignot, E. Genetics of sleep and sleep disorders.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/ j.neuropharm.2008.07.045 [8] Neubauer, D.N.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.tins.2004.07.002 [11] Murthy, R.; Kim, J.; Sun, X.; Giger, R.J.; Fink, D.J.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1186/1756-6606-6-30 [12] Ulrich, D.; Bettler, B. GABAB r e c e p t o r s :  s y n a p t i c  f u n c t i o n s  a n d  mechanisms of diversity.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.conb.2007.04.001 [13] Gottesmann, C. GABA mechanisms and sleep.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/ S0306-4522(02)00034-9 [14] Arnaud, C.; Gauthier, P.; Gottesmann, C. Study of a GABAC receptor antagonist on sleep-waking behavior in rats.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1007/s002130000653 [15] Bateson, A.N.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.sleep.2006.03.001 [16] Bateson, A.N.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/S1389-9457(04)90002-0 [17] Feren, S.; Schweitzer, P.K.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/B978-0-444-52007-4.00005-9 [18] Rudolph, U.; Knoflach, F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1038/ nrd3502 [19] Zisapel, N. Drugs for insomnia.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1517/14728214.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1345/aph.1K676 [21] Wheatley, D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1177/ 0269881105053309 [22] Heinrich, M.; Barnes, J.; Gibbons, S.; Williamson, E.M.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1007/s00213-005-2196-4 [24] Clouatre, D.L.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/ 10.1016/j.toxlet.2003.07.005 [25] Ma, Y.; Han, H.; Eun, J.S.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1248/bpb.30.1748 [26] Trauner, G.; Khom, S.; Baburin, I.; Benedek, B.; Hering, S.; Kopp, B. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1055/s-2007-993761 [27] Can, Ö.D.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1055/s-2007-993761 [28] Zhao, G.Z.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2011.03.023 [31] De Carvalho, R.S.M.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/ j.bbr.2011.02.038 [32] Singhuber, J.; Baburin, I.; Kählig, H.; Urban, E.; Kopp, B.; Hering, S. GABAA r e c e p t o r  m o d u l a t o r s  f r o m  C h i n e s e  h e r b a l  m e d i c i n e s  traditionally applied against insomnia and anxiety.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/ j.phymed.2011.10.009 [33] León-Rivera, I.; Herrera-Ruiz, M.; Estrada-Soto, S.; Gutiérrez, M.d.C.; Martínez-Duncker, I.; Navarrete-Vázquez, G.; Rios, M.Y.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2011.03.041 [34] Lozada-Lechuga, J.; Villarreal, M.L.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2009.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2009.01.012 [37] Sotoing Taïwe, G.; Ngo Bum, E.; Talla, E.; Dawe, A.; Okomolo Moto, F.C.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.jep.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"http://dx.doi.org/10.1155/2011/109164 [39] Zapata-Sudo, G.; Mendes, T.C.F.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2010.03.013 [40] Ma, Y.; Ma, H.; Jo, Y.J.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.4062/biomolther.2008.16.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.neuropharm.2012.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.bmc.2012.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/ j.foodchem.2011.08.,Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1007/s11064-010-0312-2 [45] Arceusz, A.; Wesolowski, M. Quality consistency evaluation of Melissa officinalis L. commercial herbs by HPLC fingerprint and quantitation of selected phenolic acids.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.jpba.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"http://dx.doi.org/ 10.1155/2013/909507 [47] Schnitzler, P.; Schuhmacher, A.; Astani, A.; Reichling, J. Melissa officinalis oil affects infectivity of enveloped herpesviruses.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1097/00004583-200206000-00001 [49] Stickel, F.; Baumuller, H.M.; Seitz, K.; Vasilakis, D.; Seitz, G.; Seitz, H.K.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/S0168-8278(03)00175-2 [50] Escher, M.; Desmeules, J.; Giostra, E.; Mentha, G. Hepatitis associated with Kava, a herbal remedy for anxiety.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1111/apt.12109 [52] Rowe, A.; Zhang, L.Y.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"http://dx.doi.org/10.1155/ 2011/326724 [53] Sarris, J.; Stough, C.; Bousman, C.A.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1097/JCP.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.pbb.2008.11.012,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1007/s11373-007-9197-8 [60] Saito, K.; Umeda, S.; Kawashima, K.; Kano, Y. Pharmacological properties of traditional medicines.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1248/bpb.23.76 [61] Patočka, J.; Jakl, J. Biomedically relevant chemical constituents of Valeriana officinalis.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.2478/v10136-009-0002-z [62] Sichardt, K.; Vissiennon, Z.; Koetter, U.; Brattström, A.; Nieber, K. Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A1-and GABAA-receptors.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1002/ptr.2197 [63] Ziegler, G.; Ploch, M.; Miettinen-Baumann, A.; Collet, W. Efficacy and tolerability of Valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/ 10.1016/j.amjmed.2006.02.026 [66] Fernández-San-Martín, M.I.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.sleep.2009.12.009 [67] Müller, W.; Rolli, M.; Schäfer, C.; Hafner, U.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1055/s-2000-7972 [71] Sparreboom, A.; Cox, M.C.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1200/JCO.2004.08.182 [72] Kim, Y.S.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/ 10.1016/j.fm.2004.05.002 [73] Li, H.Y.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1142/S0192415X96000050 [75] Hui, K.M.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/S0006-2952(02)01347-3 [76] Chen, L.C.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1111/j.1365-2710.2009.01038.x [77] Lee, J.C.; Lee, K.Y.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.phymed.2006.09.012 [78] Li, W.; Wen, H.M.; Cui, X.B.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"Drugs, 2007, 10, 8-11. http://dx.doi.org/10.3321/ j.issn:0253-2670.2007.10.008 [79] León-Rivera, I.; Mirón-López, G.; Molina-Salinas, G.M.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/ 10.1021/np800266a [80] Balderas, J.L.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.jep.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2012.02.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1186/1472-6882-11-43 [83] Zhang, Q.H.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.org/10.4236/BR.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.3390/ molecules18044247 [85] Kalman, D.S.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1186/1475-2891-7-11 [86] Qu, W.M.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1111/j.1476-5381.2012.02010.x [87] Fenwick, G.; Lutomski, J.; Nieman, C. Liquorice, Glycyrrhiza glabra L.—Composition, uses and analysis.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/0308-8146(90) 90159-2 [88] Kong, C.S.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.fct.2009.04.013 [89] Cho, S.; Han, D.; Kim, S.B.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/ 10.1271/bbb.110702 [90] Yi, P.L.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"Sci., 2007, 14, 285-297. http://dx.doi.org/10.1007/s11373-006-9137-z [91] Sarris, J.; Panossian, A.; Schweitzer, I.; Stough, C.; Scholey, A. Herbal medicine for depression, anxiety and insomnia: a review  of psychopharmacology and clinical evidence.",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
CrossRef DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1016/j.jep.2008.01.011 [93] Maruyama, Y.; Kuribara, H. Overview of the pharmacological features of honokiol.",OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
"CrossRef DOI: http://dx.doi.org/10.1186/1472-6882-13-18   Received: March 03, 2013 Revised: November 02, 2013 Accepted: December 24, 2013",Non-OADS,/arxiv_data1/oa_pdf/c9/ca/CN-12-289.PMC4023459.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdEDITORIAL Sasaki http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/cb/36/jdi-5-119.PMC4023571.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Schwitzgebel http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 123REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Monogenic diabetes variants,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Schwitzgebel http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 125REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Monogenic diabetes variants,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Schwitzgebel http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 127REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Monogenic diabetes variants,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Schwitzgebel http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Available at: http://eutils.ncbi.nlm.nih.go v/entrez/eutils/elink.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 129REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Monogenic diabetes variants,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Schwitzgebel http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
http://eutils.ncbi.nlm.nih.gov /entrez/eutils/elink.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Available at: http://www.plosmedicine.org/article/fetch SingleRepresentation.action?,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 131REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Monogenic diabetes variants,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
Journal of Diabetes Investigation published by AASD and Wiley Publishing Asia Pty LtdREVIEW ARTICLE Schwitzgebel http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 133REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Monogenic diabetes variants,Non-OADS,/arxiv_data1/oa_pdf/57/7e/jdi-5-121.PMC4023572.pdf
2 March 2014 135REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Blood glucose control in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
2 March 2014 137REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Blood glucose control in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
2 March 2014 139REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Blood glucose control in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
2 March 2014 141REVIEW ARTICLE http://onlinelibrary.wiley.com/journal/jdi Blood glucose control in diabetes,Non-OADS,/arxiv_data1/oa_pdf/a3/5d/jdi-5-134.PMC4023573.pdf
2 March 2014 143COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Yamane and Inagaki,Non-OADS,/arxiv_data1/oa_pdf/59/b1/jdi-5-142.PMC4023574.pdf
2 March 2014 145COMMENTARY http://onlinelibrary.wiley.com/journal/jdi Insulin on the mitochondrial function,Non-OADS,/arxiv_data1/oa_pdf/ee/51/jdi-5-144.PMC4023575.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Lee http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ee/51/jdi-5-144.PMC4023575.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY Koya http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/ca/06/jdi-5-147.PMC4023576.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY HbA 1cvariability and diabetic retinopathy http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/80/23/jdi-5-149.PMC4023577.pdf
2 March 2014 151COMMENTARY http://onlinelibrary.wiley.com/journal/jdi HbA 1cvariability and diabetic retinopathy,Non-OADS,/arxiv_data1/oa_pdf/80/23/jdi-5-149.PMC4023577.pdf
Journal of Diabete s Investigation published by AASD and Wiley Publishing Asia Pty LtdCOMMENTARY HbA 1cvariability and diabetic retinopathy http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/80/23/jdi-5-149.PMC4023577.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
2 March 2014 155ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Probiotics and autonomic nerves,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
2 March 2014 157ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Probiotics and autonomic nerves,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
2 March 2014 159ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Probiotics and autonomic nerves,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
2 March 2014 161ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Probiotics and autonomic nerves,Non-OADS,/arxiv_data1/oa_pdf/00/22/jdi-5-153.PMC4023578.pdf
2 March 2014 163ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Prevalence of diabetes and prediabetes,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
2 March 2014 165ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Prevalence of diabetes and prediabetes,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
2 March 2014 167ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Prevalence of diabetes and prediabetes,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
2 March 2014 169ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Prevalence of diabetes and prediabetes,Non-OADS,/arxiv_data1/oa_pdf/b8/45/jdi-5-162.PMC4023579.pdf
2 March 2014 171ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Type 2 diabetes and NAFLD,Non-OADS,/arxiv_data1/oa_pdf/28/79/jdi-5-170.PMC4023580.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/28/79/jdi-5-170.PMC4023580.pdf
2 March 2014 173ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Type 2 diabetes and NAFLD,Non-OADS,/arxiv_data1/oa_pdf/28/79/jdi-5-170.PMC4023580.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/28/79/jdi-5-170.PMC4023580.pdf
2 March 2014 175ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Type 2 diabetes and NAFLD,Non-OADS,/arxiv_data1/oa_pdf/28/79/jdi-5-170.PMC4023580.pdf
2 March 2014 177ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Dietary intake in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
2 March 2014 179ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Dietary intake in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
2 March 2014 181ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Dietary intake in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
2 March 2014 183ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Dietary intake in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
2 March 2014 185ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Dietary intake in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
http://www0.nih.go.jp/eiken/english/research/pdf/nhns2006_outline.pdf Accessed June 5.,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
"Available from http://www.mhlw.go.jp/bunya/kenkou /eiyou09/, Accessed January 20, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
2 March 2014 187ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi Dietary intake in Japanese T2DM patients,Non-OADS,/arxiv_data1/oa_pdf/3c/a0/jdi-5-176.PMC4023581.pdf
2 March 2014 189ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi PPARG polymorphism in T2DM,Non-OADS,/arxiv_data1/oa_pdf/e1/11/jdi-5-188.PMC4023582.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/e1/11/jdi-5-188.PMC4023582.pdf
2 March 2014 191ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi PPARG polymorphism in T2DM,Non-OADS,/arxiv_data1/oa_pdf/e1/11/jdi-5-188.PMC4023582.pdf
2 March 2014 193ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi ADIPOQ variants and cardiometabolic risk,Non-OADS,/arxiv_data1/oa_pdf/9b/76/jdi-5-192.PMC4023583.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/76/jdi-5-192.PMC4023583.pdf
2 March 2014 195ORIGINAL ARTICLE http://onlinelibrary.wiley.com/journal/jdi ADIPOQ variants and cardiometabolic risk,Non-OADS,/arxiv_data1/oa_pdf/9b/76/jdi-5-192.PMC4023583.pdf
http://onlinelibrary.wiley.com/journal/jdi,Non-OADS,/arxiv_data1/oa_pdf/9b/76/jdi-5-192.PMC4023583.pdf
